<html lang="en" class="pb-page fonts-loaded fonts-loaded" data-request-id="02d9fde3-1838-4a4b-b4ec-acf03f0aa32f" style="--article-sticky-top: 82.00019999999999px; --scroll-padding: 163.594px auto auto;"><head data-pb-dropzone="head"><meta name="pbContext" content=";product:product:elsevier\:product\:cell;website:website:cell-site;issue:issue:pii\:S0092867420X00237;ctype:string:Journal Content;article:article:pii\:S009286742101165X;journal:journal:cell;pageGroup:string:Article View;page:string:Show Full Text;requestedJournal:journal:cell;wgroup:string:Default Website Group;subPage:string:Full Text">




<!-- if there is any customization for Responsive Project widget  -->


























    
    







    
            
        



        
                <meta name="robots" content="noarchive,nocache">
            
    






    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=1, user-scalable=1">











        <meta property="og:title" content="Pan-ebolavirus protective therapy by two multifunctional human antibodies">
    


        <meta property="og:type" content="Article">
    


        <meta property="og:url" content="https://www.cell.com/cell/abstract/S0092-8674(21)01165-X">
    



        <meta property="og:site_name" content="Cell">
    


        <meta property="og:image" content="https://www.cell.com/cms/asset/2dcd8134-0acb-420e-874e-5b8c9ef10c4a/fx1.jpg">
    


        <meta property="og:description" content="A broad-spectrum therapeutic antibody treatment against medically important ebolaviruses
is not available but highly desirable. Gilchuk et&nbsp;al. report a therapeutic cocktail
comprising two broadly neutralizing human antibodies that exhibit synergistic neutralizing
activity, complementary Fc region-mediated effector functions, resistance to viral
escape, and protection of non-human primates from disease caused by Ebola, Bundibugyo,
or Sudan ebolaviruses with high effectiveness and also define the structural basis
for neutralization breadth and potency by this cocktail.">
    











        <meta name="twitter:title" content="Pan-ebolavirus protective therapy by two multifunctional human antibodies">
    




        <meta name="twitter:image" content="https://www.cell.com/cms/asset/2dcd8134-0acb-420e-874e-5b8c9ef10c4a/fx1.jpg">
    


        <meta name="twitter:description" content="A broad-spectrum therapeutic antibody treatment against medically important ebolaviruses
is not available but highly desirable. Gilchuk et&nbsp;al. report a therapeutic cocktail
comprising two broadly neutralizing human antibodies that exhibit synergistic neutralizing
activity, complementary Fc region-mediated effector functions, resistance to viral
escape, and protection of non-human primates from disease caused by Ebola, Bundibugyo,
or Sudan ebolaviruses with high effectiveness and also define the structural basis
for neutralization breadth and potency by this cocktail.">
    

        <meta name="twitter:card" content="summary_large_image">
    











    
    
            
            
        <link rel="canonical" href="https://www.cell.com/cell/fulltext/S0092-8674(21)01165-X">
    


<meta name="tdm-reservation" content="1">
<meta name="tdm-policy" content="https://www.elsevier.com/tdm/tdmrep-policy.json">

<title>Pan-ebolavirus protective therapy by two multifunctional human antibodies: Cell</title><meta name="citation_journal_title" content="Cell"> <meta name="citation_journal_abbrev" content="Cell"> <meta name="citation_publisher" content="Elsevier"> <meta name="citation_title" content="Pan-ebolavirus protective therapy by two multifunctional human antibodies"> <meta name="citation_date" content="2021/10/28"> <meta name="citation_volume" content="184"> <meta name="citation_issue" content="22"> <meta name="citation_firstpage" content="5593"> <meta name="citation_lastpage" content="5607.e18"> <meta name="citation_pmid" content="34715022"> <meta name="citation_abstract_html_url" content="https://www.cell.com/action/showAbstract?pii=S009286742101165X"> <meta name="citation_fulltext_html_url" content="https://www.cell.com/action/showFullText?pii=S009286742101165X"> <meta name="citation_pdf_url" content="https://www.cell.com/action/showPdf?pii=S009286742101165X"> <meta name="citation_issn" content="0092-8674"> <meta name="citation_issn" content="1097-4172"> <meta name="citation_language" content="English"> <meta name="citation_doi" content="10.1016/j.cell.2021.09.035"> <meta name="citation_pmid" content="34715022"> <meta name="citation_author" content="Pavlo Gilchuk"><meta name="citation_author_institution" content="Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA"><meta name="citation_author" content="Charles D. Murin"><meta name="citation_author_institution" content="Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA"><meta name="citation_author" content="Robert W. Cross"><meta name="citation_author_institution" content="Galveston National Laboratory, Galveston, TX 77550, USA"><meta name="citation_author_institution" content="Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA"><meta name="citation_author" content="Philipp A. Ilinykh"><meta name="citation_author_institution" content="Galveston National Laboratory, Galveston, TX 77550, USA"><meta name="citation_author_institution" content="Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA"><meta name="citation_author" content="Kai Huang"><meta name="citation_author_institution" content="Galveston National Laboratory, Galveston, TX 77550, USA"><meta name="citation_author_institution" content="Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA"><meta name="citation_author" content="Natalia Kuzmina"><meta name="citation_author_institution" content="Galveston National Laboratory, Galveston, TX 77550, USA"><meta name="citation_author_institution" content="Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA"><meta name="citation_author" content="Viktoriya Borisevich"><meta name="citation_author_institution" content="Galveston National Laboratory, Galveston, TX 77550, USA"><meta name="citation_author_institution" content="Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA"><meta name="citation_author" content="Krystle N. Agans"><meta name="citation_author_institution" content="Galveston National Laboratory, Galveston, TX 77550, USA"><meta name="citation_author_institution" content="Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA"><meta name="citation_author" content="Joan B. Geisbert"><meta name="citation_author_institution" content="Galveston National Laboratory, Galveston, TX 77550, USA"><meta name="citation_author_institution" content="Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA"><meta name="citation_author" content="Seth J. Zost"><meta name="citation_author_institution" content="Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA"><meta name="citation_author" content="Rachel S. Nargi"><meta name="citation_author_institution" content="Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA"><meta name="citation_author" content="Rachel E. Sutton"><meta name="citation_author_institution" content="Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA"><meta name="citation_author" content="Naveenchandra Suryadevara"><meta name="citation_author_institution" content="Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA"><meta name="citation_author" content="Robin G. Bombardi"><meta name="citation_author_institution" content="Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA"><meta name="citation_author" content="Robert H. Carnahan"><meta name="citation_author_institution" content="Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA"><meta name="citation_author_institution" content="Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA"><meta name="citation_author" content="Alexander Bukreyev"><meta name="citation_author_institution" content="Galveston National Laboratory, Galveston, TX 77550, USA"><meta name="citation_author_institution" content="Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA"><meta name="citation_author_institution" content="Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA"><meta name="citation_author" content="Thomas W. Geisbert"><meta name="citation_author_institution" content="Galveston National Laboratory, Galveston, TX 77550, USA"><meta name="citation_author_institution" content="Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA"><meta name="citation_author" content="Andrew B. Ward"><meta name="citation_author_institution" content="Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA"><meta name="citation_author" content="James E. Crowe"><meta name="citation_author_email" content="james.crowe@vumc.org"><meta name="citation_author_institution" content="Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA"><meta name="citation_author_institution" content="Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA"><meta name="citation_author_institution" content="Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA"><meta name="citation_keywords" content="Ebolavirus; ebolavirus infection; glycoprotein; viral antibodies; neutralizing antibodies; epitope mapping; antibody therapeutics"><meta name="citation_reference" content="citation_title=Privateer: software for the conformational validation of carbohydrate structures; citation_author=J. Agirre; citation_author=J. Iglesias-Fernández; citation_author=C. Rovira; citation_author=G.J. Davies; citation_author=K.S. Wilson; citation_author=K.D. Cowtan; citation_journal_title=Nat. Struct. Mol. Biol.; citation_volume=22; citation_firstpage=833; citation_lastpage=834; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=EMRinger: side chain-directed model and map validation for 3D cryo-electron microscopy; citation_author=B.A. Barad; citation_author=N. Echols; citation_author=R.Y. Wang; citation_author=Y. Cheng; citation_author=F. DiMaio; citation_author=P.D. Adams; citation_author=J.S. Fraser; citation_journal_title=Nat. Methods; citation_volume=12; citation_firstpage=943; citation_lastpage=946; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies; citation_author=A. Baum; citation_author=B.O. Fulton; citation_author=E. Wloga; citation_author=R. Copin; citation_author=K.E. Pascal; citation_author=V. Russo; citation_author=S. Giordano; citation_author=K. Lanza; citation_author=N. Negron; citation_author=M. Ni; citation_author=et al.; citation_journal_title=Science; citation_volume=369; citation_firstpage=1014; citation_lastpage=1018; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Nonhuman primate models of Ebola virus disease; citation_author=R.S. Bennett; citation_author=L.M. Huzella; citation_author=P.B. Jahrling; citation_author=L. Bollinger; citation_author=G.G. Olinger; citation_author=L.E. Hensley; citation_journal_title=Curr. Top. Microbiol. Immunol.; citation_volume=411; citation_firstpage=171; citation_lastpage=193; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information; citation_author=M. Biasini; citation_author=S. Bienert; citation_author=A. Waterhouse; citation_author=K. Arnold; citation_author=G. Studer; citation_author=T. Schmidt; citation_author=F. Kiefer; citation_author=T. Gallo Cassarino; citation_author=M. Bertoni; citation_author=L. Bordoli; citation_author=T. Schwede; citation_journal_title=Nucleic Acids Res.; citation_volume=42; citation_firstpage=W252-8; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Host-primed Ebola virus GP exposes a hydrophobic NPC1 receptor-binding pocket, revealing a target for broadly neutralizing antibodies; citation_author=Z.A. Bornholdt; citation_author=E. Ndungo; citation_author=M.L. Fusco; citation_author=S. Bale; citation_author=A.I. Flyak; citation_author=J.E. Crowe; citation_author=K. Chandran; citation_author=E.O. Saphire; citation_journal_title=MBio; citation_volume=7; citation_firstpage=e02154-15; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=A two-antibody pan-ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates; citation_author=Z.A. Bornholdt; citation_author=A.S. Herbert; citation_author=C.E. Mire; citation_author=S. He; citation_author=R.W. Cross; citation_author=A.Z. Wec; citation_author=D.M. Abelson; citation_author=J.B. Geisbert; citation_author=R.M. James; citation_author=M.N. Rahim; citation_author=et al.; citation_journal_title=Cell Host Microbe; citation_volume=25; citation_firstpage=49; citation_lastpage=58.e5; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever; citation_author=M. Bray; citation_author=K. Davis; citation_author=T. Geisbert; citation_author=C. Schmaljohn; citation_author=J. Huggins; citation_journal_title=J.&nbsp;Infect. Dis.; citation_volume=178; citation_firstpage=651; citation_lastpage=661; citation_publication_date=1998; "><meta name="citation_reference" content="citation_title=Anti-Ebola virus antibody levels in convalescent plasma and viral load after plasma infusion in patients with Ebola virus disease; citation_author=J.F. Brown; citation_author=J.M. Dye; citation_author=S. Tozay; citation_author=G. Jeh-Mulbah; citation_author=D.A. Wohl; citation_author=W.A. Fischer; citation_author=C.K. Cunningham; citation_author=K. Rowe; citation_author=P. Zacharias; citation_author=J. van Hasselt; citation_author=et al.; citation_journal_title=J.&nbsp;Infect. Dis.; citation_volume=218; citation_firstpage=555; citation_lastpage=562; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Ebola virus entry requires the cholesterol transporter Niemann-Pick C1; citation_author=J.E. Carette; citation_author=M. Raaben; citation_author=A.C. Wong; citation_author=A.S. Herbert; citation_author=G. Obernosterer; citation_author=N. Mulherkar; citation_author=A.I. Kuehne; citation_author=P.J. Kranzusch; citation_author=A.M. Griffin; citation_author=G. Ruthel; citation_author=et al.; citation_journal_title=Nature; citation_volume=477; citation_firstpage=340; citation_lastpage=343; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection; citation_author=K. Chandran; citation_author=N.J. Sullivan; citation_author=U. Felbor; citation_author=S.P. Whelan; citation_author=J.M. Cunningham; citation_journal_title=Science; citation_volume=308; citation_firstpage=1643; citation_lastpage=1645; citation_publication_date=2005; "><meta name="citation_reference" content="citation_title=Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells; citation_author=J. Chng; citation_author=T. Wang; citation_author=R. Nian; citation_author=A. Lau; citation_author=K.M. Hoi; citation_author=S.C. Ho; citation_author=P. Gagnon; citation_author=X. Bi; citation_author=Y. Yang; citation_journal_title=MAbs; citation_volume=7; citation_firstpage=403; citation_lastpage=412; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies; citation_author=R. Copin; citation_author=A. Baum; citation_author=E. Wloga; citation_author=K.E. Pascal; citation_author=S. Giordano; citation_author=B.O. Fulton; citation_author=A. Zhou; citation_author=N. Negron; citation_author=K. Lanza; citation_author=N. Chan; citation_author=et al.; citation_journal_title=Cell; citation_volume=184; citation_firstpage=3949; citation_lastpage=3961; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody; citation_author=D. Corti; citation_author=J. Misasi; citation_author=S. Mulangu; citation_author=D.A. Stanley; citation_author=M. Kanekiyo; citation_author=S. Wollen; citation_author=A. Ploquin; citation_author=N.A. Doria-Rose; citation_author=R.P. Staupe; citation_author=M. Bailey; citation_author=et al.; citation_journal_title=Science; citation_volume=351; citation_firstpage=1339; citation_lastpage=1342; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=The Domestic Ferret (Mustela putorius furo) as a lethal infection model for 3 species of ebolavirus; citation_author=R.W. Cross; citation_author=C.E. Mire; citation_author=V. Borisevich; citation_author=J.B. Geisbert; citation_author=K.A. Fenton; citation_author=T.W. Geisbert; citation_journal_title=J.&nbsp;Infect. Dis.; citation_volume=214; citation_firstpage=565; citation_lastpage=569; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Longitudinal analysis of the human B cell response to Ebola virus infection; citation_author=C.W. Davis; citation_author=K.J.L. Jackson; citation_author=A.K. McElroy; citation_author=P. Halfmann; citation_author=J. Huang; citation_author=C. Chennareddy; citation_author=A.E. Piper; citation_author=Y. Leung; citation_author=C.G. Albarino; citation_author=I. Crozier; citation_author=et al.; citation_journal_title=Cell; citation_volume=177; citation_firstpage=1566; citation_lastpage=1582; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500&nbsp;days; citation_author=B. Diallo; citation_author=D. Sissoko; citation_author=N.J. Loman; citation_author=H.A. Bah; citation_author=H. Bah; citation_author=M.C. Worrell; citation_author=L.S. Conde; citation_author=R. Sacko; citation_author=S. Mesfin; citation_author=A. Loua; citation_author=et al.; citation_journal_title=Clin. Infect. Dis.; citation_volume=63; citation_firstpage=1353; citation_lastpage=1356; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Atomic-accuracy models from 4.5-Å cryo-electron microscopy data with density-guided iterative local refinement; citation_author=F. DiMaio; citation_author=Y. Song; citation_author=X. Li; citation_author=M.J. Brunner; citation_author=C. Xu; citation_author=V. Conticello; citation_author=E. Egelman; citation_author=T. Marlovits; citation_author=Y. Cheng; citation_author=D. Baker; citation_journal_title=Nat. Methods; citation_volume=12; citation_firstpage=361; citation_lastpage=365; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=A single dose of modified Vaccinia Ankara expressing Ebola virus like particles protects nonhuman primates from lethal Ebola virus challenge; citation_author=A. Domi; citation_author=F. Feldmann; citation_author=R. Basu; citation_author=N. McCurley; citation_author=K. Shifflett; citation_author=J. Emanuel; citation_author=M.S. Hellerstein; citation_author=F. Guirakhoo; citation_author=C. Orlandi; citation_author=R. Flinko; citation_author=et al.; citation_journal_title=Sci. Rep.; citation_volume=8; citation_firstpage=864; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Features and development of Coot; citation_author=P. Emsley; citation_author=B. Lohkamp; citation_author=W.G. Scott; citation_author=K. Cowtan; citation_journal_title=Acta Crystallogr. D Biol. Crystallogr.; citation_volume=66; citation_firstpage=486; citation_lastpage=501; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Ebola; citation_author=H. Feldmann; citation_author=A. Sprecher; citation_author=T.W. Geisbert; citation_journal_title=N.&nbsp;Engl. J. Med.; citation_volume=382; citation_firstpage=1832; citation_lastpage=1842; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers; citation_author=G. Fibriansah; citation_author=K.D. Ibarra; citation_author=T.S. Ng; citation_author=S.A. Smith; citation_author=J.L. Tan; citation_author=X.N. Lim; citation_author=J.S.G. Ooi; citation_author=V.A. Kostyuchenko; citation_author=J. Wang; citation_author=A.M. de Silva; citation_author=et al.; citation_journal_title=Science; citation_volume=349; citation_firstpage=88; citation_lastpage=91; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Cross-reactive and potent neutralizing antibody responses in human survivors of natural ebolavirus infection; citation_author=A.I. Flyak; citation_author=X. Shen; citation_author=C.D. Murin; citation_author=H.L. Turner; citation_author=J.A. David; citation_author=M.L. Fusco; citation_author=R. Lampley; citation_author=N. Kose; citation_author=P.A. Ilinykh; citation_author=N. Kuzmina; citation_author=et al.; citation_journal_title=Cell; citation_volume=164; citation_firstpage=392; citation_lastpage=405; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=FDA Approves First Treatment for Ebola Virus; citation_author=Food and Drug Administration; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=FDA Approves Treatment for Ebola Virus; citation_author=Food and Drug Administration; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Discovery of an antibody for pan-ebolavirus therapy; citation_author=W. Furuyama; citation_author=A. Marzi; citation_author=A. Nanbo; citation_author=E. Haddock; citation_author=J. Maruyama; citation_author=H. Miyamoto; citation_author=M. Igarashi; citation_author=R. Yoshida; citation_author=O. Noyori; citation_author=H. Feldmann; citation_author=A. Takada; citation_journal_title=Sci. Rep.; citation_volume=6; citation_firstpage=20514; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses; citation_author=M. Garbutt; citation_author=R. Liebscher; citation_author=V. Wahl-Jensen; citation_author=S. Jones; citation_author=P. Möller; citation_author=R. Wagner; citation_author=V. Volchkov; citation_author=H.D. Klenk; citation_author=H. Feldmann; citation_author=U. Ströher; citation_journal_title=J.&nbsp;Virol.; citation_volume=78; citation_firstpage=5458; citation_lastpage=5465; citation_publication_date=2004; "><meta name="citation_reference" content="citation_title=Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study; citation_author=M.R. Gaudinski; citation_author=E.E. Coates; citation_author=L. Novik; citation_author=A. Widge; citation_author=K.V. Houser; citation_author=E. Burch; citation_author=L.A. Holman; citation_author=I.J. Gordon; citation_author=G.L. Chen; citation_author=C. Carter; citation_author=VRC 608 Study team; citation_author=et al.; citation_journal_title=Lancet; citation_volume=393; citation_firstpage=889; citation_lastpage=898; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates; citation_author=T.W. Geisbert; citation_author=K.M. Daddario-DiCaprio; citation_author=K.J. Williams; citation_author=J.B. Geisbert; citation_author=A. Leung; citation_author=F. Feldmann; citation_author=L.E. Hensley; citation_author=H. Feldmann; citation_author=S.M. Jones; citation_journal_title=J.&nbsp;Virol.; citation_volume=82; citation_firstpage=5664; citation_lastpage=5668; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=Considerations in the use of nonhuman primate models of Ebola virus and Marburg virus infection; citation_author=T.W. Geisbert; citation_author=J.E. Strong; citation_author=H. Feldmann; citation_journal_title=J.&nbsp;Infect. Dis.; citation_volume=212; citation_number=Suppl 2; citation_firstpage=S91; citation_lastpage=S97; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the Ebolavirus glycoprotein; citation_author=P. Gilchuk; citation_author=N. Kuzmina; citation_author=P.A. Ilinykh; citation_author=K. Huang; citation_author=B.M. Gunn; citation_author=A. Bryan; citation_author=E. Davidson; citation_author=B.J. Doranz; citation_author=H.L. Turner; citation_author=M.L. Fusco; citation_author=et al.; citation_journal_title=Immunity; citation_volume=49; citation_firstpage=363; citation_lastpage=374.e10; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Efficacy of human monoclonal antibody monotherapy against Bundibugyo virus infection in nonhuman primates; citation_author=P. Gilchuk; citation_author=C.E. Mire; citation_author=J.B. Geisbert; citation_author=K.N. Agans; citation_author=D.J. Deer; citation_author=R.W. Cross; citation_author=J.C. Slaughter; citation_author=A.I. Flyak; citation_author=J. Mani; citation_author=M.H. Pauly; citation_author=et al.; citation_journal_title=J.&nbsp;Infect. Dis.; citation_volume=218; citation_number=Suppl 5; citation_firstpage=S565; citation_lastpage=S573; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics; citation_author=P. Gilchuk; citation_author=R.G. Bombardi; citation_author=J.H. Erasmus; citation_author=Q. Tan; citation_author=R. Nargi; citation_author=C. Soto; citation_author=P. Abbink; citation_author=T.J. Suscovich; citation_author=L.A. Durnell; citation_author=A. Khandhar; citation_author=et al.; citation_journal_title=Nat. Biomed. Eng.; citation_volume=4; citation_firstpage=1030; citation_lastpage=1043; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization; citation_author=P. Gilchuk; citation_author=C.D. Murin; citation_author=J.C. Milligan; citation_author=R.W. Cross; citation_author=C.E. Mire; citation_author=P.A. Ilinykh; citation_author=K. Huang; citation_author=N. Kuzmina; citation_author=P.X. Altman; citation_author=S. Hui; citation_author=et al.; citation_journal_title=Immunity; citation_volume=52; citation_firstpage=388; citation_lastpage=403.e12; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses; citation_author=T. Goldstein; citation_author=S.J. Anthony; citation_author=A. Gbakima; citation_author=B.H. Bird; citation_author=J. Bangura; citation_author=A. Tremeau-Bravard; citation_author=M.N. Belaganahalli; citation_author=H.L. Wells; citation_author=J.K. Dhanota; citation_author=E. Liang; citation_author=et al.; citation_journal_title=Nat. Microbiol.; citation_volume=3; citation_firstpage=1084; citation_lastpage=1089; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition; citation_author=A.J. Greaney; citation_author=T.N. Starr; citation_author=P. Gilchuk; citation_author=S.J. Zost; citation_author=E. Binshtein; citation_author=A.N. Loes; citation_author=S.K. Hilton; citation_author=J. Huddleston; citation_author=R. Eguia; citation_author=K.H.D. Crawford; citation_author=et al.; citation_journal_title=Cell Host Microbe; citation_volume=29; citation_firstpage=44; citation_lastpage=57.e9; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Development of an antibody cocktail for treatment of Sudan virus infection; citation_author=A.S. Herbert; citation_author=J.W. Froude; citation_author=R.A. Ortiz; citation_author=A.I. Kuehne; citation_author=D.E. Dorosky; citation_author=R.R. Bakken; citation_author=S.E. Zak; citation_author=N.M. Josleyn; citation_author=K. Musiychuk; citation_author=R.M. Jones; citation_author=et al.; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=117; citation_firstpage=3768; citation_lastpage=3778; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Pan-ebolavirus and pan-filovirus mouse monoclonal antibodies: protection against Ebola and Sudan viruses; citation_author=F.W. Holtsberg; citation_author=S. Shulenin; citation_author=H. Vu; citation_author=K.A. Howell; citation_author=S.J. Patel; citation_author=B. Gunn; citation_author=M. Karim; citation_author=J.R. Lai; citation_author=J.C. Frei; citation_author=E.K. Nyakatura; citation_author=et al.; citation_journal_title=J.&nbsp;Virol.; citation_volume=90; citation_firstpage=266; citation_lastpage=278; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=SynergyFinder 2.0: visual analytics of multi-drug combination synergies; citation_author=A. Ianevski; citation_author=A.K. Giri; citation_author=T. Aittokallio; citation_journal_title=Nucleic Acids Res.; citation_volume=48; citation_number=W1; citation_firstpage=W488; citation_lastpage=W493; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Chimeric filoviruses for identification and characterization of monoclonal antibodies; citation_author=P.A. Ilinykh; citation_author=X. Shen; citation_author=A.I. Flyak; citation_author=N. Kuzmina; citation_author=T.G. Ksiazek; citation_author=J.E. Crowe; citation_author=A. Bukreyev; citation_journal_title=J.&nbsp;Virol.; citation_volume=90; citation_firstpage=3890; citation_lastpage=3901; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Recent successes in therapeutics for Ebola virus disease: no time for complacency; citation_author=P.L. Iversen; citation_author=C.D. Kane; citation_author=X. Zeng; citation_author=R.G. Panchal; citation_author=T.K. Warren; citation_author=S.R. Radoshitzky; citation_author=J.H. Kuhn; citation_author=R.R. Mudhasani; citation_author=C.L. Cooper; citation_author=A.C. Shurtleff; citation_author=et al.; citation_journal_title=Lancet Infect. Dis.; citation_volume=20; citation_firstpage=e231; citation_lastpage=e237; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Arpeggio: A web server for calculating and visualising interatomic interactions in protein structures; citation_author=H.C. Jubb; citation_author=A.P. Higueruelo; citation_author=B. Ochoa-Montaño; citation_author=W.R. Pitt; citation_author=D.B. Ascher; citation_author=T.L. Blundell; citation_journal_title=J.&nbsp;Mol. Biol.; citation_volume=429; citation_firstpage=365; citation_lastpage=371; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=The structural basis for filovirus neutralization by monoclonal antibodies; citation_author=L.B. King; citation_author=B.R. West; citation_author=S.L. Schendel; citation_author=E.O. Saphire; citation_journal_title=Curr. Opin. Immunol.; citation_volume=53; citation_firstpage=196; citation_lastpage=202; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Macaque monoclonal antibodies targeting novel conserved epitopes within filovirus glycoprotein; citation_author=Z.Y. Keck; citation_author=S.G. Enterlein; citation_author=Howell Howell; citation_author=H. Vu; citation_author=S. Shulenin; citation_author=J.W. Froude; citation_author=N. Araghi; citation_author=R. Douglas; citation_author=J. Biggins; citation_author=et al.; citation_journal_title=J. Virol; citation_volume=90; citation_firstpage=279; citation_lastpage=291; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks; citation_author=A.K. Keita; citation_author=F.R. Koundouno; citation_author=M. Faye; citation_author=A. Dux; citation_author=J. Hinzmann; citation_author=H. Diallo; citation_author=A. Ayouba; citation_author=F. Le Marcis; citation_author=B. Soropogui; citation_author=K. Ifono; citation_author=et al.; citation_journal_title=Nature; citation_volume=597; citation_firstpage=539; citation_lastpage=543; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Achieving cross-reactivity with pan-ebolavirus antibodies; citation_author=L.B. King; citation_author=J.C. Milligan; citation_author=B.R. West; citation_author=S.L. Schendel; citation_author=E. Ollmann Saphire; citation_journal_title=Curr. Opin. Virol.; citation_volume=34; citation_firstpage=140; citation_lastpage=148; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Emergence of Ebola virus escape variants in infected nonhuman primates treated with the MB-003 antibody cocktail; citation_author=J.R. Kugelman; citation_author=J. Kugelman-Tonos; citation_author=J.T. Ladner; citation_author=J. Pettit; citation_author=C.M. Keeton; citation_author=E.R. Nagle; citation_author=K.Y. Garcia; citation_author=J.W. Froude; citation_author=A.I. Kuehne; citation_author=J.H. Kuhn; citation_author=et al.; citation_journal_title=Cell Rep.; citation_volume=12; citation_firstpage=2111; citation_lastpage=2120; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=New filovirus disease classification and nomenclature; citation_author=J.H. Kuhn; citation_author=T. Adachi; citation_author=N.K.J. Adhikari; citation_author=J.R. Arribas; citation_author=I.E. Bah; citation_author=D.G. Bausch; citation_author=N. Bhadelia; citation_author=M. Borchert; citation_author=A.B. Brantsæter; citation_author=D.M. Brett-Major; citation_author=et al.; citation_journal_title=Nat. Rev. Microbiol.; citation_volume=17; citation_firstpage=261; citation_lastpage=263; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Antibody-dependent enhancement of Ebola virus infection by human antibodies isolated from survivors; citation_author=N.A. Kuzmina; citation_author=P. Younan; citation_author=P. Gilchuk; citation_author=R.I. Santos; citation_author=A.I. Flyak; citation_author=P.A. Ilinykh; citation_author=K. Huang; citation_author=N.M. Lubaki; citation_author=P. Ramanathan; citation_author=J.E. Crowe; citation_author=et al.; citation_journal_title=Cell Rep.; citation_volume=24; citation_firstpage=1802; citation_lastpage=1815; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=LigPlot+: multiple ligand-protein interaction diagrams for drug discovery; citation_author=R.A. Laskowski; citation_author=M.B. Swindells; citation_journal_title=J.&nbsp;Chem. Inf. Model.; citation_volume=51; citation_firstpage=2778; citation_lastpage=2786; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it; citation_author=J.E. Lee; citation_author=E.O. Saphire; citation_journal_title=Curr. Opin. Struct. Biol.; citation_volume=19; citation_firstpage=408; citation_lastpage=417; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor; citation_author=J.E. Lee; citation_author=M.L. Fusco; citation_author=A.J. Hessell; citation_author=W.B. Oswald; citation_author=D.R. Burton; citation_author=E.O. Saphire; citation_journal_title=Nature; citation_volume=454; citation_firstpage=177; citation_lastpage=182; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=Monoclonal antibody therapy for Ebola virus disease; citation_author=M.M. Levine; citation_journal_title=N.&nbsp;Engl. J. Med.; citation_volume=381; citation_firstpage=2365; citation_lastpage=2366; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix; citation_author=D. Liebschner; citation_author=P.V. Afonine; citation_author=M.L. Baker; citation_author=G. Bunkóczi; citation_author=V.B. Chen; citation_author=T.I. Croll; citation_author=B. Hintze; citation_author=L.W. Hung; citation_author=S. Jain; citation_author=A.J. McCoy; citation_author=et al.; citation_journal_title=Acta Crystallogr. D Struct. Biol.; citation_volume=75; citation_firstpage=861; citation_lastpage=877; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Effector-attenuating substitutions that maintain antibody stability and reduce toxicity in mice; citation_author=M. Lo; citation_author=H.S. Kim; citation_author=R.K. Tong; citation_author=T.W. Bainbridge; citation_author=J.M. Vernes; citation_author=Y. Zhang; citation_author=Y.L. Lin; citation_author=S. Chung; citation_author=M.S. Dennis; citation_author=Y.J.Y. Zuchero; citation_author=et al.; citation_journal_title=J. Biol. Chem.; citation_volume=292; citation_firstpage=3900; citation_lastpage=3908; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=pdb-care (PDB carbohydrate residue check): a program to support annotation of complex carbohydrate structures in PDB files; citation_author=T. Lütteke; citation_author=C.W. von der Lieth; citation_journal_title=BMC Bioinformatics; citation_volume=5; citation_firstpage=69; citation_publication_date=2004; "><meta name="citation_reference" content="citation_title=Medical countermeasures during the 2018 Ebola virus disease outbreak in the North Kivu and Ituri Provinces of the Democratic Republic of the Congo: a rapid genomic assessment; citation_author=P. Mbala-Kingebeni; citation_author=A. Aziza; citation_author=N. Di Paola; citation_author=M.R. Wiley; citation_author=S. Makiala-Mandanda; citation_author=K. Caviness; citation_author=C.B. Pratt; citation_author=J.T. Ladner; citation_author=J.R. Kugelman; citation_author=K. Prieto; citation_author=et al.; citation_journal_title=Lancet Infect. Dis.; citation_volume=19; citation_firstpage=648; citation_lastpage=657; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus; citation_author=C.E. Mire; citation_author=J.B. Geisbert; citation_author=A. Marzi; citation_author=K.N. Agans; citation_author=H. Feldmann; citation_author=T.W. Geisbert; citation_journal_title=PLoS Negl. Trop. Dis.; citation_volume=7; citation_firstpage=e2600; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Immunotherapeutic strategies to target vulnerabilities in the Ebolavirus glycoprotein; citation_author=J. Misasi; citation_author=N.J. Sullivan; citation_journal_title=Immunity; citation_volume=54; citation_firstpage=412; citation_lastpage=436; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=A randomized, controlled trial of Ebola virus disease therapeutics; citation_author=S. Mulangu; citation_author=L.E. Dodd; citation_author=R.T. Davey; citation_author=O. Tshiani Mbaya; citation_author=M. Proschan; citation_author=D. Mukadi; citation_author=M. Lusakibanza Manzo; citation_author=D. Nzolo; citation_author=A. Tshomba Oloma; citation_author=A. Ibanda; citation_author=PALM Writing Group; citation_author=PALM Consortium Study Team; citation_author=et al.; citation_journal_title=N.&nbsp;Engl. J. Med.; citation_volume=381; citation_firstpage=2293; citation_lastpage=2303; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies; citation_author=C.D. Murin; citation_author=P. Gilchuk; citation_author=P.A. Ilinykh; citation_author=K. Huang; citation_author=N. Kuzmina; citation_author=X. Shen; citation_author=J.F. Bruhn; citation_author=A.L. Bryan; citation_author=E. Davidson; citation_author=B.J. Doranz; citation_author=et al.; citation_journal_title=Cell Rep.; citation_volume=35; citation_firstpage=108984; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=A new cell line for high throughput HIV-specific antibody-dependent cellular cytotoxicity (ADCC) and cell-to-cell virus transmission studies; citation_author=C. Orlandi; citation_author=R. Flinko; citation_author=G.K. Lewis; citation_journal_title=J.&nbsp;Immunol. Methods; citation_volume=433; citation_firstpage=51; citation_lastpage=58; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys; citation_author=W.B. Oswald; citation_author=T.W. Geisbert; citation_author=K.J. Davis; citation_author=J.B. Geisbert; citation_author=N.J. Sullivan; citation_author=P.B. Jahrling; citation_author=P.W. Parren; citation_author=D.R. Burton; citation_journal_title=PLoS Pathog.; citation_volume=3; citation_firstpage=e9; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in nonhuman primates; citation_author=K.E. Pascal; citation_author=D. Dudgeon; citation_author=J.C. Trefry; citation_author=M. Anantpadma; citation_author=Y. Sakurai; citation_author=C.D. Murin; citation_author=H.L. Turner; citation_author=J. Fairhurst; citation_author=M. Torres; citation_author=A. Rafique; citation_author=et al.; citation_journal_title=J.&nbsp;Infect. Dis.; citation_volume=218; citation_number=Suppl 5; citation_firstpage=S612; citation_lastpage=S626; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=UCSF Chimera--a visualization system for exploratory research and analysis; citation_author=E.F. Pettersen; citation_author=T.D. Goddard; citation_author=C.C. Huang; citation_author=G.S. Couch; citation_author=D.M. Greenblatt; citation_author=E.C. Meng; citation_author=T.E. Ferrin; citation_journal_title=J.&nbsp;Comput. Chem.; citation_volume=25; citation_firstpage=1605; citation_lastpage=1612; citation_publication_date=2004; "><meta name="citation_reference" content="citation_title=cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination; citation_author=A. Punjani; citation_author=J.L. Rubinstein; citation_author=D.J. Fleet; citation_author=M.A. Brubaker; citation_journal_title=Nat. Methods; citation_volume=14; citation_firstpage=290; citation_lastpage=296; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp; citation_author=X. Qiu; citation_author=G. Wong; citation_author=J. Audet; citation_author=A. Bello; citation_author=L. Fernando; citation_author=J.B. Alimonti; citation_author=H. Fausther-Bovendo; citation_author=H. Wei; citation_author=J. Aviles; citation_author=E. Hiatt; citation_author=et al.; citation_journal_title=Nature; citation_volume=514; citation_firstpage=47; citation_lastpage=53; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Complete genome sequence of an Ebola virus (Sudan species) responsible for a 2000 outbreak of human disease in Uganda; citation_author=A. Sanchez; citation_author=P.E. Rollin; citation_journal_title=Virus Res.; citation_volume=113; citation_firstpage=16; citation_lastpage=25; citation_publication_date=2005; "><meta name="citation_reference" content="citation_title=Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection; citation_author=E.O. Saphire; citation_author=S.L. Schendel; citation_author=M.L. Fusco; citation_author=K. Gangavarapu; citation_author=B.M. Gunn; citation_author=A.Z. Wec; citation_author=P.J. Halfmann; citation_author=J.M. Brannan; citation_author=A.S. Herbert; citation_author=X. Qiu; citation_author=Viral Hemorrhagic Fever Immunotherapeutic Consortium; citation_author=et al.; citation_journal_title=Cell; citation_volume=174; citation_firstpage=938; citation_lastpage=952.e13; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 study; citation_author=S. Sivapalasingam; citation_author=M. Kamal; citation_author=R. Slim; citation_author=R. Hosain; citation_author=W. Shao; citation_author=R. Stoltz; citation_author=J. Yen; citation_author=L.G. Pologe; citation_author=Y. Cao; citation_author=M. Partridge; citation_author=et al.; citation_journal_title=Lancet Infect. Dis.; citation_volume=18; citation_firstpage=884; citation_lastpage=893; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016; citation_author=T.N. Starr; citation_author=A.J. Greaney; citation_author=A.S. Dingens; citation_author=J.D. Bloom; citation_journal_title=Cell Rep. Med.; citation_volume=2; citation_firstpage=100255; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Dynamics of Ebola RNA persistence in semen: a report from the postebogui cohort in Guinea; citation_author=F. Subtil; citation_author=C. Delaunay; citation_author=A.K. Keita; citation_author=M.S. Sow; citation_author=A. Touré; citation_author=S. Leroy; citation_author=P. Msellati; citation_author=N. Magassouba; citation_author=S. Baize; citation_author=H. Raoul; citation_author=Postebogui Study Group; citation_author=et al.; citation_journal_title=Clin. Infect. Dis.; citation_volume=64; citation_firstpage=1788; citation_lastpage=1790; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA; citation_author=E.P. Thi; citation_author=A.C. Lee; citation_author=J.B. Geisbert; citation_author=R. Ursic-Bedoya; citation_author=K.N. Agans; citation_author=M. Robbins; citation_author=D.J. Deer; citation_author=K.A. Fenton; citation_author=A.S. Kondratowicz; citation_author=I. MacLachlan; citation_author=et al.; citation_journal_title=Nat. Microbiol.; citation_volume=1; citation_firstpage=16142; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening; citation_author=J.S. Towner; citation_author=J. Paragas; citation_author=J.E. Dover; citation_author=M. Gupta; citation_author=C.S. Goldsmith; citation_author=J.W. Huggins; citation_author=S.T. Nichol; citation_journal_title=Virology; citation_volume=332; citation_firstpage=20; citation_lastpage=27; citation_publication_date=2005; "><meta name="citation_reference" content="citation_title=Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda; citation_author=J.S. Towner; citation_author=T.K. Sealy; citation_author=M.L. Khristova; citation_author=C.G. Albariño; citation_author=S. Conlan; citation_author=S.A. Reeder; citation_author=P.L. Quan; citation_author=W.I. Lipkin; citation_author=R. Downing; citation_author=J.W. Tappero; citation_author=et al.; citation_journal_title=PLoS Pathog.; citation_volume=4; citation_firstpage=e1000212; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=Persistence of Ebola virus in ocular fluid during convalescence; citation_author=J.B. Varkey; citation_author=J.G. Shantha; citation_author=I. Crozier; citation_author=C.S. Kraft; citation_author=G.M. Lyon; citation_author=A.K. Mehta; citation_author=G. Kumar; citation_author=J.R. Smith; citation_author=M.H. Kainulainen; citation_author=S. Whitmer; citation_author=et al.; citation_journal_title=N.&nbsp;Engl. J. Med.; citation_volume=372; citation_firstpage=2423; citation_lastpage=2427; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7; citation_author=P. Wang; citation_author=M.S. Nair; citation_author=L. Liu; citation_author=S. Iketani; citation_author=Y. Luo; citation_author=Y. Guo; citation_author=M. Wang; citation_author=J. Yu; citation_author=B. Zhang; citation_author=P.D. Kwong; citation_author=et al.; citation_journal_title=Nature; citation_volume=593; citation_doi=10.1038/s41586-021-03398-2; citation_firstpage=130; citation_lastpage=135; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses; citation_author=A.Z. Wec; citation_author=A.S. Herbert; citation_author=C.D. Murin; citation_author=E.K. Nyakatura; citation_author=D.M. Abelson; citation_author=J.M. Fels; citation_author=S. He; citation_author=R.M. James; citation_author=M.A. de La Vega; citation_author=W. Zhu; citation_author=et al.; citation_journal_title=Cell; citation_volume=169; citation_firstpage=878; citation_lastpage=890.e15; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Development of a human antibody cocktail that deploys multiple functions to confer pan-ebolavirus protection; citation_author=A.Z. Wec; citation_author=Z.A. Bornholdt; citation_author=S. He; citation_author=A.S. Herbert; citation_author=E. Goodwin; citation_author=A.S. Wirchnianski; citation_author=B.M. Gunn; citation_author=Z. Zhang; citation_author=W. Zhu; citation_author=G. Liu; citation_author=et al.; citation_journal_title=Cell Host Microbe; citation_volume=25; citation_firstpage=39; citation_lastpage=48.e5; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Structural basis of broad ebolavirus neutralization by a human survivor antibody; citation_author=B.R. West; citation_author=A.Z. Wec; citation_author=C.L. Moyer; citation_author=M.L. Fusco; citation_author=P.A. Ilinykh; citation_author=K. Huang; citation_author=A.S. Wirchnianski; citation_author=R.M. James; citation_author=A.S. Herbert; citation_author=S. Hui; citation_author=et al.; citation_journal_title=Nat. Struct. Mol. Biol.; citation_volume=26; citation_firstpage=204; citation_lastpage=212; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Ebola virus disease; citation_author=World Health Organization; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule; citation_author=J.W. Yewdell; citation_author=R.G. Webster; citation_author=W.U. Gerhard; citation_journal_title=Nature; citation_volume=279; citation_firstpage=246; citation_lastpage=248; citation_publication_date=1979; "><meta name="citation_reference" content="citation_title=Gctf: Real-time CTF determination and correction; citation_author=K. Zhang; citation_journal_title=J. Struct. Biol.; citation_volume=193; citation_firstpage=1; citation_lastpage=12; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Immunization-elicited broadly protective antibody reveals ebolavirus fusion loop as a site of vulnerability; citation_author=X. Zhao; citation_author=K.A. Howell; citation_author=S. He; citation_author=J.M. Brannan; citation_author=A.Z. Wec; citation_author=E. Davidson; citation_author=H.L. Turner; citation_author=C.I. Chiang; citation_author=L. Lei; citation_author=J.M. Fels; citation_author=et al.; citation_journal_title=Cell; citation_volume=169; citation_firstpage=891; citation_lastpage=904.e15; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy; citation_author=S.Q. Zheng; citation_author=E. Palovcak; citation_author=J.P. Armache; citation_author=K.A. Verba; citation_author=Y. Cheng; citation_author=D.A. Agard; citation_journal_title=Nat. Methods; citation_volume=14; citation_firstpage=331; citation_lastpage=332; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=New tools for automated high-resolution cryo-EM structure determination in RELION-3; citation_author=J. Zivanov; citation_author=T. Nakane; citation_author=B.O. Forsberg; citation_author=D. Kimanius; citation_author=W.J. Hagen; citation_author=E. Lindahl; citation_author=S.H. Scheres; citation_journal_title=eLife; citation_volume=7; citation_firstpage=e42166; citation_publication_date=2018; "><meta name="citation_abstract" content="<h2>Summary</h2><p>Ebolaviruses cause a severe and often fatal illness with the potential for global spread. Monoclonal antibody-based treatments that have become available recently have a narrow therapeutic spectrum and are ineffective against ebolaviruses other than Ebola virus (EBOV), including medically important Bundibugyo (BDBV) and Sudan (SUDV) viruses. Here, we report the development of a therapeutic cocktail comprising two broadly neutralizing human antibodies, rEBOV-515 and rEBOV-442, that recognize non-overlapping sites on the ebolavirus glycoprotein (GP). Antibodies in the cocktail exhibited synergistic neutralizing activity, resisted viral escape, and possessed differing requirements for their Fc-regions for optimal <i>in&nbsp;vivo</i> activities. The cocktail protected non-human primates from ebolavirus disease caused by EBOV, BDBV, or SUDV with high therapeutic effectiveness. High-resolution structures of the cocktail antibodies in complex with GP revealed the molecular determinants for neutralization breadth and potency. This study provides advanced preclinical data to support clinical development of this cocktail for pan-ebolavirus therapy.</p>"><meta charset="UTF-8"><!--

    Pagebuild admin UI
-->



<script type="text/javascript" src="https://bam.nr-data.net/1/16e2192192?a=916957862&amp;sa=1&amp;v=1177.96a4d39&amp;t=Unnamed%20Transaction&amp;rst=9293&amp;ck=1&amp;ref=https://www.cell.com/cell/fulltext/S0092-8674(21)01165-X&amp;be=3449&amp;fe=9252&amp;dc=7390&amp;af=err,xhr,stn,ins,spa&amp;perf=%7B%22timing%22:%7B%22of%22:1749591840774,%22n%22:0,%22f%22:2818,%22dn%22:2819,%22dne%22:2819,%22c%22:2819,%22s%22:2819,%22ce%22:2819,%22rq%22:2820,%22rp%22:3433,%22rpe%22:4137,%22dl%22:3438,%22di%22:4363,%22ds%22:7390,%22de%22:7406,%22dc%22:9252,%22l%22:9252,%22le%22:9284%7D,%22navigation%22:%7B%7D%7D&amp;jsonp=NREUM.setToken"></script><script src="https://js-agent.newrelic.com/nr-spa-1177.min.js"></script><script type="text/javascript">
    ;window.NREUM||(NREUM={});NREUM.init={privacy:{cookies_enabled:true}};
    window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{c.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(26),c={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(c.console=!0,o.indexOf("dev")!==-1&&(c.dev=!0),o.indexOf("nr_dev")!==-1&&(c.nrDev=!0))}catch(s){}c.nrDev&&i.on("internal-error",function(t){r(t.stack)}),c.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),c.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(c,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,c){try{l?l-=1:o(c||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,s.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:s.now();i("err",[t,n])}var i=t("handle"),a=t(27),c=t("ee"),s=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError",l=0;s.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(13),t(12),"addEventListener"in window&&t(6),s.xhrWrappable&&t(14),d=!0)}c.on("fn-start",function(t,e,n){d&&(l+=1)}),c.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),c.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),c.on("internal-error",function(t){i("ierr",[t,s.now(),!0])})},{}],3:[function(t,e,n){t("loader").features.ins=!0},{}],4:[function(t,e,n){function r(){_++,T=g.hash,this[u]=y.now()}function o(){_--,g.hash!==T&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var c="-start",s="-end",f="-body",u="fn"+c,d="fn"+s,p="cb"+c,l="cb"+s,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable){var x=t(10),b=t(11),E=t(8),R=t(6),O=t(13),N=t(7),M=t(14),P=t(9),S=t("ee"),C=S.get("tracer");t(16),y.features.spa=!0;var T,_=0;S.on(u,r),S.on(p,r),S.on(d,o),S.on(l,o),S.buffer([u,d,"xhr-done","xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+s,"clearTimeout"+c,u]),M.buffer([u,"new-xhr","send-xhr"+c]),N.buffer([m+c,m+"-done",m+f+c,m+f+s]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+c]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(M,"send-xhr"+c),a(S,"xhr-resolved"),a(S,"xhr-done"),a(N,m+c),a(N,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,!0),w[v]("load",i,!0),w[v]("popstate",function(){i(0,_>1)},!0)}},{}],5:[function(t,e,n){function r(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var o=t("ee"),i=t("handle"),a=t(13),c=t(12),s="learResourceTimings",f="addEventListener",u="resourcetimingbufferfull",d="bstResource",p="resource",l="-start",h="-end",m="fn"+l,v="fn"+h,w="bstTimer",g="pushState",y=t("loader");y.features.stn=!0,t(8),"addEventListener"in window&&t(6);var x=NREUM.o.EV;o.on(m,function(t,e){var n=t[0];n instanceof x&&(this.bstStart=y.now())}),o.on(v,function(t,e){var n=t[0];n instanceof x&&i("bst",[n,e,this.bstStart,y.now()])}),a.on(m,function(t,e,n){this.bstStart=y.now(),this.bstType=n}),a.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),this.bstType])}),c.on(m,function(){this.bstStart=y.now()}),c.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),"requestAnimationFrame"])}),o.on(g+l,function(t){this.time=y.now(),this.startPath=location.pathname+location.hash}),o.on(g+h,function(t){i("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),f in window.performance&&(window.performance["c"+s]?window.performance[f](u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["c"+s]()},!1):window.performance[f]("webkit"+u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["webkitC"+s]()},!1)),document[f]("scroll",r,{passive:!0}),document[f]("keypress",r,!1),document[f]("click",r,!1)}},{}],6:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){c.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),c=t("wrap-function")(a,!0),s=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1],r=s(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?c(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],7:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var c=r.apply(this,t);return o.emit(n+"start",[t,a],c),c.then(function(t){return o.emit(n+"end",[null,t],c),t},function(t){throw o.emit(n+"end",[t],c),t})})}var o=t("ee").get("fetch"),i=t(27),a=t(26);e.exports=o;var c=window,s="fetch-",f=s+"body-",u=["arrayBuffer","blob","json","text","formData"],d=c.Request,p=c.Response,l=c.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(c,"fetch",s),o.on(s+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(s+"done",[null,e],n)}else o.emit(s+"done",[t],n)}))},{}],8:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],9:[function(t,e,n){function r(t){function e(){s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}function n(){s.emit("jsonp-error",[],p),s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var u=c(a),d="function"==typeof u.parent[u.key];if(d){var p={};f.inPlace(u.parent,[u.key],"cb-",p),t.addEventListener("load",e,!1),t.addEventListener("error",n,!1),s.emit("new-jsonp",[t.src],p)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(u);return e?e[1]:null}function a(t,e){var n=t.match(p),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function c(t){var e=t.match(d);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var s=t("ee").get("jsonp"),f=t("wrap-function")(s);if(e.exports=s,o()){var u=/[?&](?:callback|cb)=([^&#]+)/,d=/(.*)\.([^.]+)/,p=/^(\w+)(\.|$)(.*)$/,l=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?f.inPlace(Node.prototype,l,"dom-"):(f.inPlace(HTMLElement.prototype,l,"dom-"),f.inPlace(HTMLHeadElement.prototype,l,"dom-"),f.inPlace(HTMLBodyElement.prototype,l,"dom-")),s.on("dom-start",function(t){r(t[0])})}},{}],10:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],11:[function(t,e,n){function r(t){var e=a.context(),n=c(t,"executor-",e),r=new f(n);return a.context(r).getCtx=function(){return e},a.emit("new-promise",[r,e],e),r}function o(t,e){return e}var i=t("wrap-function"),a=t("ee").get("promise"),c=i(a),s=t(26),f=NREUM.o.PR;e.exports=a,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){a.emit("propagate",[null,!o],i),o=o||!t}}var o=!1;s(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var i=e.apply(f,arguments),c=f.resolve(i);return c}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&a.emit("propagate",[t,!0],n),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),s(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),a.on("executor-start",function(t){t[0]=c(t[0],"resolve-",this),t[1]=c(t[1],"resolve-",this)}),a.on("executor-err",function(t,e,n){t[1](n)}),c.inPlace(f.prototype,["then"],"then-",o),a.on("then-start",function(t,e){this.promise=e,t[0]=c(t[0],"cb-",this),t[1]=c(t[1],"cb-",this)}),a.on("then-end",function(t,e,n){this.nextPromise=n;var r=this.promise;a.emit("propagate",[r,!0],n)}),a.on("cb-end",function(t,e,n){a.emit("propagate",[n,!0],this.nextPromise)}),a.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=a.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],12:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],13:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),c="setTimeout",s="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[c,"setImmediate"],c+d),a.inPlace(window,[s],s+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(s+u,r),i.on(c+u,o)},{}],14:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",c)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,g,"fn-",c)}function i(t){y.push(t),h&&(b?b.then(a):v?v(a):(E=-E,R.data=E))}function a(){for(var t=0;t<y.length;t++)r([],y[t]);y.length&&(y=[])}function c(t,e){return e}function s(t,e){for(var n in t)e[n]=t[n];return e}t(6);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=NREUM.o,l=p.XHR,h=p.MO,m=p.PR,v=p.SI,w="readystatechange",g=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],y=[];e.exports=u;var x=window.XMLHttpRequest=function(t){var e=new l(t);try{u.emit("new-xhr",[e],e),e.addEventListener(w,o,!1)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(s(l,x),x.prototype=l.prototype,d.inPlace(x.prototype,["open","send"],"-xhr-",c),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),h){var b=m&&m.resolve();if(!v&&!m){var E=1,R=document.createTextNode(E);new h(a).observe(R,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===w||a()})},{}],15:[function(t,e,n){function r(t){if(!c(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||s(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&s(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",c=1,s="",f="";return o+"@nr="+i+"-"+c+"-"+n+"-"+r+"-"+t+"-"+a+"-"+s+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var c={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(c.d.tk=i),btoa(JSON.stringify(c))}function c(t){return f()&&s(t)}function s(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(23),h=t(17);e.exports={generateTracePayload:r,shouldGenerateTrace:c}},{}],16:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,u.emit("xhr-done",[t],t),c("xhr",[e,n,this.startTime]))}}function o(t,e){var n=s(e),r=t.params;r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=s(e),t.sameOrigin=t.parsedOrigin.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable){var c=t("handle"),s=t(17),f=t(15).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(21),m=t(20),v=t(18),w=window.XMLHttpRequest;a.features.xhr=!0,t(14),t(7),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,t.addEventListener("load",function(n){i(e,t)},!1),h&&(h>34||h<10)||window.opera||t.addEventListener("progress",function(t){e.lastSize=t.loaded},!1)}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var c=0;c<p;c++)e.addEventListener(d[c],this.listener,!1)}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("addEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof w&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url&&(n=t[0].url),n&&(this.parsedOrigin=s(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)})}},{}],17:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,c=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||c),"/"===o.pathname&&(r[t]=o),o}},{}],18:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(20);e.exports=r},{}],19:[function(t,e,n){function r(){}function o(t,e,n){return function(){return i(t,[f.now()].concat(c(arguments)),e?null:this,n),e?void 0:this}}var i=t("handle"),a=t(26),c=t(27),s=t("ee").get("tracer"),f=t("loader"),u=NREUM;"undefined"==typeof window.newrelic&&(newrelic=u);var d=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],p="api-",l=p+"ixn-";a(d,function(t,e){u[e]=o(p+e,!0,"api")}),u.addPageAction=o(p+"addPageAction",!0),u.setCurrentRouteName=o(p+"routeName",!0),e.exports=newrelic,u.interaction=function(){return(new r).get()};var h=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(l+"tracer",[f.now(),t,n],r),function(){if(s.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw s.emit("fn-err",[arguments,this,t],n),t}finally{s.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){h[e]=o(l+e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),i("err",[t,f.now(),!1,e])}},{}],20:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],21:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],22:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?d("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&d("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();n.length>0&&d("lcp",[n[n.length-1]])}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||d("cls",[t])})}function a(t){if(t instanceof h&&!v){var e=Math.round(t.timeStamp),n={type:t.type};e<=p.now()?n.fid=p.now()-e:e>p.offset&&e<=Date.now()?(e-=p.offset,n.fid=p.now()-e):e=p.now(),v=!0,d("timing",["fi",e,n])}}function c(t){d("pageHide",[p.now(),t])}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var s,f,u,d=t("handle"),p=t("loader"),l=t(25),h=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){s=new PerformanceObserver(r);try{s.observe({entryTypes:["paint"]})}catch(m){}f=new PerformanceObserver(o);try{f.observe({entryTypes:["largest-contentful-paint"]})}catch(m){}u=new PerformanceObserver(i);try{u.observe({type:"layout-shift",buffered:!0})}catch(m){}}if("addEventListener"in document){var v=!1,w=["click","keydown","mousedown","pointerdown","touchstart"];w.forEach(function(t){document.addEventListener(t,a,!1)})}l(c)}},{}],23:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",c=0;c<i.length;c++)o=i[c],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(31)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],24:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var c=navigator.userAgent,s=c.match(a);s&&c.indexOf("Chrome")===-1&&c.indexOf("Chromium")===-1&&(o="Safari",i=s[1])}e.exports={agent:o,version:i,match:r}},{}],25:[function(t,e,n){function r(t){function e(){t(a&&document[a]?document[a]:document[o]?"hidden":"visible")}"addEventListener"in document&&i&&document.addEventListener(i,e,!1)}e.exports=r;var o,i,a;"undefined"!=typeof document.hidden?(o="hidden",i="visibilitychange",a="visibilityState"):"undefined"!=typeof document.msHidden?(o="msHidden",i="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(o="webkitHidden",i="webkitvisibilitychange",a="webkitVisibilityState")},{}],26:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],27:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],28:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?s(t,c,i):i()}function n(n,r,o,i){if(!p.aborted||i){t&&t(n,r,o);for(var a=e(o),c=m(n),s=c.length,f=0;f<s;f++)c[f].apply(a,r);var d=u[y[n]];return d&&d.push([x,n,r,a]),a}}function l(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return d[t]=d[t]||o(n)}function w(t,e){f(t,function(t,n){e=e||"feature",y[n]=e,e in u||(u[e]=[])})}var g={},y={},x={on:l,addEventListener:l,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:a,aborted:!1};return x}function i(){return new r}function a(){(u.api||u.feature)&&(p.aborted=!0,u=p.backlog={})}var c="nr@context",s=t("gos"),f=t(26),u={},d={},p=e.exports=o();p.backlog=u},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!E++){var t=b.info=NREUM.info,e=l.getElementsByTagName("script")[0];if(setTimeout(u.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return u.abort();f(y,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+b.offset],null,"api"),s("timing",["load",n]);var r=l.createElement("script");r.src="https://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===l.readyState&&i()}function i(){s("mark",["domContent",a()+b.offset],null,"api")}function a(){return R.exists&&performance.now?Math.round(performance.now()):(c=Math.max((new Date).getTime(),c))-b.offset}var c=(new Date).getTime(),s=t("handle"),f=t(26),u=t("ee"),d=t(24),p=window,l=p.document,h="addEventListener",m="attachEvent",v=p.XMLHttpRequest,w=v&&v.prototype;NREUM.o={ST:setTimeout,SI:p.setImmediate,CT:clearTimeout,XHR:v,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var g=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1177.min.js"},x=v&&w&&w[h]&&!/CriOS/.test(navigator.userAgent),b=e.exports={offset:c,now:a,origin:g,features:{},xhrWrappable:x,userAgent:d};t(19),t(22),l[h]?(l[h]("DOMContentLoaded",i,!1),p[h]("load",r,!1)):(l[m]("onreadystatechange",o),p[m]("onload",r)),s("mark",["firstbyte",c],null,"api");var E=0,R=t(28)},{}],"wrap-function":[function(t,e,n){function r(t){return!(t&&t instanceof Function&&t.apply&&!t[a])}var o=t("ee"),i=t(27),a="nr@original",c=Object.prototype.hasOwnProperty,s=!1;e.exports=function(t,e){function n(t,e,n,o){function nrWrapper(){var r,a,c,s;try{a=this,r=i(arguments),c="function"==typeof n?n(r,a):n||{}}catch(f){p([f,"",[r,a,o],c])}u(e+"start",[r,a,o],c);try{return s=t.apply(a,r)}catch(d){throw u(e+"err",[r,a,d],c),d}finally{u(e+"end",[r,a,s],c)}}return r(t)?t:(e||(e=""),nrWrapper[a]=t,d(t,nrWrapper),nrWrapper)}function f(t,e,o,i){o||(o="");var a,c,s,f="-"===o.charAt(0);for(s=0;s<e.length;s++)c=e[s],a=t[c],r(a)||(t[c]=n(a,f?c+o:o,i,c))}function u(n,r,o){if(!s||e){var i=s;s=!0;try{t.emit(n,r,o,e)}catch(a){p([a,n,r,o])}s=i}}function d(t,e){if(Object.defineProperty&&Object.keys)try{var n=Object.keys(t);return n.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(r){p([r])}for(var o in t)c.call(t,o)&&(e[o]=t[o]);return e}function p(e){try{t.emit("internal-error",e)}catch(n){}}return t||(t=o),n.inPlace=f,n.flag=a,n}},{}]},{},["loader",2,16,5,3,4]);
    ;NREUM.loader_config={accountID:"2095297",trustKey:"2038175",agentID:"916957862",licenseKey:"16e2192192",applicationID:"916957862"}
    ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"16e2192192",applicationID:"916957862",sa:1}
</script>
    <script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="dada9834-04e2-4bcd-b5ba-cae44d498dfa"></script>
    <script type="text/javascript">
        function getCookie(name) {
            var value = "; " + document.cookie;
            var parts = value.split("; " + name + "=");
            if (parts.length == 2) {
                return true;
            }
        }
            function OptanonWrapper() {
                var optCookie = getCookie("OptanonAlertBoxClosed");
                var isActiveCategory = "false";
                var isFoundCookieBox = "false";
                if(isActiveCategory == 'false' && isFoundCookieBox == 'false' && optCookie) {
                    OneTrust.InsertScript('/pb-assets/adobe/prod/adobedtm-1616606406233.js', 'head', null, null, '2');
                }
            }
    </script>


<noscript>
    <style>.requiresJS {
        display: none
    }

    .dartAd {
        display: block !important
    }</style>
</noscript>
        <script type="text/javascript" src="/wro/o4ny~selected-legacy.js"></script>
        <link rel="stylesheet" type="text/css" href="/wro/o4ny~selected-legacy.css">
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans">
        <script>window.MSInputMethodContext && document.documentMode && document.write('<script src="https://cdn.jsdelivr.net/gh/nuxodin/ie11CustomProperties@4.1.0/ie11CustomProperties.min.js"><\x2fscript>');</script><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/build-b26f3342b722959c7931.css"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/print-b26f3342b722959c7931.css" media="print"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/themes/theme-cell.css">







        
        
        <script class="optanon-category-4" type="text/plain" async="" src="https://www.youtube.com/iframe_api"></script>
        
    





<!---->
<meta http-equiv="X-UA-Compatible" content="IE=edge">












<script src="https://cdn.cookielaw.org/scripttemplates/202411.2.0/otBannerSdk.js" async="" type="text/javascript"></script><style id="onetrust-style">#onetrust-banner-sdk .onetrust-vendors-list-handler{cursor:pointer;color:#1f96db;font-size:inherit;font-weight:bold;text-decoration:none;margin-left:5px}#onetrust-banner-sdk .onetrust-vendors-list-handler:hover{color:#1f96db}#onetrust-banner-sdk:focus{outline:2px solid #000;outline-offset:-2px}#onetrust-banner-sdk a:focus{outline:2px solid #000}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{outline-offset:1px}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{height:64px;width:64px}#onetrust-banner-sdk .ot-tcf2-vendor-count.ot-text-bold{font-weight:bold}#onetrust-banner-sdk .ot-close-icon,#onetrust-pc-sdk .ot-close-icon,#ot-sync-ntfy .ot-close-icon{background-size:contain;background-repeat:no-repeat;background-position:center;height:12px;width:12px}#onetrust-banner-sdk .powered-by-logo,#onetrust-banner-sdk .ot-pc-footer-logo a,#onetrust-pc-sdk .powered-by-logo,#onetrust-pc-sdk .ot-pc-footer-logo a,#ot-sync-ntfy .powered-by-logo,#ot-sync-ntfy .ot-pc-footer-logo a{background-size:contain;background-repeat:no-repeat;background-position:center;height:25px;width:152px;display:block;text-decoration:none;font-size:.75em}#onetrust-banner-sdk .powered-by-logo:hover,#onetrust-banner-sdk .ot-pc-footer-logo a:hover,#onetrust-pc-sdk .powered-by-logo:hover,#onetrust-pc-sdk .ot-pc-footer-logo a:hover,#ot-sync-ntfy .powered-by-logo:hover,#ot-sync-ntfy .ot-pc-footer-logo a:hover{color:#565656}#onetrust-banner-sdk h3 *,#onetrust-banner-sdk h4 *,#onetrust-banner-sdk h6 *,#onetrust-banner-sdk button *,#onetrust-banner-sdk a[data-parent-id] *,#onetrust-pc-sdk h3 *,#onetrust-pc-sdk h4 *,#onetrust-pc-sdk h6 *,#onetrust-pc-sdk button *,#onetrust-pc-sdk a[data-parent-id] *,#ot-sync-ntfy h3 *,#ot-sync-ntfy h4 *,#ot-sync-ntfy h6 *,#ot-sync-ntfy button *,#ot-sync-ntfy a[data-parent-id] *{font-size:inherit;font-weight:inherit;color:inherit}#onetrust-banner-sdk .ot-hide,#onetrust-pc-sdk .ot-hide,#ot-sync-ntfy .ot-hide{display:none !important}#onetrust-banner-sdk button.ot-link-btn:hover,#onetrust-pc-sdk button.ot-link-btn:hover,#ot-sync-ntfy button.ot-link-btn:hover{text-decoration:underline;opacity:1}#onetrust-pc-sdk .ot-sdk-row .ot-sdk-column{padding:0}#onetrust-pc-sdk .ot-sdk-container{padding-right:0}#onetrust-pc-sdk .ot-sdk-row{flex-direction:initial;width:100%}#onetrust-pc-sdk [type=checkbox]:checked,#onetrust-pc-sdk [type=checkbox]:not(:checked){pointer-events:initial}#onetrust-pc-sdk [type=checkbox]:disabled+label::before,#onetrust-pc-sdk [type=checkbox]:disabled+label:after,#onetrust-pc-sdk [type=checkbox]:disabled+label{pointer-events:none;opacity:.8}#onetrust-pc-sdk #vendor-list-content{transform:translate3d(0, 0, 0)}#onetrust-pc-sdk li input[type=checkbox]{z-index:1}#onetrust-pc-sdk li .ot-checkbox label{z-index:2}#onetrust-pc-sdk li .ot-checkbox input[type=checkbox]{height:auto;width:auto}#onetrust-pc-sdk li .host-title a,#onetrust-pc-sdk li .ot-host-name a,#onetrust-pc-sdk li .accordion-text,#onetrust-pc-sdk li .ot-acc-txt{z-index:2;position:relative}#onetrust-pc-sdk input{margin:3px .1ex}#onetrust-pc-sdk .pc-logo,#onetrust-pc-sdk .ot-pc-logo{height:60px;width:180px;background-position:center;background-size:contain;background-repeat:no-repeat;display:inline-flex;justify-content:center;align-items:center}#onetrust-pc-sdk .pc-logo img,#onetrust-pc-sdk .ot-pc-logo img{max-height:100%;max-width:100%}#onetrust-pc-sdk .screen-reader-only,#onetrust-pc-sdk .ot-scrn-rdr,.ot-sdk-cookie-policy .screen-reader-only,.ot-sdk-cookie-policy .ot-scrn-rdr{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}#onetrust-pc-sdk.ot-fade-in,.onetrust-pc-dark-filter.ot-fade-in,#onetrust-banner-sdk.ot-fade-in{animation-name:onetrust-fade-in;animation-duration:400ms;animation-timing-function:ease-in-out}#onetrust-pc-sdk.ot-hide{display:none !important}.onetrust-pc-dark-filter.ot-hide{display:none !important}#ot-sdk-btn.ot-sdk-show-settings,#ot-sdk-btn.optanon-show-settings{color:#fff;background-color:#468254;height:auto;white-space:normal;word-wrap:break-word;padding:.8em 2em;font-size:.8em;line-height:1.2;cursor:pointer;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease}#ot-sdk-btn.ot-sdk-show-settings:hover,#ot-sdk-btn.optanon-show-settings:hover{color:#fff;background-color:#2c6415}#ot-sdk-btn.ot-sdk-show-settings:active,#ot-sdk-btn.optanon-show-settings:active{color:#fff;background-color:#2c6415;border:1px solid rgba(162,192,169,.5)}.onetrust-pc-dark-filter{background:rgba(0,0,0,.5);z-index:2147483646;width:100%;height:100%;overflow:hidden;position:fixed;top:0;bottom:0;left:0}@keyframes onetrust-fade-in{0%{opacity:0}100%{opacity:1}}.ot-cookie-label{text-decoration:underline}@media only screen and (min-width: 426px)and (max-width: 896px)and (orientation: landscape){#onetrust-pc-sdk p{font-size:.75em}}#onetrust-banner-sdk .banner-option-input:focus+label{outline:1px solid #000;outline-style:auto}.category-vendors-list-handler+a:focus,.category-vendors-list-handler+a:focus-visible{outline:2px solid #000}#onetrust-pc-sdk .ot-userid-title{margin-top:10px}#onetrust-pc-sdk .ot-userid-title>span,#onetrust-pc-sdk .ot-userid-timestamp>span{font-weight:700}#onetrust-pc-sdk .ot-userid-desc{font-style:italic}#onetrust-pc-sdk .ot-host-desc a{pointer-events:initial}#onetrust-pc-sdk .ot-ven-hdr>p a{position:relative;z-index:2;pointer-events:initial}#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info a{margin-right:auto}#onetrust-pc-sdk .ot-pc-footer-logo img{width:136px;height:16px}#onetrust-pc-sdk .ot-pur-vdr-count{font-weight:400;font-size:.7rem;padding-top:3px;display:block}#onetrust-banner-sdk .ot-optout-signal,#onetrust-pc-sdk .ot-optout-signal{border:1px solid #32ae88;border-radius:3px;padding:5px;margin-bottom:10px;background-color:#f9fffa;font-size:.85rem;line-height:2}#onetrust-banner-sdk .ot-optout-signal .ot-optout-icon,#onetrust-pc-sdk .ot-optout-signal .ot-optout-icon{display:inline;margin-right:5px}#onetrust-banner-sdk .ot-optout-signal svg,#onetrust-pc-sdk .ot-optout-signal svg{height:20px;width:30px;transform:scale(0.5)}#onetrust-banner-sdk .ot-optout-signal svg path,#onetrust-pc-sdk .ot-optout-signal svg path{fill:#32ae88}#onetrust-consent-sdk .ot-general-modal{overflow:hidden;position:fixed;margin:0 auto;top:50%;left:50%;width:40%;padding:1.5rem;max-width:575px;min-width:575px;z-index:2147483647;border-radius:2.5px;transform:translate(-50%, -50%)}#onetrust-consent-sdk .ot-signature-health-group{margin-top:1rem;padding-left:1.25rem;padding-right:1.25rem;margin-bottom:.625rem;width:calc(100% - 2.5rem)}#onetrust-consent-sdk .ot-signature-health-group .ot-signature-health-form{gap:.5rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:70%;gap:.35rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-input{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-consent-sdk .ot-signature-health .ot-signature-subtitle{font-size:1.125rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-group-title{font-size:1.25rem;font-weight:bold}#onetrust-consent-sdk .ot-signature-health,#onetrust-consent-sdk .ot-signature-health-group{display:flex;flex-direction:column;gap:1rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-cont{display:flex;flex-direction:column;gap:.25rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-paragraph,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-paragraph{margin:0;line-height:20px;font-size:max(14px,.875rem)}#onetrust-consent-sdk .ot-signature-health .ot-health-signature-error,#onetrust-consent-sdk .ot-signature-health-group .ot-health-signature-error{color:#4d4d4d;font-size:min(12px,.75rem)}#onetrust-consent-sdk .ot-signature-health .ot-signature-buttons-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-buttons-cont{margin-top:max(.75rem,2%);gap:1rem;display:flex;justify-content:flex-end}#onetrust-consent-sdk .ot-signature-health .ot-signature-button,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button{flex:1;height:auto;color:#fff;cursor:pointer;line-height:1.2;min-width:125px;font-weight:600;font-size:.813em;border-radius:2px;padding:12px 10px;white-space:normal;word-wrap:break-word;word-break:break-word;background-color:#68b631;border:2px solid #68b631}#onetrust-consent-sdk .ot-signature-health .ot-signature-button.reject,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button.reject{background-color:#fff}#onetrust-consent-sdk .ot-input-field-cont{display:flex;flex-direction:column;gap:.5rem}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:65%}#onetrust-consent-sdk .ot-signature-health-form{display:flex;flex-direction:column}#onetrust-consent-sdk .ot-signature-health-form .ot-signature-label{margin-bottom:0;line-height:20px;font-size:max(14px,.875rem)}@media only screen and (max-width: 600px){#onetrust-consent-sdk .ot-general-modal{min-width:100%}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:100%}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:100%}}#onetrust-banner-sdk,#onetrust-pc-sdk,#ot-sdk-cookie-policy,#ot-sync-ntfy{font-size:16px}#onetrust-banner-sdk *,#onetrust-banner-sdk ::after,#onetrust-banner-sdk ::before,#onetrust-pc-sdk *,#onetrust-pc-sdk ::after,#onetrust-pc-sdk ::before,#ot-sdk-cookie-policy *,#ot-sdk-cookie-policy ::after,#ot-sdk-cookie-policy ::before,#ot-sync-ntfy *,#ot-sync-ntfy ::after,#ot-sync-ntfy ::before{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}#onetrust-banner-sdk div,#onetrust-banner-sdk span,#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-banner-sdk p,#onetrust-banner-sdk img,#onetrust-banner-sdk svg,#onetrust-banner-sdk button,#onetrust-banner-sdk section,#onetrust-banner-sdk a,#onetrust-banner-sdk label,#onetrust-banner-sdk input,#onetrust-banner-sdk ul,#onetrust-banner-sdk li,#onetrust-banner-sdk nav,#onetrust-banner-sdk table,#onetrust-banner-sdk thead,#onetrust-banner-sdk tr,#onetrust-banner-sdk td,#onetrust-banner-sdk tbody,#onetrust-banner-sdk .ot-main-content,#onetrust-banner-sdk .ot-toggle,#onetrust-banner-sdk #ot-content,#onetrust-banner-sdk #ot-pc-content,#onetrust-banner-sdk .checkbox,#onetrust-pc-sdk div,#onetrust-pc-sdk span,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#onetrust-pc-sdk p,#onetrust-pc-sdk img,#onetrust-pc-sdk svg,#onetrust-pc-sdk button,#onetrust-pc-sdk section,#onetrust-pc-sdk a,#onetrust-pc-sdk label,#onetrust-pc-sdk input,#onetrust-pc-sdk ul,#onetrust-pc-sdk li,#onetrust-pc-sdk nav,#onetrust-pc-sdk table,#onetrust-pc-sdk thead,#onetrust-pc-sdk tr,#onetrust-pc-sdk td,#onetrust-pc-sdk tbody,#onetrust-pc-sdk .ot-main-content,#onetrust-pc-sdk .ot-toggle,#onetrust-pc-sdk #ot-content,#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk .checkbox,#ot-sdk-cookie-policy div,#ot-sdk-cookie-policy span,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy p,#ot-sdk-cookie-policy img,#ot-sdk-cookie-policy svg,#ot-sdk-cookie-policy button,#ot-sdk-cookie-policy section,#ot-sdk-cookie-policy a,#ot-sdk-cookie-policy label,#ot-sdk-cookie-policy input,#ot-sdk-cookie-policy ul,#ot-sdk-cookie-policy li,#ot-sdk-cookie-policy nav,#ot-sdk-cookie-policy table,#ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy tr,#ot-sdk-cookie-policy td,#ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy .ot-main-content,#ot-sdk-cookie-policy .ot-toggle,#ot-sdk-cookie-policy #ot-content,#ot-sdk-cookie-policy #ot-pc-content,#ot-sdk-cookie-policy .checkbox,#ot-sync-ntfy div,#ot-sync-ntfy span,#ot-sync-ntfy h1,#ot-sync-ntfy h2,#ot-sync-ntfy h3,#ot-sync-ntfy h4,#ot-sync-ntfy h5,#ot-sync-ntfy h6,#ot-sync-ntfy p,#ot-sync-ntfy img,#ot-sync-ntfy svg,#ot-sync-ntfy button,#ot-sync-ntfy section,#ot-sync-ntfy a,#ot-sync-ntfy label,#ot-sync-ntfy input,#ot-sync-ntfy ul,#ot-sync-ntfy li,#ot-sync-ntfy nav,#ot-sync-ntfy table,#ot-sync-ntfy thead,#ot-sync-ntfy tr,#ot-sync-ntfy td,#ot-sync-ntfy tbody,#ot-sync-ntfy .ot-main-content,#ot-sync-ntfy .ot-toggle,#ot-sync-ntfy #ot-content,#ot-sync-ntfy #ot-pc-content,#ot-sync-ntfy .checkbox{font-family:inherit;font-weight:normal;-webkit-font-smoothing:auto;letter-spacing:normal;line-height:normal;padding:0;margin:0;height:auto;min-height:0;max-height:none;width:auto;min-width:0;max-width:none;border-radius:0;border:none;clear:none;float:none;position:static;bottom:auto;left:auto;right:auto;top:auto;text-align:left;text-decoration:none;text-indent:0;text-shadow:none;text-transform:none;white-space:normal;background:none;overflow:visible;vertical-align:baseline;visibility:visible;z-index:auto;box-shadow:none}#onetrust-banner-sdk label:before,#onetrust-banner-sdk label:after,#onetrust-banner-sdk .checkbox:after,#onetrust-banner-sdk .checkbox:before,#onetrust-pc-sdk label:before,#onetrust-pc-sdk label:after,#onetrust-pc-sdk .checkbox:after,#onetrust-pc-sdk .checkbox:before,#ot-sdk-cookie-policy label:before,#ot-sdk-cookie-policy label:after,#ot-sdk-cookie-policy .checkbox:after,#ot-sdk-cookie-policy .checkbox:before,#ot-sync-ntfy label:before,#ot-sync-ntfy label:after,#ot-sync-ntfy .checkbox:after,#ot-sync-ntfy .checkbox:before{content:"";content:none}#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{position:relative;width:100%;max-width:100%;margin:0 auto;padding:0 20px;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{width:100%;float:left;box-sizing:border-box;padding:0;display:initial}@media(min-width: 400px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:90%;padding:0}}@media(min-width: 550px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:100%}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{margin-left:4%}#onetrust-banner-sdk .ot-sdk-column:first-child,#onetrust-banner-sdk .ot-sdk-columns:first-child,#onetrust-pc-sdk .ot-sdk-column:first-child,#onetrust-pc-sdk .ot-sdk-columns:first-child,#ot-sdk-cookie-policy .ot-sdk-column:first-child,#ot-sdk-cookie-policy .ot-sdk-columns:first-child{margin-left:0}#onetrust-banner-sdk .ot-sdk-two.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-two.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-two.ot-sdk-columns{width:13.3333333333%}#onetrust-banner-sdk .ot-sdk-three.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-three.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-three.ot-sdk-columns{width:22%}#onetrust-banner-sdk .ot-sdk-four.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-four.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-four.ot-sdk-columns{width:30.6666666667%}#onetrust-banner-sdk .ot-sdk-eight.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eight.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eight.ot-sdk-columns{width:65.3333333333%}#onetrust-banner-sdk .ot-sdk-nine.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-nine.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-nine.ot-sdk-columns{width:74%}#onetrust-banner-sdk .ot-sdk-ten.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-ten.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-ten.ot-sdk-columns{width:82.6666666667%}#onetrust-banner-sdk .ot-sdk-eleven.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eleven.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eleven.ot-sdk-columns{width:91.3333333333%}#onetrust-banner-sdk .ot-sdk-twelve.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-twelve.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-twelve.ot-sdk-columns{width:100%;margin-left:0}}#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6{margin-top:0;font-weight:600;font-family:inherit}#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem;line-height:1.2}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem;line-height:1.25}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem;line-height:1.3}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem;line-height:1.35}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem;line-height:1.5}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem;line-height:1.6}@media(min-width: 550px){#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem}}#onetrust-banner-sdk p,#onetrust-pc-sdk p,#ot-sdk-cookie-policy p{margin:0 0 1em 0;font-family:inherit;line-height:normal}#onetrust-banner-sdk a,#onetrust-pc-sdk a,#ot-sdk-cookie-policy a{color:#565656;text-decoration:underline}#onetrust-banner-sdk a:hover,#onetrust-pc-sdk a:hover,#ot-sdk-cookie-policy a:hover{color:#565656;text-decoration:none}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{display:inline-block;height:38px;padding:0 30px;color:#555;text-align:center;font-size:.9em;font-weight:400;line-height:38px;letter-spacing:.01em;text-decoration:none;white-space:nowrap;background-color:rgba(0,0,0,0);border-radius:2px;border:1px solid #bbb;cursor:pointer;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-button:hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#onetrust-pc-sdk .ot-sdk-button:hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#ot-sdk-cookie-policy .ot-sdk-button:hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus{color:#333;border-color:#888;opacity:.9}#onetrust-banner-sdk .ot-sdk-button:focus,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:focus,#onetrust-pc-sdk .ot-sdk-button:focus,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:focus,#ot-sdk-cookie-policy .ot-sdk-button:focus,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:focus{outline:2px solid #000}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-banner-sdk button.ot-sdk-button-primary,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-pc-sdk button.ot-sdk-button-primary,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary,#ot-sdk-cookie-policy button.ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary{color:#fff;background-color:#33c3f0;border-color:#33c3f0}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-banner-sdk button.ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-banner-sdk button.ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:focus,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-pc-sdk button.ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-pc-sdk button.ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:focus{color:#fff;background-color:#1eaedb;border-color:#1eaedb}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{-webkit-appearance:none;-moz-appearance:none;appearance:none}#onetrust-banner-sdk input[type=text]:focus,#onetrust-pc-sdk input[type=text]:focus,#ot-sdk-cookie-policy input[type=text]:focus{border:1px solid #000;outline:0}#onetrust-banner-sdk label,#onetrust-pc-sdk label,#ot-sdk-cookie-policy label{display:block;margin-bottom:.5rem;font-weight:600}#onetrust-banner-sdk input[type=checkbox],#onetrust-pc-sdk input[type=checkbox],#ot-sdk-cookie-policy input[type=checkbox]{display:inline}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{list-style:circle inside}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{padding-left:0;margin-top:0}#onetrust-banner-sdk ul ul,#onetrust-pc-sdk ul ul,#ot-sdk-cookie-policy ul ul{margin:1.5rem 0 1.5rem 3rem;font-size:90%}#onetrust-banner-sdk li,#onetrust-pc-sdk li,#ot-sdk-cookie-policy li{margin-bottom:1rem}#onetrust-banner-sdk th,#onetrust-banner-sdk td,#onetrust-pc-sdk th,#onetrust-pc-sdk td,#ot-sdk-cookie-policy th,#ot-sdk-cookie-policy td{padding:12px 15px;text-align:left;border-bottom:1px solid #e1e1e1}#onetrust-banner-sdk button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-container:after,#onetrust-banner-sdk .ot-sdk-row:after,#onetrust-pc-sdk .ot-sdk-container:after,#onetrust-pc-sdk .ot-sdk-row:after,#ot-sdk-cookie-policy .ot-sdk-container:after,#ot-sdk-cookie-policy .ot-sdk-row:after{content:"";display:table;clear:both}#onetrust-banner-sdk .ot-sdk-row,#onetrust-pc-sdk .ot-sdk-row,#ot-sdk-cookie-policy .ot-sdk-row{margin:0;max-width:none;display:block}#onetrust-banner-sdk{box-shadow:0 0 18px rgba(0,0,0,.2)}#onetrust-banner-sdk.otFlat{position:fixed;z-index:2147483645;bottom:0;right:0;left:0;background-color:#fff;max-height:90%;overflow-x:hidden;overflow-y:auto}#onetrust-banner-sdk.otFlat.top{top:0px;bottom:auto}#onetrust-banner-sdk.otRelFont{font-size:1rem}#onetrust-banner-sdk>.ot-sdk-container{overflow:hidden}#onetrust-banner-sdk::-webkit-scrollbar{width:11px}#onetrust-banner-sdk::-webkit-scrollbar-thumb{border-radius:10px;background:#c1c1c1}#onetrust-banner-sdk{scrollbar-arrow-color:#c1c1c1;scrollbar-darkshadow-color:#c1c1c1;scrollbar-face-color:#c1c1c1;scrollbar-shadow-color:#c1c1c1}#onetrust-banner-sdk #onetrust-policy{margin:1.25em 0 .625em 2em;overflow:hidden}#onetrust-banner-sdk #onetrust-policy .ot-gv-list-handler{float:left;font-size:.82em;padding:0;margin-bottom:0;border:0;line-height:normal;height:auto;width:auto}#onetrust-banner-sdk #onetrust-policy-title{font-size:1.2em;line-height:1.3;margin-bottom:10px}#onetrust-banner-sdk #onetrust-policy-text{clear:both;text-align:left;font-size:.88em;line-height:1.4}#onetrust-banner-sdk #onetrust-policy-text *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk #onetrust-policy-text a{font-weight:bold;margin-left:5px}#onetrust-banner-sdk #onetrust-policy-title,#onetrust-banner-sdk #onetrust-policy-text{color:dimgray;float:left}#onetrust-banner-sdk #onetrust-button-group-parent{min-height:1px;text-align:center}#onetrust-banner-sdk #onetrust-button-group{display:inline-block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{background-color:#68b631;color:#fff;border-color:#68b631;margin-right:1em;min-width:125px;height:auto;white-space:normal;word-break:break-word;word-wrap:break-word;padding:12px 10px;line-height:1.2;font-size:.813em;font-weight:600}#onetrust-banner-sdk #onetrust-pc-btn-handler.cookie-setting-link{background-color:#fff;border:none;color:#68b631;text-decoration:underline;padding-left:0;padding-right:0}#onetrust-banner-sdk .onetrust-close-btn-ui{width:44px;height:44px;background-size:12px;border:none;position:relative;margin:auto;padding:0}#onetrust-banner-sdk .banner_logo{display:none}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{position:absolute;top:50%;transform:translateY(-50%);left:0px}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-policy{margin-left:65px}#onetrust-banner-sdk .ot-b-addl-desc{clear:both;float:left;display:block}#onetrust-banner-sdk #banner-options{float:left;display:table;margin-right:0;margin-left:1em;width:calc(100% - 1em)}#onetrust-banner-sdk .banner-option-input{cursor:pointer;width:auto;height:auto;border:none;padding:0;padding-right:3px;margin:0 0 10px;font-size:.82em;line-height:1.4}#onetrust-banner-sdk .banner-option-input *{pointer-events:none;font-size:inherit;line-height:inherit}#onetrust-banner-sdk .banner-option-input[aria-expanded=true]~.banner-option-details{display:block;height:auto}#onetrust-banner-sdk .banner-option-input[aria-expanded=true] .ot-arrow-container{transform:rotate(90deg)}#onetrust-banner-sdk .banner-option{margin-bottom:12px;margin-left:0;border:none;float:left;padding:0}#onetrust-banner-sdk .banner-option:first-child{padding-left:2px}#onetrust-banner-sdk .banner-option:not(:first-child){padding:0;border:none}#onetrust-banner-sdk .banner-option-header{cursor:pointer;display:inline-block}#onetrust-banner-sdk .banner-option-header :first-child{color:dimgray;font-weight:bold;float:left}#onetrust-banner-sdk .banner-option-header .ot-arrow-container{display:inline-block;border-top:6px solid rgba(0,0,0,0);border-bottom:6px solid rgba(0,0,0,0);border-left:6px solid dimgray;margin-left:10px;vertical-align:middle}#onetrust-banner-sdk .banner-option-details{display:none;font-size:.83em;line-height:1.5;padding:10px 0px 5px 10px;margin-right:10px;height:0px}#onetrust-banner-sdk .banner-option-details *{font-size:inherit;line-height:inherit;color:dimgray}#onetrust-banner-sdk .ot-arrow-container,#onetrust-banner-sdk .banner-option-details{transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-banner-sdk .ot-dpd-container{float:left}#onetrust-banner-sdk .ot-dpd-title{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-title,#onetrust-banner-sdk .ot-dpd-desc{font-size:.88em;line-height:1.4;color:dimgray}#onetrust-banner-sdk .ot-dpd-title *,#onetrust-banner-sdk .ot-dpd-desc *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text *{margin-bottom:0}#onetrust-banner-sdk.ot-iab-2 .onetrust-vendors-list-handler{display:block;margin-left:0;margin-top:5px;clear:both;margin-bottom:0;padding:0;border:0;height:auto;width:auto}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk.ot-close-btn-link{padding-top:25px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container{top:15px;transform:none;right:15px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container button{padding:0;white-space:pre-wrap;border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em}#onetrust-banner-sdk #onetrust-policy-text,#onetrust-banner-sdk .ot-dpd-desc,#onetrust-banner-sdk .ot-b-addl-desc{font-size:.813em;line-height:1.5}#onetrust-banner-sdk .ot-dpd-desc{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-desc>.ot-b-addl-desc{margin-top:10px;margin-bottom:10px;font-size:1em}@media only screen and (max-width: 425px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:6px;right:2px}#onetrust-banner-sdk #onetrust-policy{margin-left:0;margin-top:3em}#onetrust-banner-sdk #onetrust-button-group{display:block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk .onetrust-close-btn-ui{top:auto;transform:none}#onetrust-banner-sdk #onetrust-policy-title{display:inline;float:none}#onetrust-banner-sdk #banner-options{margin:0;padding:0;width:100%}}@media only screen and (min-width: 426px)and (max-width: 896px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:0;right:0}#onetrust-banner-sdk #onetrust-policy{margin-left:1em;margin-right:1em}#onetrust-banner-sdk .onetrust-close-btn-ui{top:10px;right:10px}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:95%}#onetrust-banner-sdk.ot-iab-2 #onetrust-group-container{width:100%}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-button-group-parent{padding-left:50px}#onetrust-banner-sdk #onetrust-button-group-parent{width:100%;position:relative;margin-left:0}#onetrust-banner-sdk #onetrust-button-group button{display:inline-block}#onetrust-banner-sdk #onetrust-button-group{margin-right:0;text-align:center}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler{float:left}#onetrust-banner-sdk .has-reject-all-button #onetrust-reject-all-handler,#onetrust-banner-sdk .has-reject-all-button #onetrust-accept-btn-handler{float:right}#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group{width:calc(100% - 2em);margin-right:0}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler.cookie-setting-link{padding-left:0px;text-align:left}#onetrust-banner-sdk.ot-buttons-fw .ot-sdk-three button{width:100%;text-align:center}#onetrust-banner-sdk.ot-buttons-fw #onetrust-button-group-parent button{float:none}#onetrust-banner-sdk.ot-buttons-fw #onetrust-pc-btn-handler.cookie-setting-link{text-align:center}}@media only screen and (min-width: 550px){#onetrust-banner-sdk .banner-option:not(:first-child){border-left:1px solid #d8d8d8;padding-left:25px}}@media only screen and (min-width: 425px)and (max-width: 550px){#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group,#onetrust-banner-sdk.ot-iab-2 #onetrust-policy,#onetrust-banner-sdk.ot-iab-2 .banner-option{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler{float:left}}@media only screen and (min-width: 769px){#onetrust-banner-sdk #onetrust-button-group{margin-right:30%}#onetrust-banner-sdk #banner-options{margin-left:2em;margin-right:5em;margin-bottom:1.25em;width:calc(100% - 7em)}}@media only screen and (min-width: 897px)and (max-width: 1023px){#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:75%;transform:translateY(-50%)}#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;padding:0;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{position:relative;margin:0;right:-22px;top:2px}}@media only screen and (min-width: 1024px){#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{right:-12px}#onetrust-banner-sdk #onetrust-policy{margin-left:2em}#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:60%;transform:translateY(-50%)}#onetrust-banner-sdk .ot-optout-signal{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-title{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text,#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:1em;width:50%;border-right:1px solid #d8d8d8;padding-right:1rem}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-container{width:45%;padding-left:1rem;display:inline-block;float:none}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-title{line-height:1.7}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group-parent{left:auto;right:4%;margin-left:0}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:auto;width:30%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:60%}#onetrust-banner-sdk #onetrust-button-group{margin-right:auto}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{margin-top:1em}}@media only screen and (min-width: 890px){#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group-parent{padding-left:3%;padding-right:4%;margin-left:0}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{margin-right:0;margin-top:1.25em;width:100%}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button{width:100%;margin-bottom:5px;margin-top:5px}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type{margin-bottom:20px}}@media only screen and (min-width: 1280px){#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:55%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{width:44%;padding-left:2%;padding-right:2%}#onetrust-banner-sdk:not(.ot-iab-2).vertical-align-content #onetrust-button-group-parent{position:absolute;left:55%}}
        #onetrust-consent-sdk #onetrust-banner-sdk {background-color: #FFF;}
            #onetrust-consent-sdk #onetrust-policy-title,
                    #onetrust-consent-sdk #onetrust-policy-text,
                    #onetrust-consent-sdk .ot-b-addl-desc,
                    #onetrust-consent-sdk .ot-dpd-desc,
                    #onetrust-consent-sdk .ot-dpd-title,
                    #onetrust-consent-sdk #onetrust-policy-text *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk .ot-dpd-desc *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk #onetrust-banner-sdk #banner-options *,
                    #onetrust-banner-sdk .ot-cat-header,
                    #onetrust-banner-sdk .ot-optout-signal
                    {
                        color: #2E2E2E;
                    }
            #onetrust-consent-sdk #onetrust-banner-sdk .banner-option-details {
                    background-color: #E9E9E9;}
             #onetrust-consent-sdk #onetrust-banner-sdk a[href],
                    #onetrust-consent-sdk #onetrust-banner-sdk a[href] font,
                    #onetrust-consent-sdk #onetrust-banner-sdk .ot-link-btn
                        {
                            color: #007398;
                        }#onetrust-consent-sdk #onetrust-accept-btn-handler,
                         #onetrust-banner-sdk #onetrust-reject-all-handler {
                            background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-banner-sdk *:focus,
            #onetrust-consent-sdk #onetrust-banner-sdk:focus {
               outline-color: #000000;
               outline-width: 1px;
            }
            #onetrust-consent-sdk #onetrust-pc-btn-handler,
            #onetrust-consent-sdk #onetrust-pc-btn-handler.cookie-setting-link {
                color: #6CC04A; border-color: #6CC04A;
                background-color:
                #FFF;
            }/*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
#onetrust-pc-sdk.otPcCenter{overflow:hidden;position:fixed;margin:0 auto;top:5%;right:0;left:0;width:40%;max-width:575px;min-width:575px;border-radius:2.5px;z-index:2147483647;background-color:#fff;-webkit-box-shadow:0px 2px 10px -3px #999;-moz-box-shadow:0px 2px 10px -3px #999;box-shadow:0px 2px 10px -3px #999}#onetrust-pc-sdk.otPcCenter[dir=rtl]{right:0;left:0}#onetrust-pc-sdk.otRelFont{font-size:1rem}#onetrust-pc-sdk .ot-optout-signal{margin-top:.625rem}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus,#onetrust-pc-sdk .ot-hide-tgl{visibility:hidden}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr *,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus *,#onetrust-pc-sdk .ot-hide-tgl *{visibility:hidden}#onetrust-pc-sdk #ot-gn-venlst .ot-ven-item .ot-acc-hdr{min-height:40px}#onetrust-pc-sdk .ot-pc-header{height:39px;padding:10px 0 10px 30px;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk #ot-pc-title,#onetrust-pc-sdk #ot-category-title,#onetrust-pc-sdk .ot-cat-header,#onetrust-pc-sdk #ot-lst-title,#onetrust-pc-sdk .ot-ven-hdr .ot-ven-name,#onetrust-pc-sdk .ot-always-active{font-weight:bold;color:dimgray}#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:55%;font-weight:700}#onetrust-pc-sdk .ot-cat-item p{clear:both;float:left;margin-top:10px;margin-bottom:5px;line-height:1.5;font-size:.812em;color:dimgray}#onetrust-pc-sdk .ot-close-icon{height:44px;width:44px;background-size:10px}#onetrust-pc-sdk #ot-pc-title{float:left;font-size:1em;line-height:1.5;margin-bottom:10px;margin-top:10px;width:100%}#onetrust-pc-sdk #accept-recommended-btn-handler{margin-right:10px;margin-bottom:25px;outline-offset:-1px}#onetrust-pc-sdk #ot-pc-desc{clear:both;width:100%;font-size:.812em;line-height:1.5;margin-bottom:25px}#onetrust-pc-sdk #ot-pc-desc *{font-size:inherit;line-height:inherit}#onetrust-pc-sdk #ot-pc-desc ul li{padding:10px 0px}#onetrust-pc-sdk a{color:#656565;cursor:pointer}#onetrust-pc-sdk a:hover{color:#3860be}#onetrust-pc-sdk label{margin-bottom:0}#onetrust-pc-sdk #vdr-lst-dsc{font-size:.812em;line-height:1.5;padding:10px 15px 5px 15px}#onetrust-pc-sdk button{max-width:394px;padding:12px 30px;line-height:1;word-break:break-word;word-wrap:break-word;white-space:normal;font-weight:bold;height:auto}#onetrust-pc-sdk .ot-link-btn{padding:0;margin-bottom:0;border:0;font-weight:normal;line-height:normal;width:auto;height:auto}#onetrust-pc-sdk #ot-pc-content{position:absolute;overflow-y:scroll;padding-left:2px;padding-right:30px;top:60px;bottom:110px;margin:1px 3px 0 30px;width:calc(100% - 63px)}#onetrust-pc-sdk .ot-vs-list .ot-always-active,#onetrust-pc-sdk .ot-cat-grp .ot-always-active{float:right;clear:none;color:#3860be;margin:0;font-size:.813em;line-height:1.3}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-track{margin-right:20px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar{width:11px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-thumb{border-radius:10px;background:#d8d8d8}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-pc-scrollbar{scrollbar-arrow-color:#d8d8d8;scrollbar-darkshadow-color:#d8d8d8;scrollbar-face-color:#d8d8d8;scrollbar-shadow-color:#d8d8d8}#onetrust-pc-sdk .save-preference-btn-handler{margin-right:20px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-right:10px}#onetrust-pc-sdk #ot-pc-desc .privacy-notice-link{margin-left:0;margin-right:8px}#onetrust-pc-sdk #ot-pc-desc .ot-imprint-handler{margin-left:0;margin-right:8px}#onetrust-pc-sdk .ot-subgrp-cntr{display:inline-block;clear:both;width:100%;padding-top:15px}#onetrust-pc-sdk .ot-switch+.ot-subgrp-cntr{padding-top:10px}#onetrust-pc-sdk ul.ot-subgrps{margin:0;font-size:initial}#onetrust-pc-sdk ul.ot-subgrps li p,#onetrust-pc-sdk ul.ot-subgrps li h5{font-size:.813em;line-height:1.4;color:dimgray}#onetrust-pc-sdk ul.ot-subgrps .ot-switch{min-height:auto}#onetrust-pc-sdk ul.ot-subgrps .ot-switch-nob{top:0}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr{display:inline-block;width:100%}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-txt{margin:0}#onetrust-pc-sdk ul.ot-subgrps li{padding:0;border:none}#onetrust-pc-sdk ul.ot-subgrps li h5{position:relative;top:5px;font-weight:bold;margin-bottom:0;float:left}#onetrust-pc-sdk li.ot-subgrp{margin-left:20px;overflow:auto}#onetrust-pc-sdk li.ot-subgrp>h5{width:calc(100% - 100px)}#onetrust-pc-sdk .ot-cat-item p>ul,#onetrust-pc-sdk li.ot-subgrp p>ul{margin:0px;list-style:disc;margin-left:15px;font-size:inherit}#onetrust-pc-sdk .ot-cat-item p>ul li,#onetrust-pc-sdk li.ot-subgrp p>ul li{font-size:inherit;padding-top:10px;padding-left:0px;padding-right:0px;border:none}#onetrust-pc-sdk .ot-cat-item p>ul li:last-child,#onetrust-pc-sdk li.ot-subgrp p>ul li:last-child{padding-bottom:10px}#onetrust-pc-sdk .ot-pc-logo{height:40px;width:120px}#onetrust-pc-sdk .ot-pc-footer{position:absolute;bottom:0px;width:100%;max-height:160px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-refuse-all-handler{margin-bottom:0px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:160px}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-footer button{width:100%;max-width:none}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:0 30px;width:calc(100% - 60px);padding-right:0}#onetrust-pc-sdk .ot-pc-footer-logo{height:30px;width:100%;text-align:right;background:#f4f4f4}#onetrust-pc-sdk .ot-pc-footer-logo a{display:inline-block;margin-top:5px;margin-right:10px}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo{direction:rtl}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo a{margin-right:25px}#onetrust-pc-sdk .ot-tgl{float:right;position:relative;z-index:1}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background-color:#468254;border:1px solid #fff}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{-webkit-transform:translateX(20px);-ms-transform:translateX(20px);transform:translateX(20px);background-color:#fff;border-color:#fff}#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch{outline:#000 solid 1px}#onetrust-pc-sdk .ot-switch{position:relative;display:inline-block;width:45px;height:25px}#onetrust-pc-sdk .ot-switch-nob{position:absolute;cursor:pointer;top:0;left:0;right:0;bottom:0;background-color:#767676;border:1px solid #ddd;transition:all .2s ease-in 0s;-moz-transition:all .2s ease-in 0s;-o-transition:all .2s ease-in 0s;-webkit-transition:all .2s ease-in 0s;border-radius:20px}#onetrust-pc-sdk .ot-switch-nob:before{position:absolute;content:"";height:18px;width:18px;bottom:3px;left:3px;background-color:#fff;-webkit-transition:.4s;transition:.4s;border-radius:20px}#onetrust-pc-sdk .ot-chkbox input:checked~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox label{position:relative;display:inline-block;padding-left:30px;cursor:pointer;font-weight:500}#onetrust-pc-sdk .ot-chkbox label::before,#onetrust-pc-sdk .ot-chkbox label::after{position:absolute;content:"";display:inline-block;border-radius:3px}#onetrust-pc-sdk .ot-chkbox label::before{height:18px;width:18px;border:1px solid #3860be;left:0px;top:auto}#onetrust-pc-sdk .ot-chkbox label::after{height:5px;width:9px;border-left:3px solid;border-bottom:3px solid;transform:rotate(-45deg);-o-transform:rotate(-45deg);-ms-transform:rotate(-45deg);-webkit-transform:rotate(-45deg);left:4px;top:5px}#onetrust-pc-sdk .ot-label-txt{display:none}#onetrust-pc-sdk .ot-chkbox input,#onetrust-pc-sdk .ot-tgl input{position:absolute;opacity:0;width:0;height:0}#onetrust-pc-sdk .ot-arw-cntr{float:right;position:relative;pointer-events:none}#onetrust-pc-sdk .ot-arw-cntr .ot-arw{width:16px;height:16px;margin-left:5px;color:dimgray;display:inline-block;vertical-align:middle;-webkit-transition:all 150ms ease-in 0s;-moz-transition:all 150ms ease-in 0s;-o-transition:all 150ms ease-in 0s;transition:all 150ms ease-in 0s}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw-cntr svg{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-tgl-cntr,#onetrust-pc-sdk .ot-arw-cntr{display:inline-block}#onetrust-pc-sdk .ot-tgl-cntr{width:45px;float:right;margin-top:2px}#onetrust-pc-sdk #ot-lst-cnt .ot-tgl-cntr{margin-top:10px}#onetrust-pc-sdk .ot-always-active-subgroup{width:auto;padding-left:0px !important;top:3px;position:relative}#onetrust-pc-sdk .ot-label-status{font-size:.75em;display:none;font-size:.75em;position:relative;top:2px;padding-right:5px;float:left}#onetrust-pc-sdk .ot-arw-cntr{margin-top:-1px}#onetrust-pc-sdk .ot-arw-cntr svg{-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s;transition:all 300ms ease-in 0s;height:10px;width:10px}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk .ot-arw{width:10px;margin-left:15px;transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0}#onetrust-pc-sdk .ot-hlst-cntr{margin-top:5px;display:inline-block;width:100%}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{clear:both;color:#3860be;margin-left:0;font-size:.813em;text-decoration:none;float:left;overflow:hidden}#onetrust-pc-sdk .category-vendors-list-handler:hover,#onetrust-pc-sdk .category-vendors-list-handler+a:hover,#onetrust-pc-sdk .category-host-list-handler:hover{text-decoration-line:underline}#onetrust-pc-sdk .category-vendors-list-handler+a{clear:none}#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{display:inline-block;height:13px;width:13px;background-repeat:no-repeat;margin-left:1px;margin-top:6px;cursor:pointer}#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{margin-bottom:-1px}#onetrust-pc-sdk .back-btn-handler{font-size:1em;text-decoration:none}#onetrust-pc-sdk .back-btn-handler:hover{opacity:.6}#onetrust-pc-sdk #ot-lst-title h3{display:inline-block;word-break:break-word;word-wrap:break-word;margin-bottom:0;color:#656565;font-size:1em;font-weight:bold;margin-left:15px}#onetrust-pc-sdk #ot-lst-title{margin:10px 0 10px 0px;font-size:1em;text-align:left}#onetrust-pc-sdk #ot-pc-hdr{margin:0 0 0 30px;height:auto;width:auto}#onetrust-pc-sdk #ot-pc-hdr input::placeholder{color:#707070;font-style:italic}#onetrust-pc-sdk #vendor-search-handler{height:31px;width:100%;border-radius:50px;font-size:.8em;padding-right:35px;padding-left:15px;float:left;margin-left:15px}#onetrust-pc-sdk .ot-ven-name{display:block;width:auto;padding-right:5px}#onetrust-pc-sdk #ot-lst-cnt{overflow-y:auto;margin-left:20px;margin-right:7px;width:calc(100% - 27px);max-height:calc(100% - 80px);height:100%;transform:translate3d(0, 0, 0)}#onetrust-pc-sdk #ot-pc-lst{width:100%;bottom:100px;position:absolute;top:60px}#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr *{visibility:hidden}#onetrust-pc-sdk #ot-pc-lst .ot-tgl-cntr{right:12px;position:absolute}#onetrust-pc-sdk #ot-pc-lst .ot-arw-cntr{float:right;position:relative}#onetrust-pc-sdk #ot-pc-lst .ot-arw{margin-left:10px}#onetrust-pc-sdk #ot-pc-lst .ot-acc-hdr{overflow:hidden;cursor:pointer}#onetrust-pc-sdk .ot-vlst-cntr{overflow:hidden}#onetrust-pc-sdk #ot-sel-blk{overflow:hidden;width:100%;position:sticky;position:-webkit-sticky;top:0;z-index:3}#onetrust-pc-sdk #ot-back-arw{height:12px;width:12px}#onetrust-pc-sdk .ot-lst-subhdr{width:100%;display:inline-block}#onetrust-pc-sdk .ot-search-cntr{float:left;width:78%;position:relative}#onetrust-pc-sdk .ot-search-cntr>svg{width:30px;height:30px;position:absolute;float:left;right:-15px}#onetrust-pc-sdk .ot-fltr-cntr{float:right;right:50px;position:relative}#onetrust-pc-sdk #filter-btn-handler{background-color:#3860be;border-radius:17px;display:inline-block;position:relative;width:32px;height:32px;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease;padding:0;margin:0}#onetrust-pc-sdk #filter-btn-handler:hover{background-color:#3860be}#onetrust-pc-sdk #filter-btn-handler svg{width:12px;height:12px;margin:3px 10px 0 10px;display:block;position:static;right:auto;top:auto}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{color:#3860be;text-decoration:none;font-weight:100;display:inline-block;padding-top:10px;transform:translate(0, 1%);-o-transform:translate(0, 1%);-ms-transform:translate(0, 1%);-webkit-transform:translate(0, 1%);position:relative;z-index:2}#onetrust-pc-sdk .ot-ven-link *,#onetrust-pc-sdk .ot-ven-legclaim-link *{font-size:inherit}#onetrust-pc-sdk .ot-ven-link:hover,#onetrust-pc-sdk .ot-ven-legclaim-link:hover{text-decoration:underline}#onetrust-pc-sdk .ot-ven-hdr{width:calc(100% - 160px);height:auto;float:left;word-break:break-word;word-wrap:break-word;vertical-align:middle;padding-bottom:3px}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{letter-spacing:.03em;font-size:.75em;font-weight:400}#onetrust-pc-sdk .ot-ven-dets{border-radius:2px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-ven-dets li:first-child p:first-child{border-top:none}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:not(:first-child){border-top:1px solid #ddd !important}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(odd){width:30%}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(even){width:50%;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p,#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{padding-top:5px;padding-bottom:5px;display:block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-last-child(-n+1){padding-bottom:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-child(-n+2):not(.disc-pur){padding-top:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur-cont{display:inline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur{position:relative;width:50% !important;word-break:break-word;word-wrap:break-word;left:calc(30% + 17px)}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur:nth-child(-n+1){position:static}#onetrust-pc-sdk .ot-ven-dets p,#onetrust-pc-sdk .ot-ven-dets h5,#onetrust-pc-sdk .ot-ven-dets span{font-size:.69em;text-align:left;vertical-align:middle;word-break:break-word;word-wrap:break-word;margin:0;padding-bottom:10px;padding-left:15px;color:#2e3644}#onetrust-pc-sdk .ot-ven-dets h5{padding-top:5px}#onetrust-pc-sdk .ot-ven-dets span{color:dimgray;padding:0;vertical-align:baseline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-pur h5{border-top:1px solid #e9e9e9;border-bottom:1px solid #e9e9e9;padding-bottom:5px;margin-bottom:5px;font-weight:bold}#onetrust-pc-sdk #ot-host-lst .ot-sel-all{float:right;position:relative;margin-right:42px;top:10px}#onetrust-pc-sdk #ot-host-lst .ot-sel-all input[type=checkbox]{width:auto;height:auto}#onetrust-pc-sdk #ot-host-lst .ot-sel-all label{height:20px;width:20px;padding-left:0px}#onetrust-pc-sdk #ot-host-lst .ot-acc-txt{overflow:hidden;width:95%}#onetrust-pc-sdk .ot-host-hdr{position:relative;z-index:1;pointer-events:none;width:calc(100% - 125px);float:left}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-desc{display:inline-block;width:90%}#onetrust-pc-sdk .ot-host-name{pointer-events:none}#onetrust-pc-sdk .ot-host-hdr>a{text-decoration:underline;font-size:.82em;position:relative;z-index:2;float:left;margin-bottom:5px;pointer-events:initial}#onetrust-pc-sdk .ot-host-name+a{margin-top:5px}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a,#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{color:dimgray;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a{font-weight:bold;font-size:.82em;line-height:1.3}#onetrust-pc-sdk .ot-host-name a{font-size:1em}#onetrust-pc-sdk .ot-host-expand{margin-top:3px;margin-bottom:3px;clear:both;display:block;color:#3860be;font-size:.72em;font-weight:normal}#onetrust-pc-sdk .ot-host-expand *{font-size:inherit}#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{font-size:.688em;line-height:1.4;font-weight:normal}#onetrust-pc-sdk .ot-host-desc{margin-top:10px}#onetrust-pc-sdk .ot-host-opt{margin:0;font-size:inherit;display:inline-block;width:100%}#onetrust-pc-sdk .ot-host-opt li>div div{font-size:.8em;padding:5px 0}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(1){width:30%;float:left}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(2){width:70%;float:left;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-info{border:none;display:inline-block;width:calc(100% - 10px);padding:10px;margin-bottom:10px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-host-info>div{overflow:auto}#onetrust-pc-sdk #no-results{text-align:center;margin-top:30px}#onetrust-pc-sdk #no-results p{font-size:1em;color:#2e3644;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk #no-results p span{font-weight:bold}#onetrust-pc-sdk #ot-fltr-modal{width:100%;height:auto;display:none;-moz-transition:.2s ease;-o-transition:.2s ease;-webkit-transition:2s ease;transition:.2s ease;overflow:hidden;opacity:1;right:0}#onetrust-pc-sdk #ot-fltr-modal .ot-label-txt{display:inline-block;font-size:.85em;color:dimgray}#onetrust-pc-sdk #ot-fltr-cnt{z-index:2147483646;background-color:#fff;position:absolute;height:90%;max-height:300px;width:325px;left:210px;margin-top:10px;margin-bottom:20px;padding-right:10px;border-radius:3px;-webkit-box-shadow:0px 0px 12px 2px #c7c5c7;-moz-box-shadow:0px 0px 12px 2px #c7c5c7;box-shadow:0px 0px 12px 2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-scrlcnt{overflow-y:auto;overflow-x:hidden;clear:both;max-height:calc(100% - 60px)}#onetrust-pc-sdk #ot-anchor{border:12px solid rgba(0,0,0,0);display:none;position:absolute;z-index:2147483647;right:55px;top:75px;transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);-webkit-transform:rotate(45deg);background-color:#fff;-webkit-box-shadow:-3px -3px 5px -2px #c7c5c7;-moz-box-shadow:-3px -3px 5px -2px #c7c5c7;box-shadow:-3px -3px 5px -2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-btns{margin-left:15px}#onetrust-pc-sdk #filter-apply-handler{margin-right:15px}#onetrust-pc-sdk .ot-fltr-opt{margin-bottom:5px;margin-left:15px;min-height:20px;width:75%;position:relative}#onetrust-pc-sdk .ot-fltr-opt p{display:inline-block;margin:0;font-size:.9em;color:#2e3644}#onetrust-pc-sdk .ot-chkbox label span{font-size:.85em;color:dimgray}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox][aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk #ot-selall-vencntr,#onetrust-pc-sdk #ot-selall-adtlvencntr,#onetrust-pc-sdk #ot-selall-hostcntr,#onetrust-pc-sdk #ot-selall-licntr,#onetrust-pc-sdk #ot-selall-gnvencntr{right:15px;position:relative;width:20px;height:20px;float:right}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label,#onetrust-pc-sdk #ot-selall-gnvencntr label{float:left;padding-left:0}#onetrust-pc-sdk #ot-ven-lst:first-child{border-top:1px solid #e2e2e2}#onetrust-pc-sdk ul{list-style:none;padding:0}#onetrust-pc-sdk ul li{position:relative;margin:0;padding:15px 15px 15px 10px;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk ul li h3,#onetrust-pc-sdk ul li h4{font-size:.75em;color:#656565;margin:0;display:inline-block;width:70%;height:auto;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk ul li p{margin:0;font-size:.7em}#onetrust-pc-sdk ul li input[type=checkbox]{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0}#onetrust-pc-sdk .ot-cat-item>button:focus,#onetrust-pc-sdk .ot-acc-cntr>button:focus,#onetrust-pc-sdk li>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-cat-item>button,#onetrust-pc-sdk .ot-acc-cntr>button,#onetrust-pc-sdk li>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-host-item>button:focus,#onetrust-pc-sdk .ot-ven-item>button:focus{outline:0;border:2px solid #000}#onetrust-pc-sdk .ot-hide-acc>button{pointer-events:none}#onetrust-pc-sdk .ot-hide-acc .ot-plus-minus>*,#onetrust-pc-sdk .ot-hide-acc .ot-arw-cntr>*{visibility:hidden}#onetrust-pc-sdk .ot-hide-acc .ot-acc-hdr{min-height:30px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt){padding-right:10px;width:calc(100% - 37px);margin-top:10px;max-height:calc(100% - 90px)}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk{background-color:#f9f9fc;border:1px solid #e2e2e2;width:calc(100% - 2px);padding-bottom:5px;padding-top:5px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt{border:unset;background-color:unset}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all-hdr{display:none}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all{padding-right:.5rem}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all .ot-chkbox{right:0}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all{padding-right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all-chkbox{width:auto}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) ul li{border:1px solid #e2e2e2;margin-bottom:10px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-acc-cntr>.ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk.ot-addtl-vendors .ot-sel-all-chkbox{float:right}#onetrust-pc-sdk.ot-addtl-vendors .ot-plus-minus~.ot-sel-all-chkbox{right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-ven-lst:first-child{border-top:none}#onetrust-pc-sdk .ot-acc-cntr{position:relative;border-left:1px solid #e2e2e2;border-right:1px solid #e2e2e2;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr input{z-index:1}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr{background-color:#f9f9fc;padding:5px 0 5px 15px;width:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-plus-minus{vertical-align:middle;top:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-arw-cntr{right:10px}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr input{z-index:2}#onetrust-pc-sdk .ot-acc-cntr.ot-add-tech .ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk .ot-acc-cntr>input[type=checkbox]:checked~.ot-acc-hdr{border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-txt{padding-left:10px;padding-right:10px}#onetrust-pc-sdk .ot-acc-cntr button[aria-expanded=true]~.ot-acc-txt{width:auto}#onetrust-pc-sdk .ot-acc-cntr .ot-addtl-venbox{display:none}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0;width:100%}#onetrust-pc-sdk .ot-vensec-title{font-size:.813em;vertical-align:middle;display:inline-block}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a{margin-left:0;margin-top:10px}#onetrust-pc-sdk #ot-selall-vencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-adtlvencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-licntr.line-through label::after,#onetrust-pc-sdk #ot-selall-hostcntr.line-through label::after,#onetrust-pc-sdk #ot-selall-gnvencntr.line-through label::after{height:auto;border-left:0;transform:none;-o-transform:none;-ms-transform:none;-webkit-transform:none;left:5px;top:9px}#onetrust-pc-sdk #ot-category-title{float:left;padding-bottom:10px;font-size:1em;width:100%}#onetrust-pc-sdk .ot-cat-grp{margin-top:10px}#onetrust-pc-sdk .ot-cat-item{line-height:1.1;margin-top:10px;display:inline-block;width:100%}#onetrust-pc-sdk .ot-btn-container{text-align:right}#onetrust-pc-sdk .ot-btn-container button{display:inline-block;font-size:.75em;letter-spacing:.08em;margin-top:19px}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon{position:absolute;top:10px;right:0;z-index:1;padding:0;background-color:rgba(0,0,0,0);border:none}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon svg{display:block;height:10px;width:10px}#onetrust-pc-sdk #clear-filters-handler{margin-top:20px;margin-bottom:10px;float:right;max-width:200px;text-decoration:none;color:#3860be;font-size:.9em;font-weight:bold;background-color:rgba(0,0,0,0);border-color:rgba(0,0,0,0);padding:1px}#onetrust-pc-sdk #clear-filters-handler:hover{color:#2285f7}#onetrust-pc-sdk #clear-filters-handler:focus{outline:#000 solid 1px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl,#onetrust-pc-sdk .ot-enbl-chr h4~.ot-always-active{right:45px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl+.ot-tgl{right:120px}#onetrust-pc-sdk .ot-enbl-chr .ot-pli-hdr.ot-leg-border-color span:first-child{width:90px}#onetrust-pc-sdk .ot-enbl-chr li.ot-subgrp>h5+.ot-tgl-cntr{padding-right:25px}#onetrust-pc-sdk .ot-plus-minus{width:20px;height:20px;font-size:1.5em;position:relative;display:inline-block;margin-right:5px;top:3px}#onetrust-pc-sdk .ot-plus-minus span{position:absolute;background:#27455c;border-radius:1px}#onetrust-pc-sdk .ot-plus-minus span:first-of-type{top:25%;bottom:25%;width:10%;left:45%}#onetrust-pc-sdk .ot-plus-minus span:last-of-type{left:25%;right:25%;height:10%;top:45%}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:first-of-type,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{transform:rotate(90deg)}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{left:50%;right:50%}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk .ot-host-item .ot-plus-minus,#onetrust-pc-sdk .ot-ven-item .ot-plus-minus{float:left;margin-right:8px;top:10px}#onetrust-pc-sdk .ot-ven-item ul{list-style:none inside;font-size:100%;margin:0}#onetrust-pc-sdk .ot-ven-item ul li{margin:0 !important;padding:0;border:none !important}#onetrust-pc-sdk .ot-pli-hdr{color:#77808e;overflow:hidden;padding-top:7.5px;padding-bottom:7.5px;width:calc(100% - 2px);border-top-left-radius:3px;border-top-right-radius:3px}#onetrust-pc-sdk .ot-pli-hdr span:first-child{top:50%;transform:translateY(50%);max-width:90px}#onetrust-pc-sdk .ot-pli-hdr span:last-child{padding-right:10px;max-width:95px;text-align:center}#onetrust-pc-sdk .ot-li-title{float:right;font-size:.813em}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color{background-color:#f4f4f4;border:1px solid #d8d8d8}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color span:first-child{text-align:left;width:70px}#onetrust-pc-sdk li.ot-subgrp>h5,#onetrust-pc-sdk .ot-cat-header{width:calc(100% - 130px)}#onetrust-pc-sdk li.ot-subgrp>h5+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-acc-grpdesc{margin-bottom:5px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-acc-grpcntr .ot-vlst-cntr+.ot-subgrp-cntr{border-top:none}#onetrust-pc-sdk .ot-acc-hdr .ot-arw-cntr+.ot-tgl-cntr,#onetrust-pc-sdk .ot-acc-txt h4+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-subgrp>h5,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header{width:calc(100% - 145px)}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item h5+.ot-tgl-cntr,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header+.ot-tgl{padding-left:28px}#onetrust-pc-sdk .ot-sel-all-hdr,#onetrust-pc-sdk .ot-sel-all-chkbox{display:inline-block;width:100%;position:relative}#onetrust-pc-sdk .ot-sel-all-chkbox{z-index:1}#onetrust-pc-sdk .ot-sel-all{margin:0;position:relative;padding-right:23px;float:right}#onetrust-pc-sdk .ot-consent-hdr,#onetrust-pc-sdk .ot-li-hdr{float:right;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-li-hdr{max-width:100px;padding-right:10px}#onetrust-pc-sdk .ot-consent-hdr{max-width:55px}#onetrust-pc-sdk #ot-selall-licntr{display:block;width:21px;height:auto;float:right;position:relative;right:80px}#onetrust-pc-sdk #ot-selall-licntr label{position:absolute}#onetrust-pc-sdk .ot-ven-ctgl{margin-left:66px}#onetrust-pc-sdk .ot-ven-litgl+.ot-arw-cntr{margin-left:81px}#onetrust-pc-sdk .ot-enbl-chr .ot-host-cnt .ot-tgl-cntr{width:auto}#onetrust-pc-sdk #ot-lst-cnt:not(.ot-host-cnt) .ot-tgl-cntr{width:auto;top:auto;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox label{position:absolute;padding:0;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-acc-grpdesc+.ot-leg-btn-container{padding-left:20px;padding-right:20px;width:calc(100% - 40px);margin-bottom:5px}#onetrust-pc-sdk .ot-subgrp .ot-leg-btn-container{margin-bottom:5px}#onetrust-pc-sdk #ot-ven-lst .ot-leg-btn-container{margin-top:10px}#onetrust-pc-sdk .ot-leg-btn-container{display:inline-block;width:100%;margin-bottom:10px}#onetrust-pc-sdk .ot-leg-btn-container button{height:auto;padding:6.5px 8px;margin-bottom:0;letter-spacing:0;font-size:.75em;line-height:normal}#onetrust-pc-sdk .ot-leg-btn-container svg{display:none;height:14px;width:14px;padding-right:5px;vertical-align:sub}#onetrust-pc-sdk .ot-active-leg-btn{cursor:default;pointer-events:none}#onetrust-pc-sdk .ot-active-leg-btn svg{display:inline-block}#onetrust-pc-sdk .ot-remove-objection-handler{text-decoration:underline;padding:0;font-size:.75em;font-weight:600;line-height:1;padding-left:10px}#onetrust-pc-sdk .ot-obj-leg-btn-handler span{font-weight:bold;text-align:center;font-size:inherit;line-height:1.5}#onetrust-pc-sdk.ot-close-btn-link #close-pc-btn-handler{border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em;background:none;right:15px;top:15px;width:auto;font-weight:normal}#onetrust-pc-sdk .ot-pgph-link{font-size:.813em !important;margin-top:5px;position:relative}#onetrust-pc-sdk .ot-pgph-link.ot-pgph-link-subgroup{margin-bottom:1rem}#onetrust-pc-sdk .ot-pgph-contr{margin:0 2.5rem}#onetrust-pc-sdk .ot-pgph-title{font-size:1.18rem;margin-bottom:2rem}#onetrust-pc-sdk .ot-pgph-desc{font-size:1rem;font-weight:400;margin-bottom:2rem;line-height:1.5rem}#onetrust-pc-sdk .ot-pgph-desc:not(:last-child):after{content:"";width:96%;display:block;margin:0 auto;padding-bottom:2rem;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk .ot-cat-header{float:left;font-weight:600;font-size:.875em;line-height:1.5;max-width:90%;vertical-align:middle}#onetrust-pc-sdk .ot-vnd-item>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-vnd-item>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{position:relative;border-radius:2px;margin:0;padding:0;border:1px solid #d8d8d8;border-top:none;width:calc(100% - 2px);float:left}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{margin-top:10px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc{padding-left:20px;padding-right:20px;width:calc(100% - 40px);font-size:.812em;margin-bottom:10px;margin-top:15px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul{padding-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul li{padding-top:0;line-height:1.5;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout div+.ot-acc-grpdesc{margin-top:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:first-child{margin-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:last-child,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr:last-child{margin-bottom:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding-top:11.5px;padding-bottom:11.5px;padding-left:20px;padding-right:20px;width:calc(100% - 40px);display:inline-block}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-txt{width:100%;padding:0}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp-cntr{padding-left:20px;padding-right:15px;padding-bottom:0;width:calc(100% - 35px)}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp{padding-right:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpcntr{z-index:1;position:relative}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr{position:absolute;top:50%;transform:translateY(-50%);right:20px;margin-top:-2px}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr .ot-arw{width:15px;height:20px;margin-left:5px;color:dimgray}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{float:none;color:#2e3644;margin:0;display:inline-block;height:auto;word-wrap:break-word;min-height:inherit}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding-left:20px;width:calc(100% - 20px);display:inline-block;margin-top:0;padding-bottom:2px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{position:relative;min-height:25px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl,#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{position:absolute;top:50%;transform:translateY(-50%);right:20px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl+.ot-tgl{right:95px}#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler,#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler+a{margin-top:5px}#onetrust-pc-sdk #ot-lst-cnt{margin-top:1rem;max-height:calc(100% - 96px)}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list,#onetrust-pc-sdk .ot-vnd-serv{width:auto;padding:1rem 1.25rem;padding-bottom:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:600;font-size:.95em;line-height:2;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item{border:none;margin:0;padding:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button{outline:none;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button[aria-expanded=true],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button[aria-expanded=true]{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:first-child{margin-top:.25rem;border-top:unset}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child{margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child button{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 1.75rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-lbl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-cnt,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt{padding-left:40px}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-size:.8em}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-cat-header{font-size:.8em}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv{margin-bottom:1rem;padding:1rem .95rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:700;font-size:.8em;line-height:20px;margin-left:.82rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-cat-header{font-weight:700;font-size:.8em;line-height:20px}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-vnd-serv .ot-vnd-lst-cont .ot-accordion-layout .ot-acc-hdr div.ot-chkbox{margin-left:.82rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr{padding:.7rem 0;margin:0;display:flex;width:100%;align-items:center;justify-content:space-between}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:first-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:first-child{margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:last-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:last-child{margin-right:.5rem;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-always-active{position:relative;right:unset;top:unset;transform:unset}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-plus-minus{top:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-arw-cntr{float:none;top:unset;right:unset;transform:unset;margin-top:-2px;position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-cat-header{flex:1;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-tgl{position:relative;transform:none;right:0;top:0;float:none}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox{position:relative;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label{padding:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label::before{position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox input{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0;z-index:1}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h5.ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h4.ot-cat-header{margin:0}#onetrust-pc-sdk .ot-vs-config .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp h5{top:0;line-height:20px}#onetrust-pc-sdk .ot-vs-list{display:flex;flex-direction:column;padding:0;margin:.5rem 4px}#onetrust-pc-sdk .ot-vs-selc-all{display:flex;padding:0;float:unset;align-items:center;justify-content:flex-start}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf{justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf.ot-caret-conf .ot-sel-all-chkbox{margin-right:48px}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf .ot-sel-all-chkbox{margin:0;padding:0;margin-right:14px;justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-chkbox,#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-tgl{display:inline-block;right:unset;width:auto;height:auto;float:none}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr label{width:45px;height:25px}#onetrust-pc-sdk .ot-vs-selc-all .ot-sel-all-chkbox{margin-right:11px;margin-left:.75rem;display:flex;align-items:center}#onetrust-pc-sdk .ot-vs-selc-all .sel-all-hdr{margin:0 1.25rem;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-vnd-list-cnt #ot-selall-vencntr.ot-chkbox{float:unset;right:0}#onetrust-pc-sdk[dir=rtl] #ot-back-arw,#onetrust-pc-sdk[dir=rtl] input~.ot-acc-hdr .ot-arw{transform:rotate(180deg);-o-transform:rotate(180deg);-ms-transform:rotate(180deg);-webkit-transform:rotate(180deg)}#onetrust-pc-sdk[dir=rtl] input:checked~.ot-acc-hdr .ot-arw{transform:rotate(270deg);-o-transform:rotate(270deg);-ms-transform:rotate(270deg);-webkit-transform:rotate(270deg)}#onetrust-pc-sdk[dir=rtl] .ot-chkbox label::after{transform:rotate(45deg);-webkit-transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);border-left:0;border-right:3px solid}#onetrust-pc-sdk[dir=rtl] .ot-search-cntr>svg{right:0}@media only screen and (max-width: 600px){#onetrust-pc-sdk.otPcCenter{left:0;min-width:100%;height:100%;top:0;border-radius:0}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:1px 3px 0 10px;padding-right:10px;width:calc(100% - 23px)}#onetrust-pc-sdk .ot-btn-container button{max-width:none;letter-spacing:.01em}#onetrust-pc-sdk #close-pc-btn-handler{top:10px;right:17px}#onetrust-pc-sdk p{font-size:.7em}#onetrust-pc-sdk #ot-pc-hdr{margin:10px 10px 0 5px;width:calc(100% - 15px)}#onetrust-pc-sdk .vendor-search-handler{font-size:1em}#onetrust-pc-sdk #ot-back-arw{margin-left:12px}#onetrust-pc-sdk #ot-lst-cnt{margin:0;padding:0 5px 0 10px;min-width:95%}#onetrust-pc-sdk .switch+p{max-width:80%}#onetrust-pc-sdk .ot-ftr-stacked button{width:100%}#onetrust-pc-sdk #ot-fltr-cnt{max-width:320px;width:90%;border-top-right-radius:0;border-bottom-right-radius:0;margin:0;margin-left:15px;left:auto;right:40px;top:85px}#onetrust-pc-sdk .ot-fltr-opt{margin-left:25px;margin-bottom:10px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-bottom:0}#onetrust-pc-sdk #ot-fltr-cnt{right:40px}}@media only screen and (max-width: 476px){#onetrust-pc-sdk .ot-fltr-cntr,#onetrust-pc-sdk #ot-fltr-cnt{right:10px}#onetrust-pc-sdk #ot-anchor{right:25px}#onetrust-pc-sdk button{width:100%}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-sel-all{padding-right:9px}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr{right:0}}@media(min-width: 768px){#onetrust-pc-sdk.ot-tgl-with-label .ot-label-status{display:inline}#onetrust-pc-sdk.ot-tgl-with-label #ot-pc-lst .ot-label-status{display:none}}@media only screen and (max-width: 896px)and (max-height: 425px)and (orientation: landscape){#onetrust-pc-sdk.otPcCenter{left:0;top:0;min-width:100%;height:100%;border-radius:0}#onetrust-pc-sdk .ot-pc-header{height:auto;min-height:20px}#onetrust-pc-sdk .ot-pc-header .ot-pc-logo{max-height:30px}#onetrust-pc-sdk .ot-pc-footer{max-height:60px;overflow-y:auto}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk #ot-pc-lst{bottom:70px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:70px}#onetrust-pc-sdk #ot-anchor{left:initial;right:50px}#onetrust-pc-sdk #ot-lst-title{margin-top:12px}#onetrust-pc-sdk #ot-lst-title *{font-size:inherit}#onetrust-pc-sdk #ot-pc-hdr input{margin-right:0;padding-right:45px}#onetrust-pc-sdk .switch+p{max-width:85%}#onetrust-pc-sdk #ot-sel-blk{position:static}#onetrust-pc-sdk #ot-pc-lst{overflow:auto}#onetrust-pc-sdk #ot-lst-cnt{max-height:none;overflow:initial}#onetrust-pc-sdk #ot-lst-cnt.no-results{height:auto}#onetrust-pc-sdk input{font-size:1em !important}#onetrust-pc-sdk p{font-size:.6em}#onetrust-pc-sdk #ot-fltr-modal{width:100%;top:0}#onetrust-pc-sdk ul li p,#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{font-size:.6em}#onetrust-pc-sdk.ot-shw-fltr #ot-anchor{display:none !important}#onetrust-pc-sdk.ot-shw-fltr #ot-pc-lst{height:100% !important;overflow:hidden;top:0px}#onetrust-pc-sdk.ot-shw-fltr #ot-fltr-cnt{margin:0;height:100%;max-height:none;padding:10px;top:0;width:calc(100% - 20px);position:absolute;right:0;left:0;max-width:none}#onetrust-pc-sdk.ot-shw-fltr .ot-fltr-scrlcnt{max-height:calc(100% - 65px)}}
            #onetrust-consent-sdk #onetrust-pc-sdk,
                #onetrust-consent-sdk #ot-search-cntr,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-switch.ot-toggle,
                #onetrust-consent-sdk #onetrust-pc-sdk ot-grp-hdr1 .checkbox,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title:after
                ,#onetrust-consent-sdk #onetrust-pc-sdk #ot-sel-blk,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-cnt,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-anchor {
                    background-color: #FFF;
                }
               
            #onetrust-consent-sdk #onetrust-pc-sdk h3,
                #onetrust-consent-sdk #onetrust-pc-sdk h4,
                #onetrust-consent-sdk #onetrust-pc-sdk h5,
                #onetrust-consent-sdk #onetrust-pc-sdk h6,
                #onetrust-consent-sdk #onetrust-pc-sdk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-ven-lst .ot-ven-opts p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-desc,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-li-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-sel-all-hdr span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-modal #modal-header,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-checkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-sel-blk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-lst-title h3,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .back-btn-handler p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .ot-ven-name,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-ven-lst .consent-category,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-label-status,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-chkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #clear-filters-handler,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-optout-signal
                {
                    color: #2E2E2E;
                }
             #onetrust-consent-sdk #onetrust-pc-sdk .privacy-notice-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-pgph-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler + a,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-host-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-legclaim-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-name a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-acc-hdr .ot-host-expand,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-content #ot-pc-desc .ot-link-btn,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info a
                    {
                        color: #007398;
                    }
            #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler:hover { text-decoration: underline;}
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-subgrp-tgl .ot-switch.ot-toggle
             {
                background-color: #F8F8F8;
            }
             #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-ven-dets
                            {
                                background-color: #F8F8F8;
                            }
        #onetrust-consent-sdk #onetrust-pc-sdk
            button:not(#clear-filters-handler):not(.ot-close-icon):not(#filter-btn-handler):not(.ot-remove-objection-handler):not(.ot-obj-leg-btn-handler):not([aria-expanded]):not(.ot-link-btn),
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-active-leg-btn {
                background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-active-menu {
                border-color: #007398;
            }
            
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-remove-objection-handler{
                background-color: transparent;
                border: 1px solid transparent;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn {
                background-color: #FFFFFF;
                color: #4D4D4D; border-color: #4D4D4D;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-tgl input:focus + .ot-switch, .ot-switch .ot-switch-nob, .ot-switch .ot-switch-nob:before,
            #onetrust-pc-sdk .ot-checkbox input[type="checkbox"]:focus + label::before,
            #onetrust-pc-sdk .ot-chkbox input[type="checkbox"]:focus + label::before {
                outline-color: #000000;
                outline-width: 1px;
                outline-offset: 1px;
            }
            #onetrust-pc-sdk .ot-host-item > button:focus, #onetrust-pc-sdk .ot-ven-item > button:focus {
                border: 1px solid #000000;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk *:focus,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-vlst-cntr > a:focus {
               outline: 1px solid #000000;
               outline-offset: 1px;
            }#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,  #onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{
                    background-image: url('https://cdn.cookielaw.org/logos/static/ot_external_link.svg');
                }
            /*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
.ot-sdk-cookie-policy{font-family:inherit;font-size:16px}.ot-sdk-cookie-policy.otRelFont{font-size:1rem}.ot-sdk-cookie-policy h3,.ot-sdk-cookie-policy h4,.ot-sdk-cookie-policy h6,.ot-sdk-cookie-policy p,.ot-sdk-cookie-policy li,.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy th,.ot-sdk-cookie-policy #cookie-policy-description,.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}.ot-sdk-cookie-policy h4{font-size:1.2em}.ot-sdk-cookie-policy h6{font-size:1em;margin-top:2em}.ot-sdk-cookie-policy th{min-width:75px}.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy a:hover{background:#fff}.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}.ot-sdk-cookie-policy .ot-mobile-border{display:none}.ot-sdk-cookie-policy section{margin-bottom:2em}.ot-sdk-cookie-policy table{border-collapse:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy{font-family:inherit;font-size:1rem}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup{margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group-desc,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-table-header,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td{font-size:.9em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td a{font-size:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group{font-size:1em;margin-bottom:.6em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-title{margin-bottom:1.2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy>section{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th{min-width:75px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a:hover{background:#fff}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-mobile-border{display:none}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy section{margin-bottom:2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li{list-style:disc;margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li h4{display:inline-block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{border-collapse:inherit;margin:auto;border:1px solid #d7d7d7;border-radius:5px;border-spacing:initial;width:100%;overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border-bottom:1px solid #d7d7d7;border-right:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr th:last-child,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr td:last-child{border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:25%}.ot-sdk-cookie-policy[dir=rtl]{text-align:left}#ot-sdk-cookie-policy h3{font-size:1.5em}@media only screen and (max-width: 530px){.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) table,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tbody,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) th,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{display:block}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead tr{position:absolute;top:-9999px;left:-9999px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{margin:0 0 1em 0}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd),.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd) a{background:#f6f6f4}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td{border:none;border-bottom:1px solid #eee;position:relative;padding-left:50%}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{position:absolute;height:100%;left:6px;width:40%;padding-right:10px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) .ot-mobile-border{display:inline-block;background-color:#e4e4e4;position:absolute;height:100%;top:0;left:45%;width:2px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{content:attr(data-label);font-weight:bold}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border:none;border-bottom:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{display:block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:auto}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{margin:0 0 1em 0}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{height:100%;width:40%;padding-right:10px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{content:attr(data-label);font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead tr{position:absolute;top:-9999px;left:-9999px;z-index:-9999}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:1px solid #d7d7d7;border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td:last-child{border-bottom:0px}}
                
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h5,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group {
                        color: #696969;
                    }
                    
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title {
                            color: #696969;
                        }
                    
            
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th {
                            background-color: #F8F8F8;
                        }
                    
            .ot-floating-button__front{background-image:url('https://cdn.cookielaw.org/logos/static/ot_persistent_cookie_icon.png')}</style><script src="https://static.addtoany.com/menu/modules/core.pt5ow5lr.js" type="module"></script><style type="text/css">.a2a_hide{display:none}.a2a_logo_color{background-color:#0166ff}.a2a_menu,.a2a_menu *{-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box;float:none;margin:0;padding:0;position:static;height:auto;width:auto}.a2a_menu{border-radius:6px;display:none;direction:ltr;background:#FFF;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;color:#000;line-height:12px;border:1px solid #CCC;vertical-align:baseline;overflow:hidden}.a2a_mini{min-width:200px;position:absolute;width:300px;z-index:9999997}.a2a_overlay{display:none;background:#616c7deb;backdrop-filter:blur(4px);-webkit-backdrop-filter:blur(4px);position:fixed;top:0;right:0;left:0;bottom:0;z-index:9999998;-webkit-tap-highlight-color:transparent;transition:opacity .14s,backdrop-filter .14s}.a2a_full{background:#FFF;border:1px solid #FFF;box-shadow:#2a2a2a1a 0 0 20px 10px;height:auto;height:calc(320px);top:15%;left:50%;margin-left:-320px;position:fixed;text-align:center;width:640px;z-index:9999999;transition:transform .14s,opacity .14s}.a2a_full_footer,.a2a_full_header,.a2a_full_services{border:0;margin:0;padding:12px;box-sizing:border-box}.a2a_full_header{padding-bottom:8px}.a2a_full_services{height:280px;overflow-y:scroll;padding:0 12px;-webkit-overflow-scrolling:touch}.a2a_full_services .a2a_i{display:inline-block;float:none;width:181px;width:calc(33.334% - 18px)}div.a2a_full_footer{font-size:12px;text-align:center;padding:8px 14px}div.a2a_full_footer a,div.a2a_full_footer a:visited{display:inline;font-size:12px;line-height:14px;padding:8px 14px}div.a2a_full_footer a:focus,div.a2a_full_footer a:hover{background:0 0;border:0;color:#0166FF}div.a2a_full_footer a span.a2a_s_a2a,div.a2a_full_footer a span.a2a_w_a2a{background-size:14px;border-radius:3px;display:inline-block;height:14px;line-height:14px;margin:0 3px 0 0;vertical-align:top;width:14px}.a2a_modal{height:0;left:50%;margin-left:-320px;position:fixed;text-align:center;top:15%;width:640px;z-index:9999999;transition:transform .14s,opacity .14s;-webkit-tap-highlight-color:transparent}.a2a_modal_body{background:0 0;border:0;font:24px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;position:relative;height:auto;width:auto}.a2a_thanks{color:#fff;height:auto;margin-top:20px;width:auto}.a2a_thanks>div:first-child{margin:0 0 40px 0}.a2a_thanks div *{height:inherit}#a2a_copy_link{background:#FFF;border:1px solid #FFF;cursor:pointer;margin-top:15%}label.a2a_s_link#a2a_copy_link_icon,label.a2a_w_link#a2a_copy_link_icon{background-size:48px;border-radius:0;display:inline-block;height:48px;left:0;line-height:48px;margin:0 3px 0 0;position:absolute;vertical-align:top;width:48px}#a2a_modal input#a2a_copy_link_text{background-color:transparent;border:0;color:#2A2A2A;cursor:pointer;font:inherit;height:48px;left:62px;max-width:initial;min-height:auto;padding:0;position:relative;width:564px;width:calc(100% - 76px)}#a2a_copy_link_copied{background-color:#0166ff;color:#fff;display:none;font:inherit;font-size:16px;margin-top:1px;padding:3px 8px}@media (forced-colors:active){.a2a_color_buttons a,.a2a_svg{forced-color-adjust:none}}@media (prefers-color-scheme:dark){.a2a_menu a,.a2a_menu a.a2a_i,.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more,i.a2a_i{border-color:#2a2a2a!important;color:#fff!important}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover,.a2a_menu_find_container{border-color:#444!important;background-color:#444!important}.a2a_menu:not(.a2a_thanks){background-color:#2a2a2a;border-color:#2a2a2a}.a2a_menu_find{color:#fff!important}.a2a_menu label.a2a_s_find svg{background-color:transparent!important}.a2a_menu label.a2a_s_find svg path{fill:#fff!important}.a2a_full{box-shadow:#00000066 0 0 20px 10px}.a2a_overlay{background-color:#373737eb}}@media print{.a2a_floating_style,.a2a_menu,.a2a_overlay{visibility:hidden}}@keyframes a2aFadeIn{from{opacity:0}to{opacity:1}}.a2a_starting{opacity:0}.a2a_starting.a2a_full,.a2a_starting.a2a_modal{transform:scale(.8)}@media (max-width:639px){.a2a_full{border-radius:0;top:15%;left:0;margin-left:auto;width:100%}.a2a_modal{left:0;margin-left:10px;width:calc(100% - 20px)}}@media (min-width:318px) and (max-width:437px){.a2a_full .a2a_full_services .a2a_i{width:calc(50% - 18px)}}@media (max-width:317px){.a2a_full .a2a_full_services .a2a_i{width:calc(100% - 18px)}}@media (max-height:436px){.a2a_full{bottom:40px;height:auto;top:40px}}@media (max-height:550px){.a2a_modal{top:30px}}@media (max-height:360px){.a2a_modal{top:20px}.a2a_thanks>div:first-child{margin-bottom:20px}}.a2a_menu a{color:#0166FF;text-decoration:none;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;line-height:14px;height:auto;width:auto;outline:0}.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more{color:#0166FF}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover{color:#2A2A2A;border-color:#EEE;border-style:solid;background-color:#EEE;text-decoration:none}.a2a_menu label.a2a_s_find{background-size:24px;height:24px;left:8px;pointer-events:auto;position:absolute;top:7px;width:24px}.a2a_menu label.a2a_s_find svg{background-color:#FFF}.a2a_menu label.a2a_s_find svg path{fill:#CCC}#a2a_menu_container{display:inline-block}.a2a_menu_find_container{border:1px solid #CCC;border-radius:6px;padding:2px 24px 2px 0;position:relative;text-align:left}.a2a_cols_container .a2a_col1{overflow-x:hidden;overflow-y:auto;-webkit-overflow-scrolling:touch}#a2a_modal input,#a2a_modal input[type=text],.a2a_menu input,.a2a_menu input[type=text]{display:block;background-image:none;box-shadow:none;line-height:100%;margin:0;outline:0;overflow:hidden;padding:0;-moz-box-shadow:none;-webkit-box-shadow:none;-webkit-appearance:none}#a2afeed_find_container input,#a2afeed_find_container input[type=text],#a2apage_find_container input,#a2apage_find_container input[type=text]{background-color:transparent;border:0;box-sizing:content-box;color:#2A2A2A;float:none;font:inherit;font-size:16px;height:28px;line-height:20px;left:38px;outline:0;margin:0;max-width:initial;min-height:initial;padding:2px 0;position:relative;width:99%}.a2a_clear{clear:both}.a2a_svg{background-repeat:no-repeat;display:block;overflow:hidden;height:32px;line-height:32px;padding:0;pointer-events:none;width:32px}.a2a_svg svg{background-repeat:no-repeat;background-position:50% 50%;border:none;display:block;left:0;margin:0 auto;overflow:hidden;padding:0;position:relative;top:0;width:auto;height:auto}a.a2a_i,i.a2a_i{display:block;float:left;border:1px solid #FFF;line-height:24px;padding:6px 8px;text-align:left;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;width:132px}a.a2a_i span,a.a2a_more span{display:inline-block;overflow:hidden;vertical-align:top}a.a2a_i .a2a_svg{margin:0 6px 0 0}a.a2a_i .a2a_svg,a.a2a_more .a2a_svg{background-size:24px;height:24px;line-height:24px;width:24px}a.a2a_sss:hover{border-left:1px solid #CCC}a.a2a_more{border-bottom:1px solid #FFF;border-left:0;border-right:0;line-height:24px;margin:6px 0 0;padding:6px;-webkit-touch-callout:none}a.a2a_more span{height:24px;margin:0 6px 0 0}.a2a_kit .a2a_svg{background-repeat:repeat}.a2a_default_style a:empty,.a2a_flex_style a:empty,.a2a_floating_style a:empty,.a2a_overlay_style a:empty{display:none}.a2a_color_buttons a,.a2a_floating_style a{text-decoration:none}.a2a_default_style:not(.a2a_flex_style) a{float:left;line-height:16px;padding:0 2px}.a2a_default_style a:hover .a2a_svg,.a2a_floating_style a:hover .a2a_svg,.a2a_overlay_style a:hover .a2a_svg svg{opacity:.7}.a2a_overlay_style.a2a_default_style a:hover .a2a_svg{opacity:1}.a2a_default_style .a2a_count,.a2a_default_style .a2a_svg,.a2a_floating_style .a2a_svg,.a2a_menu .a2a_svg,.a2a_vertical_style .a2a_count,.a2a_vertical_style .a2a_svg{border-radius:4px}.a2a_default_style .a2a_counter img,.a2a_default_style .a2a_dd,.a2a_default_style .a2a_svg{float:left}.a2a_default_style .a2a_img_text{margin-right:4px}.a2a_default_style .a2a_divider{border-left:1px solid #000;display:inline;float:left;height:16px;line-height:16px;margin:0 5px}.a2a_kit a{cursor:pointer;transition:none}.a2a_floating_style{background-color:#fff;border-radius:6px;position:fixed;z-index:9999995}.a2a_overlay_style{z-index:2147483647}.a2a_floating_style,.a2a_overlay_style{animation:a2aFadeIn .2s ease-in;padding:4px}.a2a_vertical_style:not(.a2a_flex_style) a{clear:left;display:block;overflow:hidden;padding:4px}.a2a_floating_style.a2a_default_style{bottom:0}.a2a_floating_style.a2a_default_style a,.a2a_overlay_style.a2a_default_style a{padding:4px}.a2a_count{background-color:#fff;border:1px solid #ccc;box-sizing:border-box;color:#2a2a2a;display:block;float:left;font:12px Arial,Helvetica,sans-serif;height:16px;margin-left:4px;position:relative;text-align:center;width:50px}.a2a_count:after,.a2a_count:before{border:solid transparent;border-width:4px 4px 4px 0;content:"";height:0;left:0;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:50%;width:0}.a2a_count:before{border-right-color:#ccc}.a2a_count:after{border-right-color:#fff;margin-left:-3px}.a2a_count span{animation:a2aFadeIn .14s ease-in}.a2a_vertical_style .a2a_counter img{display:block}.a2a_vertical_style .a2a_count{float:none;margin-left:0;margin-top:6px}.a2a_vertical_style .a2a_count:after,.a2a_vertical_style .a2a_count:before{border:solid transparent;border-width:0 4px 4px 4px;content:"";height:0;left:50%;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:0;width:0}.a2a_vertical_style .a2a_count:before{border-bottom-color:#ccc}.a2a_vertical_style .a2a_count:after{border-bottom-color:#fff;margin-top:-3px}.a2a_color_buttons .a2a_count,.a2a_color_buttons .a2a_count:after,.a2a_color_buttons .a2a_count:before,.a2a_color_buttons.a2a_vertical_style .a2a_count:after,.a2a_color_buttons.a2a_vertical_style .a2a_count:before{background-color:transparent;border:none;color:#fff;float:none;width:auto}.a2a_color_buttons.a2a_vertical_style .a2a_count{margin-top:0}.a2a_flex_style{display:flex;align-items:flex-start;gap:0}.a2a_default_style.a2a_flex_style{left:0;right:0;width:100%}.a2a_vertical_style.a2a_flex_style{flex-direction:column;top:0;bottom:0}.a2a_flex_style a{display:flex;justify-content:center;flex:1;padding:4px}.a2a_flex_style.a2a_vertical_style a{flex-direction:column}.a2a_floating_style.a2a_color_buttons,.a2a_floating_style.a2a_flex_style{border-radius:0;padding:0}.a2a_floating_style.a2a_default_style.a2a_flex_style{bottom:0}.a2a_kit.a2a_flex_style .a2a_counter img,.a2a_kit.a2a_flex_style .a2a_dd,.a2a_kit.a2a_flex_style .a2a_svg{float:none}.a2a_nowrap{white-space:nowrap}.a2a_note{margin:0 auto;padding:9px;font-size:12px;text-align:center}.a2a_note .a2a_note_note{margin:0;color:#2A2A2A}.a2a_wide a{display:block;margin-top:3px;border-top:1px solid #EEE;text-align:center}.a2a_label{position:absolute!important;clip-path:polygon(0px 0px,0px 0px,0px 0px);-webkit-clip-path:polygon(0px 0px,0px 0px,0px 0px);overflow:hidden;height:1px;width:1px}.a2a_kit,.a2a_menu,.a2a_modal,.a2a_overlay{-ms-touch-action:manipulation;touch-action:manipulation;outline:0}.a2a_dd{-webkit-user-drag:none}.a2a_dd img{border:0}.a2a_button_facebook_like iframe{max-width:none}</style><style></style><link href="https://crossmark-cdn.crossref.org/widget/v2.0/style.css" type="text/css" rel="stylesheet"></head>
<body class="pb-ui">
    <div class="skip">
        <a href="#page-body-id" id="skipNavigationLink" title="Skip to Main Content" tabindex="0" class="skipToContent">Skip to Main Content</a>
        <a href="#mega-menu-nav" id="skipToMainMenu" title="Skip to Main Menu" tabindex="0" class="skipToContent">Skip to Main Menu</a>
    </div>



    <div id="pb-page-content" data-ng-non-bindable="">
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="ux3-layout-widget" data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" class="ux3">
        
    

        


    

            

            
                <div class="cell fonts-loaded">
            

            <div data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" data-widget-name="ux3-layout-widget"><div>
    

        


    

            

            

            <div id="a1f1ba25-79af-4194-aaa9-66206104a800" class="widget loginPopup none widget-none widget-compact-all"><div class="wrapped"><div class="widget-body body body-none body-compact-all"><div role="dialog" aria-modal="true" aria-label="Login" class="popup login-popup hidden"><div class="content"><a href="#" aria-label="Close login popup" title="Close login popup" role="button" class="close"><i class="icon-close_thin"></i></a><h2 class="login-title">Login to your account</h2><div class="login-form"><p tabindex="-1" class="message error"></p><form action="/action/doLogin?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901165-X" method="post"><input type="hidden" name="redirectUri" value="https://www.cell.com/cell/fulltext/S0092-8674(21)01165-X"><input type="hidden" name="referer" value="/cell/fulltext/S0092-8674(21)01165-X"><input type="hidden" name="ecommRedirect"><input type="hidden" name="code" value="cell-site"><input type="hidden" name="UX3LoginWidget" value="true"><input type="hidden" name="isPopup" value="true"><div class="input-group login-input--wrapper"><div class="label"><label for="login">Email/Username</label></div><input id="login" type="text" name="login" value="" size="15" class="login"><div role="alert" class="error-hint js--hidden"><div class="error-hint__text"><div class="error-text">Your email address is a required field.</div><div class="email-example">E.g., j.smith@mail.com</div></div></div></div><div class="input-group login-input--wrapper"><div class="label"><label for="password">Password</label></div><input id="password" type="password" name="password" value="" autocomplete="off" class="password"><a href="#" class="login__field__action js-show-password">Show</a><div role="alert" class="error-hint js--hidden"><span class="error-hint__text">Your password is a required field.</span></div><div class="actions"><a href="https://www.cell.com/action/requestResetPassword" class="link show-request-reset-password">Forgot password?</a></div></div><div class="remember"><input type="checkbox" name="savePassword" id="a1f1ba25-79af-4194-aaa9-66206104a800-remember" value="1" checked="checked"><label for="a1f1ba25-79af-4194-aaa9-66206104a800-remember">Remember me</label></div><div class="submit"><input type="submit" name="submit" value="Log in" class="button submit primary"></div></form></div><div class="create-account"><div>Don’t have an account?</div><a href="/action/registration?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901165-X" class="show-registration">Create a Free Account</a></div></div></div></div></div></div>

            

        

    

        


    

            

            

            <div role="dialog" aria-modal="true" aria-label="Reset password" class="popup top-drawer request-reset-password-drawer hidden"><div class="content"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" role="button" class="close"><i class="icon-close_thin"></i></a><div class="request-reset"><div class="form"><p class="sub">If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password</p><div tabindex="-1" class="message error"></div><form action="/action/requestResetPassword" method="post" class="request-reset-password-form"><input type="hidden" name="platform"><input type="hidden" name="requestResetPassword" value="true"><input type="hidden" name="codeSite" value="cell-site"><div class="input-group"><div class="label"><label for="reset-password-email">Email*</label></div><input id="reset-password-email" type="text" name="email" value="" size="15" class="email"></div><div class="submit" disabled="disabled"><input type="submit" name="submit" value="Submit" disabled="disabled" class="button primary submit"></div></form></div><div class="success-template hidden"><p>If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password</p></div></div><div class="request-reset-cancel"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" class="cancel">Cancel</a></div></div></div>

            

        

    

        


    

            

            
                <div class="ux3-ads">
            

            <div class="pb-ad">
            <!-- Do Not Modify without contacting ELS-HSOnlineCampaign@elsevier.com -->
<!-- To be kept in sync with Global Commercial Publishing Operations-->
<!-- Start: GPT Async -->
<div id="gpt-Variables" data-adfile="CELLJOURNAL">
	<input type="hidden" id="gptSite" value="cell">
	<input type="hidden" id="gptLoggedIn" value="no">
	<input type="hidden" id="gptAccessType" value="ae:ANON_GUEST|ae:ANON_GUEST">
	<input type="hidden" id="gptDefaultSite" value="cell">
</div>
<div id="gpt-Interscroller" class="gpt-InScrollBox" style="display:none;">
	<div class="gpt-InScrollLabel">ADVERTISEMENT</div>
	<div class="gpt-InScrollContainer">
		<div class="gpt-InScrollWrapper">
			<div class="gpt-InScrollInner">
				<div class="gpt-adinterscroller" data-adsize="interscroller"></div>
			</div>
		</div>
	</div>
	<div class="gpt-InScrollLabel">SCROLL TO CONTINUE WITH CONTENT</div>
</div>
<div id="gpt-DebugDiv" class="gpt-DebugDiv" style="display:none;">
	<div style="width: 100%; display: table;">
		<div style="display: table-row">
			<div style="width: 200px; display: table-cell;">
				<button class="gpt-DebugBtn" onclick="gpt_ShowConsole()">Open GPT Console</button><br>
				<button id="gpt_GrapeShotDebugBtn" class="gpt-DebugBtn" onclick="gpt_GrapeShotDebug();">Open Oracle Keywords</button><br>
				<br>
				<button class="gpt-DebugBtn" onclick="gpt_LoadDebugValues()">Refresh Values</button>
			</div>
			<div style="display: table-cell;">
				<table class="gpt-DebugTable">
					<thead>
						<tr>
							<th>Property</th>
							<th>Value</th>
						</tr>
					</thead>
					<tbody>
						<tr><td class="gpt-DebugTitle">Status</td><td><div class="gptStatus_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Version</td><td><div class="gptVersion_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad File</td><td><div class="gptAdFile_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Disable Ads Flag</td><td><div class="gptDisableAds_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Environment</td><td><div class="gptTestENV_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Init</td><td><div class="gptMoatInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Ready</td><td><div class="gptMoatReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Ready</td><td><div class="gptContextualReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual URL</td><td><div class="gptContextualURL_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Initial Segments</td><td><div class="gptContextualInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Used Segments</td><td><div class="gptContextualResult_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">AdUnit</td><td><div class="gptSite_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">SubAdUnit</td><td><div class="gptPage_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Custom Targeting</td><td><div class="gptCustomTargeting_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad Events</td><td><div class="gptEvent_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Invalid Ad Sizes</td><td><div class="gptInvalidAdSize_Debug"></div></td></tr>
					</tbody>
				</table>
			</div>
		</div>
	</div>
</div>
<style type="text/css">
	.gpt-DebugBtn {
		display: inline-block;
		text-align: center;
		text-decoration: none;
		margin: 2px 0;
		border: solid 1px #122b40;
		border-radius: 0.4em;
		padding: 0.5em 1em;
		color: #ffffff;
		background-color: #204d74;
		font-weight: normal;
		font-size: 12px;
	}

	.gpt-DebugDiv {
		margin: 5px;
	}

	.gpt-DebugTitle {
		font-weight: bold;
	}

	.gpt-DebugTable {
		border: 1px solid #dddddd;
		border-collapse: collapse;
		margin: 5px;
		font-size: 0.9em;
		font-family: sans-serif;
		min-width: 400px;
		margin-bottom: 25px;
	}

		.gpt-DebugTable td:first-child {
			padding: 5px;
		}

		.gpt-DebugTable thead tr th {
			background-color: #d9edf7;
			color: #ffffff;
			text-align: left;
			padding: 5px;
			border-bottom: 2px solid #204d74;
		}

		.gpt-DebugTable th,
		.gpt-DebugTable td {
			padding: 5px;
		}

		.gpt-DebugTable tbody tr {
			border-bottom: 1px solid #dddddd;
		}

			.gpt-DebugTable tbody tr:nth-of-type(even) {
				background-color: #f3f3f3;
			}

			.gpt-DebugTable tbody tr:last-of-type {
				border-bottom: 2px solid #204d74;
			}

	.gpt-InScrollLabel {
		background-color: rgb(0, 0, 0);
		color: rgb(255, 255, 255);
		position: relative;
		max-width: 100vw;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		padding: 0;
		text-align: center;
		width: 100vw !important;
		font-size: 10px;
	}

	.gpt-InScrollBox {
		height: 100vh !important;
		width: 100vw;
		cursor: pointer;
		max-width: 100vw;
		position: relative;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		margin-bottom: 50px;
		padding-top: 5px;
		padding-bottom: 5px;
		z-index: 10001;
		background-color: white;
	}

		.gpt-InScrollBox .gpt-InScrollContainer {
			height: 95vh !important;
			position: relative;
		}

		.gpt-InScrollBox .gpt-InScrollWrapper {
			position: absolute !important;
			top: 0 !important;
			left: 0;
			width: 100%;
			height: 95vh !important;
			border: 0 !important;
			margin: 0 !important;
			padding: 0 !important;
			clip: rect(0, auto, auto, 0) !important;
			-webkit-clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
			clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
		}

		.gpt-InScrollBox .gpt-InScrollInner {
			position: fixed !important;
			top: 0 !important;
			left: 0 !important;
			bottom: 0;
			margin: auto;
			width: 100vw;
			height: 95vh;
			-webkit-transform: translateZ(0) !important;
			display: -webkit-box;
			display: -ms-flexbox;
			display: flex;
			-webkit-box-orient: vertical;
			-webkit-box-direction: normal;
			-ms-flex-direction: column;
			flex-direction: column;
			-webkit-box-align: center;
			-ms-flex-align: center;
			align-items: center;
			-webkit-box-pack: center;
			-ms-flex-pack: center;
			justify-content: center;
			text-align: center;
		}
</style>
<script class="optanon-category-4" type="text/plain">
	//--------------------------------------------------------------------------
	var gpt_Version = '04072023';
	var gpt_AdFile = $('#gpt-Variables').data('adfile');
	var gpt_MaxMOATInitAttempts = 11;
	var gpt_MaxMOATReadyAttempts = 11;
	var gpt_MaxContextualReadyAttempts = 21;
	var gpt_MOATInitAttempts = 0;
	var gpt_MOATReadyAttempts = 0;
	var gpt_ContextualReadyAttempts = 0;
	var gpt_IsProd = true;
	var gpt_StartTime;
	var gs_channels = 'DEFAULT';
	var gpt_ContextualReady = false;
	var gpt_ContextualURL = 'Not enabled outside of Production';
	var gpt_DisableAdsFlagFound = false;

	var gptEvent_Debug = '';
	var gptCustomTargeting_Debug = '';
	var gptSite_Debug = "";
	var gptPage_Debug = "";
	var gptContextualEnabled = false;
	var gptContextualResult_Debug = '';
	var gptContextualInit_Debug = '';
	var gptContextualURL_Debug = '';
	var gptContextualReady_Debug = '';
	var gptMoatReady_Debug = '';
	var gptMoatInit_Debug = '';
	var gptTestENV_Debug = '';
	var gptDisableAds_Debug = '';
	var gptStatus_Debug = 'GPT Still Loading - Refresh Values';
	var gptInvalidAdSize_Debug = '';
	//--------------------------------------------------------------------------
	$(document).ready(function () {
		//Check to see if we are on a development env
		gpt_CheckEnvironment();

		if (!gpt_DisableAdsFlagFound) {
			gpt_StartTime = new Date();
			if (gpt_AdFile !== "PU") {
				//Once the dom has loaded, begin the process to init the ads.
				gpt_InitScripts();
				gpt_CheckForMOATInit();
			}
		}
	});
</script>
<script type="text/javascript">
	function gpt_CheckEnvironment() {
		if ($('#gptDisableAds').length > 0) {
			gptDisableAds_Debug = 'Flag Detected - Ads Disabled';
			gpt_DisableAdsFlagFound = true;
		}
		else {
			gptDisableAds_Debug = 'Ads Enabled';
			gpt_DisableAdsFlagFound = false;
		}
		switch (gpt_AdFile) {
			case 'PU':
				gptContextualEnabled = true;
				if ($("#Environment").val() !== "Prod") {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			case 'JBS':
			case 'LANCET':
				gptContextualEnabled = true;
				if ($(".gpt-ad").length > 0) {
					//Other ads exist, allow the Prestitial
					$(document.body).append("<div class='gpt-ad' data-adsize='prestitial'></div>");
				}
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			default:
				//Cell
				gptContextualEnabled = false;
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
    function gpt_GetNonCMEArticle() {
        var url;
        $('.articleCitation').each(function (i, obj) {
            if ($(obj).find('.toc__item__detials').length > 0) {
                var itemDetails = $(obj).first().find('.toc__item__detials');
                var cmeFound = 0;
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='CME']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='(CME)']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='Education']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='education']").length; }
                if (cmeFound == 0) {
                    var itemLink = $(itemDetails).first().find('.toc__item__title');
                    var linkCount = $(itemLink).first().find("a:contains('CME')").length;
                    if (linkCount == 0) {
                        url = $(itemLink).first().find('a').attr('href');
                        return false;   //Found a URL, break the loop
                    }
                }
            }
        });
        return url;
    }
	//--------------------------------------------------------------------------
	function gpt_GetElapsedTime() {
		var endTime = new Date();
		var timeDiff = endTime - gpt_StartTime; //in ms
		// strip the ms
		timeDiff /= 1000;

		// get seconds
		return seconds = Math.round(timeDiff) + " seconds";
	}
	//--------------------------------------------------------------------------
	function gpt_CheckSSC() {
		//Check for ScreenShot Client
		var gpt_SSC = gpt_GetQuerystring('gpt_ssc', '');
		if (gpt_SSC == '1') {
			//it's the ScreenShotClient, disable MOAT IVT Detection
			$('#gpt-Variables').append('<input type="hidden" id="gptm_data">');
			$('#gptm_data').val(0);
			gpt_Target("m_data");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_LocalSS(adTypeId) {
		window.scrollTo(0, 0);
		gpt_Sleep(1000);
		gpt_ScrollToAd(adTypeId);
		gpt_PreTearsheet(adTypeId);
	}
	//--------------------------------------------------------------------------
	function gpt_InitScripts() {
		if (gpt_AdFile == "PU") {
			if (gpt_IsProd) {
				gpt_ContextualURL = gpt_CheckForNULL($('#canonicalurl').val());
				if (gpt_ContextualURL === null) {
					gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				}
				else {
					gpt_ContextualURL = window.location.origin + gpt_ContextualURL;
				}
				var useSSL = 'https:' == document.location.protocol;
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}
		}
		else {
			//JBS-Cell-Lancet
			var useSSL = 'https:' == document.location.protocol;

			var gads = document.createElement('script');
			gads.async = true;
			gads.type = 'text/javascript';
			gads.src = (useSSL ? 'https:' : 'http:') + '//securepubads.g.doubleclick.net/tag/js/gpt.js';
			document.head.appendChild(gads);

			if (gpt_IsProd && gptContextualEnabled) {
				gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}

			var elsevierMoatHeader = document.createElement('link');
			elsevierMoatHeader.rel = 'preload';
			elsevierMoatHeader.as = 'script';
			elsevierMoatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(elsevierMoatHeader);

			var elsevierMoatAds = document.createElement('link');
			elsevierMoatAds.rel = 'preconnect';
			elsevierMoatAds.src = (useSSL ? 'https:' : 'http:') + '//mb.moatads.com';
			document.head.appendChild(elsevierMoatAds);

			var moatHeader = document.createElement('script');
			moatHeader.async = true; gads.type = 'text/javascript';
			moatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(moatHeader);
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForMOATInit() {
		//Check every 1/10 of a second until MOAT is Loaded or 1 second timeout
		if (gpt_MOATInitAttempts < gpt_MaxMOATInitAttempts) {
			gpt_MOATInitAttempts += 1;
			if (typeof window.moatPrebidApi === "object") {
				//MOAT LOADED
				gptMoatInit_Debug = '0.0' + gpt_MOATInitAttempts + ' seconds';
				gpt_CheckForMOATReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATInit(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not LOADED
			gptMoatInit_Debug = 'Timeout Expired';
			var googletag = googletag || {};
			googletag.cmd = googletag.cmd || [];
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForMOATReady() {
		//Check every 1/10 of a second until MOAT is Ready or 1 second timeout
		if (gpt_MOATReadyAttempts < gpt_MaxMOATReadyAttempts) {
			gpt_MOATReadyAttempts += 1;
			if (window.moatPrebidApi.safetyDataAvailable()) {
				//MOAT Ready
				gptMoatReady_Debug = '0.0' + gpt_MOATReadyAttempts + " seconds";
				gpt_CheckForContextualReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATReady(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not Ready
			gptMoatReady_Debug = 'Timeout Expired';
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForContextualReady() {
		//Check every 1/10 of a second until Contextual is Ready or 2 second timeout
		if (gpt_IsProd && gptContextualEnabled) {
			//Enabled
			if (gpt_ContextualReadyAttempts < gpt_MaxContextualReadyAttempts) {
				gpt_ContextualReadyAttempts += 1;
				if (gpt_ContextualReady) {
					//Contextual Ready
					gptContextualURL_Debug = gpt_ContextualURL;
					gptContextualReady_Debug = '0.0' + gpt_ContextualReadyAttempts + " seconds";
					gptContextualInit_Debug = gs_channels;
					gpt_InitAds();
				}
				else {
					setTimeout(() => { gpt_CheckForContextualReady(); }, 100);
				}
			}
			else {
				//LOG TIMEOUT error
				//REMOVE FOR NOW (SHOULD LOG TO A DIFF LOCATION)
				//TIMEOUT: Contextual Not Ready
				$('#gpt_GrapeShotDebugBtn').remove();
				gptContextualURL_Debug = gpt_ContextualURL;
				gptContextualReady_Debug = 'Timeout Expired';
				gptContextualInit_Debug = "";
				gpt_InitAds();
			}
		}
		else {
			//Not Enabled
			$('#gpt_GrapeShotDebugBtn').remove();
			switch (gpt_AdFile) {
				case 'PU':
				case 'LANCET':
				case 'JBS':
					gptContextualURL_Debug = 'Not enabled outside of Production';
					gptContextualReady_Debug = 'Not enabled outside of Production';
					gptContextualInit_Debug = 'Not enabled outside of Production';
					break;
				case "CELLJOURNAL":
				case "CELLBUCKET":
					gptContextualReady_Debug = 'Not enabled on Cell';
					gptContextualInit_Debug = 'Not enabled on Cell';
					gptContextualURL_Debug = 'Not enabled on Cell';
					break;
			}
			gpt_InitAds();
		}
	}
	//--------------------------------------------------------------------------
	function GPT_GetPageByURL() {
		var host = window.location.host.toLocaleLowerCase()
		var localpath = window.location.pathname.toLocaleLowerCase();

		///Check for Cell.com
		if (host.indexOf('cell.com') >= 0) {
			return null;
		}

		///Check for Cell.com (marlin-stag)
		if (host.indexOf('www-cell-com') >= 0) {
			return null;
		}

		///Check for Lancet
		if (host.indexOf('thelancet') >= 0) {
			return null;
		}

		if (localpath.indexOf('/article/') >= 0) {
			return 'article.fulltext';
		}

		if (localpath.indexOf('/action/dosearch') >= 0) {
			return 'search.searchResults';
		}

		if (localpath.indexOf('/content/') >= 0) {
			return 'periodical.editorial';
		}

		return 'periodical.home';
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForNULL(x, valueifnull) {
		if (typeof valueifnull == "undefined") {
			valueifnull = null;
		}

		if (typeof x == 'undefined') {
			return valueifnull;
		}
		if (x == null) {
			return valueifnull;
		}
		if (x == "null") {
			return valueifnull;
		}
		if ($.trim(x) == '') {
			return valueifnull;
		}

		return x;
	}
	//--------------------------------------------------------------------------
	function gpt_GetAdditionalTargeting() {
		//adds page level targeting of custom variables
		//the id (minus gpt) and the value will be used as a key-value pair
		//eg: <input type="hidden" id="gptissuepii" value="x" class="gpt-Target">
		//eg: target issuepii=x
		$(".gpt-Target").each(function (index) {
			var gptTargetId = $(this).attr('id');
			gptTargetId = gptTargetId.replace('gpt', '').toLowerCase();
			if (gptTargetId !== '') {
				gpt_Target(gptTargetId);
			}
		})
	}
	//--------------------------------------------------------------------------
	function gpt_GetQuerystring(key, default_) {
		//function to read querystring variables
		if (default_ === null) default_ = '';
		key = key.replace(/[\[]/, "\\\[").replace(/[\]]/, "\\\]");
		var regex = new RegExp("[\\?&]" + key + "=([^&#]*)");
		var qs = regex.exec(window.location.href);
		if (qs === null)
			return default_;
		else
			return qs[1];
	}
	//--------------------------------------------------------------------------
	function gpt_GetDFPTestId() {
		//Get any request for a test id from querystring and set custom targeting parameter
		var gptDFPTestId = gpt_GetQuerystring('dfptestid', '');
		if (gptDFPTestId !== '') {
			$('#gpt-Variables').append('<input type="hidden" id="gptDFPTestId">');
			$('#gptDFPTestId').val(gptDFPTestId);
			gpt_Target("DFPTestId");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Target(targetName) {
		//Set page level target if value is found
		if ($('#gpt' + targetName).length > 0) {
			var targetValue = $('#gpt' + targetName).val();

			if (targetValue !== '') {
				targetValue = targetValue.replace(/[^-a-z0-9]/ig, '');	//Only Allow a-z, 0-9
				googletag.pubads().setTargeting(targetName.toLowerCase(), targetValue.toLowerCase());
				gptCustomTargeting_Debug = gptCustomTargeting_Debug + targetName.toLowerCase() + ' = ' + targetValue.toLowerCase() + '<br>';
			}
		}
	}
	//--------------------------------------------------------------------------
	function gpt_TargetAccessType() {
		var currentAccessType = $('#gptAccessType').val();
		if (typeof currentAccessType == "undefined") {
			currentAccessType = "";
		}
		if (currentAccessType.indexOf('ANON_IP') >= 0) {
			googletag.pubads().setTargeting("loggedin", "yes");
		}
		else {
			gpt_Target("LoggedIn");
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_PreTearsheet(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		//Remove Elsevier Cookie Policy Notice
		if ($("#onetrust-consent-sdk").length > 0) {
			$("#onetrust-consent-sdk").remove();
		}

        //Mobile Nav
        $('#skip').remove();
        $('skipNavigationLink').remove();

		//JBS Modals
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.usabilla__overlay').length > 0) {
			$('.usabilla__overlay').remove();
		}

		//Pendo
		if ($('._pendo-step-container').length > 0) {
			$('._pendo-step-container').remove();
		}
		if ($('._pendo-guide-tt_').length > 0) {
			$('._pendo-guide-tt_').remove();
		}
		if ($('._pendo-image').length > 0) {
			$('._pendo-image').remove();
		}
		if ($('._pendo-badge-image').length > 0) {
			$('._pendo-badge-image').remove();
		}

		switch (gpt_AdFile) {
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Mobile Bug Fix on Cell
				if (parseInt(adTypeId) == 5) {
					$('.widget-horizontalAd').css('position', 'static');
					$('.body-horizontalAd').css('display', 'block');
				}
				break;
			case "JBS":
			case "LANCET":
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 3: //MPU
					case 4: //SkyScraper
						//BUGFIX: Show Sidebar ad for JBS
						//skyscraper & mpu
						if ($('.widget-verticalAd').length > 0) {
							$('.widget-verticalAd').css('display', 'block');
						}
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
					case 6:     //Prestitial
						$('#backgroundLayer').css('display', 'block');
						break;
					default:
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Sleep(ms) {
		return new Promise(resolve => setTimeout(resolve, ms));
	}
	//--------------------------------------------------------------------------
	async function gpt_ScrollToAd(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		var adId = "";
		var offset = 0;
		var objLeaderboard = "";
		var gpt_ScrollToAd = true;

		switch (gpt_AdFile) {
			case "PU": //PracticeUpdate
				var hideOtherAds = true;
				$('#modalPrestitial').modal('hide');
				$('.jumbotron-welcome').hide();
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 2:
						//LeaderBoard, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 3:
						//MPU
						adId = "adSlot2";
						break;
					case 4:
						//SkyScraper
						adId = "adSlot3";
						$('.most-read').hide();
						break;
					case 5:
						//Mobile, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 6:
						//Interstitial
						gpt_ScrollToAd = false;
						adId = "adSlot15";
						await gpt_Sleep(1000);
						$(objLeaderboard).hide();
						$('#modalPrestitial').unbind();
						$('#modalPrestitial').modal();
						break;
					case 7:
						//Native Ad
						break;
					case 10:
						//Master Companion
						hideOtherAds = false;
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
				}
				if (hideOtherAds) {
					//Hide all other ads
					$('.ad-container').each(function (i, obj) {
						if (this.id !== adId) {
							var tempParent = this.id;
							tempParent = tempParent.replace("adSlot", "adParent");
							$("#" + tempParent).addClass('hide');
						}
					});
				}
				break;
			case "JBS":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$(".widget-verticalAd").hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="sidebar"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					case 13:	    //Phone - Portrait
					case 14:        //Phone - Landscape
						$(objLeaderboard).hide();
						offset = 60;
						adId = 'gpt-Interscroller';
						gpt_ScrollToAd = true;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
			case "CELLJOURNAL":
			case "CELLBUCKET":
				objLeaderboard = ".js__adToHide";
				offset = 260;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="boombox"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				//Hide the second ad if found
				var tCount = 0;
				$(".widget.literatumAd.none.GPT-ad-placeholder.widget-horizontalAd.widget-compact-all").each(function (index) {
					tCount += 1;
					if (tCount !== 1) {
						$(this).hide();
					}
				});
				break;
			case "LANCET":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="skyscraper"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
		}

		//Scroll to Top
		var gpt_container = $("html,body");
		gpt_container.animate({ scrollTop: 0, scrollLeft: 0 });

		if (gpt_ScrollToAd) {
			//If Adexists, scroll to it
			var gpt_scrollTo = $('#' + adId);
			if (gpt_scrollTo.length > 0) {
				//Scroll to the Ad
				var gpt_topPosition = gpt_scrollTo.offset().top - gpt_container.offset().top + gpt_container.scrollTop();
				if (gpt_topPosition > 0) {
					gpt_container.animate({ scrollTop: gpt_topPosition, scrollLeft: 0 });
					if (gpt_topPosition - offset > 0 && offset > 0) {
						gpt_container.animate({ scrollTop: gpt_topPosition - offset, scrollLeft: 0 });
					}
				}
			}
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForCookiePolicy() {
		var returnVal = false;
		if ($('#onetrust-accept-btn-handler').length > 0) {
			$('#onetrust-accept-btn-handler').click();
			returnVal = true;
		}
		return returnVal;
	}
	//--------------------------------------------------------------------------
	function gpt_InitAds() {
		var gpt_ResponsiveHomepage = false;

		switch (gpt_AdFile) {
			case "JBS":
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Responsive Check
				if ($('#hdrHomeBrand').length > 0) {
					gpt_ResponsiveHomepage = true;
				}
				break;
		}

		//InterScroller Check
		if (gpt_AdFile === "JBS") {
			var gpt_InterScrollerEnabled = false;
			var gpt_InterScrollerInsertObj;

			if ($("#articleHeader").length > 0) {
				//It's an article Page
				if ($('.article__sections > section').length > 0) {
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".article__sections > section");
				}
			}
			else {
				if ($('.toc__section').length > 0) {
					//It's a TOC Page
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".toc__section").first();
				}
			}

			//Add the Interscroller
			if (gpt_InterScrollerEnabled) {
				gpt_InterScrollerInsertObj.first().append($("#gpt-Interscroller").clone());
				$("#gpt-Interscroller").remove();
				$(".gpt-adinterscroller").addClass("gpt-ad");
			}
		}

		googletag.cmd.push(function () {
			var gptBoomBoxSizeMapping;
			var gptFluidMapping;
			var gptHomePageSidebarMapping;
			var gptCellHomePageSidebarMapping;
			var gptInterscrollerMapping;
			var gptLeaderboardSizeMapping;
			var gptMobileSizeMapping;
			var gptPrestitialMapping;
			var gptRectangleShortSizeMapping;
			var gptRectangleSizeMapping;
			var gptSideBarSizeMapping;
			var gptTallSizeMapping;
			var gptWideSizeMapping;
			var gptWideRectangleSizeMapping;

			//***********************************************
			//Start Define Size mapping based on client Viewport
			//***********************************************
			if (gpt_AdFile === 'PU') {
				gptTallSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 600], [160, 600], [120, 600]]).
					addSize([0, 0], []).
					build();

				gptRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250]]).
					addSize([0, 0], []).
					build();

				gptRectangleShortSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250], [320, 50], [300, 50]]).
					addSize([0, 0], [[300, 250], [320, 50], [300, 50]]).
					build();

				gptWideSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([760, 0], [[728, 90], [320, 50], [300, 50]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptWideRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], []).
					addSize([760, 0], [[320, 50], [300, 50], [300, 250]]).
					addSize([0, 0], [[320, 50], [300, 50], [300, 250]]).
					build();

				gptMobileSizeMapping = googletag.sizeMapping().
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([760, 0], [[1, 1]]).
					build();
			}
			else {
				//JBS-CELL-LANCET
				gptLeaderboardSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([768, 0], [[728, 90]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptHomePageSidebarMapping = googletag.sizeMapping().
					addSize([2090, 795], [[300, 600], [300, 250], [160, 600], [120, 600]]).
					addSize([1910, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptCellHomePageSidebarMapping = googletag.sizeMapping().
                    addSize([2180, 795], [[300, 600], [160, 600], [120, 600], [300, 250], [336, 280]]).
					addSize([2180, 445], [[336, 280]]).
                    addSize([2090, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
                    addSize([2090, 445], [[300, 250]]).
					addSize([1830, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptSideBarSizeMapping = googletag.sizeMapping().
					addSize([1140, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
					addSize([1140, 445], [[300, 250]]).
					addSize([0, 0], []). 				
					build();

				gptBoomBoxSizeMapping = googletag.sizeMapping().
					addSize([768, 0], [[300, 250], [336, 280]]).
					addSize([0, 0], []). 						
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([600, 700], [[1, 1]]).
					addSize([0, 0], []).
					build();

				gptInterscrollerMapping = googletag.sizeMapping().
					addSize([1140, 445], []).
					addSize([1024, 768], [[1024, 768]]).
					addSize([768, 1024], [[768, 1024]]).
					addSize([480, 320], [[480, 320]]).
					addSize([320, 480], [[320, 480]]).
					build();
			}
			//***********************************************
			//End Define Size mapping based on client Viewport
			//***********************************************

			//***********************************************
			//Start detection for ad slots on page
			//***********************************************
			var gptMasterPage = gpt_CheckForNULL($('#gptPage').val());
			var gptMasterSite;

			if (gpt_AdFile === 'PU') {
				gptMasterSite = $('#gptSite').val();
			}
			else {
				//JBS-CELL-LANCET
				gptMasterSite = "dev";

				if (gpt_IsProd) {
					gptMasterSite = gpt_CheckForNULL($('#gptSite').val());

					//If there is no master site, check for a defaultsite
					if (gptMasterSite == null) {
						gptMasterSite = gpt_CheckForNULL($('#gptDefaultSite').val());
					}
				}
				else {
					//Dev ENV
					//If the page has no gptSite Value, assume no value which will disable ads
					if (gpt_CheckForNULL($('#gptSite').val()) === null) {
						gptMasterSite = null;
					}
				}

				//If there is no master Page, check for a Page using the URL
				if (gptMasterPage === null) {
					gptMasterPage = GPT_GetPageByURL();
				}
			}

			$(".gpt-ad").each(function (index) {
				var gptPage = '';
				var adSizeMapping = '';
				var gptPOS;
				var gptTC;
				var gptNative;
				var adId;
				var gptSite;
				var tempSlot = null;


                if (gpt_IsProd) {
					if (gpt_AdFile !== "CELLJOURNAL") {
						//Check if the ad slot has it's own site defined
						if (typeof $(this).data('site') === 'undefined') {
							gptSite = gptMasterSite;
						}
						else {
							gptSite = gpt_CheckForNULL($(this).data('site'));
						}
					}
					else {
						gptSite = gptMasterSite;
					}
                }
                else {
					gptSite = gptMasterSite;
                }



				if (gpt_AdFile === 'PU') {
					adId = $(this).attr('id');
				}
				else {
					//JBS-CELL-LANCET
					adId = 'gpt-ad-' + index + 1;
				}

				if (gpt_CheckForNULL(gptSite) !== null) {
					gptSite_Debug = gptSite;

					gptPOS = parseInt($(this).data('pos')) || -1;
					if (gptPOS === -1) {
						gptPOS = index + 1;
					}

					//Check if the ad slot has it's own page defined
					gptPage = $(this).data('page');
					if (gpt_CheckForNULL(gptPage) == null) {
						//Use the Master Page
						gptPage = gptMasterPage;
					}

					//If the page is not null, preceed it with a slash
					if (gptPage !== null) {
						gptPage = '/' + gptPage;
					}
					else {
						gptPage = '';
					}
					gptPage_Debug = gptPage;


					gptTC = $(this).data('tc');
					if (typeof gptTC === "undefined") {
						gptTC = '';
					}

					gptNative = $(this).data('native');
					if (typeof gptNative === "undefined") {
						gptNative = '';
					}

					//Determine sizemapping based on data-adsize
					if (gpt_AdFile === 'PU') {
						switch ($(this).data('adsize')) {
							case 'tall':
								adSizeMapping = gptTallSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600]], adId);
								break;
							case 'rectangle':
								adSizeMapping = gptRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								break;
							case 'rectangleshort':
								adSizeMapping = gptRectangleShortSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [320, 50], [300, 50]], adId);
								break;
							case 'wide':
								adSizeMapping = gptWideSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'widerectangle':
								adSizeMapping = gptWideRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50], [300, 250]], adId);
								break;
							case 'mobile':
								adSizeMapping = gptMobileSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50]], adId);
								break;
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[1, 1]], adId);
								break;
						}
					}
					else {
						//JBS-CELL-LANCET
						switch ($(this).data('adsize')) {
							case 'cell-leaderboard':
							case 'leaderboard':
								adSizeMapping = gptLeaderboardSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'bottom':
								if (gpt_ResponsiveHomepage) {
									adSizeMapping = gptHomePageSidebarMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'boombox':
								if (gpt_AdFile === "CELLJOURNAL" || gpt_AdFile == "CELLBUCKET") {
									if (gpt_ResponsiveHomepage) {
										adSizeMapping = gptCellHomePageSidebarMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250], [336, 280]], adId);
									}
									else {
										adSizeMapping = gptBoomBoxSizeMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [336, 280]], adId);
									}
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'interscroller':
								adSizeMapping = gptInterscrollerMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 480], [480, 320], [768, 1024], [1024, 768]], adId);
								break;
							case 'sidebar':
							case 'skyscraper':
								adSizeMapping = gptSideBarSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								break;
							case 'native':
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
						}
					}
				}

				//Ignore any invalid adsizes that could be on the page
				if (adSizeMapping !== '') {
					$(this).addClass('gpt-ad-defined');
					if (gpt_AdFile !== 'PU') {
						$(this).attr('id', adId);
					}
					tempSlot.defineSizeMapping(adSizeMapping).addService(googletag.pubads()).setTargeting("pos", gptPOS);

					if (gptTC !== '') {
						tempSlot.setTargeting("tc", gptTC);
					}
					if (gptNative !== '') {
						tempSlot.setTargeting("native", gptNative);
					}
					gptEvent_Debug = gptEvent_Debug + $(this).data('adsize') + ' Requested<br>';
				}
				else {
					gptInvalidAdSize_Debug = gptInvalidAdSize_Debug + "Invalid Size Found, Id: " + $(this).prop('id') + ', adSize: ' + $(this).data('adsize') + '<br>';
					$(this).remove();
				}
			});
			if (gpt_CheckForNULL(gptInvalidAdSize_Debug) === null) {
				gptInvalidAdSize_Debug = "None Detected";
			}
			//***********************************************
			//End detection for ad slots on page
			//***********************************************

			//***********************************************
			//Start page level targeting
			//***********************************************
			if (gpt_AdFile !== 'PU') {
				//Logged in or IP Access
				gpt_TargetAccessType();

				//Check for Screenshot Client
				gpt_CheckSSC();
			}

			//Check for DFP Test
			gpt_GetDFPTestId();

			//Check for Additional Targeting
			gpt_GetAdditionalTargeting();

			if (gpt_IsProd && gptContextualEnabled) {
				var gpt_ContextualRetry = false;
				//Check for Contextual Targeting
				if (gs_channels !== "DEFAULT") {
					var gpt_ContextualCategories = Array.from(gs_channels);
					for (var i = 0; i < gpt_ContextualCategories.length; i++) {
						if (gpt_ContextualCategories[i] == 'gx_retry') {
							gpt_ContextualRetry = true;
						}
						if (!gpt_ContextualCategories[i].startsWith("custom_")) {
							//Remove any tag that is not custom
							gpt_ContextualCategories.splice(i, 1);
							i--;
						}
						else {
							//Strip the 'custom_' from the tag
							gpt_ContextualCategories[i] = gpt_ContextualCategories[i].replace("custom_", "")
						}
					}
					if (gpt_ContextualCategories.length > 0) {
						googletag.pubads().setTargeting("gs_cat", gpt_ContextualCategories);
					}
					else {
						gpt_ContextualCategories = 'none';
					}
					if (gpt_ContextualRetry) {
						gpt_ContextualCategories = "*Indexing*";
					}
					gptContextualResult_Debug = gpt_ContextualCategories;
				}
				else {
					gptContextualResult_Debug = 'No segments found';
				}
			}
			else {
				//Not Prod || Contextual not enabled
				gptContextualResult_Debug = 'Not enabled';
				
				if (!gpt_IsProd) {
                    var gpt_DevSite = gpt_CheckForNULL($('#gptSite').val(), "dev");
                    $('#gpt-Variables').append('<input type="hidden" id="gptEnvironment" value="' + gpt_DevSite + '">');
                    gpt_Target("Environment");
                }

			}
			//***********************************************
			//End page level targeting
			//***********************************************

			//Enable google dfp services
			if (parseInt($('#gptLazyLoading').val()) === 1) {
				googletag.pubads().enableLazyLoad({
					fetchMarginPercent: 200,
					renderMarginPercent: 0,
					mobileScaling: 2.0
				});
			}
			else {
				googletag.pubads().enableSingleRequest();
			}

			//Add Listener for RenderEnded
			googletag.pubads().addEventListener('slotRenderEnded', function (event) {
				if (!event.isEmpty) {
					if (typeof LocalAdLoaded === "function") {
						LocalAdLoaded(event);
					}
					if (gpt_ResponsiveHomepage) {
						if (typeof positionAd === "function") {
							positionAd();
						}
					}
					if (event.size[0] == "480" || event.size[1] == "480") {
						$('.gpt-InScrollBox').css('display', 'block');
						gptEvent_Debug = gptEvent_Debug + 'Interscroller ' + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}
					else {
						gptEvent_Debug = gptEvent_Debug + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}

				}
			});

			if (gpt_AdFile !== 'PU') {
				googletag.pubads().collapseEmptyDivs();
			}
			googletag.enableServices();

			//Populate Defined Ad Slots
			$(".gpt-ad-defined").each(function (index) {
				var adId = $(this).attr('id');
				googletag.cmd.push(function () { googletag.display(adId); });
			});

			gptStatus_Debug = 'GPT Complete';
		});
	}
	//--------------------------------------------------------------------------
	function gpt_DisplayDebug() {
		//Clone the template and append to Body
		$(document.body).append($('#gpt-DebugDiv').clone());
		$('#gpt-DebugDiv').remove();

		//Populate the Values
		gpt_LoadDebugValues();

		//Display and scroll to debug section
		$('.gpt-DebugDiv').css('display', 'block');
		window.scrollTo(0, document.body.scrollHeight);
	}
	//--------------------------------------------------------------------------
	function gpt_LoadDebugValues() {
		$('.gpt-DebugBtn').blur();
		$('.gptVersion_Debug').text(gpt_Version);
		$('.gptAdFile_Debug').html(gpt_AdFile);
		$('.gptEvent_Debug').html(gptEvent_Debug);
		$('.gptCustomTargeting_Debug').html(gptCustomTargeting_Debug);
		$('.gptSite_Debug').text(gptSite_Debug);
		$('.gptContextualResult_Debug').text(gptContextualResult_Debug);
		$('.gptContextualInit_Debug').text(gptContextualInit_Debug);
		$('.gptContextualURL_Debug').text(gptContextualURL_Debug);
		$('.gptContextualReady_Debug').text(gptContextualReady_Debug);
		$('.gptMoatReady_Debug').text(gptMoatReady_Debug);
		$('.gptMoatInit_Debug').text(gptMoatInit_Debug);
		$('.gptTestENV_Debug').text(gptTestENV_Debug);
		$('.gptDisableAds_Debug').text(gptDisableAds_Debug);
		$('.gptStatus_Debug').text(gptStatus_Debug);
		$('.gptPage_Debug').text(gptPage_Debug);
		$('.gptInvalidAdSize_Debug').html(gptInvalidAdSize_Debug);
	}
	//--------------------------------------------------------------------------
	function gpt_GrapeShotDebug() {
		$('.gpt-DebugBtn').blur();
		window.open("http://admin-elsevier.grapeshot.co.uk/custom/bookmarklet.cgi?blocking=1&vn=2&url=" + encodeURIComponent(document.location), "GRAPESHOT_POPUP", "width=650,height=600,scrollbars=yes,screenX=40,screenY=50,menubar=no,toolbar=no,resizable=yes", "Custom").focus();
	}
	//--------------------------------------------------------------------------
	function gpt_ShowConsole() {
		$('.gpt-DebugBtn').blur();
		googletag.openConsole();
	}
	//--------------------------------------------------------------------------
</script>
        </div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="912135d6-7135-4d45-b457-b503cacc3c8b" data-widget-name="ux3-layout-widget"><header class="header base fixed">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header js__adToHide widget-horizontalAd" id="9d6062d7-fad6-4e64-81cc-7dd25d99b23d">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 1 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="1"></div>
<!-- End AdSlot 1 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" class="header__wrapper clearfix" data-db-parent-of="quickSearch"><div id="brandingRow"><a href="/" data-aa-name="science that inspires" data-aa-region="cp global header" title="Visit Cell.com">Science that inspires</a><p id="brandingRowRight"><a href="/" data-aa-name="cell press endorsement" data-aa-region="cp global header" title="Visit Cell.com">A Cell Press journal</a></p></div>
        
    

        


    

            

            

            <div data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" data-widget-name="ux3-layout-widget"><div class="col-xs-6 header__left-side">
    

        


    

            

            
                <a href="/home" id="cpIconLnk" data-aa-name="cell press logo" data-aa-region="cp global header" title="Cell Press" target="_blank"><svg id="cp_logo" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 100 98.1" style="enable-background:new 0 0 100 98.1;" xml:space="preserve" height="100" width="98.1"><path style="fill:#FFFFFF;" d="M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z"></path></svg></a><div class="journal-logos">
            

            <span data-widget-id="35d8d734-3aa0-4ec8-9e2d-14babe803594" data-widget-name="ux3-general-image"><a href="/cell/home" title="Cell"><img alt="Cell" src="/pb-assets/ux3/logos/cell/Cell_white-1532516611593.svg"></a></span>

            
                </div>
            

        

    

        


    

            

            
                <div class="journal-logos">
            

            <span data-widget-id="3ffcbf1f-79fd-4ba3-85b5-bef10a63475f" data-widget-name="ux3-general-image"><a href="https://www.cell.com/open-access?utm_source=oa-label&amp;__hstc=109691226.e4e812b53ff324eccbdbdb2e4fb9a6ab.1644503737405.1644524234622.1644587109507.4&amp;__hssc=109691226.7.1644587109507&amp;__hsfp=3253153019" title="This journal offers authors two options (open access or subscription) to publish research"><img alt="This journal offers authors two options (open access or subscription) to publish research" src="/pb-assets/ux3/logos/cell/Supports_open_access_border-1645554937897.svg"></a></span>

            
                </div>
            

        
</div><div class="col-xs-6">
    

        


    

            

            

            <div data-widget-id="2555f6db-b333-4edb-8b15-ef9213f1f0a5" data-widget-name="ux3-layout-widget"><div class="header__nav row">
    

        


    

            

            

            <ul data-widget-id="52432d24-0331-4c9d-85f3-2033edc7208b" data-widget-name="UX3ProfileLinksWidget" class="rlist rlist--inline profile-links"><li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login-dropdown"><div class="profile-links__user-list__wrapper"><button data-db-target-for="loginmenu-714799" aria-expanded="false" aria-controls="login-links-714799" title="Log in links dropdown" class="profile-links__username"><span>Log in</span></button><div data-db-target-of="loginmenu-714799" id="login-links--714799" class="profile-links__user-list__holder dropBlock__holder"><ul class="rlist profile-links__list"><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901165-X" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901165-X" target="_self" data-profile-link="true">Get Institutional Access</a></li></ul></div></div></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901165-X" target="_self" data-profile-link="true">Register</a></li><li class="hidden-lg"> <div class="profile-links__controls"> <button aria-expanded="false" aria-controls="links-dialog-714799" data-opens="#links-dialog-714799" class="profile-links__btn--open"><span class="sr-only">open links dialog</span><i aria-hidden="true" class="icon-gizmo-person"></i></button></div><dialog id="links-dialog-714799" aria-modal="true"><button data-closes="#links-dialog-714799" class="profile-links__btn--close"><span class="sr-only">close links dialog</span><i aria-hidden="true" class="icon-close-solid"></i></button><ul>   <li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901165-X" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901165-X" target="_self" data-profile-link="true">Get Institutional Access</a></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901165-X" target="_self" data-profile-link="true">Register</a></li></ul></dialog></li></ul>

            

        
</div></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasInstitutionBanner none  widget-none" id="51b7fa33-2137-4f58-9e98-9746c4400513" style="display: none;">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><div class="ui-state-highlight ui-corner-all csas-institution-banner hidden" data-doi="10.1016/j.cell.2021.09.035">
    <span class="ui-icon ui-icon-close banner-close"></span>
    <p>
        Access provided by <span class="accountName"></span>
    </p>
</div>

<style>
    .csas-institution-banner {
        padding: 10px 0 0 10px;
        margin: 5px;
    }

    .csas-institution-banner.ui-state-highlight .ui-icon {
        background-image: url("/templates/jsp/css/jquery-ui-1.10.2/base/images/ui-icons_454545_256x240.png");
        margin-right: 5px;
        margin-top: -4px;
    }

    .csas-institution-banner .banner-close {
        float: right;
    }
</style>

<script>

    function resetBanner(doi) {
        $.get('/action/getAccount?doi=' + doi, function(data) {
            if (data) {
                $(".csas-institution-banner p .accountName").html(data);
                $(".csasInstitutionBanner").fadeIn();
                $(".csas-institution-banner").fadeIn();
            }
        });
    }

    var flag = 0;
    $(document).ready(function() {
        if(!$(".csas-institution-banner").is(":visible")){
            $(".csasInstitutionBanner").hide();
        }

        $(".banner-close").click(function() {
            $.get("/action/dismissBanner", function(data) {
                $(".csasInstitutionBanner").fadeOut(function () {
                    if(typeof UX !== 'undefined') {
                        UX.pageBody.init();
                    }
                });
            });
        });

        $(".articleContent .tabs li[role='tab'].showFullText").click(function() {
           flag = 1;
        });

        $(document).on("reloadTabsContent", function() {
            var isSelected = $(".articleContent .tabs li[role='tab'].showFullText").hasClass("active");
            if (isSelected) {
                var isHidden =  $(".csas-institution-banner").is(".hidden");
                if (!isHidden) {
                    resetBanner($(".csas-institution-banner").data("doi"));
                    console.log("fadeIn");
                }
            } else {
                $(".csas-institution-banner").fadeOut();
                console.log("fadeOut");
            }
            flag = 0;
        });

        $(document).on("click", ".articleContent .tabs li[role='tab']", function() {

        });
    });
</script></div>
                </div>
                </div>

        
</header></div>

            

        










        <div data-widget-def="graphQueryWidget" data-widget-id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" class="ux3">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget graphQueryWidget none top-padding-handler noMargin axel-mega-menu widget-none widget-compact-all fonts-loaded" id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" style="padding-top: 115.594px;">
                
                
                    
                

                <div class="wrapped " id="CP TOP LEVEL NAV MENU">
                    
                    <div class="widget-body body body-none  body-compact-all"><nav id="mega-menu-nav" role="navigation" class="mega-menu-nav">
  <!--.skip//a(href='#searchText' aria-label='Skip menu') Skip menu
  -->
  <div class="mega-menu-nav__wrapper">
    <button class="mega-menu__toggle"><span class="sr-only">Main menu</span><i aria-hidden="true" class="icon-gizmo-hamburger"></i></button>
    <ul role="menubar" class="mega-menu rlist">
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-1" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-1" data-item-link="main-menu-link-1" data-index="0" class="mega-menu__item-link menu-link"><span>This journal</span></a>
        <div id="main-menu-panel-1" aria-labelledby="main-menu-link-1" data-item-wrapper="main-menu-link-1" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <div aria-label="Menu dropzone section" tabindex="-1" class="listDropZone">
    

        


    

            

            

            <div class="cover-image"><div class="cover-image__thumb"><a href="/issue/S0092-8674(24)X0012-4" class="menu-link"><img src="/cms/asset/atypon:cms:attachment:img:d5e6:rev:1748270185670-389:pii:S0092867424X00124/cover.tif.jpg" alt="Cover Image - Cell, Volume 188, Issue 11"></a></div><div class="cover-image__meta"></div></div>

            

        
</div>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-2" class="sub-menu__heading">Read
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/newarticles" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Online now</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/current" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Current issue</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/archive" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Archive</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/action/showPreferences?menuTab=Alerts" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Publication alerts</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sneakpeek" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Sneak Peek - preprints</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-3" class="sub-menu__heading">About
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-2">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/advisory-board" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Advisory board</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/aims" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Aims and scope</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/contact" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/editors-and-staff" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Editors and staff</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/editorial-ethics" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Ethics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/permissions" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Permissions</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Reviewer instructions</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-2" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-2" data-item-link="main-menu-link-2" data-index="1" class="mega-menu__item-link menu-link"><span>Journals</span></a>
        <div id="main-menu-panel-2" aria-labelledby="main-menu-link-2" data-item-wrapper="main-menu-link-2" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-1" class="sub-menu__heading">Life &amp; medical sciences
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-4">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cancer-cell/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cancer Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-chemical-biology" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Chemical Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-genomics/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Genomics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-host-microbe/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Host &amp; Microbe</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-metabolism/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-medicine/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-stem-cell/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Stem Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-systems/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Systems</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/current-biology/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Current Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/developmental-cell/home" data-index="11" role="menuitem" class="sub-menu__item-link menu-link"><span>Developmental Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/immunity/home" data-index="12" role="menuitem" class="sub-menu__item-link menu-link"><span>Immunity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/med/home" data-index="13" role="menuitem" class="sub-menu__item-link menu-link"><span>Med</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-cell/home" data-index="14" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/neuron/home" data-index="15" role="menuitem" class="sub-menu__item-link menu-link"><span>Neuron</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/structure/home" data-index="16" role="menuitem" class="sub-menu__item-link menu-link"><span>Structure</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/ajhg/home" data-index="17" role="menuitem" class="sub-menu__item-link menu-link"><span>American Journal of Human Genetics (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysj/home" data-index="18" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Journal (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysreports/home" data-index="19" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/hgg-advances/home" data-index="20" role="menuitem" class="sub-menu__item-link menu-link"><span>Human Genetics and Genomics Advances (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-plant/home" data-index="21" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Plant (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/molecular-therapy/home" data-index="22" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/methods/home" data-index="23" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Methods &amp; Clinical Development (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/nucleic-acids/home" data-index="24" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Nucleic Acids (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/oncology/home" data-index="25" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Oncology (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/plant-communications/home" data-index="26" role="menuitem" class="sub-menu__item-link menu-link"><span>Plant Communications (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/stem-cell-reports/home" data-index="27" role="menuitem" class="sub-menu__item-link menu-link"><span>Stem Cell Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biochemical-sciences/home" data-index="28" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biochemical Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cancer/home" data-index="29" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cancer</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cell-biology/home" data-index="30" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cell Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/ecology-evolution/home" data-index="31" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Ecology &amp; Evolution</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/endocrinology-metabolism/home" data-index="32" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Endocrinology &amp; Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/genetics/home" data-index="33" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Genetics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/immunology/home" data-index="34" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Immunology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/microbiology/home" data-index="35" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Microbiology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/molecular-medicine/home" data-index="36" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Molecular Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/neurosciences/home" data-index="37" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Neurosciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/parasitology/home" data-index="38" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Parasitology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/pharmacological-sciences/home" data-index="39" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Pharmacological Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/plant-science/home" data-index="40" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Plant Science</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 5/6" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-2" class="sub-menu__heading">Physical sciences &amp; engineering
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-biomaterials/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Biomaterials</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-physical-science/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Physical Science</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem-catalysis/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem Catalysis</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/device/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Device</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/joule/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Joule</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/matter/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Matter</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/newton/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Newton</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/chemistry/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Chemistry</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 6/7" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-3" class="sub-menu__heading">Multidisciplinary
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-methods/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Methods</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-sustainability/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Sustainability</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/heliyon/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Heliyon</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/iscience/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>iScience</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/one-earth/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>One Earth</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/patterns/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Patterns</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/star-protocols/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Protocols</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/nexus/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Nexus (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/the-innovation/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>The Innovation (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biotechnology/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biotechnology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cognitive-sciences/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cognitive Sciences</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-3" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-3" data-item-link="main-menu-link-3" data-index="2" class="mega-menu__item-link menu-link"><span>Publish</span></a>
        <div id="main-menu-panel-3" aria-labelledby="main-menu-link-3" data-item-wrapper="main-menu-link-3" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-1" class="sub-menu__heading">Authors
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://www.editorialmanager.com/cell?__hstc=25856994.7201670a4397fa03148684920d4a8d38.1672762013831.1694716659709.1694718909620.146&amp;__hssc=25856994.15.1694718909620&amp;__hsfp=1366844671" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Submit article
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/information-for-authors" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for authors</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/multi-journal-submission" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Multi-Journal Submission</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/star-authors-guide" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Methods</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-2" class="sub-menu__heading">Reviewers
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for reviewers</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-4" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-4" data-item-link="main-menu-link-4" data-index="3" class="mega-menu__item-link menu-link"><span>News &amp; events</span></a>
        <div id="main-menu-panel-4" aria-labelledby="main-menu-link-4" data-item-wrapper="main-menu-link-4" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/newsroom" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Newsroom</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/events" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Events</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/symposia" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Symposia</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/webinars" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Webinars</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/consortia" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Consortia Hub</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-5" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-5" data-item-link="main-menu-link-5" data-index="4" class="mega-menu__item-link menu-link"><span>About Cell Press</span></a>
        <div id="main-menu-panel-5" aria-labelledby="main-menu-link-5" data-item-wrapper="main-menu-link-5" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-1" class="sub-menu__heading">Cell Press
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/about" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>About Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/contact" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact us</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="https://service.elsevier.com/app/overview/cell-press/" data-index="2" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Help &amp; support
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access at Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/diversity" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Inclusion and diversity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-50" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>50th anniversary</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-2" class="sub-menu__heading">Hubs
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/biotechnology-bioengineering" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Biotechnology and bioengineering</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-chemistry" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Chemistry</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/clinical-translational" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Clinical and translational</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/covid-19" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>COVID-19</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/fundamental-biology" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Fundamental biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sustainability" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Sustainability</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/4" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-3" class="sub-menu__heading">Careers
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Press careers
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
    </ul>
    <div class="mega-menu-nav__quick-search">
    

        


    

            

            

            <div data-widget-id="a1f05748-166f-41e0-b01a-ca8ac1cc95d4" data-widget-name="UX3QuickSearchWidget" class="quick-search"><div class="dropBlock"><form action="https://www.cell.com/action/doSearch?journalCode=cell" name="quickSearchBar" method="get" title="Quick Search"><input id="type" type="hidden" value="quicksearch" name="type"><div class="quick-search__toggle autoCompleteWrapper"><input id="searchText" type="text" name="text1" placeholder="Search for..." enterkeyhint="search" autocomplete="off" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" data-group-titles-conf="3" data-publication-items-conf="3" aria-label="Enter a search term" class="searchText searchText-autocomplete ui-autocomplete-input"><button type="submit" title="Search" aria-label="Submit the search form" class="btn quick-search__button icon-search"><span>Go search</span></button><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a><ul id="ui-id-1" tabindex="0" class="ui-menu ui-widget ui-widget-content ui-autocomplete ui-front" unselectable="on" style="display: none;"></ul></div><div class="quick-search__box"><div class="quick-search__box-inner"><div class="quick-search__box-wrapper"><select name="field1" aria-label="Select a search area"><option value="AllField">All content</option><option value="Title">Article title</option><option value="Contrib">Authors</option><option value="Keyword">Keywords</option><option value="Abstract">Abstract</option><option value="AbstractTitleKeywordFilterField">Article title, abstract, keywords</option></select><input type="hidden" name="journalCode" value="cell"><div class="quick-search__scope-options"><span>Search within:</span><label title="This journal" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeSeries-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" title="This journal" value="cell" checked="checked" aria-label="Search within current journal"><span>This journal</span></label><label title="Full site" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeFullSite-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" value="" title="Full site" aria-label="Search within full site"><span>Full site</span></label></div><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a></div><a href="javascript:void(0)" aria-label="Close search options" title="Close search options" class="quick-search__box-close"><i aria-hidden="true" class="icon-tools_close"></i></a></div></div><div class="quick-search__alert hidden"><p>Please enter a term before submitting your search.</p><a href="#" class="quick-search__alert--close"> Ok</a></div></form></div></div>

            

        
</div>
  </div>
</nav>
<div id="page-body-id" class="page-body-flag"></div></div>
                </div>
                </div>

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="f8c6daf9-9df1-4fd9-ba3a-7f5d7b3d4466" data-widget-name="UX3HTMLWidget"><style>
.journal-logos:nth-of-type(2) img {
max-height: 30px !important;
}
.journal-logos:nth-of-type(3) img {
max-height: 30px !important;
}
.ux3 .journal-logos + .journal-logos {
margin-left: 30px;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 55%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 45%;
}
@media screen and (max-width: 1000px) {
.ux3 .journal-logos + .journal-logos {
display: none;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 50%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 50%;
}
}

.ux3 .journal-logos:first-of-type {
   max-width: 500px;
}

.profile-links {
   white-space: nowrap;
}

@media only screen and (min-width: 740px) and (max-width: 1600px) {
   .journal-logos:nth-of-type(2) img {
      max-width: 250px !important;
   }
}

@media only screen and (min-width: 1024px) and (max-width: 1600px) {
   .header__wrapper.clearfix .col-xs-6:first-of-type {
      width: 60% !important;
   }
   .header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
      width: 40% !important;
   }
}

@media only screen and (max-width: 1240px) {
   .ux3 .journal-logos + .journal-logos {
      display: none !important;
   }
}

</style></div>

            

        
</div></div>

            
                </div>
            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget axelPublicationContent none  widget-none" id="cadc9b41-a542-448a-9de4-8d0803320174">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><link id="build-style-article" rel="stylesheet" type="text/css" href="/products/marlin/cell/releasedAssets/css/build-article-b26f3342b722959c7931.css"><article xmlns="http://www.w3.org/1999/xhtml" data-design="pill" data-has="right-rail" vocab="http://schema.org/" typeof="ScholarlyArticle" data-pii="S0092-8674(21)01165-X" lang="en" dir="ltr"><div data-core-wrapper="header"><header data-extent="frontmatter"><div class="core-container"><div data-article-access="free" data-article-access-type="open" class="meta-panel"><span class="meta-panel__left-content"><span class="meta-panel__type"><span>Article</span></span></span><span class="meta-panel__middle-content"><span class="meta-panel__volumeIssue"><a href="/cell/issue?pii=S0092-8674(20)X0023-7"><span>Volume 184</span>, <span>Issue 22</span></a></span><span class="meta-panel__pages"><span>p5593-5607.e18</span></span><span class="meta-panel__onlineDate">October 28, 2021</span></span><span class="meta-panel__right-content"><span class="meta-panel__access meta-panel__access--archive"><span>Open Archive</span></span></span><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=184&amp;issue=22&amp;pii=S0092-8674%2820%29X0023-7" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div><h1 property="name">Pan-ebolavirus protective therapy by two multifunctional human antibodies</h1><div class="contributors"><span class="authors"><span role="list"><span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au1" aria-controls="axel_author_au1"><span property="givenName">Pavlo</span> <span property="familyName">Gilchuk</span></a><div id="au1" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Pavlo</span> <span property="familyName">Gilchuk</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">8</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Gilchuk/Pavlo" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a role="doc-noteref">8</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au2" aria-controls="axel_author_au2"><span property="givenName">Charles D.</span> <span property="familyName">Murin</span></a><div id="au2" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Charles D.</span> <span property="familyName">Murin</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">8</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Murin/Charles+D" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a role="doc-noteref">8</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au3" aria-controls="axel_author_au3"><span property="givenName">Robert W.</span> <span property="familyName">Cross</span></a><div id="au3" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Robert W.</span> <span property="familyName">Cross</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">8</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Galveston National Laboratory, Galveston, TX 77550, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Cross/Robert+W" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a role="doc-noteref">8</a></sup></span><span data-displayed-on="all"> ∙ … </span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au4" aria-controls="axel_author_au4"><span property="givenName">Philipp A.</span> <span property="familyName">Ilinykh</span></a><div id="au4" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Philipp A.</span> <span property="familyName">Ilinykh</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Galveston National Laboratory, Galveston, TX 77550, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Ilinykh/Philipp+A" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">5</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au5" aria-controls="axel_author_au5"><span property="givenName">Kai</span> <span property="familyName">Huang</span></a><div id="au5" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Kai</span> <span property="familyName">Huang</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Galveston National Laboratory, Galveston, TX 77550, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Huang/Kai" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">5</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au6" aria-controls="axel_author_au6"><span property="givenName">Natalia</span> <span property="familyName">Kuzmina</span></a><div id="au6" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Natalia</span> <span property="familyName">Kuzmina</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Galveston National Laboratory, Galveston, TX 77550, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Kuzmina/Natalia" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">5</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au7" aria-controls="axel_author_au7"><span property="givenName">Viktoriya</span> <span property="familyName">Borisevich</span></a><div id="au7" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Viktoriya</span> <span property="familyName">Borisevich</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Galveston National Laboratory, Galveston, TX 77550, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Borisevich/Viktoriya" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">4</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au8" aria-controls="axel_author_au8"><span property="givenName">Krystle N.</span> <span property="familyName">Agans</span></a><div id="au8" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Krystle N.</span> <span property="familyName">Agans</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Galveston National Laboratory, Galveston, TX 77550, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Agans/Krystle+N" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">4</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au9" aria-controls="axel_author_au9"><span property="givenName">Joan B.</span> <span property="familyName">Geisbert</span></a><div id="au9" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Joan B.</span> <span property="familyName">Geisbert</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Galveston National Laboratory, Galveston, TX 77550, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Geisbert/Joan+B" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">4</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au10" aria-controls="axel_author_au10"><span property="givenName">Seth J.</span> <span property="familyName">Zost</span></a><div id="au10" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Seth J.</span> <span property="familyName">Zost</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Zost/Seth+J" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au11" aria-controls="axel_author_au11"><span property="givenName">Rachel S.</span> <span property="familyName">Nargi</span></a><div id="au11" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Rachel S.</span> <span property="familyName">Nargi</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Nargi/Rachel+S" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au12" aria-controls="axel_author_au12"><span property="givenName">Rachel E.</span> <span property="familyName">Sutton</span></a><div id="au12" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au12"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Rachel E.</span> <span property="familyName">Sutton</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Sutton/Rachel+E" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au13" aria-controls="axel_author_au13"><span property="givenName">Naveenchandra</span> <span property="familyName">Suryadevara</span></a><div id="au13" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au13"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Naveenchandra</span> <span property="familyName">Suryadevara</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Suryadevara/Naveenchandra" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au14" aria-controls="axel_author_au14"><span property="givenName">Robin G.</span> <span property="familyName">Bombardi</span></a><div id="au14" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au14"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Robin G.</span> <span property="familyName">Bombardi</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Bombardi/Robin+G" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au15" aria-controls="axel_author_au15"><span property="givenName">Robert H.</span> <span property="familyName">Carnahan</span></a><div id="au15" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au15"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Robert H.</span> <span property="familyName">Carnahan</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Carnahan/Robert+H" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">7</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au16" aria-controls="axel_author_au16"><span property="givenName">Alexander</span> <span property="familyName">Bukreyev</span></a><div id="au16" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au16"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Alexander</span> <span property="familyName">Bukreyev</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Galveston National Laboratory, Galveston, TX 77550, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Bukreyev/Alexander" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">5</a></sup></span></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au17" aria-controls="axel_author_au17"><span property="givenName">Thomas W.</span> <span property="familyName">Geisbert</span></a><div id="au17" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au17"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Thomas W.</span> <span property="familyName">Geisbert</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Galveston National Laboratory, Galveston, TX 77550, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Geisbert/Thomas+W" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">4</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au18" aria-controls="axel_author_au18"><span property="givenName">Andrew B.</span> <span property="familyName">Ward</span></a><div id="au18" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au18"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Andrew B.</span> <span property="familyName">Ward</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Ward/Andrew+B" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au19" aria-controls="axel_author_au19"><span property="givenName">James E.</span> <span property="familyName">Crowe</span>, <span>Jr.</span></a><div id="au19" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au19"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">James E.</span> <span property="familyName">Crowe</span>, <span>Jr.</span></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0010" href="mailto:james.crowe@vumc.org" property="email" title="Send email to James E. Crowe">james.crowe@vumc.org</a></div></div><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">9</div><div id="fn2"><div id="ntpara0015" role="paragraph">Senior author</div></div></div><div role="doc-footnote" data-has="label"><div class="label">10</div><div id="fn3"><div id="ntpara0020" role="paragraph">Lead contact</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Crowe/James+E/Jr" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">6</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">7</a>,<a role="doc-noteref">9</a>,<a role="doc-noteref">10</a></sup> <a id="eadd0010" href="mailto:james.crowe@vumc.org" property="email" title="Send email to James E. Crowe">james.crowe@vumc.org</a></span><span data-displayed-on="all"> … <span><span data-action="reveal" tabindex="0" role="listitem">Show more</span></span> </span><span data-displayed-on="none" data-on-display="all" aria-hidden="true"> <span data-action="hide" tabindex="0" role="listitem">Show less</span></span></span></span></div><div class="core-self-citation"><div class="expandable-triggers"><button aria-controls="core-affiliations-notes" aria-expanded="false" tabindex="0" role="button"><span>Affiliations &amp; Notes</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button><button aria-controls="core-content-info" aria-expanded="false" tabindex="0" role="button"><span>Article Info</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button></div><div id="core-linked-content">
    

        

</div><div class="expandable-content"><div id="core-affiliations-notes" role="region" data-expandable="item" style="display: none;"><div class="affiliations"><div property="affiliation" typeof="Organization"><span class="label">1</span><span id="aff1" property="name">Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">2</span><span id="aff2" property="name">Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">3</span><span id="aff3" property="name">Galveston National Laboratory, Galveston, TX 77550, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">4</span><span id="aff4" property="name">Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">5</span><span id="aff5" property="name">Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">6</span><span id="aff6" property="name">Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">7</span><span id="aff7" property="name">Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA</span></div></div><div class="core-authors-notes"><div role="doc-footnote" data-has="label"><div class="label">8</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div><div role="doc-footnote" data-has="label"><div class="label">9</div><div id="fn2"><div id="ntpara0015" role="paragraph">Senior author</div></div></div><div role="doc-footnote" data-has="label"><div class="label">10</div><div id="fn3"><div id="ntpara0020" role="paragraph">Lead contact</div></div></div></div></div><div id="core-content-info" role="region" data-expandable="item" style="display: none;"><div class="history"><div>Publication History:</div><div><span>Received April 6, 2021</span>; <span>Revised July 27, 2021</span>; <span>Accepted September 27, 2021</span></div></div><div class="core-links"><span class="doi">DOI: <a href="https://doi.org/10.1016/j.cell.2021.09.035" property="sameAs" target="_blank">10.1016/j.cell.2021.09.035 <span class="sr-only">External Link</span></a></span><span class="science-direct">Also available on <a href="https://www.sciencedirect.com/science/article/pii/S009286742101165X" target="_blank">ScienceDirect <span class="sr-only">External Link</span></a></span></div><div role="paragraph">Copyright: © 2021 Elsevier Inc.</div><div class="core-links"><span>User License: <a href="http://www.elsevier.com/open-access/userlicense/1.0/" target="_blank">Elsevier user license</a> | <a href="https://www.elsevier.com/open-access" target="_blank">Elsevier's open access license policy</a></span></div><div class="core-crossmark-badge"><a data-target="crossmark" href="#" title="Check for updates on crossmark" data-doi="10.1016/j.cell.2021.09.035" data-id="article-info-crossmark" class="crossmark__link" style="cursor: pointer;"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 290 58" height="22px" role="presentation"><path fill="url(#horizontal_crossmark)" stroke="#948F8F" stroke-miterlimit="10" stroke-width=".75" d="M287 1H3a2 2 0 0 0-2 2v52a2 2 0 0 0 2 2h284a2 2 0 0 0 2-2V3a2 2 0 0 0-2-2Z"></path><path fill="#535353" d="M80.3 23.58a6.395 6.395 0 0 0-.55-1.43 3.92 3.92 0 0 0-2.19-1.86 5.099 5.099 0 0 0-1.71-.29 5 5 0 0 0-2.46.58 4.831 4.831 0 0 0-1.69 1.54 6.921 6.921 0 0 0-1 2.19 10.16 10.16 0 0 0 0 5 6.921 6.921 0 0 0 1 2.19 4.83 4.83 0 0 0 1.69 1.5 5 5 0 0 0 2.46.58 4.44 4.44 0 0 0 1.85-.36 4.12 4.12 0 0 0 1.38-1c.39-.436.695-.942.9-1.49A7.094 7.094 0 0 0 80.4 29h3a8.46 8.46 0 0 1-.69 2.92 7.179 7.179 0 0 1-1.59 2.29 7 7 0 0 1-2.35 1.49 8.14 8.14 0 0 1-3 .52 8.43 8.43 0 0 1-3.59-.74 7.88 7.88 0 0 1-2.69-2 9.001 9.001 0 0 1-1.69-3 11.41 11.41 0 0 1 0-7.23 9.001 9.001 0 0 1 1.69-3 8.001 8.001 0 0 1 2.69-2 8.3 8.3 0 0 1 3.59-.75 9.44 9.44 0 0 1 2.83.41c.866.242 1.68.642 2.4 1.18A6.229 6.229 0 0 1 82.65 21a6.66 6.66 0 0 1 .78 2.58H80.3ZM85.9 17.9h2.85v6.63h.05a4.15 4.15 0 0 1 1.56-1.46 4.61 4.61 0 0 1 2.31-.59 4.83 4.83 0 0 1 3.33 1.1 4.21 4.21 0 0 1 1.22 3.3v8.88H94.4v-8.13a3.51 3.51 0 0 0-.65-2.21 2.36 2.36 0 0 0-1.87-.69 3.1 3.1 0 0 0-1.3.26 2.821 2.821 0 0 0-1 .73A3.41 3.41 0 0 0 89 26.8a3.88 3.88 0 0 0-.23 1.33v7.63H85.9V17.9ZM102.47 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7A5.349 5.349 0 0 1 109.7 35a5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4A5.953 5.953 0 0 1 100 32a8.748 8.748 0 0 1-.41-2.75 7.768 7.768 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.264.905.352 1.852.26 2.79h-9.53Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.594 3.594 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM122.88 27.15a2.666 2.666 0 0 0-1-1.81 3.14 3.14 0 0 0-2-.61c-.4.005-.798.07-1.18.19-.435.136-.83.376-1.15.7a3.92 3.92 0 0 0-.87 1.43 6.783 6.783 0 0 0-.35 2.39c.002.539.065 1.076.19 1.6.113.509.316.993.6 1.43.273.41.635.752 1.06 1a3 3 0 0 0 1.58.39 2.872 2.872 0 0 0 2.06-.77 3.596 3.596 0 0 0 1-2.18h2.85a6.26 6.26 0 0 1-1.91 3.86 5.83 5.83 0 0 1-4 1.34 6.61 6.61 0 0 1-2.69-.51 5.695 5.695 0 0 1-2-1.4 6.001 6.001 0 0 1-1.21-2.11 8.279 8.279 0 0 1-.41-2.65 8.987 8.987 0 0 1 .4-2.72 6.237 6.237 0 0 1 1.2-2.21 5.614 5.614 0 0 1 2-1.47 6.7 6.7 0 0 1 2.79-.54 7.801 7.801 0 0 1 2.14.29 5.634 5.634 0 0 1 1.8.86c.529.386.969.88 1.29 1.45a5 5 0 0 1 .6 2.07h-2.85l.06-.02ZM128.13 17.9H131V28l5.15-5.22h3.5l-5 4.75 5.42 8.17h-3.47l-4-6.27-1.6 1.7v4.63h-2.85V17.9h-.02ZM147.15 22.83h2.13v-1.08a5.505 5.505 0 0 1 .3-2c.161-.456.436-.862.8-1.18.33-.273.721-.462 1.14-.55.44-.094.89-.141 1.34-.14a8.158 8.158 0 0 1 2 .18v2.24a4.113 4.113 0 0 0-.59-.11 6.343 6.343 0 0 0-.74 0 1.74 1.74 0 0 0-1 .27 1.204 1.204 0 0 0-.41 1.08v1.33h2.42V25h-2.42v10.8h-2.85V25h-2.12v-2.17ZM162.23 36.1a6.999 6.999 0 0 1-2.76-.51 5.877 5.877 0 0 1-2-1.41 5.998 5.998 0 0 1-1.33-2.18 8.775 8.775 0 0 1 0-5.48 6.008 6.008 0 0 1 1.27-2.15 5.894 5.894 0 0 1 2-1.41A7.71 7.71 0 0 1 165 23a5.894 5.894 0 0 1 2 1.41 6.003 6.003 0 0 1 1.28 2.15c.585 1.78.585 3.7 0 5.48a5.99 5.99 0 0 1-3.28 3.54 7.002 7.002 0 0 1-2.77.52Zm0-2.25a3.268 3.268 0 0 0 1.65-.4c.447-.262.83-.621 1.12-1.05.304-.444.528-.938.66-1.46a6.581 6.581 0 0 0 0-3.31 4.416 4.416 0 0 0-.66-1.46 3.526 3.526 0 0 0-1.15-1 3.6 3.6 0 0 0-3.3 0 3.526 3.526 0 0 0-1.15 1 4.414 4.414 0 0 0-.66 1.46 6.558 6.558 0 0 0 0 3.31c.132.522.356 1.016.66 1.46a3.47 3.47 0 0 0 1.15 1.05 3.26 3.26 0 0 0 1.68.4ZM171.13 22.83h2.67v2.5c.097-.362.264-.701.49-1 .251-.341.547-.647.88-.91a4.404 4.404 0 0 1 1.14-.66 3.41 3.41 0 0 1 1.28-.25c.23-.013.46-.013.69 0h.39v2.79l-.61-.09a5.173 5.173 0 0 0-.61 0 3.278 3.278 0 0 0-1.36.29 3.131 3.131 0 0 0-1.11.85 4.171 4.171 0 0 0-.75 1.39 6 6 0 0 0-.28 1.9v6.15h-2.85V22.83h.03ZM198.22 35.75h-2.8V34a3.907 3.907 0 0 1-1.56 1.56 4.25 4.25 0 0 1-2.11.59 4.742 4.742 0 0 1-3.75-1.31 5.537 5.537 0 0 1-1.12-3.84v-8.2h2.85v7.92a3.503 3.503 0 0 0 .65 2.4 2.38 2.38 0 0 0 1.83.7 3.599 3.599 0 0 0 1.5-.27 2.66 2.66 0 0 0 1-.74c.259-.326.444-.705.54-1.11a5.79 5.79 0 0 0 .16-1.4v-7.5h2.85v12.95h-.04ZM201.3 22.83h2.7v1.75a3.523 3.523 0 0 1 1.72-1.58 5.568 5.568 0 0 1 2.33-.49 6.17 6.17 0 0 1 2.66.54 5.246 5.246 0 0 1 1.89 1.47c.515.65.899 1.394 1.13 2.19.257.87.385 1.773.38 2.68.001.851-.114 1.7-.34 2.52a6.568 6.568 0 0 1-1 2.16 5.002 5.002 0 0 1-4.21 2.06c-.419 0-.837-.036-1.25-.11a5.39 5.39 0 0 1-1.2-.36A4.737 4.737 0 0 1 205 35a3.567 3.567 0 0 1-.81-.91v6.45h-2.89V22.83Zm10 6.47c0-.574-.078-1.146-.23-1.7a4.606 4.606 0 0 0-.67-1.46 3.475 3.475 0 0 0-1.12-1 3.06 3.06 0 0 0-1.55-.39A3.141 3.141 0 0 0 205 26a5.518 5.518 0 0 0-1 3.3c-.004.611.077 1.22.24 1.81.138.523.38 1.012.71 1.44a3.55 3.55 0 0 0 1.14 1 3.242 3.242 0 0 0 1.54.35 3.18 3.18 0 0 0 1.65-.4c.438-.25.817-.59 1.11-1 .299-.44.513-.931.63-1.45a7.38 7.38 0 0 0 .23-1.75h.05ZM228.67 35.75H226V34a3.38 3.38 0 0 1-1.67 1.61 5.668 5.668 0 0 1-2.33.49 6.17 6.17 0 0 1-2.66-.54 5.307 5.307 0 0 1-1.89-1.46 6.254 6.254 0 0 1-1.12-2.19 9.48 9.48 0 0 1-.37-2.71 8.67 8.67 0 0 1 .47-3 6.058 6.058 0 0 1 1.26-2.1 4.89 4.89 0 0 1 1.8-1.21 5.738 5.738 0 0 1 2.06-.39c.412 0 .824.037 1.23.11.413.073.815.194 1.2.36.38.166.736.381 1.06.64.32.255.594.562.81.91V17.9h2.85v17.85h-.03Zm-10-6.33c-.001.55.069 1.098.21 1.63.13.511.35.996.65 1.43.288.414.668.757 1.11 1a3.241 3.241 0 0 0 1.6.38 3.199 3.199 0 0 0 1.64-.4 3.398 3.398 0 0 0 1.13-1.05c.297-.447.517-.94.65-1.46.14-.542.211-1.1.21-1.66a5.227 5.227 0 0 0-1-3.35 3.175 3.175 0 0 0-2.61-1.2 3.23 3.23 0 0 0-1.69.41 3.478 3.478 0 0 0-1.12 1.07 4.494 4.494 0 0 0-.62 1.5 7.871 7.871 0 0 0-.11 1.7h-.05ZM242.6 32.88c-.018.258.03.516.14.75a.577.577 0 0 0 .54.23h.3c.135-.002.269-.019.4-.05v2l-.39.11-.49.08-.5.08h-.42a2.75 2.75 0 0 1-1.45-.35 1.731 1.731 0 0 1-.75-1.23 4.998 4.998 0 0 1-2.09 1.2 8.224 8.224 0 0 1-2.39.38 5.861 5.861 0 0 1-1.67-.24 4.394 4.394 0 0 1-1.41-.7 3.35 3.35 0 0 1-1-1.18 3.624 3.624 0 0 1-.36-1.66 3.84 3.84 0 0 1 .44-2 3.246 3.246 0 0 1 1.15-1.17 5.195 5.195 0 0 1 1.6-.61c.593-.127 1.19-.223 1.79-.29a14.77 14.77 0 0 1 1.47-.21 6.896 6.896 0 0 0 1.24-.21c.318-.077.611-.236.85-.46a1.286 1.286 0 0 0 .31-.94 1.458 1.458 0 0 0-.26-.9A1.759 1.759 0 0 0 239 25a2.807 2.807 0 0 0-.86-.25 6.941 6.941 0 0 0-.9-.06 3.58 3.58 0 0 0-2 .5 2 2 0 0 0-.87 1.55h-2.85c.021-.73.227-1.442.6-2.07.338-.54.797-.996 1.34-1.33a5.475 5.475 0 0 1 1.84-.7c.692-.134 1.395-.2 2.1-.2.632 0 1.262.067 1.88.2a5.337 5.337 0 0 1 1.66.65 3.6 3.6 0 0 1 1.19 1.16c.314.525.47 1.129.45 1.74v6.65l.02.04Zm-2.85-3.6a3.45 3.45 0 0 1-1.6.51c-.667.06-1.3.147-1.9.26a6.137 6.137 0 0 0-.87.21 2.64 2.64 0 0 0-.75.38c-.22.164-.395.38-.51.63a2.129 2.129 0 0 0-.19.94c-.011.29.085.575.27.8.182.215.407.388.66.51.269.128.555.216.85.26.277.05.558.076.84.08a4.63 4.63 0 0 0 1-.12 3.418 3.418 0 0 0 1-.43 2.73 2.73 0 0 0 .81-.76 1.93 1.93 0 0 0 .32-1.14v-2.14l.07.01ZM244.37 22.83h2.15V19h2.85v3.88h2.58V25h-2.58v6.9a7.064 7.064 0 0 0 0 .77c.016.194.074.381.17.55a.84.84 0 0 0 .41.34 2 2 0 0 0 .75.11h.6c.203-.01.404-.04.6-.09v2.2l-.93.1a8.403 8.403 0 0 1-.92 0 6.33 6.33 0 0 1-1.81-.21 2.421 2.421 0 0 1-1.08-.62 2.15 2.15 0 0 1-.52-1 7.791 7.791 0 0 1-.16-1.42V25h-2.15v-2.17h.04ZM256.22 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7a5.352 5.352 0 0 1-2.1 3.26 5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4 5.947 5.947 0 0 1-1.21-2.18 8.754 8.754 0 0 1-.41-2.75 7.758 7.758 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.243.916.308 1.87.19 2.81h-9.5V30Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.575 3.575 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM270 31.6a2.154 2.154 0 0 0 .95 1.75c.607.35 1.3.524 2 .5.304-.002.608-.022.91-.06a3.943 3.943 0 0 0 1-.24c.286-.105.54-.28.74-.51a1.23 1.23 0 0 0 .26-.89 1.261 1.261 0 0 0-.4-.9 2.779 2.779 0 0 0-1-.56 9.315 9.315 0 0 0-1.34-.36l-1.5-.33a14.219 14.219 0 0 1-1.54-.42 4.937 4.937 0 0 1-1.33-.68 3.12 3.12 0 0 1-.94-1.09 3.472 3.472 0 0 1-.35-1.64 2.94 2.94 0 0 1 .51-1.76 3.913 3.913 0 0 1 1.3-1.15 5.66 5.66 0 0 1 1.75-.61 10.316 10.316 0 0 1 1.84-.17 8.418 8.418 0 0 1 1.91.21 5.19 5.19 0 0 1 1.65.69c.496.318.916.741 1.23 1.24.341.559.55 1.188.61 1.84h-3a1.783 1.783 0 0 0-.94-1.37 3.892 3.892 0 0 0-1.69-.35 6.093 6.093 0 0 0-.71 0 3.327 3.327 0 0 0-.78.19 1.642 1.642 0 0 0-.61.4 1 1 0 0 0-.25.69 1.093 1.093 0 0 0 .36.85c.294.245.634.428 1 .54.437.153.885.274 1.34.36l1.55.33a20.9 20.9 0 0 1 1.53.42c.479.157.931.386 1.34.68.41.277.751.643 1 1.07.255.494.379 1.045.36 1.6a3.48 3.48 0 0 1-.52 2 4.15 4.15 0 0 1-1.36 1.3 6.19 6.19 0 0 1-1.86.73 9.435 9.435 0 0 1-2 .23 8.823 8.823 0 0 1-2.26-.27 5.265 5.265 0 0 1-1.8-.84 4 4 0 0 1-1.2-1.4 4.445 4.445 0 0 1-.46-2h2.7v-.02Z"></path><path fill="#C72914" d="m21.94 38.74 18.12-12.08v-14.5H21.94v26.58Z"></path><path fill="#EF3340" d="M40.06 38.74 21.94 26.66v-14.5h18.12v26.58Z"></path><path fill="#3EB1C8" d="M31 9a20 20 0 1 0 0 40 20 20 0 0 0 0-40Zm0 35.1a15.1 15.1 0 1 1 0-30.2 15.1 15.1 0 0 1 0 30.2Z"></path><path fill="#FFC72C" d="M42.09 39.23A15.09 15.09 0 0 1 17 23.38l-4.2-2.64a20 20 0 0 0 33.49 21.14l-4.2-2.65Z"></path><defs><linearGradient id="horizontal_crossmark" x1="145" x2="145" y1="7.33" y2="56.82" gradientUnits="userSpaceOnUse"><stop stop-color="#fff"></stop><stop offset="1" stop-color="#c4c4c4"></stop></linearGradient></defs></svg></a></div><div class="core-content-info"></div></div></div></div></div></header><div class="core-header-aside">
    

        


    

            

            

            <div class="cover-image cover-image--axel"><div class="cover-image__thumb"><a href="https://www.cell.com/cell/issue?pii=S0092-8674(20)X0023-7"><img src="/cms/asset/8cc74f04-4511-42ff-8aba-8b2500f3672c/cov200h.gif" alt="Cover Image - Cell, Volume 184, Issue 22"></a></div></div>

            

        
</div></div><div data-core-wrapper="content"><div id="dummy-sticky-observer"></div><div data-core-nav="header" data-extent="frontmatter"><div class="core-nav-wrapper core-container" aria-label="Article navigation"><div class="navigation-menu-pdf">
    

        


    

            

            

            <div data-widget-id="ecff07e8-0bc4-4533-b1f1-49365e2ead20" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><a href="/action/showPdf?pii=S0092-8674%2821%2901165-X" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" role="menuitem" class="article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></div>

            

        
</div><div class="core-sections-menu"><button data-id="article-toolbar-showhide" aria-controls="article_sections_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle section navigation menu" style="margin-top: 0px;"><i class="icon-list" aria-hidden="true"></i><span>Outline</span></button><nav id="article_sections_menu" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><div class="heading">Outline<button aria-haspopup="true" aria-controls="article_sections_menu" title="Close outline menu"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div><ul><li><a href="#author-highlights-abstract">Highlights</a></li><li><a href="#author-abstract">Summary</a></li><li><a href="#graphical-abstract">Graphical abstract</a></li><li><a href="#keywords">Keywords</a></li><li><a href="#sec-1">Introduction</a></li><li><a href="#sec-2">Results</a></li><li><a href="#sec-3">Discussion</a></li><li><a href="#sec-4">STAR★Methods</a></li><li><a href="#acknowledgments">Acknowledgments</a></li><li><a href="#supplementary-material">Supplemental information (1)</a></li><li><a href="#data-availability">Data and code availability</a></li><li><a href="#references">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div><div class="navigation-menu-share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="5f978446-c80a-450c-a185-94d633df2db2" data-widget-name="UX3share" aria-hidden="false" role="group" class="article-tools__dropblock article-tools__share"><button aria-label="Toggle share menu" aria-expanded="false" aria-haspopup="true" role="menuitem" aria-controls="navigation_menu_share_block" aria-labelledby="share-label" class="article-tools__item__share"><i aria-hidden="true" class="icon-article-share"></i><span id="share-label">Share</span></button><div id="navigation_menu_share_block" role="menu" class="share__block axel-share article-tools__dropblock__holder"><h4 class="axel-share__title heading">Share<button title="Close share menu" aria-expanded="false" aria-haspopup="true" aria-controls="navigation_menu_share_block"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2821%2901165-X" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="f1a208d3-ac5e-4db2-9c3a-40ef97ddfa10" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2021.09.035">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</div><div><button data-id="article-nav-menubar-more" aria-controls="article_more_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle more menu"><i aria-hidden="true" class="icon-more-mobile"></i><span>More</span></button><div class="info-panel"><div class="info-panel__left-content"><div class="info-panel__article_tools info-panel__item"><div id="article_more_menu" aria-label="More menu" data-core-nav="more"><div class="heading">More<button title="Close more menu" aria-controls="article_more_menu" aria-haspopup="true"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div>
    

        


    

            

            

            <ul data-widget-id="183a17a2-87b5-4e6f-bb85-6b5cda068c89" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><li class="article-tools__item article-tools__pdf"><a href="/action/showPdf?pii=S0092-8674%2821%2901165-X" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" class="article-tools__ctrl article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></li><li><a href="https://www.cell.com/action/showCitFormats?doi=10.1016%2Fj.cell.2021.09.035&amp;pii=S0092-8674%2821%2901165-X" title="Cite" target="_blank" aria-label="Open Cite in new tab" class="article-tools__item__displayExportCitation"><i aria-hidden="true" class="icon-export-Citation"></i><span>Cite</span></a></li><li id="article_tools_share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" data-widget-name="UX3share" class="dropBlock article-tools__dropblock article-tools__share"><button data-db-target-for="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" aria-expanded="false" title="open Share menu" class="article-tools__ctrl share__ctrl"><i aria-hidden="true" class="icon-article-share"></i><span>Share</span></button><div data-db-target-of="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da_Pop" class="share__block axel-share dropBlock__holder article-tools__dropblock__holder"><h4 class="axel-share__title">Share</h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2821%2901165-X" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>Bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="ae9bf5c5-a2ee-4f5c-8e41-9b21638b1a9f" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2021.09.035">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</li><li><a href="https://www.cell.com/action/addCitationAlert?doi=10.1016%2Fj.cell.2021.09.035" title="Set Alert" target="_blank" aria-label="Open Set Alert in new tab" class="article-tools__item__displayCreateCitationAlert"><i aria-hidden="true" class="icon-set-alert"></i><span>Set Alert</span></a></li><li><a href="https://s100.copyright.com/AppDispatchServlet?publisherName=ELS&amp;contentID=S009286742101165X&amp;orderBeanReset=true&amp;orderSource=Phoenix" title="Get Rights" target="_blank" aria-label="Open Get Rights in new tab" class="article-tools__item__request"><i aria-hidden="true" class="icon-get-rights"></i><span>Get Rights</span></a></li><li><a href="https://www.contentednet.com/salesforce-form/?pii=S009286742101165X&amp;issn=00928674&amp;source=jbs" title="Reprints" target="_blank" aria-label="Open Reprints in new tab" class="article-tools__item__reprints"><i aria-hidden="true" class="icon-article-reprints"></i><span>Reprints</span></a></li></ul>

            

        
</div></div><div class="info-panel__download-issue info-panel__item"><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=184&amp;issue=22&amp;pii=S0092-8674%2820%29X0023-7" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div></div><div class="info-panel__right-content"><div class="info-panel__navigation info-panel__item"><div class="content-navigation"><a href="/cell/fulltext/S0092-8674(21)01105-3" aria-label="Previous article" aria-disabled="false" class="content-navigation__prev"><i aria-hidden="true" class="icon-arrow_l"></i><span>Previous article</span></a><a href="/cell/fulltext/S0092-8674(21)01106-5" aria-label="Next article" aria-disabled="false" class="content-navigation__next"><span>Next article</span><i aria-hidden="true" class="icon-arrow_r"></i></a></div></div></div></div></div></div></div><div class="core-sections-menu-outer"><div class="core-sections-menu"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-show-outline" aria-hidden="true"></i><span>Show Outline</span></button><nav id="article_sections_menu-desktop" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-hide-outline" aria-hidden="true"></i><span>Hide Outline</span></button><ul><li><a href="#author-highlights-abstract">Highlights</a></li><li><a href="#author-abstract">Summary</a></li><li><a href="#graphical-abstract">Graphical abstract</a></li><li><a href="#keywords">Keywords</a></li><li><a href="#sec-1">Introduction</a></li><li><a href="#sec-2">Results</a></li><li><a href="#sec-3">Discussion</a></li><li><a href="#sec-4">STAR★Methods</a></li><li><a href="#acknowledgments">Acknowledgments</a></li><li><a href="#supplementary-material">Supplemental information (1)</a></li><li><a href="#data-availability">Data and code availability</a></li><li><a href="#references">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div></div><div><div class="core-content-inner"><div class="core-linked-content"></div><div id="abstracts" data-extent="frontmatter"><div class="core-container"><section id="author-highlights-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Highlights</h2><div id="abspara0020" role="paragraph"><div id="ulist0010" role="list"><div id="u0010" role="listitem"><div class="label">•</div><div class="content"><div id="p0010" role="paragraph">Two human antibodies recognize different conserved sites on ebolavirus glycoproteins</div></div></div><div id="u0015" role="listitem"><div class="label">•</div><div class="content"><div id="p0015" role="paragraph">The cocktail exhibits broad neutralizing activity and resists viral escape <i>in&nbsp;vitro</i></div></div></div><div id="u0020" role="listitem"><div class="label">•</div><div class="content"><div id="p0020" role="paragraph">Antibodies synergize to neutralize virus and differentially engage their Fc regions</div></div></div><div id="u0025" role="listitem"><div class="label">•</div><div class="content"><div id="p0025" role="paragraph">The therapeutic cocktail protects NHPs against three medically important ebolaviruses</div></div></div></div></div></section><section id="author-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Summary</h2><div id="abspara0010" role="paragraph">Ebolaviruses cause a severe and often fatal illness with the potential for global spread. Monoclonal antibody-based treatments that have become available recently have a narrow therapeutic spectrum and are ineffective against ebolaviruses other than Ebola virus (EBOV), including medically important Bundibugyo (BDBV) and Sudan (SUDV) viruses. Here, we report the development of a therapeutic cocktail comprising two broadly neutralizing human antibodies, rEBOV-515 and rEBOV-442, that recognize non-overlapping sites on the ebolavirus glycoprotein (GP). Antibodies in the cocktail exhibited synergistic neutralizing activity, resisted viral escape, and possessed differing requirements for their Fc-regions for optimal <i>in&nbsp;vivo</i> activities. The cocktail protected non-human primates from ebolavirus disease caused by EBOV, BDBV, or SUDV with high therapeutic effectiveness. High-resolution structures of the cocktail antibodies in complex with GP revealed the molecular determinants for neutralization breadth and potency. This study provides advanced preclinical data to support clinical development of this cocktail for pan-ebolavirus therapy.</div></section><section id="graphical-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Graphical abstract</h2><div id="abspara0015" role="paragraph"><div class="figure-wrap"><figure id="undfig1" class="graphic" data-figureviewer-ignore="true"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.09.035/asset/c374cc61-cab9-4834-a3b7-6290a1659331/main.assets/fx1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx1" alt="Graphical abstract undfig1" src="/cms/10.1016/j.cell.2021.09.035/asset/2dcd8134-0acb-420e-874e-5b8c9ef10c4a/main.assets/fx1.jpg" height="375" width="375" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/c374cc61-cab9-4834-a3b7-6290a1659331/main.assets/fx1_lrg.jpg" loading="lazy"></a></figure></div></div></section></div></div><div class="core-linked-content"></div><section id="keywords" property="keywords"><h2>Keywords</h2><ol><li><a href="/action/doSearch?AllField=&quot;Ebolavirus&quot;" alt="Search on this keyword" rel="nofollow"><i>Ebolavirus</i></a></li><li><a href="/action/doSearch?AllField=&quot;ebolavirus+infection&quot;" alt="Search on this keyword" rel="nofollow">ebolavirus infection</a></li><li><a href="/action/doSearch?AllField=&quot;glycoprotein&quot;" alt="Search on this keyword" rel="nofollow">glycoprotein</a></li><li><a href="/action/doSearch?AllField=&quot;viral+antibodies&quot;" alt="Search on this keyword" rel="nofollow">viral antibodies</a></li><li><a href="/action/doSearch?AllField=&quot;neutralizing+antibodies&quot;" alt="Search on this keyword" rel="nofollow">neutralizing antibodies</a></li><li><a href="/action/doSearch?AllField=&quot;epitope+mapping&quot;" alt="Search on this keyword" rel="nofollow">epitope mapping</a></li><li><a href="/action/doSearch?AllField=&quot;antibody+therapeutics&quot;" alt="Search on this keyword" rel="nofollow">antibody therapeutics</a></li></ol></section><div class="core-linked-content"></div><div class="core-linked-content"></div><section id="bodymatter" data-extent="bodymatter" property="articleBody" typeof="Text"><div class="core-container"><section id="sec-1"><h2>Introduction</h2><div id="p0035" role="paragraph">The genus <i>Ebolavirus</i> consists of six antigenically distinct species, including Zaire ebolavirus (represented by Ebola virus [EBOV]), Sudan ebolavirus (Sudan virus [SUDV]), Bundibugyo ebolavirus (Bundibugyo virus [BDBV]), Taï Forest ebolavirus (Taï Forest virus [TAFV]), Reston ebolavirus (Reston virus [RESV]) (<span class="dropBlock reference-citations"><a id="body-ref-sref21" href="#" role="doc-biblioref" data-xml-rid="bib21" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref21" aria-controls="sref21">Feldmann et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref21"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">21.</div><div>Feldmann, H. ∙ Sprecher, A. ∙ Geisbert, T.W.</div><div><strong>Ebola</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2020; <strong>382</strong>:1832-1842</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMra1901594" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85084681815" target="_blank" aria-label="Open Scopus in new tab">Scopus (121)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32441897/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMra1901594&amp;pmid=32441897" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref46" href="#" role="doc-biblioref" data-xml-rid="bib46" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref46" aria-controls="sref46">Kuhn et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref46"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">48.</div><div>Kuhn, J.H. ∙ Adachi, T. ∙ Adhikari, N.K.J. ...</div><div><strong>New filovirus disease classification and nomenclature</strong></div><div><em>Nat. Rev. Microbiol.</em> 2019; <strong>17</strong>:261-263</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41579-019-0187-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85063786896" target="_blank" aria-label="Open Scopus in new tab">Scopus (72)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30926957/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41579-019-0187-4&amp;pmid=30926957" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and Bombali ebolavirus (Bombali virus [BOMV]) (<span class="dropBlock reference-citations"><a id="body-ref-sref35" href="#" role="doc-biblioref" data-xml-rid="bib35" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref35" aria-controls="sref35">Goldstein et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref35"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">35.</div><div>Goldstein, T. ∙ Anthony, S.J. ∙ Gbakima, A. ...</div><div><strong>The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses</strong></div><div><em>Nat. Microbiol.</em> 2018; <strong>3</strong>:1084-1089</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41564-018-0227-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85052954021" target="_blank" aria-label="Open Scopus in new tab">Scopus (254)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30150734/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41564-018-0227-2&amp;pmid=30150734" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Three ebolaviruses—EBOV, BDBV, and SUDV—are responsible for severe&nbsp;disease and occasional deadly outbreaks in Africa posing&nbsp;a significant health threat and highlighting the urgent need for development of medical countermeasures. A total of 19 confirmed ebolavirus disease (EVD) outbreaks caused by EBOV have occurred, with &gt;30,000 people infected to date and an average reported mortality rate of ∼70% (<span class="dropBlock reference-citations"><a id="body-ref-sref78-1" href="#" role="doc-biblioref" data-xml-rid="bib78" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref78-1" aria-controls="sref78-1">World Health Organization, 2021</a><div class="dropBlock__holder" data-db-target-of="sref78-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">81.</div><div>World Health Organization</div><div><strong>Ebola virus disease</strong></div><div><a id="intref0170" href="https://www.whoint/en/news-room/fact-sheets/detail/ebola-virus-disease" target="_blank">https://www.whoint/en/news-room/fact-sheets/detail/ebola-virus-disease</a><div>Date: 2021</div></div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=World+Health+OrganizationEbola+virus+diseasehttps%3A%2F%2Fwww.whoint%2Fen%2Fnews-room%2Ffact-sheets%2Fdetail%2Febola-virus-disease2021" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In 2021, there are ongoing EVD outbreaks in the Democratic Republic of the Congo (DRC) and Guinea (<span class="dropBlock reference-citations"><a id="body-ref-sref78-2" href="#" role="doc-biblioref" data-xml-rid="bib78" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref78-2" aria-controls="sref78-2">World Health Organization, 2021</a><div class="dropBlock__holder" data-db-target-of="sref78-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">81.</div><div>World Health Organization</div><div><strong>Ebola virus disease</strong></div><div><a id="intref0170" href="https://www.whoint/en/news-room/fact-sheets/detail/ebola-virus-disease" target="_blank">https://www.whoint/en/news-room/fact-sheets/detail/ebola-virus-disease</a><div>Date: 2021</div></div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=World+Health+OrganizationEbola+virus+diseasehttps%3A%2F%2Fwww.whoint%2Fen%2Fnews-room%2Ffact-sheets%2Fdetail%2Febola-virus-disease2021" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). BDBV has caused two confirmed outbreaks and infected 206 people (∼32% mortality rate), and SUDV has been responsible for eight confirmed outbreaks and infected 779 people (∼53% mortality rate) (<span class="dropBlock reference-citations"><a id="body-ref-sref78-3" href="#" role="doc-biblioref" data-xml-rid="bib78" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref78-3" aria-controls="sref78-3">World Health Organization, 2021</a><div class="dropBlock__holder" data-db-target-of="sref78-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">81.</div><div>World Health Organization</div><div><strong>Ebola virus disease</strong></div><div><a id="intref0170" href="https://www.whoint/en/news-room/fact-sheets/detail/ebola-virus-disease" target="_blank">https://www.whoint/en/news-room/fact-sheets/detail/ebola-virus-disease</a><div>Date: 2021</div></div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=World+Health+OrganizationEbola+virus+diseasehttps%3A%2F%2Fwww.whoint%2Fen%2Fnews-room%2Ffact-sheets%2Fdetail%2Febola-virus-disease2021" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Monoclonal antibody (mAb) therapies have demonstrated safe and significant survival benefits in the treatment of acute EVD caused by EBOV in human trials (<span class="dropBlock reference-citations"><a id="body-ref-sref28" href="#" role="doc-biblioref" data-xml-rid="bib28" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref28" aria-controls="sref28">Gaudinski et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref28"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">28.</div><div>Gaudinski, M.R. ∙ Coates, E.E. ∙ Novik, L. ..., VRC 608 Study team</div><div><strong>Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study</strong></div><div><em>Lancet.</em> 2019; <strong>393</strong>:889-898</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2FS0140-6736%2819%2930036-4&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2FS0140-6736%2819%2930036-4&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85061347966" target="_blank" aria-label="Open Scopus in new tab">Scopus (88)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30686586/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0140-6736%2819%2930036-4&amp;pmid=30686586" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref51-1" href="#" role="doc-biblioref" data-xml-rid="bib51" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref51-1" aria-controls="sref51-1">Levine, 2019</a><div class="dropBlock__holder" data-db-target-of="sref51-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Levine, M.M.</div><div><strong>Monoclonal antibody therapy for Ebola virus disease</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2019; <strong>381</strong>:2365-2366</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMe1915350" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85076446841" target="_blank" aria-label="Open Scopus in new tab">Scopus (48)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31774948/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMe1915350&amp;pmid=31774948" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref57" href="#" role="doc-biblioref" data-xml-rid="bib57" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref57" aria-controls="sref57">Mulangu et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref57"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">60.</div><div>Mulangu, S. ∙ Dodd, L.E. ∙ Davey, Jr., R.T. ..., PALM Writing Group, PALM Consortium Study Team</div><div><strong>A randomized, controlled trial of Ebola virus disease therapeutics</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2019; <strong>381</strong>:2293-2303</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1910993" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85076449492" target="_blank" aria-label="Open Scopus in new tab">Scopus (1122)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31774950/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1910993&amp;pmid=31774950" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref66" href="#" role="doc-biblioref" data-xml-rid="bib66" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref66" aria-controls="sref66">Sivapalasingam et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref66"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">70.</div><div>Sivapalasingam, S. ∙ Kamal, M. ∙ Slim, R. ...</div><div><strong>Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 study</strong></div><div><em>Lancet Infect. Dis.</em> 2018; <strong>18</strong>:884-893</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2FS1473-3099%2818%2930397-9&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2FS1473-3099%2818%2930397-9&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85048770052" target="_blank" aria-label="Open Scopus in new tab">Scopus (68)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29929783/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1473-3099%2818%2930397-9&amp;pmid=29929783" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and several investigational human mAb treatments have been shown to reverse the advanced EVD in non-human primates caused by EBOV (<span class="dropBlock reference-citations"><a id="body-ref-sref7-1" href="#" role="doc-biblioref" data-xml-rid="bib7" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref7-1" aria-controls="sref7-1">Bornholdt et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref7-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">7.</div><div>Bornholdt, Z.A. ∙ Herbert, A.S. ∙ Mire, C.E. ...</div><div><strong>A two-antibody pan-ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates</strong></div><div><em>Cell Host Microbe.</em> 2019; <strong>25</strong>:49-58.e5</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2018.12.005&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2018.12.005&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85058702898" target="_blank" aria-label="Open Scopus in new tab">Scopus (73)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30629918/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.chom.2018.12.005&amp;pmid=30629918" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref14-1" href="#" role="doc-biblioref" data-xml-rid="bib14" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref14-1" aria-controls="sref14-1">Corti et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref14-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Corti, D. ∙ Misasi, J. ∙ Mulangu, S. ...</div><div><strong>Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody</strong></div><div><em>Science.</em> 2016; <strong>351</strong>:1339-1342</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aad5224" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84959359636" target="_blank" aria-label="Open Scopus in new tab">Scopus (326)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26917593/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aad5224&amp;pmid=26917593" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref34-1" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-1" aria-controls="sref34-1">Gilchuk et&nbsp;al., 2020b</a><div class="dropBlock__holder" data-db-target-of="sref34-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Gilchuk, P. ∙ Murin, C.D. ∙ Milligan, J.C. ...</div><div><strong>Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:388-403.e12</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85079145867" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32023489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2020.01.001&amp;pmid=32023489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref61-1" href="#" role="doc-biblioref" data-xml-rid="bib61" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref61-1" aria-controls="sref61-1">Pascal et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref61-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Pascal, K.E. ∙ Dudgeon, D. ∙ Trefry, J.C. ...</div><div><strong>Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in nonhuman primates</strong></div><div><em>J.&nbsp;Infect. Dis.</em> 2018; <strong>218</strong>:S612-S626</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/infdis/jiy285" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85057165662" target="_blank" aria-label="Open Scopus in new tab">Scopus (133)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29860496/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Finfdis%2Fjiy285&amp;pmid=29860496" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref64-1" href="#" role="doc-biblioref" data-xml-rid="bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64-1" aria-controls="sref64-1">Qiu et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref64-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">67.</div><div>Qiu, X. ∙ Wong, G. ∙ Audet, J. ...</div><div><strong>Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp</strong></div><div><em>Nature.</em> 2014; <strong>514</strong>:47-53</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature13777" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84907263545" target="_blank" aria-label="Open Scopus in new tab">Scopus (827)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25171469/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature13777&amp;pmid=25171469" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), BDBV (<span class="dropBlock reference-citations"><a id="body-ref-sref7-2" href="#" role="doc-biblioref" data-xml-rid="bib7" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref7-2" aria-controls="sref7-2">Bornholdt et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref7-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">7.</div><div>Bornholdt, Z.A. ∙ Herbert, A.S. ∙ Mire, C.E. ...</div><div><strong>A two-antibody pan-ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates</strong></div><div><em>Cell Host Microbe.</em> 2019; <strong>25</strong>:49-58.e5</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2018.12.005&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2018.12.005&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85058702898" target="_blank" aria-label="Open Scopus in new tab">Scopus (73)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30629918/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.chom.2018.12.005&amp;pmid=30629918" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref32" href="#" role="doc-biblioref" data-xml-rid="bib32" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref32" aria-controls="sref32">Gilchuk et&nbsp;al., 2018b</a><div class="dropBlock__holder" data-db-target-of="sref32"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">32.</div><div>Gilchuk, P. ∙ Mire, C.E. ∙ Geisbert, J.B. ...</div><div><strong>Efficacy of human monoclonal antibody monotherapy against Bundibugyo virus infection in nonhuman primates</strong></div><div><em>J.&nbsp;Infect. Dis.</em> 2018; <strong>218</strong>:S565-S573</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/infdis/jiy295" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85057209498" target="_blank" aria-label="Open Scopus in new tab">Scopus (12)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29982718/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Finfdis%2Fjiy295&amp;pmid=29982718" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), or SUDV (<span class="dropBlock reference-citations"><a id="body-ref-sref7-3" href="#" role="doc-biblioref" data-xml-rid="bib7" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref7-3" aria-controls="sref7-3">Bornholdt et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref7-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">7.</div><div>Bornholdt, Z.A. ∙ Herbert, A.S. ∙ Mire, C.E. ...</div><div><strong>A two-antibody pan-ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates</strong></div><div><em>Cell Host Microbe.</em> 2019; <strong>25</strong>:49-58.e5</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2018.12.005&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2018.12.005&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85058702898" target="_blank" aria-label="Open Scopus in new tab">Scopus (73)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30629918/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.chom.2018.12.005&amp;pmid=30629918" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref37-1" href="#" role="doc-biblioref" data-xml-rid="bib37" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref37-1" aria-controls="sref37-1">Herbert et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref37-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">37.</div><div>Herbert, A.S. ∙ Froude, J.W. ∙ Ortiz, R.A. ...</div><div><strong>Development of an antibody cocktail for treatment of Sudan virus infection</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2020; <strong>117</strong>:3768-3778</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1914985117" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85079531798" target="_blank" aria-label="Open Scopus in new tab">Scopus (18)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32015126/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1914985117&amp;pmid=32015126" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). By 2020, two mAb-based therapeutics—ansuvimab-zykl (Ebanga) and atoltivimab&nbsp;+ maftivimab&nbsp;+ odesivimab-ebgn (Inmazeb)—have been developed and approved by the Food and Drug Administration (FDA) for clinical use (<span class="dropBlock reference-citations"><a id="body-ref-sref24" href="#" role="doc-biblioref" data-xml-rid="bib24" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref24" aria-controls="sref24">Food and Drug Administration, 2020a</a><div class="dropBlock__holder" data-db-target-of="sref24"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Food and Drug Administration</div><div><strong>FDA Approves First Treatment for Ebola Virus</strong></div><div>2020</div><div><a id="intref0155" href="https://www.fdagov/news-events/press-announcements/fda-approves-first-treatment-ebola-virus" target="_blank">https://www.fdagov/news-events/press-announcements/fda-approves-first-treatment-ebola-virus</a></div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Food+and+Drug+AdministrationFDA+Approves+First+Treatment+for+Ebola+Virus2020https%3A%2F%2Fwww.fdagov%2Fnews-events%2Fpress-announcements%2Ffda-approves-first-treatment-ebola-virus" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>, <span class="dropBlock reference-citations"><a id="body-ref-sref25" href="#" role="doc-biblioref" data-xml-rid="bib25" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref25" aria-controls="sref25">2020b</a><div class="dropBlock__holder" data-db-target-of="sref25"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Food and Drug Administration</div><div><strong>FDA Approves Treatment for Ebola Virus</strong></div><div>2020</div><div><a id="intref0160" href="https://www.fdagov/drugs/drug-safety-and-availability/fda-approves-treatment-ebola-virus" target="_blank">https://www.fdagov/drugs/drug-safety-and-availability/fda-approves-treatment-ebola-virus</a></div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Food+and+Drug+AdministrationFDA+Approves+Treatment+for+Ebola+Virus2020https%3A%2F%2Fwww.fdagov%2Fdrugs%2Fdrug-safety-and-availability%2Ffda-approves-treatment-ebola-virus" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Both of these approved mAb treatments are monospecific to EBOV and therefore not indicated for treatment of BDBV or SUDV infection. Identification of mAbs that cross-neutralize EBOV, BDBV, and SUDV with high potency is challenging due to the relatively high antigenic variability between these viruses (<span class="dropBlock reference-citations"><a id="body-ref-sref44-1" href="#" role="doc-biblioref" data-xml-rid="bib44" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref44-1" aria-controls="sref44-1">King et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref44-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">46.</div><div>King, L.B. ∙ Milligan, J.C. ∙ West, B.R. ...</div><div><strong>Achieving cross-reactivity with pan-ebolavirus antibodies</strong></div><div><em>Curr. Opin. Virol.</em> 2019; <strong>34</strong>:140-148</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.coviro.2019.01.003" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85062902126" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30884329/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.coviro.2019.01.003&amp;pmid=30884329" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The efficacy of previously reported investigational mAb therapeutics typically is limited to only one of the three medically important ebolavirus species. The nature of future ebolavirus outbreaks cannot be predicted, however, and in a scenario of global spread, viruses can mutate rapidly making available mAb treatments vulnerable to escape, as has been recently shown for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (<span class="dropBlock reference-citations"><a id="body-ref-sref67" href="#" role="doc-biblioref" data-xml-rid="bib67" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref67" aria-controls="sref67">Starr et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref67"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">71.</div><div>Starr, T.N. ∙ Greaney, A.J. ∙ Dingens, A.S. ...</div><div><strong>Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016</strong></div><div><em>Cell Rep. Med.</em> 2021; <strong>2</strong>:100255</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.xcrm.2021.100255&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.xcrm.2021.100255&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85103959725" target="_blank" aria-label="Open Scopus in new tab">Scopus (307)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33842902/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.xcrm.2021.100255&amp;pmid=33842902" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref74" href="#" role="doc-biblioref" data-xml-rid="bib74" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref74" aria-controls="sref74">Wang et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref74"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">77.</div><div>Wang, P. ∙ Nair, M.S. ∙ Liu, L. ...</div><div><strong>Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7</strong></div><div><em>Nature.</em> 2021; <strong>593</strong>:130-135</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-021-03398-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_77_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85102173598" target="_blank" aria-label="Open Scopus in new tab">Scopus (1494)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33684923/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-021-03398-2&amp;pmid=33684923" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). One approach could be to develop separate therapeutic mAb products for BDBV or SUDV or future escape variants of EBOV. It is desirable from a practical standpoint, however, to identify a single broad therapeutic spectrum mAb treatment of an equivalent or higher potency to existing monospecific mAb treatments that could be used for treatment of EBOV, BDBV, or SUDV. Therefore, ongoing efforts are needed to increase the therapeutic breadth of mAb therapies while maintaining or improving efficacy.</div><div id="p0040" role="paragraph">The ebolavirus envelope glycoprotein (GP) is the key target for neutralizing mAbs (<span class="dropBlock reference-citations"><a id="body-ref-sref43" href="#" role="doc-biblioref" data-xml-rid="bib43" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref43" aria-controls="sref43">King et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref43"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">43.</div><div>King, L.B. ∙ West, B.R. ∙ Schendel, S.L. ...</div><div><strong>The structural basis for filovirus neutralization by monoclonal antibodies</strong></div><div><em>Curr. Opin. Immunol.</em> 2018; <strong>53</strong>:196-202</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.coi.2018.05.001" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85048825298" target="_blank" aria-label="Open Scopus in new tab">Scopus (14)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29940415/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.coi.2018.05.001&amp;pmid=29940415" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref50" href="#" role="doc-biblioref" data-xml-rid="bib50" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref50" aria-controls="sref50">Lee et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref50"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Lee, J.E. ∙ Fusco, M.L. ∙ Hessell, A.J. ...</div><div><strong>Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor</strong></div><div><em>Nature.</em> 2008; <strong>454</strong>:177-182</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature07082" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-47049107589" target="_blank" aria-label="Open Scopus in new tab">Scopus (577)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18615077/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature07082&amp;pmid=18615077" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref49" href="#" role="doc-biblioref" data-xml-rid="bib49" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref49" aria-controls="sref49">Lee and Saphire, 2009</a><div class="dropBlock__holder" data-db-target-of="sref49"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">51.</div><div>Lee, J.E. ∙ Saphire, E.O.</div><div><strong>Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it</strong></div><div><em>Curr. Opin. Struct. Biol.</em> 2009; <strong>19</strong>:408-417</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.sbi.2009.05.004" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-69249132055" target="_blank" aria-label="Open Scopus in new tab">Scopus (57)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19559599/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.sbi.2009.05.004&amp;pmid=19559599" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref56-1" href="#" role="doc-biblioref" data-xml-rid="bib56" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref56-1" aria-controls="sref56-1">Misasi and Sullivan, 2021</a><div class="dropBlock__holder" data-db-target-of="sref56-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">59.</div><div>Misasi, J. ∙ Sullivan, N.J.</div><div><strong>Immunotherapeutic strategies to target vulnerabilities in the Ebolavirus glycoprotein</strong></div><div><em>Immunity.</em> 2021; <strong>54</strong>:412-436</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2021.01.015&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2021.01.015&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85102002020" target="_blank" aria-label="Open Scopus in new tab">Scopus (19)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33691133/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2021.01.015&amp;pmid=33691133" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We previously described isolation of two broadly neutralizing human mAbs, EBOV-515 and EBOV-442, using a human B cell hybridoma approach (<span class="dropBlock reference-citations"><a id="body-ref-sref31-1" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-1" aria-controls="sref31-1">Gilchuk et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref31-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Gilchuk, P. ∙ Kuzmina, N. ∙ Ilinykh, P.A. ...</div><div><strong>Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the Ebolavirus glycoprotein</strong></div><div><em>Immunity.</em> 2018; <strong>49</strong>:363-374.e10</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85053075312" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30029854/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.06.018&amp;pmid=30029854" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Each of these two mAbs exhibited favorable immunological profiles, which included (1) broad reactivity for binding to GP of diverse species, (2) broad neutralization of authentic ebolaviruses (EBOV, BDBV, and SUDV), (3) recognition of distinct, non-overlapping epitopes in the GP (EBOV-515 is base-specific and EBOV-442 is glycan-cap-specific), and (4) a high level of therapeutic protection against EBOV. The antibodies EBOV-515 or EBOV-442 are analogous to the broadly reactive mAb EBOV-520 (GP-base-specific mAb) or mAb EBOV-548 (glycan-cap-specific), respectively (<span class="dropBlock reference-citations"><a id="body-ref-sref31-2" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-2" aria-controls="sref31-2">Gilchuk et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref31-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Gilchuk, P. ∙ Kuzmina, N. ∙ Ilinykh, P.A. ...</div><div><strong>Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the Ebolavirus glycoprotein</strong></div><div><em>Immunity.</em> 2018; <strong>49</strong>:363-374.e10</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85053075312" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30029854/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.06.018&amp;pmid=30029854" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>, <span class="dropBlock reference-citations"><a id="body-ref-sref34-2" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-2" aria-controls="sref34-2">2020b</a><div class="dropBlock__holder" data-db-target-of="sref34-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Gilchuk, P. ∙ Murin, C.D. ∙ Milligan, J.C. ...</div><div><strong>Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:388-403.e12</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85079145867" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32023489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2020.01.001&amp;pmid=32023489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We recently described a beneficial feature of the combination of EBOV-520&nbsp;+ EBOV-548 by showing that these two mAbs synergized for virus neutralization when combined in a cocktail and conferred therapeutic protection in EBOV-challenged rhesus macaques (<span class="dropBlock reference-citations"><a id="body-ref-sref34-3" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-3" aria-controls="sref34-3">Gilchuk et&nbsp;al., 2020b</a><div class="dropBlock__holder" data-db-target-of="sref34-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Gilchuk, P. ∙ Murin, C.D. ∙ Milligan, J.C. ...</div><div><strong>Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:388-403.e12</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85079145867" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32023489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2020.01.001&amp;pmid=32023489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We did not previously characterize the similar combination of EBOV-515&nbsp;+ EBOV-442. However, our previous studies revealed that the individual mAbs, EBOV-515 and EBOV-442, had a higher potency to neutralize the most antigenically distinct of the three viruses (SUDV) when compared, respectively, to the potency of EBOV-520 or EBOV-548. EBOV-515 monotherapy in mice also demonstrated a high level of therapeutic protection against SUDV (<span class="dropBlock reference-citations"><a id="body-ref-sref31-3" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-3" aria-controls="sref31-3">Gilchuk et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref31-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Gilchuk, P. ∙ Kuzmina, N. ∙ Ilinykh, P.A. ...</div><div><strong>Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the Ebolavirus glycoprotein</strong></div><div><em>Immunity.</em> 2018; <strong>49</strong>:363-374.e10</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85053075312" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30029854/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.06.018&amp;pmid=30029854" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>, <span class="dropBlock reference-citations"><a id="body-ref-sref34-4" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-4" aria-controls="sref34-4">2020b</a><div class="dropBlock__holder" data-db-target-of="sref34-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Gilchuk, P. ∙ Murin, C.D. ∙ Milligan, J.C. ...</div><div><strong>Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:388-403.e12</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85079145867" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32023489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2020.01.001&amp;pmid=32023489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Given the higher potency of EBOV-515 and EBOV-442 against SUDV, we suggest their combination as a candidate for a “next-generation” broad therapeutic mAb cocktail. In this study, we describe pre-clinical development of the EBOV-515&nbsp;+ EBOV-442 mAb cocktail and define the molecular basis for its pan-ebolavirus activity and efficacy.</div></section><section id="sec-2"><h2>Results</h2><section id="sec-2-1"><h3>Activities of pan-ebolavirus candidate cocktail containing recombinant mAbs rEBOV-442 and rEBOV-515</h3><div id="p0045" role="paragraph">Antibody variable gene sequences for mAbs EBOV-515 and EBOV-442 were determined, and synthetic DNAs encoding the mAbs were used to produce recombinant IgG1. Recombinant (r) mAbs, designated as rEBOV-515 and rEBOV-442, potently neutralized EBOV, BDBV, and SUDV (<a id="crosref0375" href="#fig1">Figure&nbsp;1</a>A) with a note that rEBOV-442 only partially neutralized SUDV (Gulu variant) but was more active against a chimeric vesicular stomatitis virus (VSV) expressing the Boniface variant of SUDV GP (see below). To assess the Fc-mediated effector function of these antibodies to mediate killing of antigen-expressing cells, we used a stably transfected EBOV GP-expressing SNAP-tagged 293F cell line as a target, with heterologous human peripheral blood mononuclear cells (PBMCs) as source of effector cells and a previously described assay (<span class="dropBlock reference-citations"><a id="body-ref-sref19-1" href="#" role="doc-biblioref" data-xml-rid="bib19" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref19-1" aria-controls="sref19-1">Domi et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref19-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>Domi, A. ∙ Feldmann, F. ∙ Basu, R. ...</div><div><strong>A single dose of modified Vaccinia Ankara expressing Ebola virus like particles protects nonhuman primates from lethal Ebola virus challenge</strong></div><div><em>Sci. Rep.</em> 2018; <strong>8</strong>:864</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41598-017-19041-y" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85040942560" target="_blank" aria-label="Open Scopus in new tab">Scopus (39)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29339750/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41598-017-19041-y&amp;pmid=29339750" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The glycan-cap-specific mAb rEBOV-442 immunoglobulin G1 (IgG1) exhibited a high level of cytotoxic activity, and the GP-base-specific mAb rEBOV-515 exhibited a moderate level of cytotoxic activity, relative to the control Fc-function-disabled IgG1-LALA-PG variant of rEBOV-515 (designated as rEBOV-515 LALA-PG) or an irrelevant mAb rDENV 2D22 (IgG1 isotype) specific to the dengue virus envelope (E) protein (<span class="dropBlock reference-citations"><a id="body-ref-sref22-1" href="#" role="doc-biblioref" data-xml-rid="bib22" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref22-1" aria-controls="sref22-1">Fibriansah et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref22-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Fibriansah, G. ∙ Ibarra, K.D. ∙ Ng, T.S. ...</div><div><strong>DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers</strong></div><div><em>Science.</em> 2015; <strong>349</strong>:88-91</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaa8651" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84935097021" target="_blank" aria-label="Open Scopus in new tab">Scopus (185)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26138979/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaa8651&amp;pmid=26138979" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (<a id="crosref0390" href="#fig1">Figure&nbsp;1</a>B). Neutralizing activity&nbsp;of the wild-type IgG1 and IgG1-LALA-PG variants of rEBOV-515 was equivalent (<a id="crosref0395" href="#figs1">Figure&nbsp;S1</a>A). These results taken together revealed two complementary activities exhibited by this broad mAb cocktail, specifically the Fc-mediated effector functions mediated by rEBOV-442 and the potent neutralizing activities mediated by rEBOV-442 and rEBOV-515 (<a id="crosref0400" href="#fig1">Figure&nbsp;1</a>C).</div><div class="figure-wrap"><figure id="fig1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.09.035/asset/d591796d-3fce-403c-95b8-7c2e2840e963/main.assets/gr1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr1" src="/cms/10.1016/j.cell.2021.09.035/asset/ca31aa88-56da-4a9c-9ba6-d4206fdf1f89/main.assets/gr1.jpg" height="700" width="504" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/d591796d-3fce-403c-95b8-7c2e2840e963/main.assets/gr1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;1</span> <span class="figure__title__text">Functional activities of pan-ebolavirus cocktail candidate mAbs rEBOV-442 and rEBOV-515</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0015" role="paragraph">(A) EBOV, BDBV, or SUDV neutralization. Ebolaviruses encoding enhanced green fluorescent protein (eGFP) were incubated with increasing concentrations of recombinantly produced purified mAbs, and infection was determined at 3&nbsp;days after inoculation by measuring eGFP fluorescence in cells. Mean ± SD of technical triplicates from one experiment are shown.</div><div id="fspara0020" role="paragraph">(B) <i>In&nbsp;vitro</i> killing capacity mediated by the Fc regions of IgG1-engineered variants of mAbs measured by rapid fluorometric antibody-mediated cytotoxicity (RFADCC) assay. Human PBMCs (effector cells) were incubated with a SNAP-tagged EBOV GP-expressing 293F cell line as a target in the presence of increasing concentrations of purified recombinant mAbs, and cytotoxic activity was measured by flow cytometry. Antibody rDENV 2D22 served as a negative control. The dotted line indicates assay background. Mean ± SD of technical duplicates from one experiment are shown.</div><div id="fspara0025" role="paragraph">(C) Heatmap summarizing reactivity breadth and potency of rEBOV-442 and rEBOV-515. <sup>∗</sup>Indicates data determined in our previous work using hybridoma-cell-secreted mAbs (<span class="dropBlock reference-citations"><a id="body-ref-sref31-4" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-4" aria-controls="sref31-4">Gilchuk et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref31-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Gilchuk, P. ∙ Kuzmina, N. ∙ Ilinykh, P.A. ...</div><div><strong>Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the Ebolavirus glycoprotein</strong></div><div><em>Immunity.</em> 2018; <strong>49</strong>:363-374.e10</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85053075312" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30029854/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.06.018&amp;pmid=30029854" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="fspara0030" role="paragraph">(D) Results of viral selections with individual antibodies or the combination of rEBOV-442&nbsp;+ rEBOV-515 (defined as the “cocktail”), indicating the number of replicates with escape out of total number tested, resistance of selected escape variants to individual antibodies or the cocktail, and the selected mutations in the GP that escape neutralization by indicated mAb. Broadly neutralizing mAbs ADI-15878 and ADI-15946 (<span class="dropBlock reference-citations"><a id="body-ref-sref75-1" href="#" role="doc-biblioref" data-xml-rid="bib75" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref75-1" aria-controls="sref75-1">Wec et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref75-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">78.</div><div>Wec, A.Z. ∙ Herbert, A.S. ∙ Murin, C.D. ...</div><div><strong>Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses</strong></div><div><em>Cell.</em> 2017; <strong>169</strong>:878-890.e15</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.037&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.037&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85019578866" target="_blank" aria-label="Open Scopus in new tab">Scopus (127)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28525755/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.04.037&amp;pmid=28525755" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) were included for comparative purposes. The escape selection was performed using chimeric VSV expressing EBOV or BDBV GP.</div><div id="fspara0035" role="paragraph">See also <a id="crosref1500" href="#figs1">Figure&nbsp;S1</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.09.035/asset/c5e27984-00b6-4965-9bda-13e4974e233a/main.assets/figs1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs1" src="/cms/10.1016/j.cell.2021.09.035/asset/fea80855-a1e5-42b7-b911-9798f39f96e4/main.assets/figs1.jpg" height="809" width="659" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/c5e27984-00b6-4965-9bda-13e4974e233a/main.assets/figs1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S1</span> <span class="figure__title__text">Neutralizing activity of antibody rEBOV-515 LALA-PG and mutations in the GP for the individual broadly-neutralizing mAbs rEBOV-442, rEBOV-515, ADI-15878, and ADI-15946, related to <a id="crosref1570" href="#fig1">Figure&nbsp;1</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0230" role="paragraph">(A) EBOV or SUDV neutralization by wild-type IgG1 or IgG1 LALA-PG variants of rEBOV-515. Neutralization was assessed with chimeric ebolaviruses encoding EBOV or SUDV GP as in <a id="crosref1575" href="#fig1">Figure&nbsp;1</a>A. Mean ± SD of technical triplicates from one experiment are shown.</div><div id="fspara0235" role="paragraph">(B) Example RTCA sensograms from individual wells of 96-well E-plate analysis showing VSV/EBOV GP viruses that escaped neutralization (shown with overlayed semi-transparent blue boxes) by mAb ADI-15878 after the first passage. Escape in the illustrated wells was confirmed using a second-passage study and then validated as in (C).</div><div id="fspara0240" role="paragraph">(C) RTCA sensograms for neutralization of mAbrEBOV-442-, ADI-15878-, or ADI-15946-selected escape viruses by individual mAbs rEBOV-442, rEBOV-515, ADI-15878, or ADI-15946, or a 1:1 cocktail of rEBOV-442&nbsp;+ rEBOV-515 (defined as the “cocktail”). The escape selection was performed using infectious chimeric VSV expressing EBOV or BDBV GP as in <a id="crosref1580" href="#fig1">Figure&nbsp;1</a>D. Seven viruses that escaped neutralization by rEBOV-442 and had sequence-verified mutations in the gene encoding the glycan cap region of the GP, and one representative virus that escaped neutralization by ADI-15878 or ADI-15946 with sequence-verified mutations in the GP were incubated in the presence of a saturating concentration (20&nbsp;μg/mL) of mAb used for the escape selection (shown in gray), or other indicated mAbs (see color code keys in the figure), or the cocktail (green). Cytopathic effect (CPE) was monitored kinetically in Vero cells after applying the virus-mAb mixtures to the cells. Sensograms for CPE by the wild-type chimeric VSV/EBOV GP or VSV/BDBV GP without mAb (black), and full neutralization of the wild-type virus by individual mAbs are shown as the controls. All sequence-verified escape mutations for the viruses selected by rEBOV-442, ADI-15878, and ADI-15946 are indicated in <a id="crosref1585" href="#fig1">Figure&nbsp;1</a>D.</div><div id="fspara0245" role="paragraph">(D) Mutations in indicated residues (magenta) identified in the EBOV GP (PDB: <a id="intref0190" href="http://firstglance.jmol.org/fg.htm?mol5JQ3" target="_blank">5JQ3</a>) or BDBV GP (PDB: <a id="intref0195" href="http://firstglance.jmol.org/fg.htm?mol6DZM" target="_blank">6DZM</a>) lacking mucin-like domains for the selected viruses that escaped neutralization by rEBOV-442 (top), ADI-15878 (middle), or ADI-15946 (bottom) as in (C). Positions of V311 and K510 residues that are not present in the crystal or cryo-EM GP structure and are shown with gray spheres with magenta center.</div></div></div></div></figcaption></figure></div><div id="p0050" role="paragraph">One benefit of using a cocktail of two or more neutralizing mAbs that bind to non-overlapping regions of the viral antigen is to reduce the risk of viral escape from neutralization that is inherent in monotherapy approaches (<span class="dropBlock reference-citations"><a id="body-ref-sref3" href="#" role="doc-biblioref" data-xml-rid="bib3" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref3" aria-controls="sref3">Baum et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">3.</div><div>Baum, A. ∙ Fulton, B.O. ∙ Wloga, E. ...</div><div><strong>Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies</strong></div><div><em>Science.</em> 2020; <strong>369</strong>:1014-1018</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.abd0831" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85087939157" target="_blank" aria-label="Open Scopus in new tab">Scopus (904)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32540904/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.abd0831&amp;pmid=32540904" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref56-2" href="#" role="doc-biblioref" data-xml-rid="bib56" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref56-2" aria-controls="sref56-2">Misasi and Sullivan, 2021</a><div class="dropBlock__holder" data-db-target-of="sref56-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">59.</div><div>Misasi, J. ∙ Sullivan, N.J.</div><div><strong>Immunotherapeutic strategies to target vulnerabilities in the Ebolavirus glycoprotein</strong></div><div><em>Immunity.</em> 2021; <strong>54</strong>:412-436</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2021.01.015&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2021.01.015&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85102002020" target="_blank" aria-label="Open Scopus in new tab">Scopus (19)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33691133/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2021.01.015&amp;pmid=33691133" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref79" href="#" role="doc-biblioref" data-xml-rid="bib79" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref79" aria-controls="sref79">Yewdell et&nbsp;al., 1979</a><div class="dropBlock__holder" data-db-target-of="sref79"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">82.</div><div>Yewdell, J.W. ∙ Webster, R.G. ∙ Gerhard, W.U.</div><div><strong>Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule</strong></div><div><em>Nature.</em> 1979; <strong>279</strong>:246-248</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/279246a0" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-0018346213" target="_blank" aria-label="Open Scopus in new tab">Scopus (133)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/86955/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2F279246a0&amp;pmid=86955" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). To demonstrate this feature for this cocktail directly, we next used a recombinant infectious VSV expressing EBOV or BDBV GP in place of the endogenous VSV glycoprotein (VSV/EBOV GP or VSV/BDBV GP) to select for GP mutations that escape mAb neutralization. We used rEBOV-442, rEBOV-515, or 1:1 mixture of both mAbs and a high-throughput quantitative real-time cellular analysis assay (RTCA) to select viral variants that can escape neutralization (<span class="dropBlock reference-citations"><a id="body-ref-sref34-5" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-5" aria-controls="sref34-5">Gilchuk et&nbsp;al., 2020b</a><div class="dropBlock__holder" data-db-target-of="sref34-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Gilchuk, P. ∙ Murin, C.D. ∙ Milligan, J.C. ...</div><div><strong>Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:388-403.e12</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85079145867" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32023489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2020.01.001&amp;pmid=32023489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref36-1" href="#" role="doc-biblioref" data-xml-rid="bib36" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref36-1" aria-controls="sref36-1">Greaney et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref36-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">36.</div><div>Greaney, A.J. ∙ Starr, T.N. ∙ Gilchuk, P. ...</div><div><strong>Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition</strong></div><div><em>Cell Host Microbe.</em> 2021; <strong>29</strong>:44-57.e9</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2020.11.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2020.11.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85097068093" target="_blank" aria-label="Open Scopus in new tab">Scopus (673)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33259788/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.chom.2020.11.007&amp;pmid=33259788" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). For comparative purposes, we also assessed the broadly reactive antibodies ADI-15878 and ADI-15946 that form the basis for a potent broadly protective investigational cocktail (<span class="dropBlock reference-citations"><a id="body-ref-sref7-4" href="#" role="doc-biblioref" data-xml-rid="bib7" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref7-4" aria-controls="sref7-4">Bornholdt et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref7-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">7.</div><div>Bornholdt, Z.A. ∙ Herbert, A.S. ∙ Mire, C.E. ...</div><div><strong>A two-antibody pan-ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates</strong></div><div><em>Cell Host Microbe.</em> 2019; <strong>25</strong>:49-58.e5</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2018.12.005&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2018.12.005&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85058702898" target="_blank" aria-label="Open Scopus in new tab">Scopus (73)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30629918/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.chom.2018.12.005&amp;pmid=30629918" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref75-2" href="#" role="doc-biblioref" data-xml-rid="bib75" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref75-2" aria-controls="sref75-2">Wec et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref75-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">78.</div><div>Wec, A.Z. ∙ Herbert, A.S. ∙ Murin, C.D. ...</div><div><strong>Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses</strong></div><div><em>Cell.</em> 2017; <strong>169</strong>:878-890.e15</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.037&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.037&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85019578866" target="_blank" aria-label="Open Scopus in new tab">Scopus (127)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28525755/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.04.037&amp;pmid=28525755" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We used recombinant IgG1 proteins for these antibodies that we produced using publicly available mAb variable region sequences. ADI-15946, similarly to rEBOV-515, recognizes the loop region of the internal fusion loop (IFL), whereas ADI-15878 recognizes the stem region of the IFL (<span class="dropBlock reference-citations"><a id="body-ref-sref31-5" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-5" aria-controls="sref31-5">Gilchuk et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref31-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Gilchuk, P. ∙ Kuzmina, N. ∙ Ilinykh, P.A. ...</div><div><strong>Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the Ebolavirus glycoprotein</strong></div><div><em>Immunity.</em> 2018; <strong>49</strong>:363-374.e10</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85053075312" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30029854/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.06.018&amp;pmid=30029854" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref44-2" href="#" role="doc-biblioref" data-xml-rid="bib44" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref44-2" aria-controls="sref44-2">King et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref44-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">46.</div><div>King, L.B. ∙ Milligan, J.C. ∙ West, B.R. ...</div><div><strong>Achieving cross-reactivity with pan-ebolavirus antibodies</strong></div><div><em>Curr. Opin. Virol.</em> 2019; <strong>34</strong>:140-148</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.coviro.2019.01.003" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85062902126" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30884329/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.coviro.2019.01.003&amp;pmid=30884329" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and, hence, the ADI-15878 binding site does not overlap with that of the other IFL-specific mAbs&nbsp;we tested. We selected for escape at a single saturating mAb concentration of 20&nbsp;μg/mL using ∼1 multiplicity of infection (MOI) and performing 60–154 replicates for each sample (<a id="crosref0450" href="#figs1">Figure&nbsp;S1</a>B). Only one to two passages with individual mAbs rEBOV-442, ADI-15878, or ADI-15946 led to selection of variants resistant to neutralization by 20&nbsp;μg/mL of mAb used for the escape selection. For rEBOV-515 or the rEBOV-442&nbsp;+ rEBOV-515 cocktail, escape variants were not detected in any of the 154 or 60 replicate experiments and after two passages (<a id="crosref0455" href="#fig1">Figure&nbsp;1</a>D), suggesting a lower likelihood of <i>in&nbsp;vitro</i> escape for rEBOV-515 or the cocktail. Viruses that escaped neutralization by rEBOV-442 were fully neutralized by rEBOV-515 or a mixture of rEBOV-442 and rEBOV-515 (<a id="crosref0460" href="#fig1">Figures 1</a>D and <a id="crosref0465" href="#figs1">S1</a>C), showing that the cocktail retains neutralization potency even if rEBOV-442 is impacted. Importantly, the viruses selected to be resistant to neutralization by each single mAb rEBOV-442, ADI-15878, or ADI-15946 were sensitive to neutralization by each of three other mAbs, highlighting the differences for these mAbs in their binding site residues (<a id="crosref0470" href="#fig1">Figures 1</a>D and <a id="crosref0475" href="#figs1">S1</a>C). We sequenced the viral gene encoding the GP of selected escape viruses and identified distinct point mutations (<a id="crosref0480" href="#fig1">Figure&nbsp;1</a>D), including several previously identified escape mutations at amino acid positions L273 for rEBOV-442 (<span class="dropBlock reference-citations"><a id="body-ref-sref31-6" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-6" aria-controls="sref31-6">Gilchuk et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref31-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Gilchuk, P. ∙ Kuzmina, N. ∙ Ilinykh, P.A. ...</div><div><strong>Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the Ebolavirus glycoprotein</strong></div><div><em>Immunity.</em> 2018; <strong>49</strong>:363-374.e10</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85053075312" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30029854/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.06.018&amp;pmid=30029854" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), K510 for ADI-15946, and G528 for ADI-15878 (<span class="dropBlock reference-citations"><a id="body-ref-sref75-3" href="#" role="doc-biblioref" data-xml-rid="bib75" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref75-3" aria-controls="sref75-3">Wec et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref75-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">78.</div><div>Wec, A.Z. ∙ Herbert, A.S. ∙ Murin, C.D. ...</div><div><strong>Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses</strong></div><div><em>Cell.</em> 2017; <strong>169</strong>:878-890.e15</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.037&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.037&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85019578866" target="_blank" aria-label="Open Scopus in new tab">Scopus (127)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28525755/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.04.037&amp;pmid=28525755" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In all cases, escape viruses carried GP mutations in the binding site of the respective mAb (<a id="crosref0495" href="#figs1">Figure&nbsp;S1</a>D). Together, these results demonstrated a high resistance to viral escape for the cocktail of the rEBOV-442&nbsp;+ rEBOV-515, which acts by both neutralizing and Fc-mediated activities.</div></section><section id="sec-2-2"><h3>Differential requirements for the Fc regions of antibodies rEBOV-442 and rEBOV-515 for therapeutic protection in mice</h3><div id="p0055" role="paragraph">To define the contribution of Fc-mediated effector functions to protection <i>in&nbsp;vivo</i>, each mAb of the candidate therapeutic cocktail was assessed as an IgG1 protein (the original subclass of mAb secreted by the hybridoma cell line and a functionally competent form of mAb) and as an IgG1 LALA-PG protein that is disabled for Fc function. The Fc region of the LALA-PG variant has three mutations, L234A, L235A, and P329G, which eliminate complement binding and Fc-γ-receptor-dependent, antibody-dependent, cell-mediated cytotoxicity in both murine IgG2a and human IgG1 (<span class="dropBlock reference-citations"><a id="body-ref-optIQggpIxCF6" href="#" role="doc-biblioref" data-xml-rid="bib85" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="optIQggpIxCF6" aria-controls="optIQggpIxCF6">Lo et al., 2017</a><div class="dropBlock__holder" data-db-target-of="optIQggpIxCF6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">55.</div><div>Lo, M. ∙ Kim, H.S. ∙ Tong, R.K. ...</div><div><strong>Effector-attenuating substitutions that maintain antibody stability and reduce toxicity in mice</strong></div><div><em>J. Biol. Chem.</em> 2017; <strong>292</strong>:3900-3908</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1074%2Fjbc.M116.767749&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1074%2Fjbc.M116.767749&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85014659479" target="_blank" aria-label="Open Scopus in new tab">Scopus (193)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28077575/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M116.767749&amp;pmid=28077575" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We challenged groups of mice with mouse-adapted EBOV (EBOV-MA) on day 0 and administered mAbs 1&nbsp;day later. We chose different treatment doses of rEBOV-515 (1&nbsp;mg/kg) and rEBOV-442 (5&nbsp;mg/kg) based on the known <i>in&nbsp;vivo</i> potency of the parental hybridoma-produced mAbs EBOV-442 (moderate potency at 5&nbsp;mg/kg) and EBOV-515 (high potency at 5&nbsp;mg/kg) (<span class="dropBlock reference-citations"><a id="body-ref-sref31-7" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-7" aria-controls="sref31-7">Gilchuk et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref31-7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Gilchuk, P. ∙ Kuzmina, N. ∙ Ilinykh, P.A. ...</div><div><strong>Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the Ebolavirus glycoprotein</strong></div><div><em>Immunity.</em> 2018; <strong>49</strong>:363-374.e10</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85053075312" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30029854/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.06.018&amp;pmid=30029854" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Previously we have shown that for low-dose treatment (1&nbsp;mg/kg), the Fc-disabled LALA variant of the GP base-specific mAb EBOV-520 (that is analogous to rEBOV-515 based on competition binding) offered a higher level of therapeutic protection in mice against EBOV (60% survival) when compared to that mediated by the wild-type (WT) IgG1 EBOV-520 (0% survival) (<span class="dropBlock reference-citations"><a id="body-ref-sref47" href="#" role="doc-biblioref" data-xml-rid="bib47" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref47" aria-controls="sref47">Kuzmina et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref47"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Kuzmina, N.A. ∙ Younan, P. ∙ Gilchuk, P. ...</div><div><strong>Antibody-dependent enhancement of Ebola virus infection by human antibodies isolated from survivors</strong></div><div><em>Cell Rep.</em> 2018; <strong>24</strong>:1802-1815</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.celrep.2018.07.035&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.celrep.2018.07.035&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85051108967" target="_blank" aria-label="Open Scopus in new tab">Scopus (59)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30110637/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2018.07.035&amp;pmid=30110637" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Given the full protection from weight loss and disease conferred by the 5&nbsp;mg/kg dose of hybridoma-expressed EBOV-515 (<span class="dropBlock reference-citations"><a id="body-ref-sref31-8" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-8" aria-controls="sref31-8">Gilchuk et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref31-8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Gilchuk, P. ∙ Kuzmina, N. ∙ Ilinykh, P.A. ...</div><div><strong>Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the Ebolavirus glycoprotein</strong></div><div><em>Immunity.</em> 2018; <strong>49</strong>:363-374.e10</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85053075312" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30029854/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.06.018&amp;pmid=30029854" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and to compare with the reported potency for low-dose EBOV-520 treatment, in this study, we tested the recombinant variants of rEBOV-515 using a 1&nbsp;mg/kg low-dose treatment. For comparative purposes, we also assessed the broadly reactive mAbs ADI-15946 (1&nbsp;mg/kg; analogous to rEBOV-515) and ADI-15878 (5&nbsp;mg/kg; recognizing a distinct epitope on IFL) (<span class="dropBlock reference-citations"><a id="body-ref-sref75-4" href="#" role="doc-biblioref" data-xml-rid="bib75" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref75-4" aria-controls="sref75-4">Wec et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref75-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">78.</div><div>Wec, A.Z. ∙ Herbert, A.S. ∙ Murin, C.D. ...</div><div><strong>Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses</strong></div><div><em>Cell.</em> 2017; <strong>169</strong>:878-890.e15</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.037&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.037&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85019578866" target="_blank" aria-label="Open Scopus in new tab">Scopus (127)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28525755/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.04.037&amp;pmid=28525755" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) as IgG1 proteins. The rEBOV-515 LALA-PG variant offered complete protection (100% survival) against EBOV challenge in mice at a 1&nbsp;mg/kg therapeutic dose, whereas the WT IgG1 variant showed partial protection (80% survival) (<a id="crosref0515" href="#fig2">Figure&nbsp;2</a>). ADI-15946 IgG1 did not protect at 1&nbsp;mg/kg. This finding demonstrated a higher <i>in&nbsp;vivo</i> potency of the broad GP base-specific mAb rEBOV-515 when compared to the previously reported effect of the broad GP base-specific mAb rEBOV-520 or ADI-15946 IgG1, and suggested that rEBOV-515 LALA-PG is a preferable Fc variant for the cocktail of two Fc variants tested.</div><div class="figure-wrap"><figure id="fig2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.09.035/asset/9da82d42-7a8f-48ab-a0dd-00ce8988a7ea/main.assets/gr2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr2" src="/cms/10.1016/j.cell.2021.09.035/asset/d21e8b12-1c1e-49ce-a0a0-3abfea485192/main.assets/gr2.jpg" height="669" width="645" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/9da82d42-7a8f-48ab-a0dd-00ce8988a7ea/main.assets/gr2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;2</span> <span class="figure__title__text">Differential requirements for the Fc regions of mAbs rEBOV-442 and rEBOV-515 for optimal therapeutic protection in mice</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0045" role="paragraph">C57BL/6 mice were challenged with EBOV-MA (day 0), treated at 1&nbsp;day post infection (dpi) with wild-type IgG1 or IgG1 LALA-PG variant of mAbs rEBOV-442 (5&nbsp;mg/kg) and rEBOV-515 (1&nbsp;mg/kg), and monitored for 28&nbsp;days. Antibodies ADI-15946 IgG1 (1&nbsp;mg/kg) and ADI-15878 IgG1 (5&nbsp;mg/kg) were included for comparative purposes, and mAb rDENV 2D22 was used as a control.</div><div id="fspara0050" role="paragraph">(A) Kaplan-Meier survival plot. The overall difference in survival between the groups was estimated using two-sided log-rank (Mantel-Cox) test.</div><div id="fspara0055" role="paragraph">(B) Weight change. A historical control for protection from weight loss with 5&nbsp;mg/kg of hybridoma-produced mAb EBOV-515 treatment (<span class="dropBlock reference-citations"><a id="body-ref-sref31-9" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-9" aria-controls="sref31-9">Gilchuk et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref31-9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Gilchuk, P. ∙ Kuzmina, N. ∙ Ilinykh, P.A. ...</div><div><strong>Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the Ebolavirus glycoprotein</strong></div><div><em>Immunity.</em> 2018; <strong>49</strong>:363-374.e10</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85053075312" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30029854/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.06.018&amp;pmid=30029854" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) is indicated with a raspberry dotted line.</div><div id="fspara0060" role="paragraph">(C) Clinical score.</div><div id="fspara0065" role="paragraph">Mean values are shown in (B) and (C). For the rEBOV-515 and rEBOV-442 treatment groups, a total of n&nbsp;= 10 mice per group was analyzed in two independent experiments for which cumulative data are shown. For the ADI-15946 and ADI-15878 treatment groups, data represent one experiment with 5 mice per group. Body-weight-change and clinical score data in (B) and (C) are shown only for the animals that survived at each indicated time point. Time points for mAb treatment are indicated with dotted vertical lines</div></div></div></div></figcaption></figure></div><div id="p0060" role="paragraph">Similarly, we compared the <i>in&nbsp;vivo</i> potency of WT IgG1 rEBOV-442 and rEBOV-442 LALA-PG, which were administered at a 5&nbsp;mg/kg dose 1&nbsp;day after EBOV challenge (<a id="crosref0520" href="#fig2">Figure&nbsp;2</a>). Cytotoxicity assay results (<a id="crosref0525" href="#fig1">Figure&nbsp;1</a>B) suggested that the glycan cap mAb rEBOV-442, in addition to possessing neutralizing activity, also exhibited substantial Fc effector function-mediated activity. In agreement with this finding, the results of our <i>in&nbsp;vivo</i> study showed a transient improvement in weight (i.e., reduced loss) on 2–4 and 8–10&nbsp;days post-infection with WT rEBOV-442 IgG1, which was associated with improved protection from death (90% survival in the WT mAb-treated group when compared to 70% in the rEBOV-442 LALA-PG-treated group) and faster recovery from illness (<a id="crosref0530" href="#fig2">Figure&nbsp;2</a>). ADI-15878 IgG1 at 5&nbsp;mg/kg fully protected mice against EBOV. Together, these data revealed differing requirements for the Fc regions of rEBOV-442 and rEBOV-515, demonstrated a high <i>in&nbsp;vivo</i> potency of the mAbs tested, and justified the inclusion of rEBOV-515 as a LALA-PG and rEBOV-442 as a WT IgG1 in a new broad and protective ebolavirus two-antibody cocktail.</div></section><section id="sec-2-3"><h3>Synergistic activity of rEBOV-442 and rEBOV-515 in the cocktail</h3><div id="p0065" role="paragraph">Antibodies in a cocktail directed to a common viral protein may recognize antigen in a synergistic, additive, or antagonistic manner. We first characterized the effect mediated by the mixture of two mAbs on ebolavirus GP binding. Serially diluted Alexa Fluor-647-labeled mAb rEBOV-442 IgG1 or rEBOV-515 LALA-PG was titrated into serially diluted unlabeled partner mAb to generate two pairwise combinatorial matrices of two mAbs in the mixture (<a id="crosref0535" href="#figs2">Figures S2</a>A and S2B). Binding of the Alexa Fluor-647-labeled mAb from each combination was assessed by flow cytometric analysis using a Jurkat cell line that was stably transduced to display EBOV GP on the surface as described before (<span class="dropBlock reference-citations"><a id="body-ref-sref34-6" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-6" aria-controls="sref34-6">Gilchuk et&nbsp;al., 2020b</a><div class="dropBlock__holder" data-db-target-of="sref34-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Gilchuk, P. ∙ Murin, C.D. ∙ Milligan, J.C. ...</div><div><strong>Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:388-403.e12</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85079145867" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32023489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2020.01.001&amp;pmid=32023489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The values were calculated as the percent of the relative fluorescence signal caused by the highest concentration of respective fluorescently labeled mAb alone (<a id="crosref0545" href="#figs2">Figures S2</a>A and S2B), and then compared with the expected responses calculated using the ZIP synergy-scoring model (<span class="dropBlock reference-citations"><a id="body-ref-sref39-1" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39-1" aria-controls="sref39-1">Ianevski et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref39-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Ianevski, A. ∙ Giri, A.K. ∙ Aittokallio, T.</div><div><strong>SynergyFinder 2.0: visual analytics of multi-drug combination synergies</strong></div><div><em>Nucleic Acids Res.</em> 2020; <strong>48</strong>:W488-W493</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkaa216" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85086923971" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32246720/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkaa216&amp;pmid=32246720" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The synergy score can be interpreted as the average excess response (percent change) for the mAb combination (<span class="dropBlock reference-citations"><a id="body-ref-sref39-2" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39-2" aria-controls="sref39-2">Ianevski et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref39-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Ianevski, A. ∙ Giri, A.K. ∙ Aittokallio, T.</div><div><strong>SynergyFinder 2.0: visual analytics of multi-drug combination synergies</strong></div><div><em>Nucleic Acids Res.</em> 2020; <strong>48</strong>:W488-W493</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkaa216" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85086923971" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32246720/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkaa216&amp;pmid=32246720" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The comparison revealed that the combination of mAbs rEBOV-442 and rEBOV-515 was synergistic, and each mAb reciprocally enhanced binding of the partner mAb in the mixture (<a id="crosref0560" href="#figs2">Figures S2</a>B and S2C). This finding contrasted with the unidirectional GP binding synergy observed in the cocktail of the other broad mAbs rEBOV-520 and rEBOV-548 (Gilchuk et&nbsp;al., 2020b). Binding enhancement increased steadily with increasing of mAb concentration, indicating more contribution from synergy at higher concentrations of individual mAbs in the cocktail (<a id="crosref0565" href="#figs2">Figures S2</a>B and S2C).</div><div class="figure-wrap"><figure id="figs2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.09.035/asset/f28f6465-3530-4017-b243-1ff507ee6c08/main.assets/figs2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs2" src="/cms/10.1016/j.cell.2021.09.035/asset/693be95a-2e99-4366-ab5a-1bbf47e2027e/main.assets/figs2.jpg" height="918" width="659" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/f28f6465-3530-4017-b243-1ff507ee6c08/main.assets/figs2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S2</span> <span class="figure__title__text">Reciprocal synergistic binding activity in the cocktail of rEBOV-442 and rEBOV-515, related to <a id="crosref1590" href="#fig3">Figure&nbsp;3</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0255" role="paragraph">Serially-diluted Alexa Fluor 647-labeled mAb rEBOV-442 IgG1 or rEBOV-515 LALA-PG was titrated into serially-diluted unlabeled partner mAb to generate a pairwise combinatorial matrix of two mAbs in the mixture. Binding to Jurkat EBOV-GP cells was assessed by flow cytometric analysis.</div><div id="fspara0260" role="paragraph">(A) Dose-response binding of fluorescently-labeled rEBOV-442 alone (left) or rEBOV-515 alone (right) to Jurkat-EBOV GP. Mean ± SD of technical duplicates is shown.</div><div id="fspara0265" role="paragraph">(B) Binding dose-response matrix by rEBOV-442 or rEBOV-515 bound to the EBOV-GP in the presence of a partner mAb. Axes denote the concentration of each mAb, with the percent binding shown in each square. Binding was calculated as the percent of the maximal median fluorescence intensity signal (MFI) by the highest concentration of respective fluorescently-labeled mAb alone (25&nbsp;μg/mL) as in (A). Examples of an enhanced binding activity by a combination of fluorescently-labeled mAb plus partner mAb at the highest tested concentration (green box) in a comparison to the binding by fluorescently-labeled rEBOV-442 alone (violet box) or rEBOV-515 alone (raspberry box) are shown.</div><div id="fspara0270" role="paragraph">(C) Synergy distribution map generated from the dose-response binding matrix in (B). Red color indicates areas in which synergistic neutralization was observed; shaded gray box indicates the area of maximum synergy between the two monoclonal antibodies, and δ-score for this area is shown. δ-score is a synergy score: a value of −10 indicates antagonism; a value of −10 to 10 indicates an additive effect; a value of &gt; 10 indicates synergy. Data in (A-B) are from a representative experiment performed in technical duplicate and repeated twice.</div></div></div></div></figcaption></figure></div><div id="p0070" role="paragraph">We next characterized the effect by the mixture of two mAbs on ebolavirus neutralization. Using a recently developed RTCA assay and infectious chimeric VSV/ebolavirus GP viruses (<span class="dropBlock reference-citations"><a id="body-ref-sref33-1" href="#" role="doc-biblioref" data-xml-rid="bib33" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref33-1" aria-controls="sref33-1">Gilchuk et&nbsp;al., 2020a</a><div class="dropBlock__holder" data-db-target-of="sref33-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">33.</div><div>Gilchuk, P. ∙ Bombardi, R.G. ∙ Erasmus, J.H. ...</div><div><strong>Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics</strong></div><div><em>Nat. Biomed. Eng.</em> 2020; <strong>4</strong>:1030-1043</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41551-020-0594-x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85088873601" target="_blank" aria-label="Open Scopus in new tab">Scopus (35)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32747832/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41551-020-0594-x&amp;pmid=32747832" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>, <span class="dropBlock reference-citations"><a id="body-ref-sref34-7" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-7" aria-controls="sref34-7">2020b</a><div class="dropBlock__holder" data-db-target-of="sref34-7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Gilchuk, P. ∙ Murin, C.D. ∙ Milligan, J.C. ...</div><div><strong>Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:388-403.e12</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85079145867" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32023489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2020.01.001&amp;pmid=32023489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), we showed dose-dependent neutralization of VSV/EBOV GP, VSV/BDBV GP, or VSV/SUDV GP viruses by the 1:1 mAb mixture (<a id="crosref0580" href="#fig3">Figure&nbsp;3</a>A). Then, we titrated serially diluted rEBOV-442 into serially diluted rEBOV-515 to generate a pairwise combinatorial matrix of two&nbsp;mAbs in the mixture and assessed each combination for neutralization of VSV/EBOV GP, VSV/BDBV GP, or VSV/SUDV GP viruses (<a id="crosref0585" href="#fig3">Figure&nbsp;3</a>B). Synergy analysis identified areas in the neutralization matrix (showing mAb ratios) with the most profound combination effect and suggested broad synergistic activity in the cocktail of rEBOV-442 and rEBOV-515 (<a id="crosref0590" href="#fig3">Figure&nbsp;3</a>C). Synergistic activity mediated by the cocktail also was confirmed using neutralization assays with authentic live ebolaviruses, and more prominent synergy of neutralization was identified for SUDV (<a id="crosref0595" href="#figs3">Figure&nbsp;S3</a>).</div><div class="figure-wrap"><figure id="fig3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.09.035/asset/54d9061b-9e40-4f00-8d53-2837b9e45597/main.assets/gr3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr3" src="/cms/10.1016/j.cell.2021.09.035/asset/ac033353-34a6-413e-b05e-65fee6718bf4/main.assets/gr3.jpg" height="671" width="504" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/54d9061b-9e40-4f00-8d53-2837b9e45597/main.assets/gr3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;3</span> <span class="figure__title__text">Broad and synergistic neutralizing activity mediated by the cocktail of rEBOV-442 and rEBOV-515</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0075" role="paragraph">Neutralizing activity of individual mAbs or their mixture was assessed using chimeric VSV viruses and RTCA assay.</div><div id="fspara0080" role="paragraph">(A) Neutralization of VSV/EBOV GP, VSV/BDBV GP, or VSV/SUDV GP by rEBOV-442 alone, rEBOV-515 alone, or a 1:1 mixture of rEBOV-442 and rEBOV-515. Mean ±&nbsp;SD of technical duplicates is shown.</div><div id="fspara0085" role="paragraph">(B) Serially diluted rEBOV-442 was titrated into serially diluted rEBOV-515 to generate a pairwise combinatorial matrix of two mAbs in the mixture. The matrix shows neutralization dose-response data for VSV/EBOV GP, VSV/BDBV GP, or VSV/SUDV GP, by indicated concentrations of rEBOV-442 and rEBOV-515. Axes denote the concentration of each mAb, with the percent neutralization shown in each square. The heatmap denotes a gradient of&nbsp;0 (white) to 100% (red) neutralization. Examples of neutralization by rEBOV-515 alone (raspberry box) or rEBOV-442 alone (blue box) in comparison to a combined indicated concentration of two mAbs in the cocktail (green box) is shown.</div><div id="fspara0090" role="paragraph">(C) Synergy distribution map generated from the dose-response neutralization matrix in (B). Red color indicates areas in which synergistic neutralization was observed; shaded gray box indicates the area of maximum synergy between the two mAbs, and the δ-score for this area is shown. The δ-score is a synergy score: values &lt;−10 indicate antagonism; values −10 to 10 indicate an additive effect; values &gt;10 indicate synergy. Data in (A)–(C) are from a representative experiment performed in technical duplicate and repeated three times.</div><div id="fspara0095" role="paragraph">See also <a id="crosref1510" href="#figs2">Figures S2</a> and <a id="crosref1515" href="#figs3">S3</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.09.035/asset/e1b6a834-cf20-4310-aa58-750d77d1d885/main.assets/figs3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs3" src="/cms/10.1016/j.cell.2021.09.035/asset/9fd8b7ee-a001-49e6-be96-b47bde4801f9/main.assets/figs3.jpg" height="859" width="659" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/e1b6a834-cf20-4310-aa58-750d77d1d885/main.assets/figs3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S3</span> <span class="figure__title__text">Broad and synergistic neutralizing activity mediated by the cocktail of rEBOV-442 and rEBOV-515, related to <a id="crosref1595" href="#fig3">Figure&nbsp;3</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0280" role="paragraph">Neutralizing activity of individual antibodies or their mixture was assessed using chimeric ebolaviruses encoding EBOV (Mayinga variant), BDBV (Uganda variant), or SUDV (Gulu variant) GP as in <a id="crosref1600" href="#fig1">Figure&nbsp;1</a>A.</div><div id="fspara0285" role="paragraph">(A) Neutralization of EBOV, BDBV, or SUDV by rEBOV-442 alone, rEBOV-515 alone, or a 1:1 mixture of rEBOV-442 and rEBOV-515. Mean ±&nbsp;SD of technical duplicates is shown.</div><div id="fspara0290" role="paragraph">(B) Serially-diluted rEBOV-442 was titrated into serially-diluted rEBOV-515 to generate a pairwise combinatorial matrix of two antibodies in the mixture. The matrix shows neutralization dose-response data for EBOV, BDBV, or SUDV, by indicated concentrations of rEBOV-442 and rEBOV-515. Axes denote the concentration of each mAb, with the percent neutralization shown in each square. The heatmap denotes a gradient of 0 (white) to 100% (red) neutralization. Examples of synergistic SUDV neutralization by rEBOV-515 alone (raspberry box) or rEBOV-442 alone (blue box) in comparison to a combined indicated concentration of two mAbs in the cocktail (green box) are shown.</div><div id="fspara0295" role="paragraph">(C) Synergy distribution map generated from the dose-response neutralization matrix in (B). Red color indicates areas in which synergistic neutralization was observed; shaded gray box indicates the area of maximum synergy between the two monoclonal antibodies, and the δ-score for this area is shown. The δ-score is a synergy score: values&nbsp;&lt; −10 indicate antagonism; values −10 to 10 indicate an additive effect; values &gt; 10 indicate synergy. Data in (A-C) are from one experiment performed in technical duplicate.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-4"><h3>Protective pan-ebolavirus combination therapy of nonhuman primates by antibodies rEBOV-442 and rEBOV-515</h3><div id="p0075" role="paragraph">Next, we tested the efficacy of the cocktail of rEBOV-515 LALA-PG&nbsp;+ rEBOV-442 IgG1 in nonhuman primate (NHP) challenge models for each of the three ebolaviruses, EBOV (Kikwit variant), BDBV (Uganda variant), and SUDV (Gulu variant). We chose a 2:1 mAb ratio in the cocktail (66.5% rEBOV-515 LALA-PG and 33.5% rEBOV-442 IgG1 in the mixture) empirically. We biased the composition using a higher proportion of rEBOV-515 LALA-PG based on several principles: (1) higher neutralizing potency of rEBOV-515 against SUDV, (2) higher protective efficacy of rEBOV-515 <i>in&nbsp;vivo</i>, and (3) higher resistance against mutational escape in the presence of rEBOV-515 <i>in&nbsp;vitro</i> when compared to that of rEBOV-442. Of note, at this ratio, the mAbs exhibited synergy in the cocktail to neutralize the virus as determined from the synergy distribution maps (<a id="crosref0600" href="#fig3">Figures 3</a> and <a id="crosref0605" href="#figs3">S3</a>). We used rhesus macaque EBOV and SUDV lethal challenge models and a cynomolgus monkey BDBV lethal challenge model, which recapitulate many key features of EVD in humans (<span class="dropBlock reference-citations"><a id="body-ref-sref4" href="#" role="doc-biblioref" data-xml-rid="bib4" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref4" aria-controls="sref4">Bennett et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">4.</div><div>Bennett, R.S. ∙ Huzella, L.M. ∙ Jahrling, P.B. ...</div><div><strong>Nonhuman primate models of Ebola virus disease</strong></div><div><em>Curr. Top. Microbiol. Immunol.</em> 2017; <strong>411</strong>:171-193</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28643203/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=28643203" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref30" href="#" role="doc-biblioref" data-xml-rid="bib30" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref30" aria-controls="sref30">Geisbert et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref30"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">30.</div><div>Geisbert, T.W. ∙ Strong, J.E. ∙ Feldmann, H.</div><div><strong>Considerations in the use of nonhuman primate models of Ebola virus and Marburg virus infection</strong></div><div><em>J.&nbsp;Infect. Dis.</em> 2015; <strong>212</strong>:S91-S97</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/infdis/jiv284" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84943270748" target="_blank" aria-label="Open Scopus in new tab">Scopus (113)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26063223/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Finfdis%2Fjiv284&amp;pmid=26063223" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Animals were assigned to three treatment groups of five animals per group. After intramuscular challenge with a lethal target dose of 1,000 plaque-forming units (PFUs) of EBOV, BDBV, or SUDV, all NHPs of the treatment group received intravenously two 30&nbsp;mg/kg doses of the cocktail spaced 3&nbsp;days apart (given days 3 and 6 after EBOV, days 6 and 9 after BDBV, or days 4 and 7 after SUDV inoculation). For each challenge cohort, an additional animal was studied as a contemporaneous control and was left untreated. The untreated control animals developed a high clinical score and succumbed to disease on day 6, 14, or 10 after viral challenge with EBOV, BDBV, or SUDV, respectively. The two-dose therapeutic cocktail treatment provided complete pan-ebolavirus protection of NHPs from mortality and clinical signs of EVD (<a id="crosref0620" href="#fig4">Figures 4</a>A and 4B). We next assessed changes in blood chemistries and blood cell composition that are typically associated with EVD to further characterize the efficacy of the mAb treatment (<a id="crosref0625" href="#mmc1">Tables S1</a>, <a id="crosref0630" href="#mmc1">S2</a>, <a id="crosref0635" href="#mmc1">S3</a>, <a id="crosref0640" href="#mmc1">S4</a>, <a id="crosref0645" href="#mmc1">S5</a>, and <a id="crosref0650" href="#mmc1">S6</a>). The liver enzymes alkaline phosphatase (ALP) and gamma glutamyl transferase (GGT), which are indicators of EVD (<span class="dropBlock reference-citations"><a id="body-ref-sref64-2" href="#" role="doc-biblioref" data-xml-rid="bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64-2" aria-controls="sref64-2">Qiu et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref64-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">67.</div><div>Qiu, X. ∙ Wong, G. ∙ Audet, J. ...</div><div><strong>Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp</strong></div><div><em>Nature.</em> 2014; <strong>514</strong>:47-53</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature13777" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84907263545" target="_blank" aria-label="Open Scopus in new tab">Scopus (827)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25171469/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature13777&amp;pmid=25171469" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), were elevated in untreated NHPs at the peak of the disease (<a id="optpeDuSXSL3Z" href="#fig4">Figure 4</a>C). Treated animals did not show signs of acute liver injury after the treatment, displaying low amounts of ALP, GGT, creatinine (CRE), and the other blood chemistries when compared with those of untreated NHP (<a id="crosref0665" href="#fig4">Figure&nbsp;4</a>C; <a id="crosref0670" href="#mmc1">Tables S4</a>, <a id="crosref0675" href="#mmc1">S5</a>, and <a id="crosref0680" href="#mmc1">S6</a>).</div><div class="figure-wrap"><figure id="fig4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.09.035/asset/640a633d-c920-41c3-aee0-f1a25ebd1677/main.assets/gr4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr4" src="/cms/10.1016/j.cell.2021.09.035/asset/62ebd4f6-b036-442c-90ac-38d3bd2ab169/main.assets/gr4.jpg" height="728" width="504" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/640a633d-c920-41c3-aee0-f1a25ebd1677/main.assets/gr4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;4</span> <span class="figure__title__text">The cocktail treatment provides pan-ebolavirus protection of nonhuman primates against disease</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0105" role="paragraph">Rhesus macaques were inoculated with a lethal dose of the EBOV/Kikwit or SUDV/Gulu viruses intramuscularly (i.m.) on day 0 and were treated with total 30&nbsp;mg/kg of the cocktail (1:2 mixture of rEBOV-442 and rEBOV-515) intravenously on 3 and 6 dpi (EBOV/Kikwit; n&nbsp;= 5 per cohort), or 4 and 7 dpi (SUDV/Gulu; n&nbsp;= 5 per cohort). Cynomolgus monkeys were inoculated with a lethal dose of the BDBV/Uganda i.m. on day 0 and were treated with a total dose of 30&nbsp;mg/kg of the cocktail (1:2 mixture of rEBOV-442 and rEBOV-515) intravenously on 6 and 9 dpi (n&nbsp;= 5 per cohort). The contemporaneous control was an untreated NHP challenged with the virus (n&nbsp;= 1 for each cohort). One experiment was performed.</div><div id="fspara0110" role="paragraph">(A) Kaplan-Meier survival plot. The historical untreated controls (gray) are shown for comparative purposes (see <a id="crosref1520" href="#sec-4">STAR Methods</a>). The proportion surviving at day 28 after viral challenge in the treated cohort was compared to the respective historical untreated cohort using a 2-sided exact unconditional test of homogeneity.</div><div id="fspara0115" role="paragraph">(B) Clinical score.</div><div id="fspara0120" role="paragraph">(C) Selected blood chemistry measurements: ALP,&nbsp;alkaline phosphatase; GGT, gamma-glutamyl transpeptidase; CRE, creatinine. Antibody treatment times are indicated with blue dotted vertical lines. Orange curves indicate treated, and black indicate untreated animals in (A)–(C). The black dotted line in (B) indicates the clinical score threshold for euthanasia.</div><div id="fspara0125" role="paragraph">Time points for mAb treatment are indicated with dotted vertical lines in (A)–(C).</div><div id="fspara0130" role="paragraph">See also <a id="crosref1525" href="#mmc1">Tables S1</a>, <a id="crosref1530" href="#mmc1">S2</a>, <a id="crosref1535" href="#mmc1">S3</a>, <a id="crosref1540" href="#mmc1">S4</a>, <a id="crosref1545" href="#mmc1">S5</a>, and <a id="crosref1550" href="#mmc1">S6</a>.</div></div></div></div></figcaption></figure></div><div id="p0080" role="paragraph">At the time of first treatment with the cocktail (day 3 after EBOV, day 6 after BDBV, or day 4 after SUDV inoculation), 14 NHPs from the treatment-designated group (all except one animal in EBOV-challenged group) and the control untreated NHPs were viremic and non-symptomatic, with virus titers that ranged from 5.1 to 10.6 log<sub>10</sub> genome equivalents (GEQs) per mL of plasma, as measured by quantitative reverse-transcription PCR (qRT-PCR) (<a id="crosref0685" href="#fig5">Figure&nbsp;5</a>A). A plaque assay that detects infectious virus revealed viremia in all 18 animals, with viral titers ranging from 0.7 to 7.4 log<sub>10</sub> PFUs per mL of plasma at the time of first treatment with the cocktail (<a id="crosref0690" href="#fig5">Figure&nbsp;5</a>B). This finding confirmed active ebolavirus infection in all NHPs before treatment. At the time of the second mAb treatment (day 6 after EBOV, days 9 after BDBV, or day 7 after SUDV inoculation), each untreated control NHP from a respective EBOV, BDBV, or SUDV challenge cohort developed high viremia &gt;8 log<sub>10</sub> GEQ/mL and &gt;5 log<sub>10</sub> PFU/mL (<a id="crosref0695" href="#fig5">Figures 5</a>A and 5B). Concordant with full protection from disease and death, none of the 15 treated NHPs had detectable infectious virus in the plasma at that time (limit of detection [LOD]&nbsp;= 5 PFU/mL), and viral genomes were not detected in 12 of those NHPs 3.7 (LOD&nbsp;= log<sub>10</sub> GEQ/mL) at that time (<a id="crosref0700" href="#fig4">Figures 4</a> and <a id="crosref0705" href="#fig5">5</a>). The three remaining NHPs that were from the BDBV inoculation cohort and that showed slightly delayed clearance of viral genomes in plasma no longer had detectable virus by day 15 after viral challenge. Analysis of various tissues harvested at study endpoint from treated animals (day 28 after inoculation with EBOV and SUDV or day 35 after inoculation with BDBV) and untreated animals (day 6, 14, or 10 after inoculation with EBOV, BDBV, or SUDV, respectively) revealed varying levels of viral RNA as a sign of systemic infection that had been established before the treatment (<a id="crosref0710" href="#fig5">Figure&nbsp;5</a>C). It has been shown previously that in the case of treatment failure, the infectious&nbsp;virus can be readily detected by plaque assay (<span class="dropBlock reference-citations"><a id="body-ref-sref60" href="#" role="doc-biblioref" data-xml-rid="bib60" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref60" aria-controls="sref60">Oswald et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref60"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>Oswald, W.B. ∙ Geisbert, T.W. ∙ Davis, K.J. ...</div><div><strong>Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys</strong></div><div><em>PLoS Pathog.</em> 2007; <strong>3</strong>:e9</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.ppat.0030009" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-33846490649" target="_blank" aria-label="Open Scopus in new tab">Scopus (207)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17238286/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.ppat.0030009&amp;pmid=17238286" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Therefore, we next assessed the infectious virus load in 11 representative immune-privileged tissues of treated NHPs from each cohort that was selected based on the highest viral RNA load. Infectious virus was not detected in any of these tissues (<a id="crosref0720" href="#fig5">Figure&nbsp;5</a>D), confirming virologic protection mediated by the cocktail treatment.</div><div class="figure-wrap"><figure id="fig5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.09.035/asset/3b334738-2b56-4c03-9459-1a2b2f268e5a/main.assets/gr5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr5" src="/cms/10.1016/j.cell.2021.09.035/asset/43673864-c203-4ecc-b8ec-a69d03148395/main.assets/gr5.jpg" height="581" width="504" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/3b334738-2b56-4c03-9459-1a2b2f268e5a/main.assets/gr5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;5</span> <span class="figure__title__text">The cocktail treatment provides pan-ebolavirus protection of nonhuman primates against viremia</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0140" role="paragraph">Blood viral loads were assessed from individual animals that were challenged with EBOV/Kikwit, BDBV/Uganda, or SUDV/Gulu and treated with the two-antibody cocktail as described in <a id="crosref1555" href="#fig4">Figure&nbsp;4</a>.</div><div id="fspara0145" role="paragraph">(A) Kinetics of blood viral load determined for genome equivalents (GEq) using qRT-PCR.</div><div id="fspara0150" role="paragraph">(B) Kinetics of infectious virus blood viral load as determined by plaque assay. Orange curves indicate treated, and black indicate untreated animals. Antibody treatment times are indicated with blue dotted vertical lines. The black dotted line indicates the limit of detection (LOD), which was 3.7&nbsp;log<sub>10</sub>GEq/mL (A) or 25 PFU/mL (B). Violet dot indicates one NHP confirmed to be viremic (5&nbsp;PFU/mL; LOD&nbsp;= 2 PFU/mL) at 3 dpi upon repeated test using a lower plasma dilution.</div><div id="fspara0155" role="paragraph">(C) Viral RNA load in various peripheral tissues of treated NHPs (28 dpi for EBOV and SUDV cohort or 35 dpi for BDBV cohort). Tissues from succumbed untreated NHP from each cohort were used as controls. The black dotted vertical line indicates the limit of detection, which was 2.4 log<sub>10</sub>GEq/gram. The data are shown as an aligned dot plot with bar, where orange dots indicate measurement from individual treated animals, black dots and bars indicate measurement from untreated control animals, and orange bar indicates the mean value of the measurements for treated cohorts. For samples in which viral RNA was not detected, the measurement values were set to the limit of detection, 2.4 log<sub>10</sub>GEq/gram. Brain samples from untreated animals have not been tested. Arrows with numbers indicate immune privileged tissues selected for assessment of infectious virus load as in (D).</div><div id="fspara0160" role="paragraph">(D) Plaque assay measurements of infectious virus load in representative immune privileged tissues of treated NHPs from each cohort that were selected based on the highest viral RNA load as in (C). The&nbsp;&lt; symbol indicates infections virus was not detected, and the LOD was 250 PFU/gram of tissue.</div><div id="fspara0165" role="paragraph">Each measurement in (A)–(D) represents the mean of technical duplicates. The dotted vertical lines in (A) and (B) indicate time points for mAb treatment.</div></div></div></div></figcaption></figure></div><div id="p0085" role="paragraph">Together, these results showed a high therapeutic efficacy of the cocktail of rEBOV-515 LALA-PG&nbsp;+ rEBOV-442 IgG1 to treat established viremia, clear the infectious virus from immune-privileged tissues, and prevent disease caused by EBOV, BDBV, and SUDV.</div></section><section id="sec-2-5"><h3>Structural basis for the efficacy and broad ebolavirus neutralization by the cocktail</h3><div id="p0090" role="paragraph">We previously reported the molecular determinants of the GP binding for several glycan cap-specific mAbs, including the broad mAb rEBOV-442 (<span class="dropBlock reference-citations"><a id="body-ref-sref58-1" href="#" role="doc-biblioref" data-xml-rid="bib58" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref58-1" aria-controls="sref58-1">Murin et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref58-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Murin, C.D. ∙ Gilchuk, P. ∙ Ilinykh, P.A. ...</div><div><strong>Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies</strong></div><div><em>Cell Rep.</em> 2021; <strong>35</strong>:108984</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.celrep.2021.108984&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.celrep.2021.108984&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85104082939" target="_blank" aria-label="Open Scopus in new tab">Scopus (18)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33852862/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2021.108984&amp;pmid=33852862" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and defined the structural basis of synergy for the pair of broad mAbs rEBOV-520 and rEBOV-548 (<span class="dropBlock reference-citations"><a id="body-ref-sref34-8" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-8" aria-controls="sref34-8">Gilchuk et&nbsp;al., 2020b</a><div class="dropBlock__holder" data-db-target-of="sref34-8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Gilchuk, P. ∙ Murin, C.D. ∙ Milligan, J.C. ...</div><div><strong>Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:388-403.e12</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85079145867" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32023489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2020.01.001&amp;pmid=32023489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In this new study, we focused on studies of the determinants of rEBOV-515 binding to elucidate the structural basis for the neutralization breadth and efficacy mediated by pan-ebolavirus cocktail of rEBOV-515&nbsp;+ rEBOV-442. We generated a complex of both rEBOV-515 and rEBOV-442 Fab with mucin-like domain-deleted EBOV GP from the Makona variant (EBOV GPΔMuc/Mak) and solved structures by cryogenic electron microscopy (cryo-EM) (<a id="crosref0735" href="#fig6">Figures 6</a>A and <a id="crosref0740" href="#figs4">S4</a>; <a id="crosref0745" href="#mmc1">Table S7</a>).</div><div class="figure-wrap"><figure id="fig6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.09.035/asset/73f32c9a-52a1-44bc-824e-df3b90020fdd/main.assets/gr6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr6" src="/cms/10.1016/j.cell.2021.09.035/asset/4abb4c07-3117-4c3a-a5ea-2dcfb3a04c69/main.assets/gr6.jpg" height="653" width="504" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/73f32c9a-52a1-44bc-824e-df3b90020fdd/main.assets/gr6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;6</span> <span class="figure__title__text">rEBOV-515 binds to the major site of vulnerability in the GP base region in a distinct manner</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0175" role="paragraph">(A) Cryo-EM structure of rEBOV-442 (heavy chain in blue and light chain in gray) and rEBOV-515 (heavy chain in maroon and light chain in pink) Fab&nbsp;bound to EBOV GPΔMuc/Mak. A side view in relation to the viral membrane is shown. Fab constant domains were excluded by masking.</div><div id="fspara0180" role="paragraph">(B) The predicted contact surface of broadly neutralizing mAbs rEBOV-515 and rEBOV-520 on the surface representation of the EBOV GPΔMuc/Mak monomer model (PDB: <a id="intref0175" href="http://firstglance.jmol.org/fg.htm?mol5JQ3" target="_blank">5JQ3</a>). Non-overlapping contact surfaces for rEBOV-515 or rEBOV-520 are shown, respectively, in maroon or orange, and overlapping contact surface of both mAbs is shown in yellow.</div><div id="fspara0185" role="paragraph">(C) Contact residue details of the rEBOV-515 heavy chain Fab interactions with the base of GP. CDRH3 contacts include a backbone-mediated hydrogen bond at S102<sub>H3</sub> to N512<sub>GP2</sub>, a key contact that links the β17-β18 loop to the base of the IFL via W291 in unliganded GP1. Contacts near the 3<sub>10</sub> pocket include a potential hydrogen bond between S105<sub>H3</sub> and E106<sub>GP1</sub> that forms when a large portion of the CDRH3 loop displaces the β17-β18 loop. Within the CDRH2 loop, Y52<sub>H2</sub> and Y55<sub>H2</sub> make potential hydrogen bonds via their hydroxyl groups to H549<sub>GP2</sub> or H516<sub>GP2</sub> on GP2, respectively. One of the most extensive rEBOV-515 contacts is from W103<sub>H3</sub>, which forms a strong cation-pi bond with R136<sub>GP1</sub>, allowing R136 to make additional hydrogen bonds with Y34<sub>H1</sub> and a salt bridge with E106<sub>H3</sub>.</div><div id="fspara0190" role="paragraph">(D) Epitope details of the rEBOV-515 light chain interactions with the base of GP. The rEBOV-515 light chain makes contacts with all three CDRs exclusively within GP2. Contact features include a potential hydrogen bond between N32<sub>L1</sub> and the backbone of C511<sub>GP2</sub>, and a salt bridge between D50<sub>L2</sub> and K510<sub>GP2</sub>. Pi cation interactions at W94<sub>L3</sub> with H549<sub>GP2</sub> (black dashed line) and an additional potential hydrogen bond at N92<sub>L3</sub> with N550<sub>GP2</sub> provide additional stabilizing interactions.</div><div id="fspara0195" role="paragraph">(E) Comparison of mAb CDRH3 loops that bind in and around the 3<sub>10</sub> pocket (blue dashed circle) and putative glycerol pocket (solid yellow line). rEBOV-520 and ADI-15946 replace and mimic residue W291<sub>GP1</sub> (that anchors down the β17-β18 loop in apo-GP) with a tryptophan from their CDRH3 loops. rEBOV-515 uses an analogous tryptophan residue (W103<sub>H3</sub>) to contact R136<sub>GP1</sub> via a strong cation-pi interactions bond, which causes a shift in the rotamer of R136<sub>GP1</sub>. W103<sub>H3</sub> from rEBOV-515 also accesses a pocket that is occupied by a glycerol cryoprotectant molecule in the unliganded crystal structure of GP, which is also occupied by Y28<sub>L1</sub> from ADI-15946.</div><div id="fspara0200" role="paragraph">(F) A shift in the placement of the GP1 α2 helix that cased by the CDRH3 from rEBOV-520 but is lacking in rEBOV-515 binding due to a shorter CDR loop is shown.</div><div id="fspara0205" role="paragraph">In (C) and (D): red dotted lines, hydrogen bonds; green dotted lines, salt bridge; purple dashed line, cation-pi interaction; black dashed line, carbon-pi or aromatic interactions. rEBOV-520-GP, PDB: <a id="intref0180" href="http://firstglance.jmol.org/fg.htm?mol6PCI" target="_blank">6PCI</a>; ADI-15946-GP, PDB: <a id="intref0185" href="http://firstglance.jmol.org/fg.htm?mol6MAM" target="_blank">6MAM</a>.</div><div id="fspara0210" role="paragraph">See also <a id="crosrefs0010" href="#figs4">Figures S4, S5, and S6</a> and <a id="crosref1560" href="#mmc1">Table S7</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.09.035/asset/7c241b2d-2ab7-4e1e-b1fc-4337e302a87c/main.assets/figs4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs4" src="/cms/10.1016/j.cell.2021.09.035/asset/43ad6f06-9714-4c25-a3ee-d3a99d857437/main.assets/figs4.jpg" height="490" width="499" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/7c241b2d-2ab7-4e1e-b1fc-4337e302a87c/main.assets/figs4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S4</span> <span class="figure__title__text">Cryo-EM local resolution estimation and FSC curves, related to <a id="crosref1605" href="#fig6">Figure&nbsp;6</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0305" role="paragraph">(A) The local resolution of the EBOV GPΔMuc/Mak:rEBOV-442/rEBOV-515 cryo-EM map, with local resolutions indicated according to the colors in the legend below.</div><div id="fspara0310" role="paragraph">(B) The Fourier shell correlation (FSC) curve for the EBOV GPΔMuc/Mak:rEBOV-442/rEBOV-515 cryo-EM map, generated by Relion 3.1.</div></div></div></div></figcaption></figure></div><div id="p0095" role="paragraph">The interface between GP and rEBOV-515 in this structure was resolved to ∼3 to 3.5&nbsp;Å resolution (<a id="crosref0750" href="#figs4">Figure&nbsp;S4</a>), allowing for confident modeling of most of the side-chain residues. rEBOV-515 binds to the base of the IFL, directly below the glycan cap in GP1 (<a id="crosref0755" href="#fig6">Figure&nbsp;6</a>A). There is significant overlap of the rEBOV-515 epitope with that of rEBOV-520, but rEBOV-515 has more extensive contacts in GP2 and less in GP1 (<a id="crosref0760" href="#fig6">Figure&nbsp;6</a>B). Most EBOV-515 contacts are mediated by the heavy chain (HC), with all three complementarity determining regions (CDRs) contributing to binding the base of the IFL as well as a portion of GP1 near the 3<sub>10</sub> pocket (<a id="crosref0765" href="#fig6">Figures 6</a>C, <a id="crosref0770" href="#figs5">S5</a>A, S5B, and <a id="crosref0775" href="#figs6">S6</a>). The CDRH3 contributes the most extensive contacts, including those that displace the descending β17-β18 loop of the glycan cap, making contacts near the 3<sub>10</sub> pocket, as well as a strong cation-pi bond with R136<sub>GP1</sub> (<a id="crosref0780" href="#fig6">Figure&nbsp;6</a>C). The rEBOV-515 light chain (LC) also makes contacts with all three CDRs exclusively within GP2 (<a id="crosref0785" href="#fig6">Figures 6</a>D and <a id="crosref0790" href="#figs5">S5</a>A). Together, this analysis showed that rEBOV-515 forms a strong interaction of complementary hydrophobic (<a id="crosref0795" href="#figs5">Figure&nbsp;S5</a>B) and electrostatic (<a id="crosref0800" href="#figs5">Figure&nbsp;S5</a>C) surfaces for binding to this epitope within GP.</div><div class="figure-wrap"><figure id="figs5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.09.035/asset/9fb66bbc-37d3-42a8-bc70-c425cf124ead/main.assets/figs5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs5" src="/cms/10.1016/j.cell.2021.09.035/asset/e1e0f2d2-7170-417d-8579-a879254d8c73/main.assets/figs5.jpg" height="645" width="504" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/9fb66bbc-37d3-42a8-bc70-c425cf124ead/main.assets/figs5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S5</span> <span class="figure__title__text">Epitope and paratope binding properties of rEBOV-515, related to <a id="crosref1610" href="#fig6">Figure&nbsp;6</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0320" role="paragraph">(A) LigPlot schematic showing interaction of rEBOV-515 with GP1 (above) or GP2 (below). Residues that make hydrogen bonds are rendered, and those that contribute van der Waals interactions are drawn as semi-circles. rEBOV-515 CDR loop residues are colored according to the labels, with GP residues in magenta/pink and backbone residues colored in dark cyan. Chain identifiers are in parenthesis.</div><div id="fspara0325" role="paragraph">(B) Kyte-Doolittle surface rendering of GP<sub>1,2</sub> (left) and a face-on view of the rEBOV-515 Fv paratope (right) with the interacting regions highlighted. Key hydrophobic residues are indicated with important regions of interaction labeled 1-3 on the GP epitope and the corresponding interacting residues labeled 1-3 on the rEBOV-515 paratope.</div><div id="fspara0330" role="paragraph">(C) Similar epitope/paratope interaction rendering as in (B) but with Coulombic surface rendering, indicating key electronegative regions on GP that interact with electropositive regions on the rEBOV-515 paratope.</div></div></div></div></figcaption></figure></div><div id="p0100" role="paragraph">Neutralizing potency may depend on the ability of mAb to remain bound to viral GP within the acidic environment of late endosomes, which is where pH-dependent cleavage occurs to expose the Niemann-Pick C1 (NPC1) receptor binding site (<span class="dropBlock reference-citations"><a id="body-ref-sref10" href="#" role="doc-biblioref" data-xml-rid="bib10" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref10" aria-controls="sref10">Carette et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">10.</div><div>Carette, J.E. ∙ Raaben, M. ∙ Wong, A.C. ...</div><div><strong>Ebola virus entry requires the cholesterol transporter Niemann-Pick C1</strong></div><div><em>Nature.</em> 2011; <strong>477</strong>:340-343</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature10348" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-80052851832" target="_blank" aria-label="Open Scopus in new tab">Scopus (1007)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21866103/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature10348&amp;pmid=21866103" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref11" href="#" role="doc-biblioref" data-xml-rid="bib11" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref11" aria-controls="sref11">Chandran et&nbsp;al., 2005</a><div class="dropBlock__holder" data-db-target-of="sref11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">11.</div><div>Chandran, K. ∙ Sullivan, N.J. ∙ Felbor, U. ...</div><div><strong>Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection</strong></div><div><em>Science.</em> 2005; <strong>308</strong>:1643-1645</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1110656" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-19144365133" target="_blank" aria-label="Open Scopus in new tab">Scopus (709)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15831716/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1110656&amp;pmid=15831716" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Given that rEBOV-515 strongly interacts with the EBOV GP, we assessed binding of this mAb at varying pH to recombinant EBOV, BDBV, or SUDV GPs. We used the broadly reactive base-specific mAb rEBOV-520 for comparison. rEBOV-515 and rEBOV-520 bound equivalently to the GP of each of the three ebolaviruses at neutral pH 7.4, and rEBOV-515 remained bound at acidic pH of 5.5 or 4.5, whereas rEBOV-520 lost binding activity (<a id="crosref0815" href="#figs7">Figure&nbsp;S7</a>A).</div><div id="p0105" role="paragraph">The rEBOV-515 binding site partially overlaps with those of other reported broad mAbs that bind to the 3<sub>10</sub> pocket, including rEBOV-520 (<span class="dropBlock reference-citations"><a id="body-ref-sref34-9" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-9" aria-controls="sref34-9">Gilchuk et&nbsp;al., 2020b</a><div class="dropBlock__holder" data-db-target-of="sref34-9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Gilchuk, P. ∙ Murin, C.D. ∙ Milligan, J.C. ...</div><div><strong>Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:388-403.e12</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85079145867" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32023489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2020.01.001&amp;pmid=32023489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and ADI-15946 (<span class="dropBlock reference-citations"><a id="body-ref-sref77-1" href="#" role="doc-biblioref" data-xml-rid="bib77" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref77-1" aria-controls="sref77-1">West et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref77-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">80.</div><div>West, B.R. ∙ Wec, A.Z. ∙ Moyer, C.L. ...</div><div><strong>Structural basis of broad ebolavirus neutralization by a human survivor antibody</strong></div><div><em>Nat. Struct. Mol. Biol.</em> 2019; <strong>26</strong>:204-212</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41594-019-0191-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85062447650" target="_blank" aria-label="Open Scopus in new tab">Scopus (25)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30833785/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41594-019-0191-4&amp;pmid=30833785" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (<a id="crosref0830" href="#fig6">Figures 6</a>B and 6E). Each of these mAbs relies upon E106 and R136 in GP1 and several residues at the base of the IFL, using long CDRH3 loops that mimic and replace the β17-β18 loop of the GP1 in apo-GP structure (<a id="crosref0835" href="#fig6">Figure&nbsp;6</a>E). However, characterization of the rEBOV-515 binding site revealed several unique features. rEBOV-515 uses a single CDR loop to simultaneously mimic and displace the β17-β18 loop and to bind to R136 in GP1. This feature allows rEBOV-515 to access a region that is occupied by a glycerol cryoprotectant molecule in the unliganded crystal structure of GP (PDB: <a id="intref0010" href="http://firstglance.jmol.org/fg.htm?mol5JQ3" target="_blank">5JQ3</a> and <a id="intref0015" href="http://firstglance.jmol.org/fg.htm?mol5JQB" target="_blank">5JQB</a>) that we defined as “glycerol pocket” (<a id="crosref0840" href="#fig6">Figure&nbsp;6</a>E). In addition, this mechanism facilitates greater interaction of EBOV-515 with the cleavage loop compared to that caused by rEBOV-520, which may explain the high cell surface-displayed GP cleavage-inhibiting activity of EBOV-515 (<a id="crosref0845" href="#figs7">Figure&nbsp;S7</a>B). Further, a distinct pose of rEBOV-515 binding into the 3<sub>10</sub> pocket avoids clashes with the α2 helix of the glycan cap (<a id="crosref0850" href="#fig6">Figure&nbsp;6</a>F), unlike the binding of rEBOV-520 to the GP, which requires the α2 helix shift (<span class="dropBlock reference-citations"><a id="body-ref-sref34-10" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-10" aria-controls="sref34-10">Gilchuk et&nbsp;al., 2020b</a><div class="dropBlock__holder" data-db-target-of="sref34-10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Gilchuk, P. ∙ Murin, C.D. ∙ Milligan, J.C. ...</div><div><strong>Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:388-403.e12</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85079145867" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32023489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2020.01.001&amp;pmid=32023489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). This finding suggested that the binding site of rEBOV-515 on the intact GP molecule is more accessible than the rEBOV-520 binding site, which could explain the higher neutralizing potency of rEBOV-515 when compared to the potency of rEBOV-520 against the virus carrying the intact GP as we reported previously (<span class="dropBlock reference-citations"><a id="body-ref-sref31-10" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-10" aria-controls="sref31-10">Gilchuk et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref31-10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Gilchuk, P. ∙ Kuzmina, N. ∙ Ilinykh, P.A. ...</div><div><strong>Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the Ebolavirus glycoprotein</strong></div><div><em>Immunity.</em> 2018; <strong>49</strong>:363-374.e10</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85053075312" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30029854/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.06.018&amp;pmid=30029854" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Of note, we have shown previously that GP cleavage, which removes the glycan cap along with the β17-β18 loop, resulted in enhanced binding to cell-surface-displayed cleaved GP and increased neutralizing potency for both rEBOV-515 and rEBOV-520 (<span class="dropBlock reference-citations"><a id="body-ref-sref31-11" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-11" aria-controls="sref31-11">Gilchuk et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref31-11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Gilchuk, P. ∙ Kuzmina, N. ∙ Ilinykh, P.A. ...</div><div><strong>Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the Ebolavirus glycoprotein</strong></div><div><em>Immunity.</em> 2018; <strong>49</strong>:363-374.e10</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85053075312" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30029854/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.06.018&amp;pmid=30029854" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>, <span class="dropBlock reference-citations"><a id="body-ref-sref34-11" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-11" aria-controls="sref34-11">2020b</a><div class="dropBlock__holder" data-db-target-of="sref34-11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Gilchuk, P. ∙ Murin, C.D. ∙ Milligan, J.C. ...</div><div><strong>Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:388-403.e12</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85079145867" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32023489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2020.01.001&amp;pmid=32023489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0110" role="paragraph">There are notable differences in degree of pan-ebolavirus neutralization and protection by each of three reported broadly reactive human mAbs despite recognition of partially overlapped epitopes they recognize on the GP base (<a id="crosref0875" href="#fig6">Figure&nbsp;6</a>B). ADI-15946 did not fully neutralize most antigenically distinct SUDV (<span class="dropBlock reference-citations"><a id="body-ref-sref75-5" href="#" role="doc-biblioref" data-xml-rid="bib75" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref75-5" aria-controls="sref75-5">Wec et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref75-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">78.</div><div>Wec, A.Z. ∙ Herbert, A.S. ∙ Murin, C.D. ...</div><div><strong>Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses</strong></div><div><em>Cell.</em> 2017; <strong>169</strong>:878-890.e15</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.037&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.037&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85019578866" target="_blank" aria-label="Open Scopus in new tab">Scopus (127)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28525755/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.04.037&amp;pmid=28525755" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref77-2" href="#" role="doc-biblioref" data-xml-rid="bib77" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref77-2" aria-controls="sref77-2">West et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref77-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">80.</div><div>West, B.R. ∙ Wec, A.Z. ∙ Moyer, C.L. ...</div><div><strong>Structural basis of broad ebolavirus neutralization by a human survivor antibody</strong></div><div><em>Nat. Struct. Mol. Biol.</em> 2019; <strong>26</strong>:204-212</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41594-019-0191-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85062447650" target="_blank" aria-label="Open Scopus in new tab">Scopus (25)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30833785/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41594-019-0191-4&amp;pmid=30833785" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), rEBOV-520 neutralized SUDV with modest potency but showed weak protection against SUDV in mice, and rEBOV-515 potently neutralized each of three viruses and protected against SUDV in mice (<span class="dropBlock reference-citations"><a id="body-ref-sref31-12" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-12" aria-controls="sref31-12">Gilchuk et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref31-12"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Gilchuk, P. ∙ Kuzmina, N. ∙ Ilinykh, P.A. ...</div><div><strong>Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the Ebolavirus glycoprotein</strong></div><div><em>Immunity.</em> 2018; <strong>49</strong>:363-374.e10</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85053075312" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30029854/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.06.018&amp;pmid=30029854" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>, <span class="dropBlock reference-citations"><a id="body-ref-sref34-12" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-12" aria-controls="sref34-12">2020b</a><div class="dropBlock__holder" data-db-target-of="sref34-12"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Gilchuk, P. ∙ Murin, C.D. ∙ Milligan, J.C. ...</div><div><strong>Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:388-403.e12</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85079145867" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32023489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2020.01.001&amp;pmid=32023489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Our structural analysis allowed us to compare the epitope footprint and contacts for each of these antibodies in relation to sequence conservation between the three major ebolavirus (<a id="crosref0900" href="#fig7">Figures 7</a> and <a id="crosref0905" href="#figs6">S6</a>), providing insight that may help explain differences in neutralization breadth. ADI-15946 makes fewer contacts with GP1 but more contacts to the N terminus of GP2, a region that is less conserved that may explain weak SUDV neutralization. Conversely, rEBOV-520 makes more extensive contacts with GP1, because this region is generally less conserved. rEBOV-515 relies on minimal contacts with&nbsp;GP1, except in regions that are completely conserved, including R136 and E106. Taken together with a more conserved footprint, these observations provide a molecular basis for the superior breadth of neutralization and protection exhibited by rEBOV-515 over similar mAbs.</div><div class="figure-wrap"><figure id="fig7" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.09.035/asset/95d350f0-369c-45c9-8795-8da73e54f5fd/main.assets/gr7_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr7" src="/cms/10.1016/j.cell.2021.09.035/asset/b2864383-60ca-461c-b09e-bdbf8328f987/main.assets/gr7.jpg" height="502" width="659" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/95d350f0-369c-45c9-8795-8da73e54f5fd/main.assets/gr7_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig7-title" class="figure__title"><span class="label figure__label">Figure&nbsp;7</span> <span class="figure__title__text">Conservation of the binding sites for broad mAbs rEBOV-515, rEBOV-520, and ADI-15946</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig7-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0220" role="paragraph">Apo-GP is surface-rendered according to residue conservation on the left, with no conservation in dark purple (0%) and complete conservation in white (100%). The corresponding mAb footprints are highlighted. On the right are aligned sequences of the interacting regions on GP from EBOV, BDBV, and SUDV. Total contacts for each residue at 4&nbsp;Å distance or less were determined (see <a id="crosref1565" href="#mmc1">Table S7</a>), and residues are highlighted in blue according to the number of contacts, with darker blue indicating more contacts and thus a higher likelihood for contributing critically to binding. Residues that are variable are marked with a green diamond. HC contacts are indicated below in dark purple and LC contacts in pink.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.09.035/asset/8a6ef808-257e-47ff-b558-850ca5030a97/main.assets/figs6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs6" src="/cms/10.1016/j.cell.2021.09.035/asset/a52e45f9-3512-479a-88c3-b34aacf19720/main.assets/figs6.jpg" height="620" width="659" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/8a6ef808-257e-47ff-b558-850ca5030a97/main.assets/figs6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S6</span> <span class="figure__title__text">Contact residues for broadly reactive antibodies rEBOV-515, rEBOV-520, and ADI-15946, related to <a id="crosref1615" href="#fig6">Figure&nbsp;6</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0340" role="paragraph">Base binding mAb contacts on EBOV GP determined by UCSF Chimera with a default cutoff value of −0.4&nbsp;Å and an allowance of 0&nbsp;Å (<span class="dropBlock reference-citations"><a id="body-ref-sref62-1" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-1" aria-controls="sref62-1">Pettersen et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref62-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">65.</div><div>Pettersen, E.F. ∙ Goddard, T.D. ∙ Huang, C.C. ...</div><div><strong>UCSF Chimera--a visualization system for exploratory research and analysis</strong></div><div><em>J.&nbsp;Comput. Chem.</em> 2004; <strong>25</strong>:1605-1612</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/jcc.20084" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-4444221565" target="_blank" aria-label="Open Scopus in new tab">Scopus (33444)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15264254/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fjcc.20084&amp;pmid=15264254" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). rEBOV-520 from PDB <a id="intref0200" href="http://firstglance.jmol.org/fg.htm?mol6PCI" target="_blank">6PCI</a> (<span class="dropBlock reference-citations"><a id="body-ref-sref34-13" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-13" aria-controls="sref34-13">Gilchuk et&nbsp;al., 2020b</a><div class="dropBlock__holder" data-db-target-of="sref34-13"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Gilchuk, P. ∙ Murin, C.D. ∙ Milligan, J.C. ...</div><div><strong>Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:388-403.e12</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85079145867" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32023489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2020.01.001&amp;pmid=32023489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), ADI-15946 from PDB <a id="intref0205" href="http://firstglance.jmol.org/fg.htm?mol6MAM" target="_blank">6MAM</a> (<span class="dropBlock reference-citations"><a id="body-ref-sref77-3" href="#" role="doc-biblioref" data-xml-rid="bib77" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref77-3" aria-controls="sref77-3">West et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref77-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">80.</div><div>West, B.R. ∙ Wec, A.Z. ∙ Moyer, C.L. ...</div><div><strong>Structural basis of broad ebolavirus neutralization by a human survivor antibody</strong></div><div><em>Nat. Struct. Mol. Biol.</em> 2019; <strong>26</strong>:204-212</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41594-019-0191-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85062447650" target="_blank" aria-label="Open Scopus in new tab">Scopus (25)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30833785/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41594-019-0191-4&amp;pmid=30833785" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Gradient is green to red, with green being fewer contacts and red being the most contacts.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs7" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.09.035/asset/03f64a6a-abdd-4a6c-a3be-6b1fb277d494/main.assets/figs7_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs7" src="/cms/10.1016/j.cell.2021.09.035/asset/1fbc3199-ebc7-4694-892f-ed76f780291c/main.assets/figs7.jpg" height="360" width="658" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/03f64a6a-abdd-4a6c-a3be-6b1fb277d494/main.assets/figs7_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs7-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S7</span> <span class="figure__title__text">rEBOV-515 retains GP-binding capacity at low pH and efficiently inhibits GP cleavage, related to <a id="crosref1635" href="#fig6">Figure&nbsp;6</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs7-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0350" role="paragraph">(A) ELISA binding of rEBOV-515 or rEBOV-520 to the recombinant EBOV, BDBV, or SUDV GP ΔTM at neutral or acidic pH. The mean ± SD of technical triplicates and one of two independent experiments are shown.</div><div id="fspara0355" role="paragraph">(B) Cleavage inhibition by the GP-base specific antibodies. Jurkat EBOV-GP cells were pre-incubated with various concentrations of indicated antibodies, treated with thermolysin, then incubated with fluorescently-labeled mAb MR78 that recognizes the receptor binding site (RBS) of the cleaved EBOV GP, does not bind to uncleaved EBOV GP, and does not compete with rEBOV-515 or rEBOV-520 for EBOV GP<sub>CL</sub> binding. An unlabeled mAb rDENV 2D22 was used as control for non-inhibitory mAb activity. Results are expressed as the percent of inhibition of RBS exposure in the presence of tested mAb relative to controls for minimal binding of labeled MR78 mAb-only to intact (uncleaved) Jurkat EBOV-GP, and maximal binding of labeled MR78 mAb-only to cleaved Jurkat-EBOV GP. Mean ± SD of technical triplicates and one of two independent experiments are shown.</div></div></div></div></figcaption></figure></div></section></section><section id="sec-3"><h2>Discussion</h2><div id="p0115" role="paragraph">Here, we report comprehensive studies of pan-ebolavirus mAb cocktail treatment with a well-defined and complex molecular basis of broad neutralization and potency. The cocktail exhibited high therapeutic efficacy against all three medically important ebolaviruses in nonhuman primates. The discovery and recent approval of human mAb-based therapeutics represents a landmark&nbsp;achievement in the development of EVD medical countermeasures. The clinical trials in the DRC outbreak, however, highlighted that substantial gaps remained in improving the treatment of acute EVD (<span class="dropBlock reference-citations"><a id="body-ref-sref41" href="#" role="doc-biblioref" data-xml-rid="bib41" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref41" aria-controls="sref41">Iversen et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref41"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">41.</div><div>Iversen, P.L. ∙ Kane, C.D. ∙ Zeng, X. ...</div><div><strong>Recent successes in therapeutics for Ebola virus disease: no time for complacency</strong></div><div><em>Lancet Infect. Dis.</em> 2020; <strong>20</strong>:e231-e237</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2FS1473-3099%2820%2930282-6&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2FS1473-3099%2820%2930282-6&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85086661359" target="_blank" aria-label="Open Scopus in new tab">Scopus (38)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32563280/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1473-3099%2820%2930282-6&amp;pmid=32563280" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The greatest benefit of mAb treatment in patients was mainly in those receiving early therapy, and only moderate benefit was observed in severely ill patients (<span class="dropBlock reference-citations"><a id="body-ref-sref51-2" href="#" role="doc-biblioref" data-xml-rid="bib51" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref51-2" aria-controls="sref51-2">Levine, 2019</a><div class="dropBlock__holder" data-db-target-of="sref51-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Levine, M.M.</div><div><strong>Monoclonal antibody therapy for Ebola virus disease</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2019; <strong>381</strong>:2365-2366</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMe1915350" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85076446841" target="_blank" aria-label="Open Scopus in new tab">Scopus (48)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31774948/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMe1915350&amp;pmid=31774948" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Another remaining challenge for implementation of the current regimens is the logistical complexity of intravenous drug administration in the field, which may limit widespread application of mAb therapy in future outbreak scenarios.</div><div id="p0120" role="paragraph">Given the difference in efficacy mediated by different mAb drugs that was observed for advanced EVD treatments, mAb potency likely is a key contributing determinant of treatment efficacy. Inmazeb and Ebanga demonstrated higher efficacy when compared to that of the mAb cocktail ZMapp in clinical trials (<span class="dropBlock reference-citations"><a id="body-ref-sref51-3" href="#" role="doc-biblioref" data-xml-rid="bib51" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref51-3" aria-controls="sref51-3">Levine, 2019</a><div class="dropBlock__holder" data-db-target-of="sref51-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Levine, M.M.</div><div><strong>Monoclonal antibody therapy for Ebola virus disease</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2019; <strong>381</strong>:2365-2366</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMe1915350" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85076446841" target="_blank" aria-label="Open Scopus in new tab">Scopus (48)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31774948/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMe1915350&amp;pmid=31774948" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Inmazeb is a three-antibody cocktail based on REGN-EB3 mAb sequences (<span class="dropBlock reference-citations"><a id="body-ref-sref61-2" href="#" role="doc-biblioref" data-xml-rid="bib61" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref61-2" aria-controls="sref61-2">Pascal et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref61-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Pascal, K.E. ∙ Dudgeon, D. ∙ Trefry, J.C. ...</div><div><strong>Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in nonhuman primates</strong></div><div><em>J.&nbsp;Infect. Dis.</em> 2018; <strong>218</strong>:S612-S626</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/infdis/jiy285" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85057165662" target="_blank" aria-label="Open Scopus in new tab">Scopus (133)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29860496/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Finfdis%2Fjiy285&amp;pmid=29860496" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), Ebanga is a monotherapy based on the antibody mAb114 (<span class="dropBlock reference-citations"><a id="body-ref-sref14-2" href="#" role="doc-biblioref" data-xml-rid="bib14" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref14-2" aria-controls="sref14-2">Corti et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref14-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Corti, D. ∙ Misasi, J. ∙ Mulangu, S. ...</div><div><strong>Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody</strong></div><div><em>Science.</em> 2016; <strong>351</strong>:1339-1342</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aad5224" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84959359636" target="_blank" aria-label="Open Scopus in new tab">Scopus (326)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26917593/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aad5224&amp;pmid=26917593" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and ZMapp is a cocktail of three murine-human chimeric mAbs (<span class="dropBlock reference-citations"><a id="body-ref-sref64-3" href="#" role="doc-biblioref" data-xml-rid="bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64-3" aria-controls="sref64-3">Qiu et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref64-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">67.</div><div>Qiu, X. ∙ Wong, G. ∙ Audet, J. ...</div><div><strong>Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp</strong></div><div><em>Nature.</em> 2014; <strong>514</strong>:47-53</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature13777" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84907263545" target="_blank" aria-label="Open Scopus in new tab">Scopus (827)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25171469/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature13777&amp;pmid=25171469" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). A comparison with the historical NHPs studies with REGN-EB3 (3&nbsp;× 50&nbsp;mg/kg dose at days 5, 8, and 11 after exposure) (<span class="dropBlock reference-citations"><a id="body-ref-sref61-3" href="#" role="doc-biblioref" data-xml-rid="bib61" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref61-3" aria-controls="sref61-3">Pascal et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref61-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Pascal, K.E. ∙ Dudgeon, D. ∙ Trefry, J.C. ...</div><div><strong>Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in nonhuman primates</strong></div><div><em>J.&nbsp;Infect. Dis.</em> 2018; <strong>218</strong>:S612-S626</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/infdis/jiy285" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85057165662" target="_blank" aria-label="Open Scopus in new tab">Scopus (133)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29860496/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Finfdis%2Fjiy285&amp;pmid=29860496" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), mAb114 (3&nbsp;× 50&nbsp;mg/kg dose at days 1, 2, and 3 after exposure) (<span class="dropBlock reference-citations"><a id="body-ref-sref14-3" href="#" role="doc-biblioref" data-xml-rid="bib14" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref14-3" aria-controls="sref14-3">Corti et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref14-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Corti, D. ∙ Misasi, J. ∙ Mulangu, S. ...</div><div><strong>Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody</strong></div><div><em>Science.</em> 2016; <strong>351</strong>:1339-1342</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aad5224" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84959359636" target="_blank" aria-label="Open Scopus in new tab">Scopus (326)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26917593/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aad5224&amp;pmid=26917593" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and ZMapp (3&nbsp;× 50&nbsp;mg/kg dose at days 3, 6, and 9 after exposure) (<span class="dropBlock reference-citations"><a id="body-ref-sref64-4" href="#" role="doc-biblioref" data-xml-rid="bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64-4" aria-controls="sref64-4">Qiu et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref64-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">67.</div><div>Qiu, X. ∙ Wong, G. ∙ Audet, J. ...</div><div><strong>Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp</strong></div><div><em>Nature.</em> 2014; <strong>514</strong>:47-53</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature13777" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84907263545" target="_blank" aria-label="Open Scopus in new tab">Scopus (827)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25171469/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature13777&amp;pmid=25171469" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) suggested equivalent or likely higher potency of our EBOV-442 IgG1&nbsp;+ EBOV-515 LALA-PG cocktail treatment (2&nbsp;× 30&nbsp;mg/kg at days 3 and 6 after exposure) against homologous EBOV. More studies are needed to compare available treatments and to determine if increasing mAb therapeutic potency would benefit clinical outcomes in treatment of severely ill patients and/or allow for rapid and more practical treatment by an alternative (intramuscular or subcutaneous) route of mAb delivery.</div><div id="p0125" role="paragraph">Broadly reactive mouse (<span class="dropBlock reference-citations"><a id="body-ref-sref26" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26" aria-controls="sref26">Furuyama et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref26"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">26.</div><div>Furuyama, W. ∙ Marzi, A. ∙ Nanbo, A. ...</div><div><strong>Discovery of an antibody for pan-ebolavirus therapy</strong></div><div><em>Sci. Rep.</em> 2016; <strong>6</strong>:20514</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/srep20514" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84958078190" target="_blank" aria-label="Open Scopus in new tab">Scopus (78)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26861827/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fsrep20514&amp;pmid=26861827" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref38" href="#" role="doc-biblioref" data-xml-rid="bib38" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref38" aria-controls="sref38">Holtsberg et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref38"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">38.</div><div>Holtsberg, F.W. ∙ Shulenin, S. ∙ Vu, H. ...</div><div><strong>Pan-ebolavirus and pan-filovirus mouse monoclonal antibodies: protection against Ebola and Sudan viruses</strong></div><div><em>J.&nbsp;Virol.</em> 2015; <strong>90</strong>:266-278</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.02171-15" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_38_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84953862148" target="_blank" aria-label="Open Scopus in new tab">Scopus (88)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26468533/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.02171-15&amp;pmid=26468533" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), macaque (<span class="dropBlock reference-citations"><a id="body-ref-optpM755u5WS5" href="#" role="doc-biblioref" data-xml-rid="bib83" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="optpM755u5WS5" aria-controls="optpM755u5WS5">Keck et al., 2016</a><div class="dropBlock__holder" data-db-target-of="optpM755u5WS5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">44.</div><div>Keck, Z.Y. ∙ Enterlein, S.G. ∙ Howell, Howell ...</div><div><strong>Macaque monoclonal antibodies targeting novel conserved epitopes within filovirus glycoprotein</strong></div><div><em>J. Virol.</em> 2016; <strong>90</strong>:279-291</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.02172-15" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84953931579" target="_blank" aria-label="Open Scopus in new tab">Scopus (68)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26468532/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.02172-15&amp;pmid=26468532" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref80-1" href="#" role="doc-biblioref" data-xml-rid="bib80" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref80-1" aria-controls="sref80-1">Zhao et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref80-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">84.</div><div>Zhao, X. ∙ Howell, K.A. ∙ He, S. ...</div><div><strong>Immunization-elicited broadly protective antibody reveals ebolavirus fusion loop as a site of vulnerability</strong></div><div><em>Cell.</em> 2017; <strong>169</strong>:891-904.e15</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.038&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.038&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85019650530" target="_blank" aria-label="Open Scopus in new tab">Scopus (84)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28525756/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.04.038&amp;pmid=28525756" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and human (<span class="dropBlock reference-citations"><a id="body-ref-sref23" href="#" role="doc-biblioref" data-xml-rid="bib23" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref23" aria-controls="sref23">Flyak et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref23"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">23.</div><div>Flyak, A.I. ∙ Shen, X. ∙ Murin, C.D. ...</div><div><strong>Cross-reactive and potent neutralizing antibody responses in human survivors of natural ebolavirus infection</strong></div><div><em>Cell.</em> 2016; <strong>164</strong>:392-405</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2015.12.022&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2015.12.022&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84955572428" target="_blank" aria-label="Open Scopus in new tab">Scopus (148)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26806128/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2015.12.022&amp;pmid=26806128" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref80-2" href="#" role="doc-biblioref" data-xml-rid="bib80" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref80-2" aria-controls="sref80-2">Zhao et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref80-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">84.</div><div>Zhao, X. ∙ Howell, K.A. ∙ He, S. ...</div><div><strong>Immunization-elicited broadly protective antibody reveals ebolavirus fusion loop as a site of vulnerability</strong></div><div><em>Cell.</em> 2017; <strong>169</strong>:891-904.e15</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.038&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.038&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85019650530" target="_blank" aria-label="Open Scopus in new tab">Scopus (84)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28525756/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.04.038&amp;pmid=28525756" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) mAbs that exhibited varying degrees of EBOV, BDBV, and SUDV cross-neutralization and protection <i>in&nbsp;vivo</i> have been reported. One of the most well-characterized broadly neutralizing mAbs is the macaque mAb CA45 that also demonstrated broad protection in animals (<span class="dropBlock reference-citations"><a id="body-ref-sref80-3" href="#" role="doc-biblioref" data-xml-rid="bib80" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref80-3" aria-controls="sref80-3">Zhao et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref80-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">84.</div><div>Zhao, X. ∙ Howell, K.A. ∙ He, S. ...</div><div><strong>Immunization-elicited broadly protective antibody reveals ebolavirus fusion loop as a site of vulnerability</strong></div><div><em>Cell.</em> 2017; <strong>169</strong>:891-904.e15</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.038&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.038&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85019650530" target="_blank" aria-label="Open Scopus in new tab">Scopus (84)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28525756/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.04.038&amp;pmid=28525756" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Anticipation of future EVD outbreaks requires consideration of therapeutic breadth, and mAbs of human origin are most suitable for the development of human therapeutics. As an added feature, the two-antibody cocktail we describe here offered an increased therapeutic breadth that extended to protection against BDBV and SUDV in NHP models. One other investigational human mAb cocktail that demonstrated broad efficacy in NHPs, MBP134<sup>AF</sup>, has been described (<span class="dropBlock reference-citations"><a id="body-ref-sref7-5" href="#" role="doc-biblioref" data-xml-rid="bib7" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref7-5" aria-controls="sref7-5">Bornholdt et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref7-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">7.</div><div>Bornholdt, Z.A. ∙ Herbert, A.S. ∙ Mire, C.E. ...</div><div><strong>A two-antibody pan-ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates</strong></div><div><em>Cell Host Microbe.</em> 2019; <strong>25</strong>:49-58.e5</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2018.12.005&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2018.12.005&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85058702898" target="_blank" aria-label="Open Scopus in new tab">Scopus (73)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30629918/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.chom.2018.12.005&amp;pmid=30629918" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). MBP134<sup>AF</sup> is comprised of mAb ADI-15878 and a derivative of mAb ADI-15946 (defined as ADI-23774), which was engineered to improve its specificity against SUDV GP (<span class="dropBlock reference-citations"><a id="body-ref-sref76" href="#" role="doc-biblioref" data-xml-rid="bib76" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref76" aria-controls="sref76">Wec et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref76"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">79.</div><div>Wec, A.Z. ∙ Bornholdt, Z.A. ∙ He, S. ...</div><div><strong>Development of a human antibody cocktail that deploys multiple functions to confer pan-ebolavirus protection</strong></div><div><em>Cell Host Microbe.</em> 2019; <strong>25</strong>:39-48.e5</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2018.12.004&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2018.12.004&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85058800693" target="_blank" aria-label="Open Scopus in new tab">Scopus (75)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30629917/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.chom.2018.12.004&amp;pmid=30629917" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). A comparison of our results to the reported activities of ADI-15946 or ADI-23774 (<span class="dropBlock reference-citations"><a id="body-ref-sref75-6" href="#" role="doc-biblioref" data-xml-rid="bib75" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref75-6" aria-controls="sref75-6">Wec et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref75-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">78.</div><div>Wec, A.Z. ∙ Herbert, A.S. ∙ Murin, C.D. ...</div><div><strong>Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses</strong></div><div><em>Cell.</em> 2017; <strong>169</strong>:878-890.e15</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.037&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.037&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85019578866" target="_blank" aria-label="Open Scopus in new tab">Scopus (127)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28525755/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.04.037&amp;pmid=28525755" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) indicates a high potency for the homologous base-specific mAb rEBOV-515 that we describe. In agreement with this functional assessment, our structural data showed that rEBOV-515 strongly interacts with conserved residues in the GP, with a unique footprint among base-specific broadly reactive human mAbs rEBOV-515, rEBOV-520, and ADI-15946, suggesting a structural basis for its remarkable breadth and potency. In addition, the analysis revealed features that are essential for synergistic and efficient GP binding in the cocktail of rEBOV-515&nbsp;+ rEBOV-442 but distinct from those in the cocktail of rEBOV-520&nbsp;+ rEBOV-548 we previously described. First, there is a reciprocal enhancement of the GP binding in the cocktail of rEBOV-515&nbsp;+ rEBOV-442. Second, binding to the GP occurs without major structural remodeling of the GP1 while displacing the β17-β18 loop from the binding site of rEBOV-515. Together, this suggests a mechanism for high neutralization potency in the cocktail.</div><div id="p0130" role="paragraph">Multifunctionality is another desirable feature in mAb cocktails in addition to neutralizing potency and breadth (<span class="dropBlock reference-citations"><a id="body-ref-sref65" href="#" role="doc-biblioref" data-xml-rid="bib65" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref65" aria-controls="sref65">Saphire et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref65"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">69.</div><div>Saphire, E.O. ∙ Schendel, S.L. ∙ Fusco, M.L. ..., Viral Hemorrhagic Fever Immunotherapeutic Consortium</div><div><strong>Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection</strong></div><div><em>Cell.</em> 2018; <strong>174</strong>:938-952.e13</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2018.07.033&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2018.07.033&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85050869127" target="_blank" aria-label="Open Scopus in new tab">Scopus (147)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30096313/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.07.033&amp;pmid=30096313" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Reports of human EVD cases revealed high plasma viral RNA titers at the time of patient admission into mAb treatment studies (<span class="dropBlock reference-citations"><a id="body-ref-sref9" href="#" role="doc-biblioref" data-xml-rid="bib9" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref9" aria-controls="sref9">Brown et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">9.</div><div>Brown, J.F. ∙ Dye, J.M. ∙ Tozay, S. ...</div><div><strong>Anti-Ebola virus antibody levels in convalescent plasma and viral load after plasma infusion in patients with Ebola virus disease</strong></div><div><em>J.&nbsp;Infect. Dis.</em> 2018; <strong>218</strong>:555-562</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/infdis/jiy199" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85050790127" target="_blank" aria-label="Open Scopus in new tab">Scopus (32)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29659889/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Finfdis%2Fjiy199&amp;pmid=29659889" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref54" href="#" role="doc-biblioref" data-xml-rid="bib54" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref54" aria-controls="sref54">Mbala-Kingebeni et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref54"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">57.</div><div>Mbala-Kingebeni, P. ∙ Aziza, A. ∙ Di Paola, N. ...</div><div><strong>Medical countermeasures during the 2018 Ebola virus disease outbreak in the North Kivu and Ituri Provinces of the Democratic Republic of the Congo: a rapid genomic assessment</strong></div><div><em>Lancet Infect. Dis.</em> 2019; <strong>19</strong>:648-657</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2FS1473-3099%2819%2930118-5&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2FS1473-3099%2819%2930118-5&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85065874808" target="_blank" aria-label="Open Scopus in new tab">Scopus (58)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31000464/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1473-3099%2819%2930118-5&amp;pmid=31000464" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Similarly,&nbsp;we observed high serum viral titers in each cohort of challenged NHPs before mAb treatment (<a id="crosref1010" href="#fig5">Figure&nbsp;5</a>), indicating that at the time of treatment many cells in multiple organs are already infected. This finding highlights the importance to retain&nbsp;Fc-mediated effector function activity in mAb cocktails in&nbsp;order&nbsp;to preserve the ability to eliminate infected cells. Conversely, using mouse challenge models we demonstrated that the complementary&nbsp;Fc-region-mediated functions of rEBOV-515-like neutralizing mAbs measured by <i>in&nbsp;vitro</i> assays do not benefit therapeutic efficacy but instead resulted in lower levels of <i>in&nbsp;vivo</i> protection. In the cocktails of EBOV-442 IgG1&nbsp;+ EBOV-515 LALA-PG, the stronger and broader neutralizing mAb EBOV-515 LALA-PG may act directly to neutralize circulating virus, and this activity is enhanced synergistically in the presence of rEBOV-442 IgG1. rEBOV-442 IgG1, in addition to direct virus neutralization, may act through Fc-mediated functions by binding to the non-overlapping antigenic site on the GP on infected cells, and this activity could be enhanced reciprocally in the presence of EBOV-515 LALA-PG. Such a combination of activities may facilitate viral clearance and potentially decrease the likelihood of viral mutations that facilitate escape from the cocktail treatment. The relative contribution of these activities to the therapeutic efficacy exhibited by this cocktail needs further investigation.</div><div id="p0135" role="paragraph">Defining the likelihood of the viral escape for clinical candidate mAbs has important implications for predicting therapeutic efficacy following mAb treatment (<span class="dropBlock reference-citations"><a id="body-ref-sref13" href="#" role="doc-biblioref" data-xml-rid="bib13" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref13" aria-controls="sref13">Copin et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref13"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">13.</div><div>Copin, R. ∙ Baum, A. ∙ Wloga, E. ...</div><div><strong>The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies</strong></div><div><em>Cell.</em> 2021; <strong>184</strong>:3949-3961</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2021.06.002&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2021.06.002&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85109085109" target="_blank" aria-label="Open Scopus in new tab">Scopus (134)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34161776/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2021.06.002&amp;pmid=34161776" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Our study suggests that individual mAbs may differ in their ability to limit the occurrence of escape variants and showed “orthogonality” of the escape mutations for broadly neutralizing mAbs we tested. In an outbreak scenario, implementation of several broad cocktails exhibiting such complementary neutralizing activities may safeguard against escape mutant selection in the population.</div><div id="p0140" role="paragraph">During acute EVD, circulating infectious virus sometimes seeds immune-privileged tissues, including the brain, eyes, and testes, and persist after clearance from the blood and recovery (<span class="dropBlock reference-citations"><a id="body-ref-sref17" href="#" role="doc-biblioref" data-xml-rid="bib17" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref17" aria-controls="sref17">Diallo et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref17"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">17.</div><div>Diallo, B. ∙ Sissoko, D. ∙ Loman, N.J. ...</div><div><strong>Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500&nbsp;days</strong></div><div><em>Clin. Infect. Dis.</em> 2016; <strong>63</strong>:1353-1356</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/cid/ciw601" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84994399203" target="_blank" aria-label="Open Scopus in new tab">Scopus (177)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27585800/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fcid%2Fciw601&amp;pmid=27585800" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref68" href="#" role="doc-biblioref" data-xml-rid="bib68" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref68" aria-controls="sref68">Subtil et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref68"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">72.</div><div>Subtil, F. ∙ Delaunay, C. ∙ Keita, A.K. ..., Postebogui Study Group</div><div><strong>Dynamics of Ebola RNA persistence in semen: a report from the postebogui cohort in Guinea</strong></div><div><em>Clin. Infect. Dis.</em> 2017; <strong>64</strong>:1788-1790</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/cid/cix210" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85021169770" target="_blank" aria-label="Open Scopus in new tab">Scopus (19)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28329169/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fcid%2Fcix210&amp;pmid=28329169" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref72" href="#" role="doc-biblioref" data-xml-rid="bib72" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref72" aria-controls="sref72">Varkey et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref72"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">76.</div><div>Varkey, J.B. ∙ Shantha, J.G. ∙ Crozier, I. ...</div><div><strong>Persistence of Ebola virus in ocular fluid during convalescence</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2015; <strong>372</strong>:2423-2427</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1500306" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_76_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84931393635" target="_blank" aria-label="Open Scopus in new tab">Scopus (367)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25950269/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1500306&amp;pmid=25950269" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Until recently, it was generally assumed that Ebola epidemics start upon zoonotic transmission. On February 14, 2021, a new EVD outbreak was declared in Guinea, and viral genome sequencing reports suggested that the outbreak was caused by the Makona variant of EBOV that caused the 2014 EVD epidemics (<span class="dropBlock reference-citations"><a id="body-ref-optQ5fJzyWWM6-1" href="#" role="doc-biblioref" data-xml-rid="bib84" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="optQ5fJzyWWM6-1" aria-controls="optQ5fJzyWWM6-1">Keita et al., 2021</a><div class="dropBlock__holder" data-db-target-of="optQ5fJzyWWM6-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">45.</div><div>Keita, A.K. ∙ Koundouno, F.R. ∙ Faye, M. ...</div><div><strong>Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks</strong></div><div><em>Nature.</em> 2021; <strong>597</strong>:539-543</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-021-03901-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85115265904" target="_blank" aria-label="Open Scopus in new tab">Scopus (99)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34526718/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-021-03901-9&amp;pmid=34526718" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The index case of the 2021 Guinea cluster likely was infected from a persistent source, such as via sexual transmission from an EVD survivor (<span class="dropBlock reference-citations"><a id="body-ref-optQ5fJzyWWM6-2" href="#" role="doc-biblioref" data-xml-rid="bib84" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="optQ5fJzyWWM6-2" aria-controls="optQ5fJzyWWM6-2">Keita et al., 2021</a><div class="dropBlock__holder" data-db-target-of="optQ5fJzyWWM6-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">45.</div><div>Keita, A.K. ∙ Koundouno, F.R. ∙ Faye, M. ...</div><div><strong>Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks</strong></div><div><em>Nature.</em> 2021; <strong>597</strong>:539-543</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-021-03901-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85115265904" target="_blank" aria-label="Open Scopus in new tab">Scopus (99)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34526718/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-021-03901-9&amp;pmid=34526718" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) raising concerns about possible person-to-person transmission and reignition of outbreaks. The existing therapies and those that are currently in clinical development should be evaluated for their efficacy in clearing infectious virus from immune-privileged sites. Further, NHP studies suggested a genetic drift upon selection pressure with sub-optimal mAb treatment that could be a potential cause for failure during EVD treatment (<span class="dropBlock reference-citations"><a id="body-ref-sref45" href="#" role="doc-biblioref" data-xml-rid="bib45" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref45" aria-controls="sref45">Kugelman et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref45"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">47.</div><div>Kugelman, J.R. ∙ Kugelman-Tonos, J. ∙ Ladner, J.T. ...</div><div><strong>Emergence of Ebola virus escape variants in infected nonhuman primates treated with the MB-003 antibody cocktail</strong></div><div><em>Cell Rep.</em> 2015; <strong>12</strong>:2111-2120</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.celrep.2015.08.038&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.celrep.2015.08.038&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84942826507" target="_blank" aria-label="Open Scopus in new tab">Scopus (66)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26365189/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2015.08.038&amp;pmid=26365189" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Potent mAb cocktails like EBOV-442 IgG1&nbsp;+ EBOV-515 LALA-PG may help thwart antigenic drift by targeting non-overlapping vulnerable sites on GP and exhibiting complementary mechanisms of action.</div><div id="p0145" role="paragraph">In summary, these studies highlight the power of implementing a rational mAb cocktail development program using structure-function-guided principles (e.g., knowledge of binding sites, neutralization breadth, resistance to escape, multifunctionality, synergy, etc.). We identified a pan-ebolavirus biologic comprising a two-antibody cocktail that exhibits high efficacy for treatment of all three medically important ebolaviruses. These findings set the stage for clinical evaluation of pan-ebolavirus combination therapy with the two human antibodies rEBOV-442 IgG1 and rEBOV-515 LALA-PG.</div><section id="sec-3-1"><h3>Limitations of study</h3><div id="p0150" role="paragraph">The degree to which the Fc-region mediated effector functions studied in animal models using fully human EBOV-442 IgG1 and rEBOV-515 LALA-PG mAbs translated into a therapeutic potential by these mAbs against human EVD is unknown and should be further investigated. The protection of NHPs from advanced EVD by the described mAb cocktail treatment should be assessed in future studies. The developability (manufacturability) of antibodies described here needs to be assessed in future studies.</div></section></section><section id="sec-4"><h2>STAR★Methods</h2><section id="sec-4-1"><h3>Key resources table</h3><div id="p0160" role="paragraph"><div class="figure-wrap"><figure id="undtbl1" class="table" data-figureviewer-ignore="true"><div class="table-wrap"><table data-figureviewer-ignore="true" tabindex="0"><thead><tr class="rowsep"><th>REAGENT or RESOURCE</th><th>SOURCE</th><th>IDENTIFIER</th></tr></thead><tbody><tr class="rowsep"><td colspan="3"><b>Antibodies</b></td></tr><tr><td>rEBOV-515 IgG1 (recombinant CHO-produced)</td><td>This study</td><td>N/A</td></tr><tr><td>rEBOV-515 LALA-PG (recombinant CHO-produced)</td><td>This study</td><td>N/A</td></tr><tr><td>rEBOV-442 IgG1 (recombinant CHO-produced)</td><td>This paper</td><td>N/A</td></tr><tr><td>rEBOV-442 LALA-PG (recombinant CHO-produced)</td><td>This paper</td><td>N/A</td></tr><tr><td>ADI-15878 IgG1 (recombinant CHO-produced); heavy chain V region</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref75-7" href="#" role="doc-biblioref" data-xml-rid="bib75" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref75-7" aria-controls="sref75-7">Wec et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref75-7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">78.</div><div>Wec, A.Z. ∙ Herbert, A.S. ∙ Murin, C.D. ...</div><div><strong>Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses</strong></div><div><em>Cell.</em> 2017; <strong>169</strong>:878-890.e15</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.037&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.037&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85019578866" target="_blank" aria-label="Open Scopus in new tab">Scopus (127)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28525755/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.04.037&amp;pmid=28525755" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>GenBank: <a id="intref0020" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=nucleotide&amp;doptcmdl=genbank&amp;term=KU602365" target="_blank">KU602365</a></td></tr><tr><td>ADI-15878 IgG1 (recombinant CHO-produced); light chain V region</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref75-8" href="#" role="doc-biblioref" data-xml-rid="bib75" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref75-8" aria-controls="sref75-8">Wec et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref75-8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">78.</div><div>Wec, A.Z. ∙ Herbert, A.S. ∙ Murin, C.D. ...</div><div><strong>Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses</strong></div><div><em>Cell.</em> 2017; <strong>169</strong>:878-890.e15</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.037&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.037&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85019578866" target="_blank" aria-label="Open Scopus in new tab">Scopus (127)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28525755/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.04.037&amp;pmid=28525755" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>GenBank: <a id="intref0025" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=nucleotide&amp;doptcmdl=genbank&amp;term=KU602366" target="_blank">KU602366</a></td></tr><tr><td>ADI-15946 IgG1 (recombinant CHO-produced); heavy chain V region</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref75-9" href="#" role="doc-biblioref" data-xml-rid="bib75" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref75-9" aria-controls="sref75-9">Wec et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref75-9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">78.</div><div>Wec, A.Z. ∙ Herbert, A.S. ∙ Murin, C.D. ...</div><div><strong>Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses</strong></div><div><em>Cell.</em> 2017; <strong>169</strong>:878-890.e15</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.037&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.037&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85019578866" target="_blank" aria-label="Open Scopus in new tab">Scopus (127)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28525755/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.04.037&amp;pmid=28525755" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>GenBank: <a id="intref0030" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=nucleotide&amp;doptcmdl=genbank&amp;term=KU602499" target="_blank">KU602499</a></td></tr><tr><td>ADI-15946 IgG1 (recombinant CHO-produced); light chain V region</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref75-10" href="#" role="doc-biblioref" data-xml-rid="bib75" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref75-10" aria-controls="sref75-10">Wec et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref75-10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">78.</div><div>Wec, A.Z. ∙ Herbert, A.S. ∙ Murin, C.D. ...</div><div><strong>Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses</strong></div><div><em>Cell.</em> 2017; <strong>169</strong>:878-890.e15</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.037&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.037&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85019578866" target="_blank" aria-label="Open Scopus in new tab">Scopus (127)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28525755/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.04.037&amp;pmid=28525755" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>GenBank: <a id="intref0035" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=nucleotide&amp;doptcmdl=genbank&amp;term=KU602500" target="_blank">KU602500</a></td></tr><tr><td>rDENV 2D22 (recombinant CHO-produced)</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref22-2" href="#" role="doc-biblioref" data-xml-rid="bib22" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref22-2" aria-controls="sref22-2">Fibriansah et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref22-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Fibriansah, G. ∙ Ibarra, K.D. ∙ Ng, T.S. ...</div><div><strong>DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers</strong></div><div><em>Science.</em> 2015; <strong>349</strong>:88-91</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaa8651" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84935097021" target="_blank" aria-label="Open Scopus in new tab">Scopus (185)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26138979/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaa8651&amp;pmid=26138979" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Goat anti-human IgG-HRP</td><td>Southern Biotech</td><td>Cat# 2040-05; RRID:<a id="intref0040" href="https://antibodyregistry.org/AB_2795644" target="_blank">AB_2795644</a></td></tr><tr><td>rEBOV-515 Fab</td><td>This paper</td><td>N/A</td></tr><tr><td>rEBOV-442 Fab</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref58-2" href="#" role="doc-biblioref" data-xml-rid="bib58" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref58-2" aria-controls="sref58-2">Murin et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref58-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Murin, C.D. ∙ Gilchuk, P. ∙ Ilinykh, P.A. ...</div><div><strong>Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies</strong></div><div><em>Cell Rep.</em> 2021; <strong>35</strong>:108984</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.celrep.2021.108984&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.celrep.2021.108984&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85104082939" target="_blank" aria-label="Open Scopus in new tab">Scopus (18)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33852862/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2021.108984&amp;pmid=33852862" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>rEBOV-515 LALA-PG Alexa Fluor 647-labeled</td><td>This paper</td><td>N/A</td></tr><tr><td>rEBOV-442 IgG1 Alexa Fluor 647-labeled</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td>MR78 Alexa Fluor 647-labeled</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Bacterial and virus strains</b></td></tr><tr><td>Mouse-adapted EBOV /Mayinga (EBOV/M.mus-tc/COD/76/Yambuku-Mayinga, GenBank: <a id="intref0045" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=nucleotide&amp;doptcmdl=genbank&amp;term=AF499101" target="_blank">AF499101</a>)</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref8-1" href="#" role="doc-biblioref" data-xml-rid="bib8" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref8-1" aria-controls="sref8-1">Bray et&nbsp;al., 1998</a><div class="dropBlock__holder" data-db-target-of="sref8-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">8.</div><div>Bray, M. ∙ Davis, K. ∙ Geisbert, T. ...</div><div><strong>A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever</strong></div><div><em>J.&nbsp;Infect. Dis.</em> 1998; <strong>178</strong>:651-661</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1086/515386" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-0031688699" target="_blank" aria-label="Open Scopus in new tab">Scopus (346)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9728532/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1086%2F515386&amp;pmid=9728532" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>EBOV-eGFP/Mayinga</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref70-1" href="#" role="doc-biblioref" data-xml-rid="bib70" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref70-1" aria-controls="sref70-1">Towner et&nbsp;al., 2005</a><div class="dropBlock__holder" data-db-target-of="sref70-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">74.</div><div>Towner, J.S. ∙ Paragas, J. ∙ Dover, J.E. ...</div><div><strong>Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening</strong></div><div><em>Virology.</em> 2005; <strong>332</strong>:20-27</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.virol.2004.10.048" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-12344297305" target="_blank" aria-label="Open Scopus in new tab">Scopus (157)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15661137/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.virol.2004.10.048&amp;pmid=15661137" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>SUDV strain Gulu (GenBank: <a id="intref0050" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=nucleotide&amp;doptcmdl=genbank&amp;term=AY729654" target="_blank">AY729654</a>)</td><td><span class="dropBlock reference-citations"><a id="body-ref-optt1ET2gZXw9" href="#" role="doc-biblioref" data-xml-rid="bib86" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="optt1ET2gZXw9" aria-controls="optt1ET2gZXw9">Sanchez and Rollin, 2005</a><div class="dropBlock__holder" data-db-target-of="optt1ET2gZXw9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">68.</div><div>Sanchez, A. ∙ Rollin, P.E.</div><div><strong>Complete genome sequence of an Ebola virus (Sudan species) responsible for a 2000 outbreak of human disease in Uganda</strong></div><div><em>Virus Res.</em> 2005; <strong>113</strong>:16-25</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.virusres.2005.03.028" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-24044509755" target="_blank" aria-label="Open Scopus in new tab">Scopus (44)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16139097/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.virusres.2005.03.028&amp;pmid=16139097" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Chimeric EBOV/BDBV-GP-eGFP (GenBank: <a id="intref0055" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=nucleotide&amp;doptcmdl=genbank&amp;term=KU174137" target="_blank">KU174137</a>)</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref40-1" href="#" role="doc-biblioref" data-xml-rid="bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40-1" aria-controls="sref40-1">Ilinykh et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref40-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Ilinykh, P.A. ∙ Shen, X. ∙ Flyak, A.I. ...</div><div><strong>Chimeric filoviruses for identification and characterization of monoclonal antibodies</strong></div><div><em>J.&nbsp;Virol.</em> 2016; <strong>90</strong>:3890-3901</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.00101-16" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84963838685" target="_blank" aria-label="Open Scopus in new tab">Scopus (35)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26819310/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.00101-16&amp;pmid=26819310" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Chimeric EBOV/SUDV-GP-eGFP (GenBank: <a id="intref0060" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=nucleotide&amp;doptcmdl=genbank&amp;term=KU174142" target="_blank">KU174142</a>)</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref40-2" href="#" role="doc-biblioref" data-xml-rid="bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40-2" aria-controls="sref40-2">Ilinykh et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref40-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Ilinykh, P.A. ∙ Shen, X. ∙ Flyak, A.I. ...</div><div><strong>Chimeric filoviruses for identification and characterization of monoclonal antibodies</strong></div><div><em>J.&nbsp;Virol.</em> 2016; <strong>90</strong>:3890-3901</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.00101-16" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84963838685" target="_blank" aria-label="Open Scopus in new tab">Scopus (35)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26819310/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.00101-16&amp;pmid=26819310" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>EBOV isolate 199510621 (Kikwit variant)</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref15-1" href="#" role="doc-biblioref" data-xml-rid="bib15" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref15-1" aria-controls="sref15-1">Cross et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref15-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">15.</div><div>Cross, R.W. ∙ Mire, C.E. ∙ Borisevich, V. ...</div><div><strong>The Domestic Ferret (Mustela putorius furo) as a lethal infection model for 3 species of ebolavirus</strong></div><div><em>J.&nbsp;Infect. Dis.</em> 2016; <strong>214</strong>:565-569</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/infdis/jiw209" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84988962295" target="_blank" aria-label="Open Scopus in new tab">Scopus (74)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27354371/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Finfdis%2Fjiw209&amp;pmid=27354371" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>BDBV isolate 200706291 (Uganda variant)</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref71-1" href="#" role="doc-biblioref" data-xml-rid="bib71" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref71-1" aria-controls="sref71-1">Towner et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref71-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">75.</div><div>Towner, J.S. ∙ Sealy, T.K. ∙ Khristova, M.L. ...</div><div><strong>Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda</strong></div><div><em>PLoS Pathog.</em> 2008; <strong>4</strong>:e1000212</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.ppat.1000212" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_75_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-57149120780" target="_blank" aria-label="Open Scopus in new tab">Scopus (422)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19023410/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.ppat.1000212&amp;pmid=19023410" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>SUDV isolate 200011676 (Gulu variant)</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref69-1" href="#" role="doc-biblioref" data-xml-rid="bib69" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref69-1" aria-controls="sref69-1">Thi et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref69-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">73.</div><div>Thi, E.P. ∙ Lee, A.C. ∙ Geisbert, J.B. ...</div><div><strong>Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA</strong></div><div><em>Nat. Microbiol.</em> 2016; <strong>1</strong>:16142</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmicrobiol.2016.142" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_73_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84983509313" target="_blank" aria-label="Open Scopus in new tab">Scopus (48)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27670117/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmicrobiol.2016.142&amp;pmid=27670117" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>rVSV/EBOV GP (Mayinga variant)</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref27-1" href="#" role="doc-biblioref" data-xml-rid="bib27" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref27-1" aria-controls="sref27-1">Garbutt et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref27-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">27.</div><div>Garbutt, M. ∙ Liebscher, R. ∙ Wahl-Jensen, V. ...</div><div><strong>Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses</strong></div><div><em>J.&nbsp;Virol.</em> 2004; <strong>78</strong>:5458-5465</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.78.10.5458-5465.2004" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-2342455182" target="_blank" aria-label="Open Scopus in new tab">Scopus (313)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15113924/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.78.10.5458-5465.2004&amp;pmid=15113924" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>rVSV/BDBV GP (Uganda variant)</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref55-1" href="#" role="doc-biblioref" data-xml-rid="bib55" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref55-1" aria-controls="sref55-1">Mire et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref55-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">58.</div><div>Mire, C.E. ∙ Geisbert, J.B. ∙ Marzi, A. ...</div><div><strong>Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus</strong></div><div><em>PLoS Negl. Trop. Dis.</em> 2013; <strong>7</strong>:e2600</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pntd.0002600" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84892698411" target="_blank" aria-label="Open Scopus in new tab">Scopus (78)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24367715/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pntd.0002600&amp;pmid=24367715" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>rVSV/SUDV GP (Boniface variant)</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref29-1" href="#" role="doc-biblioref" data-xml-rid="bib29" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref29-1" aria-controls="sref29-1">Geisbert et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref29-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Geisbert, T.W. ∙ Daddario-DiCaprio, K.M. ∙ Williams, K.J. ...</div><div><strong>Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates</strong></div><div><em>J.&nbsp;Virol.</em> 2008; <strong>82</strong>:5664-5668</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.00456-08" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-43949115183" target="_blank" aria-label="Open Scopus in new tab">Scopus (140)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18385248/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.00456-08&amp;pmid=18385248" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr class="rowsep"><td>rVSV/EBOV GP and rVSV/BDBV GP viruses that escape neutralization by rEBOV-442, or ADI-15878, or ADI-15946</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Biological samples</b></td></tr><tr class="rowsep"><td>Human PBMCs</td><td>StemCell Technologies</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Chemicals, peptides, and recombinant proteins</b></td></tr><tr><td>EBOV GP ΔTM (aa 1-636; Makona)</td><td>This paper</td><td>N/A</td></tr><tr><td>BDBV GP ΔTM (aa 1-643; 200706291&nbsp;Uganda)</td><td>This paper</td><td>N/A</td></tr><tr><td>SUDV GP ΔTM (aa 1-637; Gulu)</td><td>This paper</td><td>N/A</td></tr><tr><td>EBOV/Makona GPΔMuc</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref58-3" href="#" role="doc-biblioref" data-xml-rid="bib58" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref58-3" aria-controls="sref58-3">Murin et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref58-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Murin, C.D. ∙ Gilchuk, P. ∙ Ilinykh, P.A. ...</div><div><strong>Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies</strong></div><div><em>Cell Rep.</em> 2021; <strong>35</strong>:108984</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.celrep.2021.108984&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.celrep.2021.108984&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85104082939" target="_blank" aria-label="Open Scopus in new tab">Scopus (18)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33852862/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2021.108984&amp;pmid=33852862" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Thermolysin</td><td>Promega</td><td>Cat# 9PIV400</td></tr><tr><td>Immobilized papain</td><td>ThermoFisher</td><td>Cat# 20341</td></tr><tr><td>Alexa Fluor 647 NHS ester</td><td>ThermoFisher</td><td>Cat# A37573</td></tr><tr><td>SNAP-Surface Alexa Fluor 647</td><td>New England Biolabs</td><td>Cat# S9136S</td></tr><tr><td>EZ-Link Sulfo-NHS-LC-LC-Biotin</td><td>ThermoFisher</td><td>Cat# 21338</td></tr><tr><td>1-Step Ultra TMB-ELISA</td><td>ThermoFisher</td><td>Cat# 34029</td></tr><tr><td>Freestyle 293 expression medium</td><td>ThermoFisher</td><td>Cat# 12338002</td></tr><tr><td>ExpiCHO Expression Medium</td><td>ThermoFisher</td><td>Cat# A2910001</td></tr><tr><td>Fetal Bovine Serum, ultra-low IgG</td><td>ThermoFisher</td><td>Cat# 16250078</td></tr><tr><td>MabSelect Sure antibody purification resin</td><td>Cytiva</td><td>Cat# 17543802</td></tr><tr class="rowsep"><td>Sephadex G-25 medium</td><td>Cytiva</td><td>Cat# 17-0033-01</td></tr><tr class="rowsep"><td colspan="3"><b>Critical commercial assays</b></td></tr><tr class="rowsep"><td>Abbott Piccolo BioChemistry Panel Plus analyzer discs</td><td>Fisher Scientific</td><td>Cat# 07-P02-15A</td></tr><tr class="rowsep"><td colspan="3"><b>Deposited data</b></td></tr><tr><td>rEBOV-515/rEBOV-442 Fab complex with EBOV GP ΔMucΔTM Makona (cryo-EM)</td><td>This paper</td><td>PDB:<a id="interref210" href="http://firstglance.jmol.org/fg.htm?mol7M8L" target="_blank">7M8L</a></td></tr><tr class="rowsep"><td>rEBOV-515/rEBOV-442 Fab complex with EBOV GP ΔMucΔTM Makona (cryo-EM)</td><td>This paper</td><td>EMD-23719</td></tr><tr class="rowsep"><td colspan="3"><b>Experimental models: cell lines</b></td></tr><tr><td>Human: Jurkat, clone E6-1</td><td>ATCC</td><td>ATCC: TIB-152, RRID:CVCL_0367</td></tr><tr><td>Human: Jurkat-EBOV GP (Makona)</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref31-13" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-13" aria-controls="sref31-13">Gilchuk et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref31-13"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Gilchuk, P. ∙ Kuzmina, N. ∙ Ilinykh, P.A. ...</div><div><strong>Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the Ebolavirus glycoprotein</strong></div><div><em>Immunity.</em> 2018; <strong>49</strong>:363-374.e10</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85053075312" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30029854/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.06.018&amp;pmid=30029854" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref16-1" href="#" role="doc-biblioref" data-xml-rid="bib16" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref16-1" aria-controls="sref16-1">Davis et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref16-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">16.</div><div>Davis, C.W. ∙ Jackson, K.J.L. ∙ McElroy, A.K. ...</div><div><strong>Longitudinal analysis of the human B cell response to Ebola virus infection</strong></div><div><em>Cell.</em> 2019; <strong>177</strong>:1566-1582</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2019.04.036&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2019.04.036&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85065804877" target="_blank" aria-label="Open Scopus in new tab">Scopus (114)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31104840/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2019.04.036&amp;pmid=31104840" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Hamster: ExpiCHO-S</td><td>ThermoFisher Scientific</td><td>Cat# A29127, RRID:CVCL_5J31</td></tr><tr><td>Human: FreeStyle 293-F</td><td>ThermoFisher Scientific</td><td>Cat# R79007, RRID:CVCL_D603</td></tr><tr><td>Human: EBOV GPkik-293FS EGFP CCR5-SNAP</td><td>J. Lewis</td><td>N/A</td></tr><tr><td>Monkey: Vero-E6</td><td>ATCC</td><td>ATCC: CRL-1586, RRID:CVCL_0574</td></tr><tr class="rowsep"><td>Monkey: Vero</td><td>ATCC</td><td>ATCC: CCL-81, RRID:CVCL_0059</td></tr><tr class="rowsep"><td colspan="3"><b>Experimental models: organisms/strains</b></td></tr><tr><td>Mouse: BALB/cJ</td><td>The Jackson Laboratory</td><td>Cat# JAX:000651, RRID:IMSR_JAX:000651</td></tr><tr><td>NHP: Macaca mulatta, Chinese origin</td><td>PrimGen</td><td>N/A</td></tr><tr class="rowsep"><td>NHP: Macaca fascicularis, Chinese origin</td><td>Worldwide Primates</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Recombinant DNA</b></td></tr><tr><td>Plasmid: EBOV GP ΔTM (aa 1-636; Makona)</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref31-14" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-14" aria-controls="sref31-14">Gilchuk et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref31-14"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Gilchuk, P. ∙ Kuzmina, N. ∙ Ilinykh, P.A. ...</div><div><strong>Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the Ebolavirus glycoprotein</strong></div><div><em>Immunity.</em> 2018; <strong>49</strong>:363-374.e10</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85053075312" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30029854/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.06.018&amp;pmid=30029854" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Plasmid: BDBV GP ΔTM (aa 1-643; 200706291&nbsp;Uganda)</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref31-15" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-15" aria-controls="sref31-15">Gilchuk et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref31-15"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Gilchuk, P. ∙ Kuzmina, N. ∙ Ilinykh, P.A. ...</div><div><strong>Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the Ebolavirus glycoprotein</strong></div><div><em>Immunity.</em> 2018; <strong>49</strong>:363-374.e10</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85053075312" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30029854/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.06.018&amp;pmid=30029854" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Plasmid: SUDV GP ΔTM (aa 1-637; Gulu)</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref31-16" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-16" aria-controls="sref31-16">Gilchuk et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref31-16"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Gilchuk, P. ∙ Kuzmina, N. ∙ Ilinykh, P.A. ...</div><div><strong>Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the Ebolavirus glycoprotein</strong></div><div><em>Immunity.</em> 2018; <strong>49</strong>:363-374.e10</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85053075312" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30029854/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.06.018&amp;pmid=30029854" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Plasmid: pTwist_rEBOV-515-hG1</td><td>This study</td><td>N/A</td></tr><tr><td>Plasmid: pTwist_rEBOV-515-LALA-PG</td><td>This study</td><td>N/A</td></tr><tr><td>Plasmid: pTwist_rEBOV-442-hG1</td><td>This study</td><td>N/A</td></tr><tr><td>Plasmid: pTwist_rEBOV-442-LALA-PG</td><td>This study</td><td>N/A</td></tr><tr><td>Plasmid: pTwist_ADI-15878-hG1</td><td>This paper</td><td>N/A</td></tr><tr><td>Plasmid: pTwist_ADI-15946-hG1</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td>Plasmid: pTwist_2D22-hG1</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Software and algorithms</b></td></tr><tr><td>GraphPad Prism 8.4.3</td><td>GraphPad Software</td><td>GraphPad Prism, RRID:<a id="intref0065" href="https://scicrunch.org/resources/Any/search?q=undefined&amp;l=SCR_002798" target="_blank">SCR_002798</a></td></tr><tr><td>ForeCyt Standard 6.2 (R1)</td><td>Intellicyt</td><td>ForeCyt</td></tr><tr><td>RTCA version 2.1.0</td><td>Agilent Technologies</td><td>RTCA Software, RRID:<a id="intref0070" href="https://scicrunch.org/resources/Any/search?q=undefined&amp;l=SCR_014821" target="_blank">SCR_014821</a></td></tr><tr><td>MotionCorr2</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref81-1" href="#" role="doc-biblioref" data-xml-rid="bib81" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref81-1" aria-controls="sref81-1">Zheng et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref81-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">85.</div><div>Zheng, S.Q. ∙ Palovcak, E. ∙ Armache, J.P. ...</div><div><strong>MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy</strong></div><div><em>Nat. Methods.</em> 2017; <strong>14</strong>:331-332</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.4193" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85014129582" target="_blank" aria-label="Open Scopus in new tab">Scopus (4513)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28250466/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.4193&amp;pmid=28250466" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>MotionCorr2</td></tr><tr><td>GCTF</td><td>(<span class="dropBlock reference-citations"><a id="body-ref-opt9mqh0D8gRn" href="#" role="doc-biblioref" data-xml-rid="bib88" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="opt9mqh0D8gRn" aria-controls="opt9mqh0D8gRn">Zhang, 2016</a><div class="dropBlock__holder" data-db-target-of="opt9mqh0D8gRn"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">83.</div><div>Zhang, K.</div><div><strong>Gctf: Real-time CTF determination and correction</strong></div><div><em>J. Struct. Biol.</em> 2016; <strong>193</strong>:1-12</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jsb.2015.11.003" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84955216953" target="_blank" aria-label="Open Scopus in new tab">Scopus (2386)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26592709/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jsb.2015.11.003&amp;pmid=26592709" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>)</td><td>GCTF, RRID:<a id="intref0075" href="https://scicrunch.org/resources/Any/search?q=undefined&amp;l=SCR_016500" target="_blank">SCR_016500</a></td></tr><tr><td>CryoSPARK 2.0</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref63-1" href="#" role="doc-biblioref" data-xml-rid="bib63" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref63-1" aria-controls="sref63-1">Punjani et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref63-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">66.</div><div>Punjani, A. ∙ Rubinstein, J.L. ∙ Fleet, D.J. ...</div><div><strong>cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination</strong></div><div><em>Nat. Methods.</em> 2017; <strong>14</strong>:290-296</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.4169" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85011645437" target="_blank" aria-label="Open Scopus in new tab">Scopus (4028)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28165473/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.4169&amp;pmid=28165473" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>CryoSPARK 2.0</td></tr><tr><td>RELION 3.1</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref82-1" href="#" role="doc-biblioref" data-xml-rid="bib82" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref82-1" aria-controls="sref82-1">Zivanov et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref82-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">86.</div><div>Zivanov, J. ∙ Nakane, T. ∙ Forsberg, B.O. ...</div><div><strong>New tools for automated high-resolution cryo-EM structure determination in RELION-3</strong></div><div><em>eLife.</em> 2018; <strong>7</strong>:e42166</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.7554/eLife.42166" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_86_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85056950318" target="_blank" aria-label="Open Scopus in new tab">Scopus (2936)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30412051/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.7554%2FeLife.42166&amp;pmid=30412051" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>RELION, RRID:<a id="intref0080" href="https://scicrunch.org/resources/Any/search?q=undefined&amp;l=SCR_016274" target="_blank">SCR_016274</a></td></tr><tr><td>UCSF Chimera</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref62-2" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-2" aria-controls="sref62-2">Pettersen et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref62-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">65.</div><div>Pettersen, E.F. ∙ Goddard, T.D. ∙ Huang, C.C. ...</div><div><strong>UCSF Chimera--a visualization system for exploratory research and analysis</strong></div><div><em>J.&nbsp;Comput. Chem.</em> 2004; <strong>25</strong>:1605-1612</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/jcc.20084" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-4444221565" target="_blank" aria-label="Open Scopus in new tab">Scopus (33444)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15264254/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fjcc.20084&amp;pmid=15264254" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>UCSF Chimera, RRID:<a id="intref0085" href="https://scicrunch.org/resources/Any/search?q=undefined&amp;l=SCR_004097" target="_blank">SCR_004097</a></td></tr><tr><td>Phenix</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref52-1" href="#" role="doc-biblioref" data-xml-rid="bib52" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref52-1" aria-controls="sref52-1">Liebschner et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref52-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">54.</div><div>Liebschner, D. ∙ Afonine, P.V. ∙ Baker, M.L. ...</div><div><strong>Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix</strong></div><div><em>Acta Crystallogr. D Struct. Biol.</em> 2019; <strong>75</strong>:861-877</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S2059798319011471" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85072914312" target="_blank" aria-label="Open Scopus in new tab">Scopus (3348)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31588918/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS2059798319011471&amp;pmid=31588918" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>Phenix, RRID:<a id="intref0090" href="https://scicrunch.org/resources/Any/search?q=undefined&amp;l=SCR_014224" target="_blank">SCR_014224</a></td></tr><tr><td>Rosetta</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref18-1" href="#" role="doc-biblioref" data-xml-rid="bib18" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref18-1" aria-controls="sref18-1">DiMaio et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref18-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">18.</div><div>DiMaio, F. ∙ Song, Y. ∙ Li, X. ...</div><div><strong>Atomic-accuracy models from 4.5-Å cryo-electron microscopy data with density-guided iterative local refinement</strong></div><div><em>Nat. Methods.</em> 2015; <strong>12</strong>:361-365</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.3286" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84926520440" target="_blank" aria-label="Open Scopus in new tab">Scopus (238)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25707030/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.3286&amp;pmid=25707030" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>Rosetta, RRID:<a id="intref0095" href="https://scicrunch.org/resources/Any/search?q=undefined&amp;l=SCR_015701" target="_blank">SCR_015701</a></td></tr><tr><td>EMRinger</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref2-1" href="#" role="doc-biblioref" data-xml-rid="bib2" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref2-1" aria-controls="sref2-1">Barad et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref2-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Barad, B.A. ∙ Echols, N. ∙ Wang, R.Y. ...</div><div><strong>EMRinger: side chain-directed model and map validation for 3D cryo-electron microscopy</strong></div><div><em>Nat. Methods.</em> 2015; <strong>12</strong>:943-946</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.3541" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84959080555" target="_blank" aria-label="Open Scopus in new tab">Scopus (542)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26280328/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.3541&amp;pmid=26280328" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>EMRinger</td></tr><tr><td>Coot</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref20-1" href="#" role="doc-biblioref" data-xml-rid="bib20" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref20-1" aria-controls="sref20-1">Emsley et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref20-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">20.</div><div>Emsley, P. ∙ Lohkamp, B. ∙ Scott, W.G. ...</div><div><strong>Features and development of Coot</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:486-501</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444910007493" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-77949535720" target="_blank" aria-label="Open Scopus in new tab">Scopus (20200)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20383002/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444910007493&amp;pmid=20383002" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>Coot, RRID:<a id="intref0100" href="https://scicrunch.org/resources/Any/search?q=undefined&amp;l=SCR_014222" target="_blank">SCR_014222</a></td></tr><tr><td>SWISS-MODEL</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref5-1" href="#" role="doc-biblioref" data-xml-rid="bib5" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref5-1" aria-controls="sref5-1">Biasini et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref5-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">5.</div><div>Biasini, M. ∙ Bienert, S. ∙ Waterhouse, A. ...</div><div><strong>SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information</strong></div><div><em>Nucleic Acids Res.</em> 2014; <strong>42</strong>:W252-8</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gku340" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84904815625" target="_blank" aria-label="Open Scopus in new tab">Scopus (3931)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24782522/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgku340&amp;pmid=24782522" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>SWISS-MODEL RRID:<a id="intref0105" href="https://scicrunch.org/resources/Any/search?q=undefined&amp;l=SCR_018123" target="_blank">SCR_018123</a></td></tr><tr><td>LigPlot</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref48-1" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48-1" aria-controls="sref48-1">Laskowski and Swindells, 2011</a><div class="dropBlock__holder" data-db-target-of="sref48-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">50.</div><div>Laskowski, R.A. ∙ Swindells, M.B.</div><div><strong>LigPlot+: multiple ligand-protein interaction diagrams for drug discovery</strong></div><div><em>J.&nbsp;Chem. Inf. Model.</em> 2011; <strong>51</strong>:2778-2786</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/ci200227u" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-80054911951" target="_blank" aria-label="Open Scopus in new tab">Scopus (4092)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21919503/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Fci200227u&amp;pmid=21919503" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>LigPlot</td></tr><tr><td>Arpeggio</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref42-1" href="#" role="doc-biblioref" data-xml-rid="bib42" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref42-1" aria-controls="sref42-1">Jubb et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref42-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">42.</div><div>Jubb, H.C. ∙ Higueruelo, A.P. ∙ Ochoa-Montaño, B. ...</div><div><strong>Arpeggio: A web server for calculating and visualising interatomic interactions in protein structures</strong></div><div><em>J.&nbsp;Mol. Biol.</em> 2017; <strong>429</strong>:365-371</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jmb.2016.12.004" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85009250602" target="_blank" aria-label="Open Scopus in new tab">Scopus (282)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27964945/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jmb.2016.12.004&amp;pmid=27964945" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>Arpeggio</td></tr><tr class="rowsep"><td>SynergyFinder 2.0</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref39-3" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39-3" aria-controls="sref39-3">Ianevski et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref39-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Ianevski, A. ∙ Giri, A.K. ∙ Aittokallio, T.</div><div><strong>SynergyFinder 2.0: visual analytics of multi-drug combination synergies</strong></div><div><em>Nucleic Acids Res.</em> 2020; <strong>48</strong>:W488-W493</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkaa216" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85086923971" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32246720/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkaa216&amp;pmid=32246720" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>SynergyFinder</td></tr><tr class="rowsep"><td colspan="3"><b>Other</b></td></tr><tr><td>Piccolo point-of-care analyzer</td><td>Abbott</td><td>N/A</td></tr><tr><td>iQue Screener Plus flow cytometer</td><td>Intellicyt</td><td>N/A</td></tr><tr><td>ÄKTA Pure chromatography system</td><td>Cytiva</td><td>N/A</td></tr><tr><td>Protein Maker</td><td>Protein BioSolutions</td><td>N/A</td></tr><tr><td>Tecnai Spirit electron microscope with TemCam F416 4k x 4k CCD</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref80-4" href="#" role="doc-biblioref" data-xml-rid="bib80" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref80-4" aria-controls="sref80-4">Zhao et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref80-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">84.</div><div>Zhao, X. ∙ Howell, K.A. ∙ He, S. ...</div><div><strong>Immunization-elicited broadly protective antibody reveals ebolavirus fusion loop as a site of vulnerability</strong></div><div><em>Cell.</em> 2017; <strong>169</strong>:891-904.e15</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.038&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.038&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85019650530" target="_blank" aria-label="Open Scopus in new tab">Scopus (84)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28525756/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.04.038&amp;pmid=28525756" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Synergy H1 microplate reader</td><td>BioTek</td><td>N/A</td></tr><tr><td>Synergy 2 microplate reader</td><td>BioTek</td><td>N/A</td></tr><tr><td>EL406 washer dispenser</td><td>BioTek</td><td>N/A</td></tr><tr><td>Biostack microplate stacker</td><td>BioTek</td><td>N/A</td></tr><tr><td>StrepTrap HP 5&nbsp;mL column</td><td>Cytiva</td><td>N/A</td></tr><tr><td>HiTrap MabSelect SuRe 5&nbsp;mL column</td><td>Cytiva</td><td>Cat# 17-0404-01</td></tr><tr><td>xCELLigence RTCA MP analyzer</td><td>Agilent Technologies</td><td>N/A</td></tr></tbody></table></div><figcaption><div class="core-table-tools"><ul><li><a class="core-table-show-action" href="/action/showFullTableHTML?isHtml=true&amp;tableId=undtbl1&amp;pii=S0092-8674%2821%2901165-X" target="_blank">Open table in a new tab</a></li></ul></div></figcaption></figure></div></div></section><section id="sec-4-2"><h3>Resource availability</h3><section id="sec-4-2-1"><h4>Lead contact</h4><div id="p0165" role="paragraph">Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, James E. Crowe, Jr. (<a id="intref0110" href="mailto:james.crowe@vumc.org">james.crowe@vumc.org</a>).</div></section><section id="sec-4-2-2"><h4>Materials availability</h4><div id="p0170" role="paragraph">Materials described in this paper are available for distribution under the Uniform Biological Material Transfer Agreement, a master agreement that was developed by the NIH to simplify transfers of biological research materials.</div></section></section><section id="sec-4-3"><h3>Experimental model and subject details</h3><section id="sec-4-3-1"><h4>Cell lines</h4><div id="p0175" role="paragraph">Vero-E6 (monkey, female origin) and Vero CCL-81 (monkey, female origin) were obtained from the American Type Culture Collection (ATCC). Vero-E6 cells were cultured in Minimal Essential Medium (MEM) (Thermo Fisher Scientific) supplemented with 10% fetal bovine serum (FBS; HyClone) and 1% penicillin-streptomycin in 5% CO<sub>2</sub>, 37°C. Vero CCL-81 cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM; Thermo Fisher Scientific)</div><div id="p0180" role="paragraph">supplemented with 10% Ultra-Low IgG FBS (GIBCO), 25&nbsp;mM HEPES, and 100 units/mL of penicillin, and 100&nbsp;μg/mL of streptomycin (GIBCO) in 5% CO<sub>2</sub>, 37°C. A 293F cell line (human, female origin) stably-transfected to express SNAP-tagged EBOV GP was described previously (<span class="dropBlock reference-citations"><a id="body-ref-sref19-2" href="#" role="doc-biblioref" data-xml-rid="bib19" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref19-2" aria-controls="sref19-2">Domi et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref19-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>Domi, A. ∙ Feldmann, F. ∙ Basu, R. ...</div><div><strong>A single dose of modified Vaccinia Ankara expressing Ebola virus like particles protects nonhuman primates from lethal Ebola virus challenge</strong></div><div><em>Sci. Rep.</em> 2018; <strong>8</strong>:864</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41598-017-19041-y" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85040942560" target="_blank" aria-label="Open Scopus in new tab">Scopus (39)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29339750/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41598-017-19041-y&amp;pmid=29339750" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). ExpiCHO (hamster, female origin) and FreeStyle 293F (human, female origin) cell lines were purchased from Thermo Fisher Scientific and cultured according to the manufacturer’s protocol. The Jurkat-EBOV GP (Makona variant) cell line stably transduced to display EBOV GP on the surface (<span class="dropBlock reference-citations"><a id="body-ref-sref16-2" href="#" role="doc-biblioref" data-xml-rid="bib16" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref16-2" aria-controls="sref16-2">Davis et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref16-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">16.</div><div>Davis, C.W. ∙ Jackson, K.J.L. ∙ McElroy, A.K. ...</div><div><strong>Longitudinal analysis of the human B cell response to Ebola virus infection</strong></div><div><em>Cell.</em> 2019; <strong>177</strong>:1566-1582</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2019.04.036&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2019.04.036&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85065804877" target="_blank" aria-label="Open Scopus in new tab">Scopus (114)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31104840/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2019.04.036&amp;pmid=31104840" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) was a kind gift from Carl Davis (Emory University, Atlanta, GA). All cell lines were tested on a monthly basis for <i>Mycoplasma</i> and found to be negative in all cases.</div></section><section id="sec-4-3-2"><h4>Viruses</h4><div id="p0185" role="paragraph">The mouse-adapted EBOV Mayinga variant (EBOV-MA, GenBank: AF49101) (<span class="dropBlock reference-citations"><a id="body-ref-sref8-2" href="#" role="doc-biblioref" data-xml-rid="bib8" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref8-2" aria-controls="sref8-2">Bray et&nbsp;al., 1998</a><div class="dropBlock__holder" data-db-target-of="sref8-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">8.</div><div>Bray, M. ∙ Davis, K. ∙ Geisbert, T. ...</div><div><strong>A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever</strong></div><div><em>J.&nbsp;Infect. Dis.</em> 1998; <strong>178</strong>:651-661</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1086/515386" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-0031688699" target="_blank" aria-label="Open Scopus in new tab">Scopus (346)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9728532/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1086%2F515386&amp;pmid=9728532" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), authentic EBOV Mayinga variant expressing eGFP (<span class="dropBlock reference-citations"><a id="body-ref-sref70-2" href="#" role="doc-biblioref" data-xml-rid="bib70" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref70-2" aria-controls="sref70-2">Towner et&nbsp;al., 2005</a><div class="dropBlock__holder" data-db-target-of="sref70-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">74.</div><div>Towner, J.S. ∙ Paragas, J. ∙ Dover, J.E. ...</div><div><strong>Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening</strong></div><div><em>Virology.</em> 2005; <strong>332</strong>:20-27</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.virol.2004.10.048" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-12344297305" target="_blank" aria-label="Open Scopus in new tab">Scopus (157)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15661137/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.virol.2004.10.048&amp;pmid=15661137" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), the chimeric infectious EBOV/BDBV-GP (GenBank: <a id="intref0115" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=nucleotide&amp;doptcmdl=genbank&amp;term=KU174137" target="_blank">KU174137</a>) and EBOV/SUDV-GP (GenBank: <a id="intref0120" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=nucleotide&amp;doptcmdl=genbank&amp;term=KU174142" target="_blank">KU174142</a>) viruses expressing eGFP (<span class="dropBlock reference-citations"><a id="body-ref-sref40-3" href="#" role="doc-biblioref" data-xml-rid="bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40-3" aria-controls="sref40-3">Ilinykh et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref40-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Ilinykh, P.A. ∙ Shen, X. ∙ Flyak, A.I. ...</div><div><strong>Chimeric filoviruses for identification and characterization of monoclonal antibodies</strong></div><div><em>J.&nbsp;Virol.</em> 2016; <strong>90</strong>:3890-3901</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.00101-16" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84963838685" target="_blank" aria-label="Open Scopus in new tab">Scopus (35)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26819310/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.00101-16&amp;pmid=26819310" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), the infectious vesicular stomatitis viruses rVSV/EBOV GP (Mayinga variant) (<span class="dropBlock reference-citations"><a id="body-ref-sref27-2" href="#" role="doc-biblioref" data-xml-rid="bib27" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref27-2" aria-controls="sref27-2">Garbutt et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref27-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">27.</div><div>Garbutt, M. ∙ Liebscher, R. ∙ Wahl-Jensen, V. ...</div><div><strong>Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses</strong></div><div><em>J.&nbsp;Virol.</em> 2004; <strong>78</strong>:5458-5465</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.78.10.5458-5465.2004" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-2342455182" target="_blank" aria-label="Open Scopus in new tab">Scopus (313)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15113924/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.78.10.5458-5465.2004&amp;pmid=15113924" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), rVSV/BDBV GP (Uganda variant) (<span class="dropBlock reference-citations"><a id="body-ref-sref55-2" href="#" role="doc-biblioref" data-xml-rid="bib55" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref55-2" aria-controls="sref55-2">Mire et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref55-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">58.</div><div>Mire, C.E. ∙ Geisbert, J.B. ∙ Marzi, A. ...</div><div><strong>Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus</strong></div><div><em>PLoS Negl. Trop. Dis.</em> 2013; <strong>7</strong>:e2600</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pntd.0002600" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84892698411" target="_blank" aria-label="Open Scopus in new tab">Scopus (78)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24367715/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pntd.0002600&amp;pmid=24367715" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), or rVSV/SUDV GP (Boniface variant) (<span class="dropBlock reference-citations"><a id="body-ref-sref29-2" href="#" role="doc-biblioref" data-xml-rid="bib29" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref29-2" aria-controls="sref29-2">Geisbert et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref29-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Geisbert, T.W. ∙ Daddario-DiCaprio, K.M. ∙ Williams, K.J. ...</div><div><strong>Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates</strong></div><div><em>J.&nbsp;Virol.</em> 2008; <strong>82</strong>:5664-5668</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.00456-08" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-43949115183" target="_blank" aria-label="Open Scopus in new tab">Scopus (140)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18385248/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.00456-08&amp;pmid=18385248" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) expressing an ebolavirus GP that replaces VSV G protein were used for mouse challenge studies or neutralization assays. Viruses were grown and titrated in Vero cell monolayer cultures.</div><div id="p0190" role="paragraph">Authentic ebolaviruses EBOV (<span class="dropBlock reference-citations"><a id="body-ref-sref15-2" href="#" role="doc-biblioref" data-xml-rid="bib15" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref15-2" aria-controls="sref15-2">Cross et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref15-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">15.</div><div>Cross, R.W. ∙ Mire, C.E. ∙ Borisevich, V. ...</div><div><strong>The Domestic Ferret (Mustela putorius furo) as a lethal infection model for 3 species of ebolavirus</strong></div><div><em>J.&nbsp;Infect. Dis.</em> 2016; <strong>214</strong>:565-569</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/infdis/jiw209" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84988962295" target="_blank" aria-label="Open Scopus in new tab">Scopus (74)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27354371/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Finfdis%2Fjiw209&amp;pmid=27354371" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), BDBV (<span class="dropBlock reference-citations"><a id="body-ref-sref71-2" href="#" role="doc-biblioref" data-xml-rid="bib71" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref71-2" aria-controls="sref71-2">Towner et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref71-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">75.</div><div>Towner, J.S. ∙ Sealy, T.K. ∙ Khristova, M.L. ...</div><div><strong>Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda</strong></div><div><em>PLoS Pathog.</em> 2008; <strong>4</strong>:e1000212</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.ppat.1000212" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_75_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-57149120780" target="_blank" aria-label="Open Scopus in new tab">Scopus (422)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19023410/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.ppat.1000212&amp;pmid=19023410" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and SUDV (<span class="dropBlock reference-citations"><a id="body-ref-sref69-2" href="#" role="doc-biblioref" data-xml-rid="bib69" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref69-2" aria-controls="sref69-2">Thi et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref69-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">73.</div><div>Thi, E.P. ∙ Lee, A.C. ∙ Geisbert, J.B. ...</div><div><strong>Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA</strong></div><div><em>Nat. Microbiol.</em> 2016; <strong>1</strong>:16142</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmicrobiol.2016.142" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_73_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84983509313" target="_blank" aria-label="Open Scopus in new tab">Scopus (48)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27670117/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmicrobiol.2016.142&amp;pmid=27670117" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) were used for NHP challenge studies. The EBOV isolate 199510621 (Kikwit variant) originated from a 65-year-old female patient who died on 5 May 1995. The study challenge material was from the second Vero-E6 passage of EBOV isolate 199510621. The first passage at UTMB consisted of inoculating CDC 807223 (passage 1 of EBOV isolate 199510621) at a MOI of 0.001 onto Vero E6 cells. SUDV isolate 200011676 (Gulu variant) originated from a 35-year-old male patient who died on 16 October 2000. The study challenge material was from the second Vero-E6 cell passage of SUDV isolate 200011676. The first passage at UTMB consisted of inoculating CDC 808892 (CDC passage 1 of SUDV isolate 200011676) at a MOI of 0.001 onto Vero-E6 cells. BDBV isolate 200706291 (Uganda variant) originated from serum of a patient collected in Uganda on 1 October 2007. The study challenge material was from the second Vero-E6 cell passage of BDBV isolate 200706291 variant Uganda. Briefly, the first passage at UTMB consisted of inoculating CDC 811250 (CDC passage 1 of BDBV isolate 200706291) at a MOI of 0.001 onto Vero-E6 cells. The cell culture fluids were subsequently harvested at day 10 post inoculation with each of indicated viruses and stored at −80°C as ∼1&nbsp;mL aliquots. Neither mycoplasma nor endotoxin were detected (˂ 0.5 endotoxin units (EU)/mL).</div></section><section id="sec-4-3-3"><h4>Mouse model</h4><div id="p0195" role="paragraph">Seven- to eight-week old female BALB/c mice were obtained from the Jackson Laboratory. Mice were housed in microisolator cages and provided food and water <i>ad libitum</i>. Challenge studies were conducted under maximum containment in an animal biosafety level 4 (ABSL-4) facility of the Galveston National Laboratory, UTMB. The animal protocols for testing of mAbs in mice were approved by the Institutional Animal Care and Use Committee of the University of Texas Medical Branch (UTMB) in compliance with the Animal Welfare Act and other applicable federal statutes and regulations relating to animals and experiments involving animals.</div></section><section id="sec-4-3-4"><h4>Nonhuman primate (NHP) model</h4><div id="p0200" role="paragraph">Three- to four-year-old male (n&nbsp;= 6) or female (n&nbsp;= 6) rhesus macaques used in this study were obtained from PrimGen. Four-year-old male (n&nbsp;= 3) or female (n&nbsp;= 3) cynomolgus monkeys were obtained from Worldwide Primates. NHP research adhered to principles stated in the eighth edition of the Guide for the Care and Use of Laboratory Animals . The facility where this research was conducted [University of Texas Medical Branch (UTMB)] is fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International and has an approved Office of Laboratory Animal Welfare Assurance (#A3314-01).</div></section></section><section id="sec-4-4"><h3>Method details</h3><section id="sec-4-4-1"><h4>Monoclonal antibody production and purification</h4><div id="p0205" role="paragraph">Sequences of monoclonal antibodies that had been synthesized as cDNA (Twist Bioscience) and cloned into an IgG1 or IgG1 LALA-PG monocistronic expression vector (designated as pTwist-mCis_G1 or pTwist-mCis_hG1 LALA-PG) were used for monoclonal antibody secretion in mammalian cell culture. This vector contains an enhanced 2A sequence and GSG linker that allows the simultaneous expression of monoclonal antibody heavy and light chain genes from a single construct upon transfection (<span class="dropBlock reference-citations"><a id="body-ref-sref12" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12" aria-controls="sref12">Chng et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref12"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">12.</div><div>Chng, J. ∙ Wang, T. ∙ Nian, R. ...</div><div><strong>Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells</strong></div><div><em>MAbs.</em> 2015; <strong>7</strong>:403-412</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1080/19420862.2015.1008351" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84924585125" target="_blank" aria-label="Open Scopus in new tab">Scopus (115)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25621616/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1080%2F19420862.2015.1008351&amp;pmid=25621616" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). CHO cell cultures were transfected using the GIBCO ExpiCHO Expression System protocols as described by the vendor. Culture supernatants were purified using 5&nbsp;mL HiTrap MabSelect SuRe (Cytiva, formerly GE Healthcare Life Sciences) column and an ÄKTA pure chromatography system (Cytiva). Purified monoclonal antibodies were buffer-exchanged into PBS, concentrated using Amicon Ultra-4 50-kDa centrifugal filter units (Millipore Sigma) and stored at 4 °C until use. For NHP treatment studies antibodies were purified from 5 to 15&nbsp;L of CHO supernatant using HiScale 26/20 column (Cytiva) packed with MabSelect SuRe resin, purified protein was buffer-exchanged into PBS using HiScale 50/40 column packed with Sephadex G-25 (medium) resin (GE Healthcare Life Sciences), concentrated, and stored at −80 °C until use. Purified monoclonal antibodies were tested routinely for endotoxin levels (found to be less than 30 EU per mg IgG for mouse studies and less than 1 EU per mg IgG for NHP studies). Endotoxin testing was performed using the PTS201F cartridge (Charles River), with a sensitivity range from 10 to 0.1 EU per mL, and an Endosafe Nexgen-MCS instrument (Charles River). For structural studies, Fab was produced after co-transfection of ExpiCHO cells with two separate mammalian expression vectors containing antibody light chain and Fab heavy chain sequences as described previously&nbsp;(<span class="dropBlock reference-citations"><a id="body-ref-sref34-14" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-14" aria-controls="sref34-14">Gilchuk et&nbsp;al., 2020b</a><div class="dropBlock__holder" data-db-target-of="sref34-14"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Gilchuk, P. ∙ Murin, C.D. ∙ Milligan, J.C. ...</div><div><strong>Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:388-403.e12</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85079145867" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32023489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2020.01.001&amp;pmid=32023489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Fab proteins were purified using CaptureSelect column (Thermo Fisher Scientific). Purified antibodies were buffer-exchanged into PBS, concentrated using Amicon Ultra-4 30&nbsp;kDa MWCO centrifugal filter units (Millipore Sigma) and stored at 4°C until use.</div></section><section id="sec-4-4-2"><h4>GP expression and purification</h4><div id="p0210" role="paragraph">For ELISA studies, the ectodomains of EBOV GP ΔTM (residues 1-636; strain Makona; GenBank: <a id="intref0125" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=nucleotide&amp;doptcmdl=genbank&amp;term=KM233070" target="_blank">KM233070</a>), BDBV GP ΔTM (residues 1-643; strain 200706291&nbsp;Uganda; GenBank: <a id="intref0130" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=nucleotide&amp;doptcmdl=genbank&amp;term=NC_014373" target="_blank">NC_014373</a>), and SUDV GP ΔTM (residues 1-637; strain Gulu; GenBank: <a id="intref0135" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=nucleotide&amp;doptcmdl=genbank&amp;term=NC_006432" target="_blank">NC_006432</a>) were expressed and purified as described before (<span class="dropBlock reference-citations"><a id="body-ref-sref31-17" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-17" aria-controls="sref31-17">Gilchuk et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref31-17"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Gilchuk, P. ∙ Kuzmina, N. ∙ Ilinykh, P.A. ...</div><div><strong>Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the Ebolavirus glycoprotein</strong></div><div><em>Immunity.</em> 2018; <strong>49</strong>:363-374.e10</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85053075312" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30029854/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.06.018&amp;pmid=30029854" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). For structural studies, the ectodomain of EBOV/Makona GP (residues 32-644, GenBank AKG65268.1) lacking residues 310-460 of the mucin-like domain to produce EBOV/Makona GPΔMuc was produced and purified as described before (<span class="dropBlock reference-citations"><a id="body-ref-sref58-4" href="#" role="doc-biblioref" data-xml-rid="bib58" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref58-4" aria-controls="sref58-4">Murin et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref58-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Murin, C.D. ∙ Gilchuk, P. ∙ Ilinykh, P.A. ...</div><div><strong>Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies</strong></div><div><em>Cell Rep.</em> 2021; <strong>35</strong>:108984</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.celrep.2021.108984&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.celrep.2021.108984&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85104082939" target="_blank" aria-label="Open Scopus in new tab">Scopus (18)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33852862/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2021.108984&amp;pmid=33852862" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section><section id="sec-4-4-3"><h4>ELISA binding assay</h4><div id="p0215" role="paragraph">To assess mAb binding at different pH, wells of 96-well microtiter plates were coated with purified, recombinant EBOV, BDBV or SUDV GPΔTM ectodomains at 4°C overnight. Plates were blocked with 2% non-fat dry milk and 2% normal goat serum in DPBS containing 0.05% Tween-20 (DPBS-T) for 1 h. Purified mAbs were diluted serially in DPBS-T (pH 7.4), or DPBS-T that was adjusted to pH 5.5 or 4.5 with hydrochloric acid, added to the wells and incubated for 1 h at ambient temperature. The bound antibodies were detected using goat anti-human IgG conjugated with horseradish peroxidase (Southern Biotech) diluted in blocking buffer. Color development was monitored using TMB (3,3′,5,5′-tetramethylbenzidine) substrate (Thermo Fisher Scientific), 1N hydrochloric acid was added to stop the reaction, and the absorbance was measured at 450 nm using a spectrophotometer (Biotek).</div></section><section id="sec-4-4-4"><h4>Mammalian cell-surface-displayed GP antibody binding</h4><div id="p0220" role="paragraph">Binding of Alexa Fluor 647-labeled antibody to Jurkat-EBOV GP cell line was assessed by flow cytometry using an iQue Screener Plus high throughput flow cytometer (Intellicyt) as we described previously (<span class="dropBlock reference-citations"><a id="body-ref-sref34-15" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-15" aria-controls="sref34-15">Gilchuk et&nbsp;al., 2020b</a><div class="dropBlock__holder" data-db-target-of="sref34-15"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Gilchuk, P. ∙ Murin, C.D. ∙ Milligan, J.C. ...</div><div><strong>Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:388-403.e12</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85079145867" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32023489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2020.01.001&amp;pmid=32023489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section><section id="sec-4-4-5"><h4>Measurement of synergistic GP binding by a combination of antibodies</h4><div id="p0225" role="paragraph">Serially-diluted Alexa Fluor 647-labeled antibody rEBOV-442 IgG1 or rEBOV-515 LALA-PG was titrated into serially-diluted unlabeled partner antibody to generate a pairwise combinatorial matrix of two antibodies in the mixture. For antibody dilutions and washes, we used DPBS (Dulbecco’s phosphate-buffered saline) containing 2% of heat-inactivated FBS and 2&nbsp;mM EDTA (ethylenediaminetetraacetic acid, sodium salt) (pH 8.0) designated as incubation buffer. For antibody staining, ∼5&nbsp;× 10<sup>4</sup> Jurkat EBOV-GP cells were added per each well of V-bottom 96-well plate (Corning) in 5&nbsp;μL of the incubation buffer, and antibody mixtures were added to the cells in duplicate for total volume of 50&nbsp;μL per well, followed by 2&nbsp;hr incubation at 4°C. Cells were washed with the incubation buffer by centrifugation at 400 x <i>g</i> for 5&nbsp;min at ambient temperature and binding to the GP was assessed using iQue Screener Plus flow cytometer. Data for up to 5,000 events per well were acquired, and data were analyzed with ForeCyt (Intellicyt) software. Dead cells were excluded from the analysis on the basis of forward and side scatter gate for viable cell population. Binding was calculated as the percent of the maximal median fluorescence intensity signal (MFI) by the highest concentration of respective fluorescently-labeled antibody alone (25&nbsp;μg/mL). Synergy distribution maps were generated from the dose-response binding matrix using a web application, SynergyFinder 2.0, and data were analyzed using ZIP synergy scoring model (<span class="dropBlock reference-citations"><a id="body-ref-sref39-4" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39-4" aria-controls="sref39-4">Ianevski et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref39-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Ianevski, A. ∙ Giri, A.K. ∙ Aittokallio, T.</div><div><strong>SynergyFinder 2.0: visual analytics of multi-drug combination synergies</strong></div><div><em>Nucleic Acids Res.</em> 2020; <strong>48</strong>:W488-W493</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkaa216" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85086923971" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32246720/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkaa216&amp;pmid=32246720" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section><section id="sec-4-4-6"><h4>Selection and sequencing of VSV/EBOV GP mutants that escape antibody neutralization</h4><div id="p0230" role="paragraph">To screen for escape mutations selected in the presence of individual antibodies or antibody cocktails, we used a real-time cell analysis (RTCA) assay and xCELLigence RTCA MP Analyzer (ACEA Biosciences) with modification of recently described assays (<span class="dropBlock reference-citations"><a id="body-ref-sref33-2" href="#" role="doc-biblioref" data-xml-rid="bib33" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref33-2" aria-controls="sref33-2">Gilchuk et&nbsp;al., 2020a</a><div class="dropBlock__holder" data-db-target-of="sref33-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">33.</div><div>Gilchuk, P. ∙ Bombardi, R.G. ∙ Erasmus, J.H. ...</div><div><strong>Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics</strong></div><div><em>Nat. Biomed. Eng.</em> 2020; <strong>4</strong>:1030-1043</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41551-020-0594-x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85088873601" target="_blank" aria-label="Open Scopus in new tab">Scopus (35)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32747832/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41551-020-0594-x&amp;pmid=32747832" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref36-2" href="#" role="doc-biblioref" data-xml-rid="bib36" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref36-2" aria-controls="sref36-2">Greaney et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref36-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">36.</div><div>Greaney, A.J. ∙ Starr, T.N. ∙ Gilchuk, P. ...</div><div><strong>Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition</strong></div><div><em>Cell Host Microbe.</em> 2021; <strong>29</strong>:44-57.e9</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2020.11.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2020.11.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85097068093" target="_blank" aria-label="Open Scopus in new tab">Scopus (673)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33259788/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.chom.2020.11.007&amp;pmid=33259788" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Fifty (50) μL of cell culture medium (DMEM supplemented with 2% FBS) was added to each well of a 96-well E-plate to obtain a background reading. Eighteen thousand (18,000) Vero cells in 50&nbsp;μL of cell culture medium were seeded per each well, and plates were placed on the analyzer. Measurements were taken automatically every 15&nbsp;min and the sensograms were visualized using RTCA software version 2.1.0 (ACEA Biosciences Inc). VSV/EBOV GP virus (20,000 plaque forming units [PFU] per well, ∼1 MOI) was mixed with a saturating neutralizing concentration of individual antibody (10&nbsp;μg/mL) or two-antibody cocktail (1:1 antibody ratio, 10&nbsp;μg/mL total antibody concentration) in a total volume of 100&nbsp;μL and incubated for 1&nbsp;h at 37°C. At 16-20&nbsp;h after seeding the cells, the virus-antibody mixtures were added into 8 to 96 replicate wells of 96-well E-plates with cell monolayers. Wells containing only virus in the absence of antibody and wells containing only Vero cells in medium were included on each plate as controls. Plates were measured continuously (every 15&nbsp;min) for 72 h. The escape mutants were identified by delayed CPE in wells containing antibody. To verify escape from antibody selection, isolated viruses were assessed in a subsequent RTCA experiment in the presence of 20&nbsp;μg/mL of antibody used for the escape selection, or 20&nbsp;μg/mL of the other tested individual mAbs (rEBOV-442, rEBOV-515, ADI-15878, or ADI-15946), or 20&nbsp;μg/mL of 1:1 cocktail of rEBOV-442+rEBOV-515 (see <a id="crosref1305" href="#figs1">Figure&nbsp;S1</a>C).</div><div id="p0235" role="paragraph">To verify the escape phenotype mediated by mutations present in GP protein-expressing VSV antibody-selected escape variants, the escape viruses isolated after RTCA escape screening were propagated in 6-well culture plates with confluent Vero cells in the presence of 20&nbsp;μg/mL of mAb used. Viral RNA was isolated using a QiAmp Viral RNA extraction kit (QIAGEN) from aliquots of supernatant containing a suspension of the selected virus population. The GP protein gene cDNA was amplified with a SuperScript IV One-Step RT-PCR kit (Thermo Fisher Scientific) using primers flanking the GP gene. The amplified PCR product (∼2,400&nbsp;bp) was purified using SPRI magnetic beads (Beckman Coulter) at a 1:1 ratio and sequenced by the Sanger sequence technique using primers giving forward and reverse reads of the glycan cap region of the GP.</div></section><section id="sec-4-4-7"><h4>Neutralization assays</h4><div id="p0240" role="paragraph">BSL-4 virus neutralization assays were performed using recombinant EBOV-eGFP or chimeric EBOV viruses in which GP was replaced with its counterpart from BDBV or SUDV, as described previously (<span class="dropBlock reference-citations"><a id="body-ref-sref40-4" href="#" role="doc-biblioref" data-xml-rid="bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40-4" aria-controls="sref40-4">Ilinykh et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref40-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Ilinykh, P.A. ∙ Shen, X. ∙ Flyak, A.I. ...</div><div><strong>Chimeric filoviruses for identification and characterization of monoclonal antibodies</strong></div><div><em>J.&nbsp;Virol.</em> 2016; <strong>90</strong>:3890-3901</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.00101-16" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84963838685" target="_blank" aria-label="Open Scopus in new tab">Scopus (35)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26819310/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.00101-16&amp;pmid=26819310" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Briefly, four-fold dilutions of the respective mAb starting at 200&nbsp;μg/mL were mixed in triplicate with 400 PFU of the virus in U-bottom 96-well plates and incubated for 1&nbsp;hr at 37°C. Mixtures were applied on Vero-E6 cell monolayer cultures in 96-well plates and incubated for four days at 37°C. In the absence of mAb neutralizing activity, the infection resulted in uniform eGFP fluorescence from the monolayer of cells that was detected readily by fluorescence microscopy. Fluorescence was measured using Synergy HT microplate reader (BioTek). Half maximal inhibitory concentration (IC<sub>50</sub>) values were determined by nonlinear regression analysis using Prism software.</div><div id="p0245" role="paragraph">BSL-2 virus neutralization experiments were performed using the infectious rVSV/EBOV GP, rVSV/BDBV GP, and rVSV/SUDV GP viruses, and we adopted high-throughput RTCA assay that quantify virus-induced cytopathic effect (CPE) (<span class="dropBlock reference-citations"><a id="body-ref-sref33-3" href="#" role="doc-biblioref" data-xml-rid="bib33" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref33-3" aria-controls="sref33-3">Gilchuk et&nbsp;al., 2020a</a><div class="dropBlock__holder" data-db-target-of="sref33-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">33.</div><div>Gilchuk, P. ∙ Bombardi, R.G. ∙ Erasmus, J.H. ...</div><div><strong>Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics</strong></div><div><em>Nat. Biomed. Eng.</em> 2020; <strong>4</strong>:1030-1043</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41551-020-0594-x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85088873601" target="_blank" aria-label="Open Scopus in new tab">Scopus (35)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32747832/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41551-020-0594-x&amp;pmid=32747832" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>, <span class="dropBlock reference-citations"><a id="body-ref-sref34-16" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-16" aria-controls="sref34-16">2020b</a><div class="dropBlock__holder" data-db-target-of="sref34-16"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Gilchuk, P. ∙ Murin, C.D. ∙ Milligan, J.C. ...</div><div><strong>Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:388-403.e12</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85079145867" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32023489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2020.01.001&amp;pmid=32023489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Viruses were pre-titrated by RTCA to determine dilution of each virus stock to achieve similar CPE kinetics and complete CPE in 32&nbsp;h after applying virus alone to Vero cells. Fifty (50) μL of cell culture medium (DMEM supplemented with 2% FBS) was added to each well of a 96-well E-plate using a ViaFlo384 liquid handler (Integra Biosciences) to obtain background reading. Eighteen thousand (18,000) Vero cells in 50&nbsp;μL of cell culture medium were seeded per each well, and the plate was placed on the analyzer. Measurements were taken automatically every 15&nbsp;min, and the sensograms were visualized using RTCA software version 2.1.0 (ACEA Biosciences Inc). VSV/EBOV GP (∼0.1 MOI, ∼2,000 PFU per well), or VSV/BDBV GP (0.04 MOI, ∼800 PFU per well) or VSV/SUDV GP (0.01 MOI, ∼240 PFU per well) were mixed 1:1 with respective dilution of mAb in triplicate a total volume of 100&nbsp;μL using DMEM supplemented with 2% FBS as a diluent and incubated for 1&nbsp;h at 37°C in 5% CO<sub>2</sub>. At 16 to 18&nbsp;h after seeding the cells, the virus-mAb mixtures were added to the cells in 96-well E-plates. Triplicate wells containing virus only (maximal CPE in the absence of mAb) and wells containing only Vero cells in medium (no-CPE wells) were included as controls. Plates were measured continuously (every 15&nbsp;min) for 48&nbsp;h to assess virus neutralization. Normalized cellular index (CI) values at the endpoint (42&nbsp;h after incubation with the virus) were determined using the RTCA software version 2.1.0 (ACEA Biosciences). Results were expressed as percent neutralization in the presence of a particular mAb relative to no-CPE control wells minus CI values from control wells with maximum CPE. RTCA IC<sub>50</sub> values were determined by nonlinear regression analysis using Prism software.</div></section><section id="sec-4-4-8"><h4>Measurement of synergistic virus neutralization by a combination of antibodies</h4><div id="p0250" role="paragraph">We used RTCA assay to assess neutralizing activity from a pairwise combinatorial matrix of two antibodies in the mixture. Serially-diluted rEBOV-442 (2-fold dilutions) was titrated into serially-diluted rEBOV-515 (two-fold dilutions) and incubated with rVSV/EBOV GP, rVSV/BDBV GP, or rVSV/SUDV GP viruses for 1&nbsp;h at 37°C. Virus-antibody mixtures were applied to Vero cells grown in 96-well E-plates in duplicates for each virus and using separate plates for each pairwise combinatorial matrix. Triplicate wells containing virus only (maximal CPE in the absence of mAb) and wells containing only Vero cells in medium (no CPE wells) were included as controls. Plates were measured continuously (every 15&nbsp;min) for 48&nbsp;h to assess virus neutralization. Normalized cellular index (CI) values at the endpoint (42&nbsp;h after incubation with the virus) were determined using the RTCA software version 2.1.0 (ACEA Biosciences). Results were expressed as percent neutralization in the presence of a particular mAb relative to control wells with no CPE minus CI values from control wells with maximum CPE. Synergy distribution maps were generated from the dose-response binding matrix using a web application, SynergyFinder 2.0, and data were analyzed using ZIP synergy scoring model (<span class="dropBlock reference-citations"><a id="body-ref-sref39-5" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39-5" aria-controls="sref39-5">Ianevski et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref39-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Ianevski, A. ∙ Giri, A.K. ∙ Aittokallio, T.</div><div><strong>SynergyFinder 2.0: visual analytics of multi-drug combination synergies</strong></div><div><em>Nucleic Acids Res.</em> 2020; <strong>48</strong>:W488-W493</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkaa216" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85086923971" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32246720/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkaa216&amp;pmid=32246720" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section><section id="sec-4-4-9"><h4>Rapid fluorometric antibody-mediated cytotoxicity assay (RFADCC)</h4><div id="p0255" role="paragraph">Antibody-dependent cell-mediated cytotoxicity activity of EBOV GP-reactive IgG was quantified with an EBOV-adapted modification of the RFADCC assay (<span class="dropBlock reference-citations"><a id="body-ref-sref19-3" href="#" role="doc-biblioref" data-xml-rid="bib19" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref19-3" aria-controls="sref19-3">Domi et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref19-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>Domi, A. ∙ Feldmann, F. ∙ Basu, R. ...</div><div><strong>A single dose of modified Vaccinia Ankara expressing Ebola virus like particles protects nonhuman primates from lethal Ebola virus challenge</strong></div><div><em>Sci. Rep.</em> 2018; <strong>8</strong>:864</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41598-017-19041-y" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85040942560" target="_blank" aria-label="Open Scopus in new tab">Scopus (39)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29339750/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41598-017-19041-y&amp;pmid=29339750" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref59" href="#" role="doc-biblioref" data-xml-rid="bib59" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref59" aria-controls="sref59">Orlandi et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref59"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Orlandi, C. ∙ Flinko, R. ∙ Lewis, G.K.</div><div><strong>A new cell line for high throughput HIV-specific antibody-dependent cellular cytotoxicity (ADCC) and cell-to-cell virus transmission studies</strong></div><div><em>J.&nbsp;Immunol. Methods.</em> 2016; <strong>433</strong>:51-58</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jim.2016.03.002" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84963628567" target="_blank" aria-label="Open Scopus in new tab">Scopus (34)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26969387/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jim.2016.03.002&amp;pmid=26969387" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Briefly, a target cell line was made by transfecting 293F cells with a full-length DNA expressing GP from the EBOV (Kikwit variant) followed by transfecting with two separate DNA constructs expressing eGFP and the chimeric CCR5-SNAP tag protein. The new cell line, designated EBOV GPkik-293FS eGFP CCR5-SNAP, expresses EBOV-Kikwit GP on the plasma membrane, eGFP in the cytoplasm and the SNAP-tag CCR5, which can be specifically labeled with SNAP-Surface Alexa Fluor 647 (New England Biolabs), on the cell surface (<span class="dropBlock reference-citations"><a id="body-ref-sref19-4" href="#" role="doc-biblioref" data-xml-rid="bib19" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref19-4" aria-controls="sref19-4">Domi et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref19-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>Domi, A. ∙ Feldmann, F. ∙ Basu, R. ...</div><div><strong>A single dose of modified Vaccinia Ankara expressing Ebola virus like particles protects nonhuman primates from lethal Ebola virus challenge</strong></div><div><em>Sci. Rep.</em> 2018; <strong>8</strong>:864</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41598-017-19041-y" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85040942560" target="_blank" aria-label="Open Scopus in new tab">Scopus (39)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29339750/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41598-017-19041-y&amp;pmid=29339750" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The unrelated human mAb DENV 2D22 and the Fc effector function disabled mAb rEBOV-515 LALA-PG were used as negative controls for the assay background. The ADCC activity was quantified by incubating three-fold serial dilutions of mAbs with EBOV GPkik-293FS eGFP CCR5-SNAP target cells for 15&nbsp;min at ambient temperature and then adding human PBMC (STEMCELL Technologies) as effector cells for 2&nbsp;hr at 37°C, after which cells were washed once with PBS, fixed with 2% paraformaldehyde, stained and analyzed using an iQue Screener Plus flow cytometer (Intellicyt). Data analysis was performed with ForeCyt (Intellicyt) software. The percentage cytotoxicity of the mAb was determined as the number of target cells losing eGFP signal (by virtue of ADCC) but retaining the surface expression of CCR5-SNAP.</div></section><section id="sec-4-4-10"><h4>GP cleavage inhibition</h4><div id="p0260" role="paragraph">The assay was performed as we described previously (<span class="dropBlock reference-citations"><a id="body-ref-sref31-18" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-18" aria-controls="sref31-18">Gilchuk et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref31-18"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Gilchuk, P. ∙ Kuzmina, N. ∙ Ilinykh, P.A. ...</div><div><strong>Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the Ebolavirus glycoprotein</strong></div><div><em>Immunity.</em> 2018; <strong>49</strong>:363-374.e10</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85053075312" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30029854/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.06.018&amp;pmid=30029854" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Briefly, Jurkat-EBOV GP cells were pre-incubated with&nbsp;serial dilutions of mAbs in DPBS for 20&nbsp;min at room temperature, then incubated with thermolysin (Promega) diluted in DPBS to 1&nbsp;mg/mL for 20&nbsp;min at 37°C. The reaction was stopped by addition of the incubation buffer containing DPBS, 2% heat-inactivated FBS and 2&nbsp;mM EDTA (pH 8.0). Washed cells were incubated with 5&nbsp;μg/mL of Alexa Fluor 647-labeled EBOV GP RBD-reactive mAb MR78 (<span class="dropBlock reference-citations"><a id="body-ref-sref6" href="#" role="doc-biblioref" data-xml-rid="bib6" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref6" aria-controls="sref6">Bornholdt et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">6.</div><div>Bornholdt, Z.A. ∙ Ndungo, E. ∙ Fusco, M.L. ...</div><div><strong>Host-primed Ebola virus GP exposes a hydrophobic NPC1 receptor-binding pocket, revealing a target for broadly neutralizing antibodies</strong></div><div><em>MBio.</em> 2016; <strong>7</strong>:e02154-15</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/mBio.02154-15" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84960154024" target="_blank" aria-label="Open Scopus in new tab">Scopus (79)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26908579/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FmBio.02154-15&amp;pmid=26908579" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) at 4°C for 60&nbsp;min. Stained cells were washed, fixed, and analyzed by flow cytometry using Intellicyt iQue. Cells were gated for the viable population, and median fluorescence intensity from Alexa Fluor 647 was determined. Background staining was determined from binding of the labeled mAb MR78 to Jurkat-EBOV GP (uncleaved) cells. Results are expressed as the percent of RBS exposure inhibition in the presence of tested mAb relative to controls for minimal binding of labeled MR78 mAb-only to intact (uncleaved) Jurkat EBOV-GP, and maximal binding of labeled MR78 mAb-only to cleaved Jurkat-EBOV GP.</div></section><section id="sec-4-4-11"><h4>Mouse challenge</h4><div id="p0265" role="paragraph">Groups of mice (n&nbsp;= 5 per group) were inoculated with 1,000 PFU of the EBOV-MA by the intraperitoneal (i.p.) route. Mice were treated i.p. with indicated doses of individual mAbs on 1&nbsp;day after virus inoculation (dpi). Human mAb DENV 2D22 served as a control. Mice were monitored twice daily from 0 to 14 dpi for illness, survival, and weight loss, followed by once daily monitoring from 15 dpi to the&nbsp;end of the study at 28 dpi. The extent of disease was scored using the following parameters: score 1 – healthy; score 2 – ruffled fur and hunched posture; score 3 – a score of 2 plus one additional clinical sign such as orbital tightening and/or &gt;15% weight loss; score 4 – a score of 3 plus one additional clinical sign such as reluctance to move when stimulated, or any neurologic signs (seizures, tremors, head tilt, paralysis, etc.), or &gt;20% weight loss. Animals reaching a score of 4 were euthanized as per the IACUC-approved protocol. All mice were euthanized on day 28 after EBOV challenge.</div></section><section id="sec-4-4-12"><h4>NHP challenge</h4><div id="p0270" role="paragraph">Twelve healthy adult rhesus macaques (<i>Macaca mulatta</i>) of Chinese origin and six healthy adult cynomolgus monkeys (<i>Macaca fascicularis</i>) were studied. Animals were assigned to three groups of five animals per treatment group and a control untreated animal. Animals were randomized by random number assignment (with Microsoft Excel) into a treatment group and a control animal. Previous studies showed a difference of the disease courses between EBOV, BDBV, or SUDV challenged NHP models of EVD (<span class="dropBlock reference-citations"><a id="body-ref-sref7-6" href="#" role="doc-biblioref" data-xml-rid="bib7" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref7-6" aria-controls="sref7-6">Bornholdt et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref7-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">7.</div><div>Bornholdt, Z.A. ∙ Herbert, A.S. ∙ Mire, C.E. ...</div><div><strong>A two-antibody pan-ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates</strong></div><div><em>Cell Host Microbe.</em> 2019; <strong>25</strong>:49-58.e5</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2018.12.005&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2018.12.005&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85058702898" target="_blank" aria-label="Open Scopus in new tab">Scopus (73)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30629918/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.chom.2018.12.005&amp;pmid=30629918" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref34-17" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-17" aria-controls="sref34-17">Gilchuk et&nbsp;al., 2020b</a><div class="dropBlock__holder" data-db-target-of="sref34-17"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Gilchuk, P. ∙ Murin, C.D. ∙ Milligan, J.C. ...</div><div><strong>Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:388-403.e12</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85079145867" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32023489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2020.01.001&amp;pmid=32023489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref37-2" href="#" role="doc-biblioref" data-xml-rid="bib37" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref37-2" aria-controls="sref37-2">Herbert et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref37-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">37.</div><div>Herbert, A.S. ∙ Froude, J.W. ∙ Ortiz, R.A. ...</div><div><strong>Development of an antibody cocktail for treatment of Sudan virus infection</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2020; <strong>117</strong>:3768-3778</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1914985117" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85079531798" target="_blank" aria-label="Open Scopus in new tab">Scopus (18)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32015126/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1914985117&amp;pmid=32015126" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). EBOV causes rapid infection with readily detectable systemic viremia by 3 dpi. In the SUDV challenge model, the disease course is slower than that caused by EBOV, and the disease course caused by BDBV is even slower than those of EBOV or SUDV. Given these differences, the first antibody treatment in each model was delivered at the earliest time points after viral challenge at which animals are expected to be uniformly viremic (<i>e.g</i>., day 3 after EBOV, day 4 after SUDV, or day 6 after BDBV challenge). The treatment schedule using a two-dose 30&nbsp;mg/kg/dose regimen given 3&nbsp;days apart was the same as in our previous work in which we tested a different cocktail of mAbs (rEBOV-520 LALA&nbsp;+ rEBOV-548 IgG) in NHPs against EBOV only (<span class="dropBlock reference-citations"><a id="body-ref-sref34-18" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-18" aria-controls="sref34-18">Gilchuk et&nbsp;al., 2020b</a><div class="dropBlock__holder" data-db-target-of="sref34-18"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Gilchuk, P. ∙ Murin, C.D. ∙ Milligan, J.C. ...</div><div><strong>Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:388-403.e12</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85079145867" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32023489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2020.01.001&amp;pmid=32023489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) to allow comparisons between two studies. After intramuscular challenge with a lethal target dose of 1,000 plaque-forming units (PFU) of EBOV/Kikwit, BDBV/Uganda, or SUDV/Gulu, each of the NHPs of the treatment group received intravenously two 30&nbsp;mg/kg doses of the cocktail (a 2:1 mixture of rEBOV-515 LALA-PG and rEBOV-442 IgG1) spaced 3&nbsp;days apart (days 3 and 6 after EBOV/Kikwit, days 6 and 9 after BDBV/Uganda, or days 4 and 7 after SUDV/Gulu inoculation). The back-titer of the EBOV, BDBV, and SUDV inoculum identified 963, 1113, and 988 PFU as the actual inoculation dose for the respective virus. Historical untreated controls for EBOV challenge cohort included fourteen untreated animals from separate studies including 11 animals, as we reported previously (<span class="dropBlock reference-citations"><a id="body-ref-sref34-19" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-19" aria-controls="sref34-19">Gilchuk et&nbsp;al., 2020b</a><div class="dropBlock__holder" data-db-target-of="sref34-19"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Gilchuk, P. ∙ Murin, C.D. ∙ Milligan, J.C. ...</div><div><strong>Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:388-403.e12</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85079145867" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32023489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2020.01.001&amp;pmid=32023489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), which were challenged with the same target dose of EBOV/Kikwit and by the same route. Historical untreated controls for SUDV/Gulu challenge cohort included five untreated animals from previous study (<span class="dropBlock reference-citations"><a id="body-ref-sref69-3" href="#" role="doc-biblioref" data-xml-rid="bib69" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref69-3" aria-controls="sref69-3">Thi et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref69-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">73.</div><div>Thi, E.P. ∙ Lee, A.C. ∙ Geisbert, J.B. ...</div><div><strong>Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA</strong></div><div><em>Nat. Microbiol.</em> 2016; <strong>1</strong>:16142</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmicrobiol.2016.142" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_73_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84983509313" target="_blank" aria-label="Open Scopus in new tab">Scopus (48)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27670117/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmicrobiol.2016.142&amp;pmid=27670117" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and four untreated animals from two other studies (T.W.G. and R.W.C., unpublished data) that were challenged with the same target dose of BDBV and by the same route. Historical untreated controls for BDBV challenge cohort included three untreated animals from a previous study (<span class="dropBlock reference-citations"><a id="body-ref-sref7-7" href="#" role="doc-biblioref" data-xml-rid="bib7" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref7-7" aria-controls="sref7-7">Bornholdt et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref7-7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">7.</div><div>Bornholdt, Z.A. ∙ Herbert, A.S. ∙ Mire, C.E. ...</div><div><strong>A two-antibody pan-ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates</strong></div><div><em>Cell Host Microbe.</em> 2019; <strong>25</strong>:49-58.e5</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2018.12.005&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2018.12.005&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85058702898" target="_blank" aria-label="Open Scopus in new tab">Scopus (73)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30629918/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.chom.2018.12.005&amp;pmid=30629918" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and seventeen untreated animals from the other studies (T.W.G. and R.W.C., unpublished data) that were challenged with the same target dose of BDBV/Uganda and by the same route. All animals were given physical exams, and blood was collected at the time of inoculation and at indicated times after virus inoculation. In addition, all animals were monitored daily and scored for disease progression with an internal filovirus scoring protocol approved by the UTMB Institutional Animal Care and Use Committee. The scoring measured from baseline and included posture or activity level, attitude or behavior, food and water intake, respiration, and disease manifestations such as visible rash, hemorrhage, ecchymosis, or flushed skin. A score of ≥ 9 indicated that an animal met criteria for euthanasia. These studies were not blinded, and all animals were included in analysis.</div></section><section id="sec-4-4-13"><h4>Measurement of virus load in NHP blood and tissues</h4><div id="p0275" role="paragraph">Titration of virus in plasma samples and 10% tissue homogenates (w/v) was performed by plaque assay in Vero-E6 cell culture monolayers. Briefly, serial 10-fold dilutions of the samples were applied to Vero-E6 cell monolayers in duplicate wells (200&nbsp;μL); the limit of detection was 25 PFU/mL for plasma and 250 PFU/gram for tissue. For qRT-PCR analysis, RNA was isolated from whole blood or tissue using the Viral RNA Mini-kit (QIAGEN) using 100&nbsp;μL of blood or 100&nbsp;mg of tissue into 600&nbsp;μL of buffer AVL. Primers (probes) targeting the VP30 gene of EBOV probe sequence of 6-carboxyflourescein (6FAM)-5′ CCG TCA ATC AAG GAG CGC CTC 3′-6 carboxytetramethylrhodamine (TAMRA) (Thermo Fisher Scientific), the VP35 intergenic region of BDBV probe sequence of 6FAM-5′ CGCAACCTCCACAGTCGCCT 3′-TAMRA, and the L gene of SUDV probe sequence of 6FAM-5′ CAT CCA ATC AAA GAC ATT GCG A 3′-TAMRA were used for qRT-PCR. EBOV RNA was detected using the CFX96 detection system (BioRad Laboratories) in One-step probe qRT-PCR kits (QIAGEN) with the following cycle conditions: 50°C for 10&nbsp;min, 95°C for 10 s, and 40 cycles of 95°C for 10&nbsp;s and 57°C for 30&nbsp;s for EBOV and BDBV and 50°C for 10&nbsp;min, 95°C for 10 s, and 40 cycles of 95°C for 10&nbsp;s and 59°C for 30&nbsp;s for SUDV. Threshold cycle (CT) values representing EBOV, BDBV and SUDV genomes were analyzed with CFX Manager Software, and data are depicted as genome equivalents (GEq); the limit of detection was 3.7 log<sub>10</sub>GEq/mL for blood and 3.7 log<sub>10</sub>GEq/g for the tissues.</div></section><section id="sec-4-4-14"><h4>NHP serum biochemistry</h4><div id="p0280" role="paragraph">Serum samples collected from NHPs were tested for concentrations of albumin, amylase, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, gamma-glutamyltransferase, glucose, blood urea nitrogen, creatinine, total protein, and C-reactive protein by using a Piccolo point-of-care analyzer and Abbott Piccolo BioChemistry Panel Plus analyzer discs (Fisher Scientific).</div></section><section id="sec-4-4-15"><h4>Sample preparation for cryogenic electron microscopy</h4><div id="p0285" role="paragraph">EBOV/Makona GPΔmuc was incubated overnight with a 5-fold molar excess of rEBOV-515 Fab, rEBOV-442 Fab, and rADI-16061 Fab at 4°C. The complexes were then purified by SEC using an S200I column equilibrated in 1X TBS and concentrated to 5&nbsp;mg/mL using a 100-kDa concentrator (Amicon Ultra, Millipore). Immediately prior to freezing, 0.06&nbsp;mM of n-Dodecyl β-D-maltoside (Anatrace) was added to 3&nbsp;μL of the complex. Vitrification was performed with a Vitrobot (Thermo Fisher Scientific) equilibrated to 4°C and 100% humidity. Cryo-EM grids were plasma cleaned for 5&nbsp;s using a mixture of Ar/O2 (Gatan Solarus 950 Plasma system) followed by blotting on both sides of the grid with filter paper (Whattman No. 1). See <a id="crosref1390" href="#mmc1">Table S7</a> for additional details. Note that ADI-16061 Fab was added to assist in angular sampling and orientations of the complexes in ice as we described previously (<span class="dropBlock reference-citations"><a id="body-ref-sref34-20" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-20" aria-controls="sref34-20">Gilchuk et&nbsp;al., 2020b</a><div class="dropBlock__holder" data-db-target-of="sref34-20"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Gilchuk, P. ∙ Murin, C.D. ∙ Milligan, J.C. ...</div><div><strong>Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:388-403.e12</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85079145867" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32023489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2020.01.001&amp;pmid=32023489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section><section id="sec-4-4-16"><h4>Cryogenic electron microscopy data collection and processing</h4><div id="p0290" role="paragraph">Cryo-EM data were collected according to <a id="crosref1400" href="#mmc1">Table S7</a>. Micrographs were aligned and dose-weighted using MotionCor2 (<span class="dropBlock reference-citations"><a id="body-ref-sref81-2" href="#" role="doc-biblioref" data-xml-rid="bib81" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref81-2" aria-controls="sref81-2">Zheng et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref81-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">85.</div><div>Zheng, S.Q. ∙ Palovcak, E. ∙ Armache, J.P. ...</div><div><strong>MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy</strong></div><div><em>Nat. Methods.</em> 2017; <strong>14</strong>:331-332</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.4193" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85014129582" target="_blank" aria-label="Open Scopus in new tab">Scopus (4513)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28250466/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.4193&amp;pmid=28250466" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). CTF estimation was completed using GCTF (<span class="dropBlock reference-citations"><a id="body-ref-sref81-3" href="#" role="doc-biblioref" data-xml-rid="bib81" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref81-3" aria-controls="sref81-3">Zheng et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref81-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">85.</div><div>Zheng, S.Q. ∙ Palovcak, E. ∙ Armache, J.P. ...</div><div><strong>MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy</strong></div><div><em>Nat. Methods.</em> 2017; <strong>14</strong>:331-332</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.4193" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85014129582" target="_blank" aria-label="Open Scopus in new tab">Scopus (4513)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28250466/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.4193&amp;pmid=28250466" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Particle picking and initial 2D classification were initially performed using CryoSPARC 2.0 (<span class="dropBlock reference-citations"><a id="body-ref-sref63-2" href="#" role="doc-biblioref" data-xml-rid="bib63" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref63-2" aria-controls="sref63-2">Punjani et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref63-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">66.</div><div>Punjani, A. ∙ Rubinstein, J.L. ∙ Fleet, D.J. ...</div><div><strong>cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination</strong></div><div><em>Nat. Methods.</em> 2017; <strong>14</strong>:290-296</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.4169" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85011645437" target="_blank" aria-label="Open Scopus in new tab">Scopus (4028)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28165473/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.4169&amp;pmid=28165473" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) to clean up particle stacks and exclude any complexes that were degrading. Particle picks were then imported into Relion 3.1 (<span class="dropBlock reference-citations"><a id="body-ref-sref82-2" href="#" role="doc-biblioref" data-xml-rid="bib82" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref82-2" aria-controls="sref82-2">Zivanov et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref82-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">86.</div><div>Zivanov, J. ∙ Nakane, T. ∙ Forsberg, B.O. ...</div><div><strong>New tools for automated high-resolution cryo-EM structure determination in RELION-3</strong></div><div><em>eLife.</em> 2018; <strong>7</strong>:e42166</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.7554/eLife.42166" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_86_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85056950318" target="_blank" aria-label="Open Scopus in new tab">Scopus (2936)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30412051/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.7554%2FeLife.42166&amp;pmid=30412051" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) for 3D classification and refinement using C3 symmetry and a tight mask around the GP/rEBOV-515 Fab/rEBOV-442 Fab complex. CTF refinement was then performed by either Relion or Cryosparc to increase map quality and resolution. There was no electron density for ADI-16061 Fab.</div></section><section id="sec-4-4-17"><h4>Cryogenic electron microscopy model building and refinement</h4><div id="p0295" role="paragraph">Homology models of Fab were first generated using SWISS-MODEL (<span class="dropBlock reference-citations"><a id="body-ref-sref5-2" href="#" role="doc-biblioref" data-xml-rid="bib5" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref5-2" aria-controls="sref5-2">Biasini et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref5-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">5.</div><div>Biasini, M. ∙ Bienert, S. ∙ Waterhouse, A. ...</div><div><strong>SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information</strong></div><div><em>Nucleic Acids Res.</em> 2014; <strong>42</strong>:W252-8</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gku340" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84904815625" target="_blank" aria-label="Open Scopus in new tab">Scopus (3931)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24782522/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgku340&amp;pmid=24782522" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). A model of EBOV GP (PDB: <a id="intref0140" href="http://firstglance.jmol.org/fg.htm?mol5JQ3" target="_blank">5JQ3</a>) was then added to generate a starting model used for refinement. The starting model was fit into the cryo-EM map using UCSF Chimera (<span class="dropBlock reference-citations"><a id="body-ref-sref62-3" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-3" aria-controls="sref62-3">Pettersen et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref62-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">65.</div><div>Pettersen, E.F. ∙ Goddard, T.D. ∙ Huang, C.C. ...</div><div><strong>UCSF Chimera--a visualization system for exploratory research and analysis</strong></div><div><em>J.&nbsp;Comput. Chem.</em> 2004; <strong>25</strong>:1605-1612</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/jcc.20084" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-4444221565" target="_blank" aria-label="Open Scopus in new tab">Scopus (33444)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15264254/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fjcc.20084&amp;pmid=15264254" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and refined initially using Phenix real-space refinement (<span class="dropBlock reference-citations"><a id="body-ref-sref52-2" href="#" role="doc-biblioref" data-xml-rid="bib52" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref52-2" aria-controls="sref52-2">Liebschner et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref52-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">54.</div><div>Liebschner, D. ∙ Afonine, P.V. ∙ Baker, M.L. ...</div><div><strong>Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix</strong></div><div><em>Acta Crystallogr. D Struct. Biol.</em> 2019; <strong>75</strong>:861-877</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S2059798319011471" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85072914312" target="_blank" aria-label="Open Scopus in new tab">Scopus (3348)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31588918/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS2059798319011471&amp;pmid=31588918" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The refined model was then used as a starting model for relaxed refinement in Rosetta (<span class="dropBlock reference-citations"><a id="body-ref-sref18-2" href="#" role="doc-biblioref" data-xml-rid="bib18" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref18-2" aria-controls="sref18-2">DiMaio et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref18-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">18.</div><div>DiMaio, F. ∙ Song, Y. ∙ Li, X. ...</div><div><strong>Atomic-accuracy models from 4.5-Å cryo-electron microscopy data with density-guided iterative local refinement</strong></div><div><em>Nat. Methods.</em> 2015; <strong>12</strong>:361-365</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.3286" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84926520440" target="_blank" aria-label="Open Scopus in new tab">Scopus (238)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25707030/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.3286&amp;pmid=25707030" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The top five models then were evaluated for fit in EM density and adjusted manually using Coot (<span class="dropBlock reference-citations"><a id="body-ref-sref20-2" href="#" role="doc-biblioref" data-xml-rid="bib20" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref20-2" aria-controls="sref20-2">Emsley et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref20-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">20.</div><div>Emsley, P. ∙ Lohkamp, B. ∙ Scott, W.G. ...</div><div><strong>Features and development of Coot</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:486-501</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444910007493" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-77949535720" target="_blank" aria-label="Open Scopus in new tab">Scopus (20200)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20383002/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444910007493&amp;pmid=20383002" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) to maximize fit. Finally, Man9 glycans were fit into glycan densities, trimmed and then a final refinement was performed in Rosetta. The final structures were evaluated using EMRinger (<span class="dropBlock reference-citations"><a id="body-ref-sref2-2" href="#" role="doc-biblioref" data-xml-rid="bib2" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref2-2" aria-controls="sref2-2">Barad et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref2-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Barad, B.A. ∙ Echols, N. ∙ Wang, R.Y. ...</div><div><strong>EMRinger: side chain-directed model and map validation for 3D cryo-electron microscopy</strong></div><div><em>Nat. Methods.</em> 2015; <strong>12</strong>:943-946</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.3541" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84959080555" target="_blank" aria-label="Open Scopus in new tab">Scopus (542)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26280328/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.3541&amp;pmid=26280328" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and Molprobity from Phenix. Glycans were validated using Privateer (<span class="dropBlock reference-citations"><a id="body-ref-sref1" href="#" role="doc-biblioref" data-xml-rid="bib1" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref1" aria-controls="sref1">Agirre et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Agirre, J. ∙ Iglesias-Fernández, J. ∙ Rovira, C. ...</div><div><strong>Privateer: software for the conformational validation of carbohydrate structures</strong></div><div><em>Nat. Struct. Mol. Biol.</em> 2015; <strong>22</strong>:833-834</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nsmb.3115" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84947945686" target="_blank" aria-label="Open Scopus in new tab">Scopus (250)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26581513/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnsmb.3115&amp;pmid=26581513" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and PDBcare (<span class="dropBlock reference-citations"><a id="body-ref-sref53" href="#" role="doc-biblioref" data-xml-rid="bib53" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref53" aria-controls="sref53">Lütteke and von der Lieth, 2004</a><div class="dropBlock__holder" data-db-target-of="sref53"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">56.</div><div>Lütteke, T. ∙ von der Lieth, C.W.</div><div><strong>pdb-care (PDB carbohydrate residue check): a program to support annotation of complex carbohydrate structures in PDB files</strong></div><div><em>BMC Bioinformatics.</em> 2004; <strong>5</strong>:69</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/1471-2105-5-69" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-13244253766" target="_blank" aria-label="Open Scopus in new tab">Scopus (146)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15180909/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2F1471-2105-5-69&amp;pmid=15180909" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). All map and model images were generated in UCSF Chimera (<span class="dropBlock reference-citations"><a id="body-ref-sref62-4" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-4" aria-controls="sref62-4">Pettersen et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref62-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">65.</div><div>Pettersen, E.F. ∙ Goddard, T.D. ∙ Huang, C.C. ...</div><div><strong>UCSF Chimera--a visualization system for exploratory research and analysis</strong></div><div><em>J.&nbsp;Comput. Chem.</em> 2004; <strong>25</strong>:1605-1612</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/jcc.20084" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-4444221565" target="_blank" aria-label="Open Scopus in new tab">Scopus (33444)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15264254/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fjcc.20084&amp;pmid=15264254" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Antibody contacts were analyzed using LigPlot (<span class="dropBlock reference-citations"><a id="body-ref-sref48-2" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48-2" aria-controls="sref48-2">Laskowski and Swindells, 2011</a><div class="dropBlock__holder" data-db-target-of="sref48-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">50.</div><div>Laskowski, R.A. ∙ Swindells, M.B.</div><div><strong>LigPlot+: multiple ligand-protein interaction diagrams for drug discovery</strong></div><div><em>J.&nbsp;Chem. Inf. Model.</em> 2011; <strong>51</strong>:2778-2786</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/ci200227u" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-80054911951" target="_blank" aria-label="Open Scopus in new tab">Scopus (4092)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21919503/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Fci200227u&amp;pmid=21919503" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), Arpeggio (<span class="dropBlock reference-citations"><a id="body-ref-sref42-2" href="#" role="doc-biblioref" data-xml-rid="bib42" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref42-2" aria-controls="sref42-2">Jubb et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref42-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">42.</div><div>Jubb, H.C. ∙ Higueruelo, A.P. ∙ Ochoa-Montaño, B. ...</div><div><strong>Arpeggio: A web server for calculating and visualising interatomic interactions in protein structures</strong></div><div><em>J.&nbsp;Mol. Biol.</em> 2017; <strong>429</strong>:365-371</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jmb.2016.12.004" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85009250602" target="_blank" aria-label="Open Scopus in new tab">Scopus (282)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27964945/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jmb.2016.12.004&amp;pmid=27964945" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and UCSF Chimera (<span class="dropBlock reference-citations"><a id="body-ref-sref62-5" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-5" aria-controls="sref62-5">Pettersen et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref62-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">65.</div><div>Pettersen, E.F. ∙ Goddard, T.D. ∙ Huang, C.C. ...</div><div><strong>UCSF Chimera--a visualization system for exploratory research and analysis</strong></div><div><em>J.&nbsp;Comput. Chem.</em> 2004; <strong>25</strong>:1605-1612</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/jcc.20084" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-4444221565" target="_blank" aria-label="Open Scopus in new tab">Scopus (33444)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15264254/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fjcc.20084&amp;pmid=15264254" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section></section><section id="sec-4-5"><h3>Quantification and statistical analysis</h3><div id="p0300" role="paragraph">The descriptive statistics mean ± SEM or mean ± SD were determined for continuous variables as noted. Survival curves were estimated using the Kaplan-Meier method and overall difference in survival between the groups in mouse studies was estimated using two-sided log rank test (Mantel-Cox) with subjects right censored, if they survived until the end of the study. In NHP studies, survival curves were estimated using the Kaplan-Meier method, and the proportion surviving at day 28 after virus inoculation was compared using a 2-sided exact unconditional test of homogeneity. Curves for antibody binding were fitted after log transformation of antibody concentrations using a four-parameter log-logistic (4PL) analysis. In neutralization assays and GP cleavage inhibition assays, IC<sub>50</sub> values were calculated after log transformation of antibody concentrations using a four-parameter log-logistic (4PL) analysis. Synergy distribution maps were generated from the dose-response binding matrix using an open-source software SynergyFinder 2.0: visual analytics of multi-drug combination synergies (<a id="intref0145" href="https://synergyfinder.fimm.fi" target="_blank">https://synergyfinder.fimm.fi</a>), and data were analyzed using ZIP synergy scoring model (<span class="dropBlock reference-citations"><a id="body-ref-sref39-6" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39-6" aria-controls="sref39-6">Ianevski et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref39-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Ianevski, A. ∙ Giri, A.K. ∙ Aittokallio, T.</div><div><strong>SynergyFinder 2.0: visual analytics of multi-drug combination synergies</strong></div><div><em>Nucleic Acids Res.</em> 2020; <strong>48</strong>:W488-W493</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkaa216" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85086923971" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32246720/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkaa216&amp;pmid=32246720" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Technical and biological replicates are indicated in the figure legends. Statistical analyses were performed using Prism v8.4.3 (GraphPad).</div></section></section><section id="acknowledgments" role="doc-acknowledgments"><h2>Acknowledgments</h2><div id="p0305" role="paragraph">We thank D. Deer for technical assistance with NHP studies. We thank George K. Lewis, Robin Flinko, and Chiara Orlandi for providing target cell line and protocols for RFADCC assay. The Jurkat-EBOV GP cell line was a kind gift from C. Davis and R. Ahmed. This work was supported by NIH (U19 AI109711 to J.E.C. and A.B., U19 AI142785 to J.E.C. and T.W.G., and U19 AI109762 to A.B.W.), HHS (HHSN272201400058C to J.E.C.), and DTRA (HDTRA1-13-1-0034 to J.E.C. and A.B.). J.E.C. is a recipient of the 2019 Future Insight Prize from Merck KGaA, which supported this work with a grant. The project was supported by The Vanderbilt Institute for Clinical and Translational Research (VICTR) funded by the National Center for Advancing Translational Sciences (NCATS) Clinical Translational Science Award (CTSA) Program (5UL1TR002243-03). Work in BSL-4 and ABSL-4 was supported by NIH (5UC7AI094660-07) and by the Animal Resource Center of the Galveston National Laboratory. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.</div><section id="sec-5"><h3>Author contributions</h3><div id="p0310" role="paragraph">P.G., C.D.M., R.W.C., R.H.C., A.B., T.W.G., A.B.W., and J.E.C. planned the studies. P.G., C.D.M., R.W.C., P.A.I., K.H., V.B., K.N.A., J.B.G., N.K., T.A., R.S.N., R.E.S., N.S., S.J.Z., and R.G.B. conducted experiments. P.G., C.D.M., R.W.C., A.B., T.W.G., A.B.W., and J.E.C. interpreted the studies. P.G., C.D.M., and J.E.C. wrote the first draft of the paper. A.B., T.W.G., A.B.W, and J.E.C. obtained funding. All authors reviewed, edited, and approved the paper.</div></section><section id="sec-6"><h3>Declaration of interests</h3><div id="p0315" role="paragraph">J.E.C. has served as a consultant for Eli Lilly, GlaxoSmithKline and Luna Biologics, is a member of the Scientific Advisory Boards of CompuVax and Meissa Vaccines, and is Founder of IDBiologics. The Crowe laboratory at Vanderbilt University Medical Center has received unrelated sponsored research agreements from Takeda Vaccines, IDBiologics, and AstraZeneca. Vanderbilt University has applied for patents concerning ebolavirus antibodies that are related to this work. All other authors declare no competing interests.</div></section></section><section id="supplementary-material" data-type="supplementary-materials"><h2>Supplemental information (1)</h2><div id="p0325" role="paragraph"><div id="mmc1" class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="/cms/10.1016/j.cell.2021.09.035/attachment/7bbea07a-109a-419f-bbe4-c33f97512cd1/mmc1.pdf" download="mmc1.pdf" aria-labelledby="mmc1-heading mmc1-link"><span id="mmc1-link">PDF (207.22 KB)</span></a></div><div class="core-description"><div id="mmc1-heading" class="heading">Document S1. Tables S1–S7</div></div></div></div></section></div></section><div class="core-linked-content">
    

        

</div><section id="backmatter" data-extent="backmatter"><div class="core-container"><section id="data-availability" class="core-data-availability"><h2>Data and code availability</h2><div id="p0030" role="paragraph">The EBOV GP ΔMuc ΔTM (Makona)−rEBOV-515−rEBOV-442 Fab cryo-EM structure has been deposited in the PDB with accession code 7M8L. The accession number for the cryo-EM reconstruction reported in this paper have been deposited to the Electron Microscopy Data Bank under accession code EMD-23719 (see <a id="crosref0195" href="#sec-4-1">Key Resources Table</a> for details). All data needed to evaluate the conclusions in the paper are present in the paper or the Supplemental information; source data for each of the display items is provided in <a id="crosref0200" href="#sec-4-1">Key Resources Table</a>.</div></section><section id="references"><h2>References</h2><div id="bibliography" role="doc-bibliography"><div role="list"><div role="listitem" data-has="label"><div id="bib1" class="citations"><div id="sref1" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref1" title="View in article">1.</a></div><div>Agirre, J. ∙ Iglesias-Fernández, J. ∙ Rovira, C. ...</div><div><strong>Privateer: software for the conformational validation of carbohydrate structures</strong></div><div><em>Nat. Struct. Mol. Biol.</em> 2015; <strong>22</strong>:833-834</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nsmb.3115" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84947945686" target="_blank" aria-label="Open Scopus in new tab">Scopus (250)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26581513/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnsmb.3115&amp;pmid=26581513" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib2" class="citations"><div id="sref2" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref2-1" title="View in article">2.</a></div><div>Barad, B.A. ∙ Echols, N. ∙ Wang, R.Y. ...</div><div><strong>EMRinger: side chain-directed model and map validation for 3D cryo-electron microscopy</strong></div><div><em>Nat. Methods.</em> 2015; <strong>12</strong>:943-946</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.3541" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84959080555" target="_blank" aria-label="Open Scopus in new tab">Scopus (542)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26280328/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.3541&amp;pmid=26280328" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib3" class="citations"><div id="sref3" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref3" title="View in article">3.</a></div><div>Baum, A. ∙ Fulton, B.O. ∙ Wloga, E. ...</div><div><strong>Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies</strong></div><div><em>Science.</em> 2020; <strong>369</strong>:1014-1018</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.abd0831" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85087939157" target="_blank" aria-label="Open Scopus in new tab">Scopus (904)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32540904/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.abd0831&amp;pmid=32540904" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib4" class="citations"><div id="sref4" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref4" title="View in article">4.</a></div><div>Bennett, R.S. ∙ Huzella, L.M. ∙ Jahrling, P.B. ...</div><div><strong>Nonhuman primate models of Ebola virus disease</strong></div><div><em>Curr. Top. Microbiol. Immunol.</em> 2017; <strong>411</strong>:171-193</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28643203/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=28643203" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib5" class="citations"><div id="sref5" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref5-1" title="View in article">5.</a></div><div>Biasini, M. ∙ Bienert, S. ∙ Waterhouse, A. ...</div><div><strong>SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information</strong></div><div><em>Nucleic Acids Res.</em> 2014; <strong>42</strong>:W252-8</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gku340" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84904815625" target="_blank" aria-label="Open Scopus in new tab">Scopus (3931)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24782522/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgku340&amp;pmid=24782522" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib6" class="citations"><div id="sref6" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref6" title="View in article">6.</a></div><div>Bornholdt, Z.A. ∙ Ndungo, E. ∙ Fusco, M.L. ...</div><div><strong>Host-primed Ebola virus GP exposes a hydrophobic NPC1 receptor-binding pocket, revealing a target for broadly neutralizing antibodies</strong></div><div><em>MBio.</em> 2016; <strong>7</strong>:e02154-15</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/mBio.02154-15" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84960154024" target="_blank" aria-label="Open Scopus in new tab">Scopus (79)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26908579/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FmBio.02154-15&amp;pmid=26908579" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib7" class="citations"><div id="sref7" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref7-1" title="View in article">7.</a></div><div>Bornholdt, Z.A. ∙ Herbert, A.S. ∙ Mire, C.E. ...</div><div><strong>A two-antibody pan-ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates</strong></div><div><em>Cell Host Microbe.</em> 2019; <strong>25</strong>:49-58.e5</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2018.12.005&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2018.12.005&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85058702898" target="_blank" aria-label="Open Scopus in new tab">Scopus (73)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30629918/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.chom.2018.12.005&amp;pmid=30629918" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib8" class="citations"><div id="sref8" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref8-1" title="View in article">8.</a></div><div>Bray, M. ∙ Davis, K. ∙ Geisbert, T. ...</div><div><strong>A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever</strong></div><div><em>J.&nbsp;Infect. Dis.</em> 1998; <strong>178</strong>:651-661</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1086/515386" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-0031688699" target="_blank" aria-label="Open Scopus in new tab">Scopus (346)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9728532/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1086%2F515386&amp;pmid=9728532" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib9" class="citations"><div id="sref9" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref9" title="View in article">9.</a></div><div>Brown, J.F. ∙ Dye, J.M. ∙ Tozay, S. ...</div><div><strong>Anti-Ebola virus antibody levels in convalescent plasma and viral load after plasma infusion in patients with Ebola virus disease</strong></div><div><em>J.&nbsp;Infect. Dis.</em> 2018; <strong>218</strong>:555-562</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/infdis/jiy199" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85050790127" target="_blank" aria-label="Open Scopus in new tab">Scopus (32)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29659889/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Finfdis%2Fjiy199&amp;pmid=29659889" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib10" class="citations"><div id="sref10" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref10" title="View in article">10.</a></div><div>Carette, J.E. ∙ Raaben, M. ∙ Wong, A.C. ...</div><div><strong>Ebola virus entry requires the cholesterol transporter Niemann-Pick C1</strong></div><div><em>Nature.</em> 2011; <strong>477</strong>:340-343</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature10348" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-80052851832" target="_blank" aria-label="Open Scopus in new tab">Scopus (1007)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21866103/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature10348&amp;pmid=21866103" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib11" class="citations"><div id="sref11" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref11" title="View in article">11.</a></div><div>Chandran, K. ∙ Sullivan, N.J. ∙ Felbor, U. ...</div><div><strong>Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection</strong></div><div><em>Science.</em> 2005; <strong>308</strong>:1643-1645</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1110656" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-19144365133" target="_blank" aria-label="Open Scopus in new tab">Scopus (709)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15831716/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1110656&amp;pmid=15831716" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib12" class="citations"><div id="sref12" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref12" title="View in article">12.</a></div><div>Chng, J. ∙ Wang, T. ∙ Nian, R. ...</div><div><strong>Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells</strong></div><div><em>MAbs.</em> 2015; <strong>7</strong>:403-412</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1080/19420862.2015.1008351" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84924585125" target="_blank" aria-label="Open Scopus in new tab">Scopus (115)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25621616/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1080%2F19420862.2015.1008351&amp;pmid=25621616" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib13" class="citations"><div id="sref13" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref13" title="View in article">13.</a></div><div>Copin, R. ∙ Baum, A. ∙ Wloga, E. ...</div><div><strong>The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies</strong></div><div><em>Cell.</em> 2021; <strong>184</strong>:3949-3961</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2021.06.002&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2021.06.002&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85109085109" target="_blank" aria-label="Open Scopus in new tab">Scopus (134)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34161776/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2021.06.002&amp;pmid=34161776" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib14" class="citations"><div id="sref14" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref14-1" title="View in article">14.</a></div><div>Corti, D. ∙ Misasi, J. ∙ Mulangu, S. ...</div><div><strong>Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody</strong></div><div><em>Science.</em> 2016; <strong>351</strong>:1339-1342</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aad5224" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84959359636" target="_blank" aria-label="Open Scopus in new tab">Scopus (326)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26917593/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aad5224&amp;pmid=26917593" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib15" class="citations"><div id="sref15" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref15-1" title="View in article">15.</a></div><div>Cross, R.W. ∙ Mire, C.E. ∙ Borisevich, V. ...</div><div><strong>The Domestic Ferret (Mustela putorius furo) as a lethal infection model for 3 species of ebolavirus</strong></div><div><em>J.&nbsp;Infect. Dis.</em> 2016; <strong>214</strong>:565-569</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/infdis/jiw209" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84988962295" target="_blank" aria-label="Open Scopus in new tab">Scopus (74)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27354371/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Finfdis%2Fjiw209&amp;pmid=27354371" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib16" class="citations"><div id="sref16" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref16-1" title="View in article">16.</a></div><div>Davis, C.W. ∙ Jackson, K.J.L. ∙ McElroy, A.K. ...</div><div><strong>Longitudinal analysis of the human B cell response to Ebola virus infection</strong></div><div><em>Cell.</em> 2019; <strong>177</strong>:1566-1582</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2019.04.036&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2019.04.036&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85065804877" target="_blank" aria-label="Open Scopus in new tab">Scopus (114)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31104840/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2019.04.036&amp;pmid=31104840" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib17" class="citations"><div id="sref17" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref17" title="View in article">17.</a></div><div>Diallo, B. ∙ Sissoko, D. ∙ Loman, N.J. ...</div><div><strong>Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500&nbsp;days</strong></div><div><em>Clin. Infect. Dis.</em> 2016; <strong>63</strong>:1353-1356</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/cid/ciw601" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84994399203" target="_blank" aria-label="Open Scopus in new tab">Scopus (177)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27585800/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fcid%2Fciw601&amp;pmid=27585800" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib18" class="citations"><div id="sref18" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref18-1" title="View in article">18.</a></div><div>DiMaio, F. ∙ Song, Y. ∙ Li, X. ...</div><div><strong>Atomic-accuracy models from 4.5-Å cryo-electron microscopy data with density-guided iterative local refinement</strong></div><div><em>Nat. Methods.</em> 2015; <strong>12</strong>:361-365</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.3286" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84926520440" target="_blank" aria-label="Open Scopus in new tab">Scopus (238)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25707030/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.3286&amp;pmid=25707030" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib19" class="citations"><div id="sref19" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref19-1" title="View in article">19.</a></div><div>Domi, A. ∙ Feldmann, F. ∙ Basu, R. ...</div><div><strong>A single dose of modified Vaccinia Ankara expressing Ebola virus like particles protects nonhuman primates from lethal Ebola virus challenge</strong></div><div><em>Sci. Rep.</em> 2018; <strong>8</strong>:864</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41598-017-19041-y" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85040942560" target="_blank" aria-label="Open Scopus in new tab">Scopus (39)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29339750/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41598-017-19041-y&amp;pmid=29339750" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib20" class="citations"><div id="sref20" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref20-1" title="View in article">20.</a></div><div>Emsley, P. ∙ Lohkamp, B. ∙ Scott, W.G. ...</div><div><strong>Features and development of Coot</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:486-501</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444910007493" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-77949535720" target="_blank" aria-label="Open Scopus in new tab">Scopus (20200)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20383002/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444910007493&amp;pmid=20383002" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib21" class="citations"><div id="sref21" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref21" title="View in article">21.</a></div><div>Feldmann, H. ∙ Sprecher, A. ∙ Geisbert, T.W.</div><div><strong>Ebola</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2020; <strong>382</strong>:1832-1842</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMra1901594" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85084681815" target="_blank" aria-label="Open Scopus in new tab">Scopus (121)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32441897/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMra1901594&amp;pmid=32441897" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib22" class="citations"><div id="sref22" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref22-1" title="View in article">22.</a></div><div>Fibriansah, G. ∙ Ibarra, K.D. ∙ Ng, T.S. ...</div><div><strong>DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers</strong></div><div><em>Science.</em> 2015; <strong>349</strong>:88-91</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaa8651" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84935097021" target="_blank" aria-label="Open Scopus in new tab">Scopus (185)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26138979/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaa8651&amp;pmid=26138979" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib23" class="citations"><div id="sref23" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref23" title="View in article">23.</a></div><div>Flyak, A.I. ∙ Shen, X. ∙ Murin, C.D. ...</div><div><strong>Cross-reactive and potent neutralizing antibody responses in human survivors of natural ebolavirus infection</strong></div><div><em>Cell.</em> 2016; <strong>164</strong>:392-405</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2015.12.022&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2015.12.022&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84955572428" target="_blank" aria-label="Open Scopus in new tab">Scopus (148)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26806128/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2015.12.022&amp;pmid=26806128" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib24" class="citations"><div id="sref24" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref24" title="View in article">24.</a></div><div>Food and Drug Administration</div><div><strong>FDA Approves First Treatment for Ebola Virus</strong></div><div>2020</div><div><a id="intref0155" href="https://www.fdagov/news-events/press-announcements/fda-approves-first-treatment-ebola-virus" target="_blank">https://www.fdagov/news-events/press-announcements/fda-approves-first-treatment-ebola-virus</a></div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Food+and+Drug+AdministrationFDA+Approves+First+Treatment+for+Ebola+Virus2020https%3A%2F%2Fwww.fdagov%2Fnews-events%2Fpress-announcements%2Ffda-approves-first-treatment-ebola-virus" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib25" class="citations"><div id="sref25" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref25" title="View in article">25.</a></div><div>Food and Drug Administration</div><div><strong>FDA Approves Treatment for Ebola Virus</strong></div><div>2020</div><div><a id="intref0160" href="https://www.fdagov/drugs/drug-safety-and-availability/fda-approves-treatment-ebola-virus" target="_blank">https://www.fdagov/drugs/drug-safety-and-availability/fda-approves-treatment-ebola-virus</a></div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Food+and+Drug+AdministrationFDA+Approves+Treatment+for+Ebola+Virus2020https%3A%2F%2Fwww.fdagov%2Fdrugs%2Fdrug-safety-and-availability%2Ffda-approves-treatment-ebola-virus" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib26" class="citations"><div id="sref26" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref26" title="View in article">26.</a></div><div>Furuyama, W. ∙ Marzi, A. ∙ Nanbo, A. ...</div><div><strong>Discovery of an antibody for pan-ebolavirus therapy</strong></div><div><em>Sci. Rep.</em> 2016; <strong>6</strong>:20514</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/srep20514" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84958078190" target="_blank" aria-label="Open Scopus in new tab">Scopus (78)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26861827/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fsrep20514&amp;pmid=26861827" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib27" class="citations"><div id="sref27" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref27-1" title="View in article">27.</a></div><div>Garbutt, M. ∙ Liebscher, R. ∙ Wahl-Jensen, V. ...</div><div><strong>Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses</strong></div><div><em>J.&nbsp;Virol.</em> 2004; <strong>78</strong>:5458-5465</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.78.10.5458-5465.2004" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-2342455182" target="_blank" aria-label="Open Scopus in new tab">Scopus (313)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15113924/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.78.10.5458-5465.2004&amp;pmid=15113924" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib28" class="citations"><div id="sref28" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref28" title="View in article">28.</a></div><div>Gaudinski, M.R. ∙ Coates, E.E. ∙ Novik, L. ..., VRC 608 Study team</div><div><strong>Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study</strong></div><div><em>Lancet.</em> 2019; <strong>393</strong>:889-898</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2FS0140-6736%2819%2930036-4&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2FS0140-6736%2819%2930036-4&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85061347966" target="_blank" aria-label="Open Scopus in new tab">Scopus (88)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30686586/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0140-6736%2819%2930036-4&amp;pmid=30686586" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib29" class="citations"><div id="sref29" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref29-1" title="View in article">29.</a></div><div>Geisbert, T.W. ∙ Daddario-DiCaprio, K.M. ∙ Williams, K.J. ...</div><div><strong>Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates</strong></div><div><em>J.&nbsp;Virol.</em> 2008; <strong>82</strong>:5664-5668</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.00456-08" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-43949115183" target="_blank" aria-label="Open Scopus in new tab">Scopus (140)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18385248/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.00456-08&amp;pmid=18385248" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib30" class="citations"><div id="sref30" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref30" title="View in article">30.</a></div><div>Geisbert, T.W. ∙ Strong, J.E. ∙ Feldmann, H.</div><div><strong>Considerations in the use of nonhuman primate models of Ebola virus and Marburg virus infection</strong></div><div><em>J.&nbsp;Infect. Dis.</em> 2015; <strong>212</strong>:S91-S97</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/infdis/jiv284" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84943270748" target="_blank" aria-label="Open Scopus in new tab">Scopus (113)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26063223/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Finfdis%2Fjiv284&amp;pmid=26063223" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib31" class="citations"><div id="sref31" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref31-1" title="View in article">31.</a></div><div>Gilchuk, P. ∙ Kuzmina, N. ∙ Ilinykh, P.A. ...</div><div><strong>Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the Ebolavirus glycoprotein</strong></div><div><em>Immunity.</em> 2018; <strong>49</strong>:363-374.e10</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2018.06.018&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85053075312" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30029854/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.06.018&amp;pmid=30029854" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib32" class="citations"><div id="sref32" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref32" title="View in article">32.</a></div><div>Gilchuk, P. ∙ Mire, C.E. ∙ Geisbert, J.B. ...</div><div><strong>Efficacy of human monoclonal antibody monotherapy against Bundibugyo virus infection in nonhuman primates</strong></div><div><em>J.&nbsp;Infect. Dis.</em> 2018; <strong>218</strong>:S565-S573</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/infdis/jiy295" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85057209498" target="_blank" aria-label="Open Scopus in new tab">Scopus (12)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29982718/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Finfdis%2Fjiy295&amp;pmid=29982718" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib33" class="citations"><div id="sref33" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref33-1" title="View in article">33.</a></div><div>Gilchuk, P. ∙ Bombardi, R.G. ∙ Erasmus, J.H. ...</div><div><strong>Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics</strong></div><div><em>Nat. Biomed. Eng.</em> 2020; <strong>4</strong>:1030-1043</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41551-020-0594-x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85088873601" target="_blank" aria-label="Open Scopus in new tab">Scopus (35)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32747832/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41551-020-0594-x&amp;pmid=32747832" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib34" class="citations"><div id="sref34" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref34-1" title="View in article">34.</a></div><div>Gilchuk, P. ∙ Murin, C.D. ∙ Milligan, J.C. ...</div><div><strong>Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization</strong></div><div><em>Immunity.</em> 2020; <strong>52</strong>:388-403.e12</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2020.01.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85079145867" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32023489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2020.01.001&amp;pmid=32023489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib35" class="citations"><div id="sref35" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref35" title="View in article">35.</a></div><div>Goldstein, T. ∙ Anthony, S.J. ∙ Gbakima, A. ...</div><div><strong>The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses</strong></div><div><em>Nat. Microbiol.</em> 2018; <strong>3</strong>:1084-1089</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41564-018-0227-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85052954021" target="_blank" aria-label="Open Scopus in new tab">Scopus (254)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30150734/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41564-018-0227-2&amp;pmid=30150734" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib36" class="citations"><div id="sref36" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref36-1" title="View in article">36.</a></div><div>Greaney, A.J. ∙ Starr, T.N. ∙ Gilchuk, P. ...</div><div><strong>Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition</strong></div><div><em>Cell Host Microbe.</em> 2021; <strong>29</strong>:44-57.e9</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2020.11.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2020.11.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85097068093" target="_blank" aria-label="Open Scopus in new tab">Scopus (673)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33259788/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.chom.2020.11.007&amp;pmid=33259788" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib37" class="citations"><div id="sref37" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref37-1" title="View in article">37.</a></div><div>Herbert, A.S. ∙ Froude, J.W. ∙ Ortiz, R.A. ...</div><div><strong>Development of an antibody cocktail for treatment of Sudan virus infection</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2020; <strong>117</strong>:3768-3778</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1914985117" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85079531798" target="_blank" aria-label="Open Scopus in new tab">Scopus (18)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32015126/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1914985117&amp;pmid=32015126" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib38" class="citations"><div id="sref38" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref38" title="View in article">38.</a></div><div>Holtsberg, F.W. ∙ Shulenin, S. ∙ Vu, H. ...</div><div><strong>Pan-ebolavirus and pan-filovirus mouse monoclonal antibodies: protection against Ebola and Sudan viruses</strong></div><div><em>J.&nbsp;Virol.</em> 2015; <strong>90</strong>:266-278</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.02171-15" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_38_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84953862148" target="_blank" aria-label="Open Scopus in new tab">Scopus (88)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26468533/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.02171-15&amp;pmid=26468533" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib39" class="citations"><div id="sref39" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref39-1" title="View in article">39.</a></div><div>Ianevski, A. ∙ Giri, A.K. ∙ Aittokallio, T.</div><div><strong>SynergyFinder 2.0: visual analytics of multi-drug combination synergies</strong></div><div><em>Nucleic Acids Res.</em> 2020; <strong>48</strong>:W488-W493</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkaa216" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85086923971" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32246720/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkaa216&amp;pmid=32246720" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib40" class="citations"><div id="sref40" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref40-1" title="View in article">40.</a></div><div>Ilinykh, P.A. ∙ Shen, X. ∙ Flyak, A.I. ...</div><div><strong>Chimeric filoviruses for identification and characterization of monoclonal antibodies</strong></div><div><em>J.&nbsp;Virol.</em> 2016; <strong>90</strong>:3890-3901</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.00101-16" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84963838685" target="_blank" aria-label="Open Scopus in new tab">Scopus (35)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26819310/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.00101-16&amp;pmid=26819310" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib41" class="citations"><div id="sref41" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref41" title="View in article">41.</a></div><div>Iversen, P.L. ∙ Kane, C.D. ∙ Zeng, X. ...</div><div><strong>Recent successes in therapeutics for Ebola virus disease: no time for complacency</strong></div><div><em>Lancet Infect. Dis.</em> 2020; <strong>20</strong>:e231-e237</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2FS1473-3099%2820%2930282-6&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2FS1473-3099%2820%2930282-6&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85086661359" target="_blank" aria-label="Open Scopus in new tab">Scopus (38)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32563280/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1473-3099%2820%2930282-6&amp;pmid=32563280" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib42" class="citations"><div id="sref42" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref42-1" title="View in article">42.</a></div><div>Jubb, H.C. ∙ Higueruelo, A.P. ∙ Ochoa-Montaño, B. ...</div><div><strong>Arpeggio: A web server for calculating and visualising interatomic interactions in protein structures</strong></div><div><em>J.&nbsp;Mol. Biol.</em> 2017; <strong>429</strong>:365-371</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jmb.2016.12.004" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85009250602" target="_blank" aria-label="Open Scopus in new tab">Scopus (282)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27964945/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jmb.2016.12.004&amp;pmid=27964945" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib43" class="citations"><div id="sref43" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref43" title="View in article">43.</a></div><div>King, L.B. ∙ West, B.R. ∙ Schendel, S.L. ...</div><div><strong>The structural basis for filovirus neutralization by monoclonal antibodies</strong></div><div><em>Curr. Opin. Immunol.</em> 2018; <strong>53</strong>:196-202</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.coi.2018.05.001" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85048825298" target="_blank" aria-label="Open Scopus in new tab">Scopus (14)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29940415/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.coi.2018.05.001&amp;pmid=29940415" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib83" class="citations"><div id="optpM755u5WS5" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-optpM755u5WS5" title="View in article">44.</a></div><div>Keck, Z.Y. ∙ Enterlein, S.G. ∙ Howell, Howell ...</div><div><strong>Macaque monoclonal antibodies targeting novel conserved epitopes within filovirus glycoprotein</strong></div><div><em>J. Virol.</em> 2016; <strong>90</strong>:279-291</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.02172-15" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84953931579" target="_blank" aria-label="Open Scopus in new tab">Scopus (68)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26468532/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.02172-15&amp;pmid=26468532" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib84" class="citations"><div id="optQ5fJzyWWM6" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-optQ5fJzyWWM6-1" title="View in article">45.</a></div><div>Keita, A.K. ∙ Koundouno, F.R. ∙ Faye, M. ...</div><div><strong>Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks</strong></div><div><em>Nature.</em> 2021; <strong>597</strong>:539-543</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-021-03901-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85115265904" target="_blank" aria-label="Open Scopus in new tab">Scopus (99)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34526718/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-021-03901-9&amp;pmid=34526718" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib44" class="citations"><div id="sref44" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref44-1" title="View in article">46.</a></div><div>King, L.B. ∙ Milligan, J.C. ∙ West, B.R. ...</div><div><strong>Achieving cross-reactivity with pan-ebolavirus antibodies</strong></div><div><em>Curr. Opin. Virol.</em> 2019; <strong>34</strong>:140-148</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.coviro.2019.01.003" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85062902126" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30884329/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.coviro.2019.01.003&amp;pmid=30884329" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib45" class="citations"><div id="sref45" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref45" title="View in article">47.</a></div><div>Kugelman, J.R. ∙ Kugelman-Tonos, J. ∙ Ladner, J.T. ...</div><div><strong>Emergence of Ebola virus escape variants in infected nonhuman primates treated with the MB-003 antibody cocktail</strong></div><div><em>Cell Rep.</em> 2015; <strong>12</strong>:2111-2120</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.celrep.2015.08.038&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.celrep.2015.08.038&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84942826507" target="_blank" aria-label="Open Scopus in new tab">Scopus (66)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26365189/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2015.08.038&amp;pmid=26365189" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib46" class="citations"><div id="sref46" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref46" title="View in article">48.</a></div><div>Kuhn, J.H. ∙ Adachi, T. ∙ Adhikari, N.K.J. ...</div><div><strong>New filovirus disease classification and nomenclature</strong></div><div><em>Nat. Rev. Microbiol.</em> 2019; <strong>17</strong>:261-263</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41579-019-0187-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85063786896" target="_blank" aria-label="Open Scopus in new tab">Scopus (72)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30926957/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41579-019-0187-4&amp;pmid=30926957" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib47" class="citations"><div id="sref47" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref47" title="View in article">49.</a></div><div>Kuzmina, N.A. ∙ Younan, P. ∙ Gilchuk, P. ...</div><div><strong>Antibody-dependent enhancement of Ebola virus infection by human antibodies isolated from survivors</strong></div><div><em>Cell Rep.</em> 2018; <strong>24</strong>:1802-1815</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.celrep.2018.07.035&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.celrep.2018.07.035&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85051108967" target="_blank" aria-label="Open Scopus in new tab">Scopus (59)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30110637/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2018.07.035&amp;pmid=30110637" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib48" class="citations"><div id="sref48" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref48-1" title="View in article">50.</a></div><div>Laskowski, R.A. ∙ Swindells, M.B.</div><div><strong>LigPlot+: multiple ligand-protein interaction diagrams for drug discovery</strong></div><div><em>J.&nbsp;Chem. Inf. Model.</em> 2011; <strong>51</strong>:2778-2786</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/ci200227u" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-80054911951" target="_blank" aria-label="Open Scopus in new tab">Scopus (4092)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21919503/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Fci200227u&amp;pmid=21919503" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib49" class="citations"><div id="sref49" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref49" title="View in article">51.</a></div><div>Lee, J.E. ∙ Saphire, E.O.</div><div><strong>Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it</strong></div><div><em>Curr. Opin. Struct. Biol.</em> 2009; <strong>19</strong>:408-417</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.sbi.2009.05.004" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-69249132055" target="_blank" aria-label="Open Scopus in new tab">Scopus (57)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19559599/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.sbi.2009.05.004&amp;pmid=19559599" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib50" class="citations"><div id="sref50" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref50" title="View in article">52.</a></div><div>Lee, J.E. ∙ Fusco, M.L. ∙ Hessell, A.J. ...</div><div><strong>Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor</strong></div><div><em>Nature.</em> 2008; <strong>454</strong>:177-182</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature07082" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-47049107589" target="_blank" aria-label="Open Scopus in new tab">Scopus (577)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18615077/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature07082&amp;pmid=18615077" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib51" class="citations"><div id="sref51" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref51-1" title="View in article">53.</a></div><div>Levine, M.M.</div><div><strong>Monoclonal antibody therapy for Ebola virus disease</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2019; <strong>381</strong>:2365-2366</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMe1915350" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85076446841" target="_blank" aria-label="Open Scopus in new tab">Scopus (48)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31774948/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMe1915350&amp;pmid=31774948" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib52" class="citations"><div id="sref52" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref52-1" title="View in article">54.</a></div><div>Liebschner, D. ∙ Afonine, P.V. ∙ Baker, M.L. ...</div><div><strong>Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix</strong></div><div><em>Acta Crystallogr. D Struct. Biol.</em> 2019; <strong>75</strong>:861-877</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S2059798319011471" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85072914312" target="_blank" aria-label="Open Scopus in new tab">Scopus (3348)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31588918/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS2059798319011471&amp;pmid=31588918" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib85" class="citations"><div id="optIQggpIxCF6" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-optIQggpIxCF6" title="View in article">55.</a></div><div>Lo, M. ∙ Kim, H.S. ∙ Tong, R.K. ...</div><div><strong>Effector-attenuating substitutions that maintain antibody stability and reduce toxicity in mice</strong></div><div><em>J. Biol. Chem.</em> 2017; <strong>292</strong>:3900-3908</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1074%2Fjbc.M116.767749&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1074%2Fjbc.M116.767749&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85014659479" target="_blank" aria-label="Open Scopus in new tab">Scopus (193)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28077575/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M116.767749&amp;pmid=28077575" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib53" class="citations"><div id="sref53" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref53" title="View in article">56.</a></div><div>Lütteke, T. ∙ von der Lieth, C.W.</div><div><strong>pdb-care (PDB carbohydrate residue check): a program to support annotation of complex carbohydrate structures in PDB files</strong></div><div><em>BMC Bioinformatics.</em> 2004; <strong>5</strong>:69</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/1471-2105-5-69" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-13244253766" target="_blank" aria-label="Open Scopus in new tab">Scopus (146)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15180909/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2F1471-2105-5-69&amp;pmid=15180909" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib54" class="citations"><div id="sref54" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref54" title="View in article">57.</a></div><div>Mbala-Kingebeni, P. ∙ Aziza, A. ∙ Di Paola, N. ...</div><div><strong>Medical countermeasures during the 2018 Ebola virus disease outbreak in the North Kivu and Ituri Provinces of the Democratic Republic of the Congo: a rapid genomic assessment</strong></div><div><em>Lancet Infect. Dis.</em> 2019; <strong>19</strong>:648-657</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2FS1473-3099%2819%2930118-5&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2FS1473-3099%2819%2930118-5&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85065874808" target="_blank" aria-label="Open Scopus in new tab">Scopus (58)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31000464/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1473-3099%2819%2930118-5&amp;pmid=31000464" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib55" class="citations"><div id="sref55" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref55-1" title="View in article">58.</a></div><div>Mire, C.E. ∙ Geisbert, J.B. ∙ Marzi, A. ...</div><div><strong>Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus</strong></div><div><em>PLoS Negl. Trop. Dis.</em> 2013; <strong>7</strong>:e2600</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pntd.0002600" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84892698411" target="_blank" aria-label="Open Scopus in new tab">Scopus (78)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24367715/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pntd.0002600&amp;pmid=24367715" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib56" class="citations"><div id="sref56" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref56-1" title="View in article">59.</a></div><div>Misasi, J. ∙ Sullivan, N.J.</div><div><strong>Immunotherapeutic strategies to target vulnerabilities in the Ebolavirus glycoprotein</strong></div><div><em>Immunity.</em> 2021; <strong>54</strong>:412-436</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2021.01.015&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.immuni.2021.01.015&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85102002020" target="_blank" aria-label="Open Scopus in new tab">Scopus (19)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33691133/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2021.01.015&amp;pmid=33691133" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib57" class="citations"><div id="sref57" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref57" title="View in article">60.</a></div><div>Mulangu, S. ∙ Dodd, L.E. ∙ Davey, Jr., R.T. ..., PALM Writing Group, PALM Consortium Study Team</div><div><strong>A randomized, controlled trial of Ebola virus disease therapeutics</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2019; <strong>381</strong>:2293-2303</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1910993" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85076449492" target="_blank" aria-label="Open Scopus in new tab">Scopus (1122)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31774950/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1910993&amp;pmid=31774950" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib58" class="citations"><div id="sref58" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref58-1" title="View in article">61.</a></div><div>Murin, C.D. ∙ Gilchuk, P. ∙ Ilinykh, P.A. ...</div><div><strong>Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies</strong></div><div><em>Cell Rep.</em> 2021; <strong>35</strong>:108984</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.celrep.2021.108984&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.celrep.2021.108984&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85104082939" target="_blank" aria-label="Open Scopus in new tab">Scopus (18)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33852862/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2021.108984&amp;pmid=33852862" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib59" class="citations"><div id="sref59" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref59" title="View in article">62.</a></div><div>Orlandi, C. ∙ Flinko, R. ∙ Lewis, G.K.</div><div><strong>A new cell line for high throughput HIV-specific antibody-dependent cellular cytotoxicity (ADCC) and cell-to-cell virus transmission studies</strong></div><div><em>J.&nbsp;Immunol. Methods.</em> 2016; <strong>433</strong>:51-58</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jim.2016.03.002" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84963628567" target="_blank" aria-label="Open Scopus in new tab">Scopus (34)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26969387/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jim.2016.03.002&amp;pmid=26969387" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib60" class="citations"><div id="sref60" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref60" title="View in article">63.</a></div><div>Oswald, W.B. ∙ Geisbert, T.W. ∙ Davis, K.J. ...</div><div><strong>Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys</strong></div><div><em>PLoS Pathog.</em> 2007; <strong>3</strong>:e9</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.ppat.0030009" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-33846490649" target="_blank" aria-label="Open Scopus in new tab">Scopus (207)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17238286/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.ppat.0030009&amp;pmid=17238286" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib61" class="citations"><div id="sref61" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref61-1" title="View in article">64.</a></div><div>Pascal, K.E. ∙ Dudgeon, D. ∙ Trefry, J.C. ...</div><div><strong>Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in nonhuman primates</strong></div><div><em>J.&nbsp;Infect. Dis.</em> 2018; <strong>218</strong>:S612-S626</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/infdis/jiy285" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85057165662" target="_blank" aria-label="Open Scopus in new tab">Scopus (133)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29860496/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Finfdis%2Fjiy285&amp;pmid=29860496" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib62" class="citations"><div id="sref62" class="citation"><div class="citation-content"><div class="label"><a href="#figs6" title="View in article">65.</a></div><div>Pettersen, E.F. ∙ Goddard, T.D. ∙ Huang, C.C. ...</div><div><strong>UCSF Chimera--a visualization system for exploratory research and analysis</strong></div><div><em>J.&nbsp;Comput. Chem.</em> 2004; <strong>25</strong>:1605-1612</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/jcc.20084" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-4444221565" target="_blank" aria-label="Open Scopus in new tab">Scopus (33444)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15264254/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fjcc.20084&amp;pmid=15264254" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib63" class="citations"><div id="sref63" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref63-1" title="View in article">66.</a></div><div>Punjani, A. ∙ Rubinstein, J.L. ∙ Fleet, D.J. ...</div><div><strong>cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination</strong></div><div><em>Nat. Methods.</em> 2017; <strong>14</strong>:290-296</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.4169" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85011645437" target="_blank" aria-label="Open Scopus in new tab">Scopus (4028)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28165473/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.4169&amp;pmid=28165473" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib64" class="citations"><div id="sref64" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref64-1" title="View in article">67.</a></div><div>Qiu, X. ∙ Wong, G. ∙ Audet, J. ...</div><div><strong>Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp</strong></div><div><em>Nature.</em> 2014; <strong>514</strong>:47-53</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature13777" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84907263545" target="_blank" aria-label="Open Scopus in new tab">Scopus (827)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25171469/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature13777&amp;pmid=25171469" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib86" class="citations"><div id="optt1ET2gZXw9" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-optt1ET2gZXw9" title="View in article">68.</a></div><div>Sanchez, A. ∙ Rollin, P.E.</div><div><strong>Complete genome sequence of an Ebola virus (Sudan species) responsible for a 2000 outbreak of human disease in Uganda</strong></div><div><em>Virus Res.</em> 2005; <strong>113</strong>:16-25</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.virusres.2005.03.028" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-24044509755" target="_blank" aria-label="Open Scopus in new tab">Scopus (44)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16139097/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.virusres.2005.03.028&amp;pmid=16139097" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib65" class="citations"><div id="sref65" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref65" title="View in article">69.</a></div><div>Saphire, E.O. ∙ Schendel, S.L. ∙ Fusco, M.L. ..., Viral Hemorrhagic Fever Immunotherapeutic Consortium</div><div><strong>Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection</strong></div><div><em>Cell.</em> 2018; <strong>174</strong>:938-952.e13</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2018.07.033&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2018.07.033&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85050869127" target="_blank" aria-label="Open Scopus in new tab">Scopus (147)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30096313/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.07.033&amp;pmid=30096313" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib66" class="citations"><div id="sref66" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref66" title="View in article">70.</a></div><div>Sivapalasingam, S. ∙ Kamal, M. ∙ Slim, R. ...</div><div><strong>Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 study</strong></div><div><em>Lancet Infect. Dis.</em> 2018; <strong>18</strong>:884-893</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2FS1473-3099%2818%2930397-9&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2FS1473-3099%2818%2930397-9&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85048770052" target="_blank" aria-label="Open Scopus in new tab">Scopus (68)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29929783/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1473-3099%2818%2930397-9&amp;pmid=29929783" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib67" class="citations"><div id="sref67" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref67" title="View in article">71.</a></div><div>Starr, T.N. ∙ Greaney, A.J. ∙ Dingens, A.S. ...</div><div><strong>Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016</strong></div><div><em>Cell Rep. Med.</em> 2021; <strong>2</strong>:100255</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.xcrm.2021.100255&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.xcrm.2021.100255&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85103959725" target="_blank" aria-label="Open Scopus in new tab">Scopus (307)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33842902/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.xcrm.2021.100255&amp;pmid=33842902" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib68" class="citations"><div id="sref68" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref68" title="View in article">72.</a></div><div>Subtil, F. ∙ Delaunay, C. ∙ Keita, A.K. ..., Postebogui Study Group</div><div><strong>Dynamics of Ebola RNA persistence in semen: a report from the postebogui cohort in Guinea</strong></div><div><em>Clin. Infect. Dis.</em> 2017; <strong>64</strong>:1788-1790</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/cid/cix210" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85021169770" target="_blank" aria-label="Open Scopus in new tab">Scopus (19)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28329169/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fcid%2Fcix210&amp;pmid=28329169" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib69" class="citations"><div id="sref69" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref69-1" title="View in article">73.</a></div><div>Thi, E.P. ∙ Lee, A.C. ∙ Geisbert, J.B. ...</div><div><strong>Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA</strong></div><div><em>Nat. Microbiol.</em> 2016; <strong>1</strong>:16142</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmicrobiol.2016.142" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_73_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84983509313" target="_blank" aria-label="Open Scopus in new tab">Scopus (48)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27670117/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmicrobiol.2016.142&amp;pmid=27670117" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib70" class="citations"><div id="sref70" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref70-1" title="View in article">74.</a></div><div>Towner, J.S. ∙ Paragas, J. ∙ Dover, J.E. ...</div><div><strong>Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening</strong></div><div><em>Virology.</em> 2005; <strong>332</strong>:20-27</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.virol.2004.10.048" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-12344297305" target="_blank" aria-label="Open Scopus in new tab">Scopus (157)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15661137/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.virol.2004.10.048&amp;pmid=15661137" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib71" class="citations"><div id="sref71" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref71-1" title="View in article">75.</a></div><div>Towner, J.S. ∙ Sealy, T.K. ∙ Khristova, M.L. ...</div><div><strong>Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda</strong></div><div><em>PLoS Pathog.</em> 2008; <strong>4</strong>:e1000212</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.ppat.1000212" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_75_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-57149120780" target="_blank" aria-label="Open Scopus in new tab">Scopus (422)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19023410/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.ppat.1000212&amp;pmid=19023410" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib72" class="citations"><div id="sref72" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref72" title="View in article">76.</a></div><div>Varkey, J.B. ∙ Shantha, J.G. ∙ Crozier, I. ...</div><div><strong>Persistence of Ebola virus in ocular fluid during convalescence</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2015; <strong>372</strong>:2423-2427</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1500306" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_76_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84931393635" target="_blank" aria-label="Open Scopus in new tab">Scopus (367)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25950269/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1500306&amp;pmid=25950269" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib74" class="citations"><div id="sref74" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref74" title="View in article">77.</a></div><div>Wang, P. ∙ Nair, M.S. ∙ Liu, L. ...</div><div><strong>Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7</strong></div><div><em>Nature.</em> 2021; <strong>593</strong>:130-135</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-021-03398-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_77_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85102173598" target="_blank" aria-label="Open Scopus in new tab">Scopus (1494)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33684923/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-021-03398-2&amp;pmid=33684923" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib75" class="citations"><div id="sref75" class="citation"><div class="citation-content"><div class="label"><a href="#fig1" title="View in article">78.</a></div><div>Wec, A.Z. ∙ Herbert, A.S. ∙ Murin, C.D. ...</div><div><strong>Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses</strong></div><div><em>Cell.</em> 2017; <strong>169</strong>:878-890.e15</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.037&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.037&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85019578866" target="_blank" aria-label="Open Scopus in new tab">Scopus (127)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28525755/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.04.037&amp;pmid=28525755" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib76" class="citations"><div id="sref76" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref76" title="View in article">79.</a></div><div>Wec, A.Z. ∙ Bornholdt, Z.A. ∙ He, S. ...</div><div><strong>Development of a human antibody cocktail that deploys multiple functions to confer pan-ebolavirus protection</strong></div><div><em>Cell Host Microbe.</em> 2019; <strong>25</strong>:39-48.e5</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2018.12.004&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.chom.2018.12.004&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85058800693" target="_blank" aria-label="Open Scopus in new tab">Scopus (75)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30629917/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.chom.2018.12.004&amp;pmid=30629917" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib77" class="citations"><div id="sref77" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref77-1" title="View in article">80.</a></div><div>West, B.R. ∙ Wec, A.Z. ∙ Moyer, C.L. ...</div><div><strong>Structural basis of broad ebolavirus neutralization by a human survivor antibody</strong></div><div><em>Nat. Struct. Mol. Biol.</em> 2019; <strong>26</strong>:204-212</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41594-019-0191-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85062447650" target="_blank" aria-label="Open Scopus in new tab">Scopus (25)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30833785/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41594-019-0191-4&amp;pmid=30833785" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib78" class="citations"><div id="sref78" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref78-1" title="View in article">81.</a></div><div>World Health Organization</div><div><strong>Ebola virus disease</strong></div><div><a id="intref0170" href="https://www.whoint/en/news-room/fact-sheets/detail/ebola-virus-disease" target="_blank">https://www.whoint/en/news-room/fact-sheets/detail/ebola-virus-disease</a><div>Date: 2021</div></div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=World+Health+OrganizationEbola+virus+diseasehttps%3A%2F%2Fwww.whoint%2Fen%2Fnews-room%2Ffact-sheets%2Fdetail%2Febola-virus-disease2021" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib79" class="citations"><div id="sref79" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref79" title="View in article">82.</a></div><div>Yewdell, J.W. ∙ Webster, R.G. ∙ Gerhard, W.U.</div><div><strong>Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule</strong></div><div><em>Nature.</em> 1979; <strong>279</strong>:246-248</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/279246a0" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-0018346213" target="_blank" aria-label="Open Scopus in new tab">Scopus (133)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/86955/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2F279246a0&amp;pmid=86955" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib88" class="citations"><div id="opt9mqh0D8gRn" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-opt9mqh0D8gRn" title="View in article">83.</a></div><div>Zhang, K.</div><div><strong>Gctf: Real-time CTF determination and correction</strong></div><div><em>J. Struct. Biol.</em> 2016; <strong>193</strong>:1-12</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jsb.2015.11.003" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-84955216953" target="_blank" aria-label="Open Scopus in new tab">Scopus (2386)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26592709/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jsb.2015.11.003&amp;pmid=26592709" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib80" class="citations"><div id="sref80" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref80-1" title="View in article">84.</a></div><div>Zhao, X. ∙ Howell, K.A. ∙ He, S. ...</div><div><strong>Immunization-elicited broadly protective antibody reveals ebolavirus fusion loop as a site of vulnerability</strong></div><div><em>Cell.</em> 2017; <strong>169</strong>:891-904.e15</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.038&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=10.1016%2Fj.cell.2017.04.038&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85019650530" target="_blank" aria-label="Open Scopus in new tab">Scopus (84)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28525756/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.04.038&amp;pmid=28525756" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib81" class="citations"><div id="sref81" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref81-1" title="View in article">85.</a></div><div>Zheng, S.Q. ∙ Palovcak, E. ∙ Armache, J.P. ...</div><div><strong>MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy</strong></div><div><em>Nat. Methods.</em> 2017; <strong>14</strong>:331-332</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.4193" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85014129582" target="_blank" aria-label="Open Scopus in new tab">Scopus (4513)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28250466/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.4193&amp;pmid=28250466" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib82" class="citations"><div id="sref82" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref82-1" title="View in article">86.</a></div><div>Zivanov, J. ∙ Nakane, T. ∙ Forsberg, B.O. ...</div><div><strong>New tools for automated high-resolution cryo-EM structure determination in RELION-3</strong></div><div><em>eLife.</em> 2018; <strong>7</strong>:e42166</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.7554/eLife.42166" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_86_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.09.035&amp;key=2-s2.0-85056950318" target="_blank" aria-label="Open Scopus in new tab">Scopus (2936)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30412051/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.7554%2FeLife.42166&amp;pmid=30412051" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div></div></div></section></div></section><div class="core-linked-content">
    

        


    

            

            

            <div data-widget-id="8633d695-b258-4908-b86f-e2c268ec3c6b" data-widget-name="UX3HTMLWidget"><script type="text/javascript">
if($('.content-navigation__body__title').length){
$('.content-navigation__body__title').each(function(){
var html=this.innerHTML;
var div = document.createElement("div");
div.innerHTML = html;
var text = div.textContent || div.innerText || "";
this.innerHTML=text;
});
}
</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="393effff-5b44-4681-a9b4-4f029b3540b7" data-widget-name="UX3HTMLWidget"><style>
.linkback-ad .pb-ad {
    display: block;
   height: auto;
    margin-left: 0px;
    margin-right: auto;
}
</style></div>

            

        

    

        

</div></div></div><div class="core-collateral-aside"><section id="core-collateral-figures"><h2>Figures (14)<button class="js--openFigureViewer"><span>Figure Viewer</span></button></h2><div class="core-collateral-aside-wrapper"><div class="grid"><a class="figure__open__ctrl" href="#fig1" aria-label="Go to Figure&amp;nbsp;1"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.09.035/asset/ca31aa88-56da-4a9c-9ba6-d4206fdf1f89/main.assets/gr1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs1" aria-label="Go to Figure&amp;nbsp;S1"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.09.035/asset/fea80855-a1e5-42b7-b911-9798f39f96e4/main.assets/figs1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig2" aria-label="Go to Figure&amp;nbsp;2"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.09.035/asset/d21e8b12-1c1e-49ce-a0a0-3abfea485192/main.assets/gr2.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs2" aria-label="Go to Figure&amp;nbsp;S2"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.09.035/asset/693be95a-2e99-4366-ab5a-1bbf47e2027e/main.assets/figs2.jpg" aria-hidden="true"></a></div><div id="collapsible-figures" data-expandable="item"><div class="content grid" style="display:none;" role="region" id="collapsible-figures_content"><a class="figure__open__ctrl" href="#fig3" aria-label="Go to Figure&amp;nbsp;3"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.09.035/asset/ac033353-34a6-413e-b05e-65fee6718bf4/main.assets/gr3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs3" aria-label="Go to Figure&amp;nbsp;S3"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.09.035/asset/9fd8b7ee-a001-49e6-be96-b47bde4801f9/main.assets/figs3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig4" aria-label="Go to Figure&amp;nbsp;4"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.09.035/asset/62ebd4f6-b036-442c-90ac-38d3bd2ab169/main.assets/gr4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig5" aria-label="Go to Figure&amp;nbsp;5"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.09.035/asset/43673864-c203-4ecc-b8ec-a69d03148395/main.assets/gr5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig6" aria-label="Go to Figure&amp;nbsp;6"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.09.035/asset/4abb4c07-3117-4c3a-a5ea-2dcfb3a04c69/main.assets/gr6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs4" aria-label="Go to Figure&amp;nbsp;S4"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.09.035/asset/43ad6f06-9714-4c25-a3ee-d3a99d857437/main.assets/figs4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs5" aria-label="Go to Figure&amp;nbsp;S5"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.09.035/asset/e1e0f2d2-7170-417d-8579-a879254d8c73/main.assets/figs5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig7" aria-label="Go to Figure&amp;nbsp;7"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.09.035/asset/b2864383-60ca-461c-b09e-bdbf8328f987/main.assets/gr7.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs6" aria-label="Go to Figure&amp;nbsp;S6"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.09.035/asset/a52e45f9-3512-479a-88c3-b34aacf19720/main.assets/figs6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs7" aria-label="Go to Figure&amp;nbsp;S7"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.09.035/asset/1fbc3199-ebc7-4694-892f-ed76f780291c/main.assets/figs7.jpg" aria-hidden="true"></a></div><button class="trigger" aria-controls="collapsible-figures_content" aria-expanded="false" tabindex="0" role="button"><span class="expand">Show all figures</span><span class="collapse">Hide figures</span><i class="icon-section_arrow_d" aria-hidden="true"></i></button></div></div></section>
    

        


    

            

            

            <section id="core-collateral-metrics" class="publication-list__axel-section"><h2>Article metrics</h2><div><ul class="publication-list rlist publication-list--list plum-x--lazy-load publication-list--axel" data-plum-x-url="/pb/widgets/ux3/publicationList/plumx?widgetId=66dd7e11-7768-4006-93d8-a72b60e2a264&amp;pbContext=%3Bproduct%3Aproduct%3Aelsevier%5C%3Aproduct%5C%3Acell%3Bwebsite%3Awebsite%3Acell-site%3Bissue%3Aissue%3Apii%5C%3AS0092867420X00237%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3Apii%5C%3AS009286742101165X%3Bjournal%3Ajournal%3Acell%3BpageGroup%3Astring%3AArticle+View%3Bpage%3Astring%3AShow+Full+Text%3BrequestedJournal%3Ajournal%3Acell%3Bwgroup%3Astring%3ADefault+Website+Group%3BsubPage%3Astring%3AFull+Text" data-pb-mode-enabled="false"><li aria-label="loading articles" role="alert" class="js--loading plum-x--spinner hidden"></li></ul></div></section>

            

        
<section id="core-collateral-supplementary"><h2>Supplemental information (1)</h2><div class="core-collateral-aside-wrapper"><div class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2021.09.035/attachment/7bbea07a-109a-419f-bbe4-c33f97512cd1/mmc1.pdf" download="mmc1.pdf"><span id="mmc1-link">PDF (207.22 KB)</span></a><div class="core-description">Document S1. Tables S1–S7</div></div></div></div></section>
    

        


    

            

            

            <section id="core-collateral-relatedArticles" class="axel-related-articles"><h2 id="relatedArticles" class="top axel-related-articles__title" data-title="Related articles">Related Articles</h2><div data-pb-widget-type="ux3-relatedArticles" data-widget-id="8d3844d1-450e-497c-ab75-a63fc41750ac" data-widget-name="AtyponTempUX3RelatedArticlesWidget" data-article-pii="S009286742101165X" class="ux3DeferredOnScrollWidget axel-related-articles__body" data-show-more="true"></div></section>

            

        
</div></div><aside data-core-aside="right-rail"><div class="inner-wrapper">

    

        


    

            

            

            <div data-widget-id="dca7470d-9085-4d21-a6f4-a66397718146" data-widget-name="UX3HTMLWidget"><input type="hidden" id="gptPage" value="cell-videos"></div>

            

        











        <div data-widget-def="literatumAd" data-widget-id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc" class="adplaceholders" style="right: 0px; position: static;">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd alignCenter  widget-verticalAd" id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc">
                
                
                    
                

                <div class="wrapped " id="Marketplace-Recs">
                    
                    <div class="widget-body body body-verticalAd "><div class="verticalAdContainer">
    <div class="verticalAdLabelContainer">
        <div class="verticalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adVert.gif" alt="Advertisement">
        </div>
    </div>
    <div class="verticalAd">
        





        <div class="pb-ad">
            <script src="//cdn.pbgrd.com/core-cell.js" async=""></script>
<div id="pbgrd-skyr-c"><div id="pbgrd-skyr" style="width: inherit; position: relative; background: transparent;"></div></div>
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

        </div>
    

</div></aside><div class="core-authors-details" style="display:none"><section class="core-authors"></section></div></article><div data-extent="article-wrapper"><div class="core-container"></div></div><script id="axel-publication-metadata" type="application/json">{"doi":"10.1016/j.cell.2021.09.035","data-is-retraction":false,"data-is-retired":false}
</script><script type="text/javascript" data-ot-ignore="data-ot-ignore" defer="defer" src="https://static.addtoany.com/menu/page.js" class="optanon-category-C0004 ot-vscat-C0004"></script><template id="figure_nav_template"><a href="#" class="open-in-viewer btn btn-dark figure-pop-btn"><i aria-hidden="true" class="icon-export_citation"></i><span>Open in viewer</span></a></template><div id="figure-viewer" role="dialog" aria-modal="true" aria-label="Figure Viewer" class="showCaption showThumbstrip figure-viewer"><nav class="nav-bar figure-viewer__top"><a href="#" title="Close Figure Viewer" role="button" class="figure-viewer__close"><i aria-hidden="true" class="icon-tools_close"></i></a><div class="figure-viewer__title">Pan-ebolavirus protective therapy by two multifunctional human antibodies</div></nav><div class="frames"><ul class="frames__list"><li><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2021.09.035/asset/ca31aa88-56da-4a9c-9ba6-d4206fdf1f89/main.assets/gr1.jpg" height="700" width="504" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/d591796d-3fce-403c-95b8-7c2e2840e963/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2021.09.035/asset/fea80855-a1e5-42b7-b911-9798f39f96e4/main.assets/figs1.jpg" height="809" width="659" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/c5e27984-00b6-4965-9bda-13e4974e233a/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2021.09.035/asset/d21e8b12-1c1e-49ce-a0a0-3abfea485192/main.assets/gr2.jpg" height="669" width="645" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/9da82d42-7a8f-48ab-a0dd-00ce8988a7ea/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2021.09.035/asset/693be95a-2e99-4366-ab5a-1bbf47e2027e/main.assets/figs2.jpg" height="918" width="659" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/f28f6465-3530-4017-b243-1ff507ee6c08/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2021.09.035/asset/ac033353-34a6-413e-b05e-65fee6718bf4/main.assets/gr3.jpg" height="671" width="504" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/54d9061b-9e40-4f00-8d53-2837b9e45597/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2021.09.035/asset/9fd8b7ee-a001-49e6-be96-b47bde4801f9/main.assets/figs3.jpg" height="859" width="659" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/e1b6a834-cf20-4310-aa58-750d77d1d885/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2021.09.035/asset/62ebd4f6-b036-442c-90ac-38d3bd2ab169/main.assets/gr4.jpg" height="728" width="504" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/640a633d-c920-41c3-aee0-f1a25ebd1677/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2021.09.035/asset/43673864-c203-4ecc-b8ec-a69d03148395/main.assets/gr5.jpg" height="581" width="504" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/3b334738-2b56-4c03-9459-1a2b2f268e5a/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2021.09.035/asset/4abb4c07-3117-4c3a-a5ea-2dcfb3a04c69/main.assets/gr6.jpg" height="653" width="504" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/73f32c9a-52a1-44bc-824e-df3b90020fdd/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2021.09.035/asset/43ad6f06-9714-4c25-a3ee-d3a99d857437/main.assets/figs4.jpg" height="490" width="499" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/7c241b2d-2ab7-4e1e-b1fc-4337e302a87c/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2021.09.035/asset/e1e0f2d2-7170-417d-8579-a879254d8c73/main.assets/figs5.jpg" height="645" width="504" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/9fb66bbc-37d3-42a8-bc70-c425cf124ead/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr7" src="/cms/10.1016/j.cell.2021.09.035/asset/b2864383-60ca-461c-b09e-bdbf8328f987/main.assets/gr7.jpg" height="502" width="659" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/95d350f0-369c-45c9-8795-8da73e54f5fd/main.assets/gr7_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2021.09.035/asset/a52e45f9-3512-479a-88c3-b34aacf19720/main.assets/figs6.jpg" height="620" width="659" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/8a6ef808-257e-47ff-b558-850ca5030a97/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs7" src="/cms/10.1016/j.cell.2021.09.035/asset/1fbc3199-ebc7-4694-892f-ed76f780291c/main.assets/figs7.jpg" height="360" width="658" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/03f64a6a-abdd-4a6c-a3be-6b1fb277d494/main.assets/figs7_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li></ul><a href="#" title="Previous Frame" class="frameButton previousFrameButton frames__prev"><!--span Previous Frame--><i class="icon-arrow_l"></i></a><a href="#" title="Next Frame" class="frameButton nextFrameButton frames__next"><!--span Next Frame--><i class="icon-arrow_r"></i></a></div><div class="caption"><div class="figure-viewer__caption-body"></div></div><div class="toolbar figure-viewer__toolbar"><span class="figure-viewer__counter"></span><a href="#" class="button toggle-caption-button figure-viewer__caption__ctrl"><i aria-hidden="true" class="icon icon-info"></i><span class="label">Hide Caption</span></a><a href="#" class="button download-options-button"><i aria-hidden="true" class="icon icon-gizmo-folder-in download-size-icon"></i><span class="label">Download</span></a><a href="#figures" class="button see-figures figure-viewer__see-figure__ctrl"><i aria-hidden="true" class="icon icon-gizmo-image_figure viewer-size-icon"></i><span class="label">See figure in Article</span></a></div><div class="thumbstrip"><a href="#" class="toggleButton thumbstrip__ctrl"><span>Toggle Thumbstrip</span></a><a href="#" title="Previous Thumbnails" class="thumbstripButton previousThumbstripButton thumbstrip__prev"><i aria-hidden="true" class="icon-arrow_l"></i></a><a href="#" title="Next Thumbnails" class="thumbstripButton nextThumbstripButton thumbstrip__next"><i aria-hidden="true" class="icon-arrow_r"></i></a><div class="thumbstrip__wrapper"><ul class="rlist figure-viewer__thumbslist"><li><div class="thumbnail__label">Figure&nbsp;1</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2021.09.035/asset/ca31aa88-56da-4a9c-9ba6-d4206fdf1f89/main.assets/gr1.jpg" height="700" width="504" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/d591796d-3fce-403c-95b8-7c2e2840e963/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S1</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2021.09.035/asset/fea80855-a1e5-42b7-b911-9798f39f96e4/main.assets/figs1.jpg" height="809" width="659" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/c5e27984-00b6-4965-9bda-13e4974e233a/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;2</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2021.09.035/asset/d21e8b12-1c1e-49ce-a0a0-3abfea485192/main.assets/gr2.jpg" height="669" width="645" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/9da82d42-7a8f-48ab-a0dd-00ce8988a7ea/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S2</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2021.09.035/asset/693be95a-2e99-4366-ab5a-1bbf47e2027e/main.assets/figs2.jpg" height="918" width="659" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/f28f6465-3530-4017-b243-1ff507ee6c08/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;3</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2021.09.035/asset/ac033353-34a6-413e-b05e-65fee6718bf4/main.assets/gr3.jpg" height="671" width="504" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/54d9061b-9e40-4f00-8d53-2837b9e45597/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S3</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2021.09.035/asset/9fd8b7ee-a001-49e6-be96-b47bde4801f9/main.assets/figs3.jpg" height="859" width="659" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/e1b6a834-cf20-4310-aa58-750d77d1d885/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;4</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2021.09.035/asset/62ebd4f6-b036-442c-90ac-38d3bd2ab169/main.assets/gr4.jpg" height="728" width="504" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/640a633d-c920-41c3-aee0-f1a25ebd1677/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;5</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2021.09.035/asset/43673864-c203-4ecc-b8ec-a69d03148395/main.assets/gr5.jpg" height="581" width="504" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/3b334738-2b56-4c03-9459-1a2b2f268e5a/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;6</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2021.09.035/asset/4abb4c07-3117-4c3a-a5ea-2dcfb3a04c69/main.assets/gr6.jpg" height="653" width="504" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/73f32c9a-52a1-44bc-824e-df3b90020fdd/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S4</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2021.09.035/asset/43ad6f06-9714-4c25-a3ee-d3a99d857437/main.assets/figs4.jpg" height="490" width="499" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/7c241b2d-2ab7-4e1e-b1fc-4337e302a87c/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S5</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2021.09.035/asset/e1e0f2d2-7170-417d-8579-a879254d8c73/main.assets/figs5.jpg" height="645" width="504" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/9fb66bbc-37d3-42a8-bc70-c425cf124ead/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;7</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr7" src="/cms/10.1016/j.cell.2021.09.035/asset/b2864383-60ca-461c-b09e-bdbf8328f987/main.assets/gr7.jpg" height="502" width="659" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/95d350f0-369c-45c9-8795-8da73e54f5fd/main.assets/gr7_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S6</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2021.09.035/asset/a52e45f9-3512-479a-88c3-b34aacf19720/main.assets/figs6.jpg" height="620" width="659" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/8a6ef808-257e-47ff-b558-850ca5030a97/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S7</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs7" src="/cms/10.1016/j.cell.2021.09.035/asset/1fbc3199-ebc7-4694-892f-ed76f780291c/main.assets/figs7.jpg" height="360" width="658" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2021.09.035/asset/03f64a6a-abdd-4a6c-a3be-6b1fb277d494/main.assets/figs7_lrg.jpg" loading="lazy" tabindex="0"></div></div></li></ul></div></div><div class="download figure-viewer__download"><div class="pointer"></div><ul class="rlist downlad__wrapper"><li class="hidden-xs hidden-sm"><a href="/action/downloadFigures?pii=e00489&amp;id=" class="downloadAllButton"><i class="icon icon-gizmo-ppt figure-viewer__download__viewer-size-icon figure-viewer__download__viewer-size-icon--ppt"></i><span class="figure-viewer__download__text"> Download .PPT</span></a></li></ul></div></div><template id="toCitationLink" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></a></div></template><template id="toCitationButton" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><button class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></button></div></template><template id="toCitationAccordion" data-collapse-citation="Hide Citations" data-expand-citation="Show Citations" data-collapse-footnote="Hide Footnotes" data-expand-footnote="Show Footnotes"><div class="to-citation__wrapper"><button aria-controls="aria-controls" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="data-expand-title" data-collapsed-title="data-collapsed-title" class="accordion__toggle__title"></span></button><div role="menu" aria-label="links" class="to-citation__accordion no-separator"><ul></ul></div></div></template><template id="toCitationAccordionItem"><li><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span></span></a></li></template><template id="citations_truncate_template"><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--inverse"><span>Show all references</span></button></div></template><template id="collateral_texts_template" data-do="Digital Object" data-figures="Figures" data-metrics="Article Metrics" data-related="Related articles" data-supplementary="Supplemental information"></template><template id="collapsible_authors_template"><button aria-expanded="false" data-expandable="all" data-label-expand="Expand All" data-label-collapse="Collapse All" class="collateral-contributors-control"><span>Expand All</span></button></template>
<template id="collapsible_tables_collapse_template"><div class="collapsible-figure-btn__wrapper expanded"><button aria-expanded="true" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-up"></i><span class="text-uppercase">Collapse</span></button></div></template>
<template id="collapsible_tables_expand_template"><div class="collapsible-figure-btn__wrapper collapsed"><button aria-expanded="false" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-down"></i><span class="text-uppercase">Expand Table</span></button></div></template><template id="authorsAffiliationsLink"><a href="#tab-contributors" class="to-authors-affiliations">Authors Info &amp; Affiliations</a></template></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-  widget-compact-all" id="756cf18d-e910-4468-936c-0225ae7c669f">
                
                
                    
                

                <div class="wrapped " id="ad for nucleus-single-molecule-technologies">
                    
                    <div class="widget-body body body-  body-compact-all"><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(21)01165-X';

if(URL_var.indexOf("S0165-6147(17)30205-5") > -1
|| URL_var.indexOf("S0167-7799(18)30204-X") > -1 
|| URL_var.indexOf("S0092-8674(18)31649-0") > -1 
|| URL_var.indexOf("S0092-8674(19)30404-0") > -1 
|| URL_var.indexOf("S1097-2765(18)30756-1") > -1 
|| URL_var.indexOf("S0092-8674(18)31452-1") > -1 
|| URL_var.indexOf("S1097-2765(19)30175-3") > -1 
|| URL_var.indexOf("S0092-8674(18)30852-3") > -1 
|| URL_var.indexOf("S0006-3495(18)30295-9") > -1 
|| URL_var.indexOf("S1097-2765(19)30063-2") > -1 
|| URL_var.indexOf("S0006-3495(17)33208-3") > -1 
|| URL_var.indexOf("S2211-1247(18)31639-5") > -1 
|| URL_var.indexOf("S1097-2765(18)30978-X") > -1 
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-single-molecule-technologies" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-" id="754b1780-1117-4371-9285-9cd7020963d5">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body- "><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(21)01165-X';

if(URL_var.indexOf("S1535-6108(19)30104-7") > -1
|| URL_var.indexOf("S0092-8674(18)31394-1") > -1
|| URL_var.indexOf("S1074-7613(19)30033-0") > -1
|| URL_var.indexOf("S1535-6108(18)30473-2") > -1
|| URL_var.indexOf("S0092-8674(19)30154-0") > -1
|| URL_var.indexOf("S1550-4131(18)30178-5") > -1
|| URL_var.indexOf("S1535-6108(19)30242-9") > -1
|| URL_var.indexOf("S1074-7613(18)30431-X") > -1
|| URL_var.indexOf("S0092-8674(19)30618-X") > -1
|| URL_var.indexOf("S1535-6108(18)30472-0") > -1
|| URL_var.indexOf("S1535-6108(18)30120-X") > -1
|| URL_var.indexOf("S0092-8674(18)31247-9") > -1
|| URL_var.indexOf("S1074-7613(18)30085-2") > -1
|| URL_var.indexOf("S1074-7613(18)30080-3") > -1
|| URL_var.indexOf("S1471-4906(18)30210-2") > -1
|| URL_var.indexOf("S1550-4131(19)30304-3") > -1
|| URL_var.indexOf("S1934-5909(18)30599-X") > -1
|| URL_var.indexOf("S2405-8033(19)30024-X") > -1
|| URL_var.indexOf("S1535-6108(18)30109-0") > -1
|| URL_var.indexOf("S0962-8924(18)30127-2") > -1
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-tumor-immune-microenvironment" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="9c9ff7a1-a035-49f6-a336-600c9419c518" data-widget-name="UX3HTMLWidget"><!-- Start of HubSpot Embed Code --> 

<script type="text/plain" class="optanon-category-4" id="hs-script-loader" async="" defer="" src="//js.hs-scripts.com/519224.js"></script> 

<!-- End of HubSpot Embed Code --></div>

            

        

    

        


    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget sessionValidationWidget none  widget-none  widget-compact-all" id="0257aef7-6074-4898-a989-1c3f693225a2">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><script>
    $.ajax({
        url: "https://www.cell.com/ssoSessionCheck",
        type: "GET",
        dataType: "jsonp",
        success: function (data) {
            if(data.RefreshSession) {
                location.reload();
            }
        },
        error : function (){
            console.warn("can't validate CSAS session.");
        }
    });
</script></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasSsoUrls none  widget-none  widget-compact-all" id="948bc5c4-8b0d-47be-b5ad-6570559802d1">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><!-- clear SSO URLs after all iFrames are rendered or after passing a time out-->
<script>
    setTimeout(clearSsoUrlsFun,10000);
    var iFramesList = document.getElementById("sso-urls-div").getElementsByTagName("iframe");
    var renderedIFramesCount = 0;
    var numberOfIFrames = iFramesList.length;
    var skipRefresh = false;
    for (var i = 0; i < iFramesList.length; i++) {
        var iFrame = iFramesList[i];
        iFrame.addEventListener("load", function() {
            renderedIFramesCount = renderedIFramesCount + 1;
            if (renderedIFramesCount >= numberOfIFrames)
            {
                clearSsoUrlsFun();
            }
        });
    }

    function clearSsoUrlsFun() {
        if (skipRefresh == false && numberOfIFrames > 0)
        {
            skipRefresh = true;
            $.ajax({
                url: "https://www.cell.com/action/clearSsoUrls",
                type: "GET",
                dataType: "jsonp",
                error : errorCallingAjx
            });
        }
    }

    function errorCallingAjx(){
        console.log("can't delete sso urls .")
    }
</script></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" class="ux3 ">
        
    

        


    

            

            

            <div data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" data-widget-name="ux3-layout-widget" class="fonts-loaded"><div class="footer clearfix">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header widget-horizontalAd" id="a07ee92b-3942-49f8-9186-a2a08fc3fc56">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 4 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="4"></div>
<!-- End AdSlot 4 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="23703bbc-af46-4f3f-a5bb-dd52891ff0ff" data-widget-name="UX3HTMLWidget"><div class="footer__top">
    <div class="footer__logo centered"><a href="/home" title="Cell Press"><!-- Generator: Adobe Illustrator 25.2.1, SVG Export Plug-In . SVG Version: 6.00 Build 0)  -->
<svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 300 72" style="enable-background:new 0 0 300 72;" xml:space="preserve">
<style type="text/css">
	.st0{fill:#007DBC;}
</style>
<g>
	<path class="st0" d="M39.4,7.5c-2.3-0.3-4.4,1.1-4.9,3.3l-1.8,7.4c-0.4,1.8-1.9,3.1-3.8,3.3l-10.5,1.2C7.1,24-1,34.3,0.7,45.6
		c1.3,9,8.6,15.7,17.2,17c2.3,0.3,4.4-1.1,4.9-3.3l1.8-7.4c0.4-1.8,1.9-3.1,3.8-3.3l10.5-1.2c11.3-1.2,19.4-11.6,17.8-22.9
		C55.3,15.4,48.1,8.8,39.4,7.5z M37.1,34l-6.6,0.8c-1.1,0.1-2,0.9-2.3,2l-1.9,8.1c-0.6,2.4-2.5,4.2-5,4.5c-3.8,0.4-7.1-2.4-7.4-6.2
		c-0.3-3.7,2.6-6.8,6.3-7.2l6.6-0.8c1.1-0.1,2-0.9,2.3-2l1.9-8.1c0.6-2.4,2.5-4.2,5-4.5c3.8-0.4,7.1,2.4,7.4,6.2
		C43.7,30.5,40.8,33.6,37.1,34z"></path>
	<rect x="153.1" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M90.2,20.4c7.3,0,8.6,4.8,9.4,7.3h8.8c-0.5-6.2-5.6-14.9-18.2-14.9c-10.9,0-19.4,7.5-19.4,22.3
		c0,14.6,8.1,22.2,19.3,22.2c10.6,0,16.6-6.4,18.4-15.6h-8.8c-1.1,5.2-4.5,7.9-9.4,7.9c-7.5,0-10.5-6.8-10.5-14.4
		C79.7,23.3,85.9,20.4,90.2,20.4z"></path>
	<path class="st0" d="M125.2,24c-13.7,0-15,12.1-15,15.8c0,12.9,6.8,17.1,15.6,17.1c5.4,0,11.6-2.5,13.8-10H131
		c-0.7,2.2-3,3.4-5.3,3.4c-6.6,0-7.1-5.3-7.3-7.7h21.5v-1.5C139.9,27,131.3,24,125.2,24z M118.6,37.4c0.5-4.1,2.5-6.6,6.4-6.6
		c2.6,0,5.9,1.5,6.4,6.6H118.6z"></path>
	<rect x="142" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M174,13.8h-9.8V21h7.2c4.3,0,8.2,0.9,8.2,6.4c0,5.4-3.9,6.4-8.2,6.4h-7.2V41h9.8c10.6,0,14.7-6.7,14.7-13.6
		C188.7,20.5,184.6,13.8,174,13.8z"></path>
	<path class="st0" d="M210.5,24.9c-0.5-0.2-1.2-0.3-1.8-0.3c-4.1,0-8.3,2.7-9.8,6.5h-0.1v-5.7h-8v30.7h8.4V42.3
		c0-5.4,2.1-9.9,8.3-9.9c1,0,2.3,0.1,3,0.3V24.9z"></path>
	<path class="st0" d="M225.6,24.6c-9.3,0-15.7,7-15.7,16.2c0,9.5,6,16.1,15.7,16.1c6.9,0,12-3.1,14.4-10.3h-7.4
		c-0.5,1.9-3.3,4-6.6,4c-4.7,0-7.3-2.4-7.5-7.8h22.1C241.1,33.4,236,24.6,225.6,24.6z M218.4,37.5c0.1-2.4,1.7-6.5,7-6.5
		c4.1,0,5.9,2.3,6.7,6.5H218.4z"></path>
	<path class="st0" d="M260.3,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		C242,54.3,248.9,57,256,57c7,0,14-2.6,14-10.7C270.1,40.6,265.2,38.8,260.3,37.7z"></path>
	<path class="st0" d="M289.8,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		c0.4,8.1,7.3,10.8,14.4,10.8c7,0,14-2.6,14-10.7C299.6,40.6,294.7,38.8,289.8,37.7z"></path>
	<path class="st0" d="M34.1,57.6c0.3-0.2,0.4-0.6,0.4-1c0-0.5-0.2-0.9-0.5-1.1c-0.3-0.2-0.8-0.3-1.4-0.3h-1.9v5.1h0.8V58h0.8
		l1.3,2.2h0.9l-1.4-2.2C33.6,57.9,33.9,57.8,34.1,57.6z M32.5,57.3h-0.9v-1.5h1c0.1,0,0.3,0,0.4,0c0.1,0,0.3,0,0.4,0.1
		c0.1,0,0.2,0.1,0.3,0.2c0.1,0.1,0.1,0.2,0.1,0.4c0,0.2,0,0.3-0.1,0.4c-0.1,0.1-0.2,0.2-0.3,0.2c-0.1,0.1-0.2,0.1-0.4,0.1
		C32.8,57.3,32.6,57.3,32.5,57.3z"></path>
	<path class="st0" d="M35.6,54.2c-0.4-0.4-0.9-0.7-1.4-0.9c-0.5-0.2-1.1-0.3-1.7-0.3c-0.6,0-1.2,0.1-1.7,0.3c-0.6,0.2-1,0.5-1.4,0.9
		c-0.4,0.4-0.7,0.9-1,1.5c-0.2,0.6-0.4,1.2-0.4,1.9c0,0.7,0.1,1.3,0.3,1.8c0.2,0.6,0.5,1,0.9,1.5c0.4,0.4,0.9,0.7,1.4,1
		c0.6,0.2,1.2,0.4,1.8,0.4c0.6,0,1.2-0.1,1.7-0.3c0.5-0.2,1-0.5,1.4-0.9c0.4-0.4,0.7-0.9,1-1.5c0.2-0.6,0.4-1.2,0.4-1.9
		c0-0.7-0.1-1.3-0.4-1.9C36.4,55.1,36,54.6,35.6,54.2z M35.7,59.1c-0.2,0.5-0.4,0.9-0.8,1.2c-0.3,0.3-0.7,0.6-1.1,0.8
		c-0.4,0.2-0.9,0.3-1.4,0.3c-0.6,0-1-0.1-1.5-0.3c-0.4-0.2-0.8-0.5-1.1-0.8c-0.3-0.3-0.5-0.7-0.7-1.2c-0.2-0.5-0.2-1-0.2-1.5
		c0-0.6,0.1-1.1,0.3-1.5c0.2-0.5,0.4-0.9,0.8-1.2c0.3-0.3,0.7-0.6,1.1-0.8c0.4-0.2,0.9-0.3,1.4-0.3c0.5,0,1,0.1,1.4,0.3
		c0.4,0.2,0.8,0.4,1.1,0.8c0.3,0.3,0.6,0.7,0.8,1.2c0.2,0.5,0.3,1,0.3,1.5C36,58.1,35.9,58.6,35.7,59.1z"></path>
</g>
</svg></a></div>
    <div class="footer__social-links">
        <ul class="rlist rlist--inline centered">
            <li><a href="http://on.fb.me/1tgHakh" title="Facebook" target="_blank"><i aria-hidden="true" class="icon-Icon_Facebook"></i></a></li>

            <li><a href="https://www.instagram.com/cellpress/" title="Instagram" target="_blank"><svg width="18px" height="18px" viewBox="0 0 18 18" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-147.000000, -16.000000)" fill-rule="nonzero" fill="#969696"> <g id="Instagram-Logo" transform="translate(147.000000, 16.000000)"> <path d="M9,1.62580645 C11.4096774,1.62580645 11.7,1.62580645 12.6290323,1.68387097 C13.5,1.71290323 13.9935484,1.85806452 14.3129032,2.00322581 C14.7193548,2.17741935 15.0387097,2.3516129 15.3580645,2.67096774 C15.6774194,2.99032258 15.8806452,3.28064516 16.0258065,3.71612903 C16.1419355,4.03548387 16.2870968,4.5 16.3451613,5.4 C16.3741935,6.35806452 16.4032258,6.61935484 16.4032258,9.02903226 C16.4032258,11.4387097 16.4032258,11.7290323 16.3451613,12.6580645 C16.316129,13.5290323 16.1709677,14.0225806 16.0258065,14.3419355 C15.8516129,14.7483871 15.6774194,15.0677419 15.3580645,15.3870968 C15.0387097,15.7064516 14.7483871,15.9096774 14.3129032,16.0548387 C13.9935484,16.1709677 13.5290323,16.316129 12.6290323,16.3741935 C11.6709677,16.4032258 11.4096774,16.4322581 9,16.4322581 C6.59032258,16.4322581 6.3,16.4322581 5.37096774,16.3741935 C4.5,16.3451613 4.00645161,16.2 3.68709677,16.0548387 C3.28064516,15.8806452 2.96129032,15.7064516 2.64193548,15.3870968 C2.32258065,15.0677419 2.11935484,14.7774194 1.97419355,14.3419355 C1.85806452,14.0225806 1.71290323,13.5580645 1.65483871,12.6580645 C1.62580645,11.7 1.62580645,11.4096774 1.62580645,9 C1.62580645,6.59032258 1.62580645,6.3 1.68387097,5.37096774 C1.71290323,4.5 1.85806452,4.00645161 2.00322581,3.68709677 C2.17741935,3.28064516 2.3516129,2.96129032 2.67096774,2.64193548 C2.99032258,2.32258065 3.28064516,2.11935484 3.71612903,1.97419355 C4.03548387,1.85806452 4.5,1.71290323 5.4,1.65483871 C6.3,1.62580645 6.59032258,1.62580645 9,1.62580645 L9,1.62580645 Z M9,0 C6.56129032,0 6.24193548,0 5.28387097,0.0580645161 C4.32580645,0.116129032 3.65806452,0.261290323 3.10645161,0.464516129 C2.52580645,0.696774194 2.00322581,1.01612903 1.50967742,1.50967742 C1.01612903,2.00322581 0.696774194,2.52580645 0.464516129,3.10645161 C0.232258065,3.68709677 0.0870967742,4.32580645 0.0580645161,5.28387097 C0,6.24193548 0,6.56129032 0,9 C0,11.4387097 0,11.7580645 0.0580645161,12.716129 C0.116129032,13.6741935 0.261290323,14.3419355 0.464516129,14.8935484 C0.696774194,15.4741935 1.01612903,15.9967742 1.50967742,16.4903226 C2.00322581,16.983871 2.52580645,17.3032258 3.10645161,17.5354839 C3.68709677,17.7677419 4.32580645,17.9129032 5.28387097,17.9419355 C6.24193548,18 6.56129032,18 9,18 C11.4387097,18 11.7580645,18 12.716129,17.9419355 C13.6741935,17.883871 14.3419355,17.7387097 14.8935484,17.5354839 C15.4741935,17.3032258 15.9967742,16.983871 16.4903226,16.4903226 C16.983871,15.9967742 17.3032258,15.4741935 17.5354839,14.8935484 C17.7677419,14.3129032 17.9129032,13.6741935 17.9419355,12.716129 C18,11.7580645 18,11.4387097 18,9 C18,6.56129032 18,6.24193548 17.9419355,5.28387097 C17.883871,4.32580645 17.7387097,3.65806452 17.5354839,3.10645161 C17.3032258,2.52580645 16.983871,2.00322581 16.4903226,1.50967742 C15.9967742,1.01612903 15.4741935,0.696774194 14.8935484,0.464516129 C14.3129032,0.232258065 13.6741935,0.0870967742 12.716129,0.0580645161 C11.7580645,0 11.4387097,0 9,0 L9,0 Z"></path> <path d="M9,4.38387097 C6.44516129,4.38387097 4.38387097,6.44516129 4.38387097,9 C4.38387097,11.5548387 6.44516129,13.616129 9,13.616129 C11.5548387,13.616129 13.616129,11.5548387 13.616129,9 C13.616129,6.44516129 11.5548387,4.38387097 9,4.38387097 Z M9,11.9903226 C7.34516129,11.9903226 6.00967742,10.6548387 6.00967742,9 C6.00967742,7.34516129 7.34516129,6.00967742 9,6.00967742 C10.6548387,6.00967742 11.9903226,7.34516129 11.9903226,9 C11.9903226,10.6548387 10.6548387,11.9903226 9,11.9903226 Z"></path> <circle id="Oval" cx="13.7903226" cy="4.20967742" r="1.07419355"></circle> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.linkedin.com/company/cell-press/" title="LinkedIn" target="_blank"><i aria-hidden="true" class="icon-linkedin"></i></a></li>
            
                        <li><a href="http://bit.ly/1zq7Q5T" title="Twitter" target="_blank">
                <!--<i aria-hidden="true" class="icon-Icon_Twitter"></i></a>-->
                
                <svg id="xicon" viewBox="0 0 1200 1227" xmlns="http://www.w3.org/2000/svg" aria-hidden="true" role="none"><path fill="#969696" d="M714.163 519.284L1160.89 0H1055.03L667.137 450.887L357.328 0H0L468.492 681.821L0 1226.37H105.866L515.491 750.218L842.672 1226.37H1200L714.137 519.284H714.163ZM569.165 687.828L521.697 619.934L144.011 79.6944H306.615L611.412 515.685L658.88 583.579L1055.08 1150.3H892.476L569.165 687.854V687.828Z"></path></svg> 

                    <style>
                    .footer svg#xicon {
                      height: 16px;
                    }
                    </style>
            </a></li>

            
            <li><a href="/pb-assets/marketing/WeChat/WeChat-1557753222727.jpg" title="WeChat" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-122.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="wechat" transform="translate(122.000000, 17.000000)"> <path d="M12.375,4.5 L12.375,4.5 L12.4875,4.5 L12.4875,4.5 C12.6898579,4.48604473 12.8520408,4.32704187 12.87,4.125 C12.8705905,4.04725572 12.8470025,3.9712499 12.8025,3.9075 C11.94,1.5675 9.4425,0 6.5625,0 C2.9475,0 0,2.52 0,5.625 C0.0313772094,7.34410122 0.895513317,8.94093526 2.3175,9.9075 L1.5675,11.46 C1.49009368,11.6087816 1.52088865,11.7908702 1.64291494,11.9059236 C1.76494122,12.0209769 1.94852501,12.0410168 2.0925,11.955 L4.08,10.8225 C4.61861992,11.0129999 5.17724298,11.1413322 5.745,11.205 C5.86564124,11.2178337 5.98503738,11.1715098 6.06545426,11.0806685 C6.14587113,10.9898272 6.17737153,10.865694 6.15,10.7475 C6.06148727,10.4219419 6.01114891,10.0871918 6,9.75 C6,6.855 8.8575,4.5 12.375,4.5 Z M8.25,3 C8.66421356,3 9,3.33578644 9,3.75 C9,4.16421356 8.66421356,4.5 8.25,4.5 C7.83578644,4.5 7.5,4.16421356 7.5,3.75 C7.5,3.33578644 7.83578644,3 8.25,3 Z M4.5,4.5 C4.08578644,4.5 3.75,4.16421356 3.75,3.75 C3.75,3.33578644 4.08578644,3 4.5,3 C4.91421356,3 5.25,3.33578644 5.25,3.75 C5.25,4.16421356 4.91421356,4.5 4.5,4.5 Z"></path> <path d="M18,9.75 C18,7.2675 15.48,5.25 12.375,5.25 C9.27,5.25 6.75,7.2675 6.75,9.75 C6.75,12.2325 9.27,14.25 12.375,14.25 C12.9568557,14.2502837 13.5364258,14.1772075 14.1,14.0325 L15.96,14.9625 C16.0114248,14.9874074 16.0678613,15.0002339 16.125,15 C16.2497193,14.9993787 16.3659682,14.9367912 16.4351508,14.8330172 C16.5043335,14.7292432 16.5173955,14.5978644 16.47,14.4825 L15.96,13.2075 C17.1784092,12.4716325 17.9450305,11.1723221 18,9.75 L18,9.75 Z M10.5,9 C10.0857864,9 9.75,8.66421356 9.75,8.25 C9.75,7.83578644 10.0857864,7.5 10.5,7.5 C10.9142136,7.5 11.25,7.83578644 11.25,8.25 C11.25,8.66421356 10.9142136,9 10.5,9 Z M14.25,9 C13.8357864,9 13.5,8.66421356 13.5,8.25 C13.5,7.83578644 13.8357864,7.5 14.25,7.5 C14.6642136,7.5 15,7.83578644 15,8.25 C15,8.66421356 14.6642136,9 14.25,9 Z" opacity="0.959999979"></path> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.weibo.com/CellPress" title="Weibo" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-99.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="weibo" transform="translate(99.000000, 14.000000)"> <g transform="translate(0.000000, 3.000000)"> <path d="M13.2402211,7.47054172 C12.9918392,7.39866484 12.821608,7.34902326 12.9514975,7.03290287 C13.232804,6.34602189 13.2622915,5.75359781 12.9571055,5.33095486 C12.3847236,4.5380684 10.8191759,4.58064295 9.02514573,5.30975376 C9.02514573,5.30889193 8.46144724,5.54882627 8.60544724,5.11515185 C8.88150754,4.25435294 8.83953769,3.53386047 8.41043216,3.11759508 C7.43716583,2.17285363 4.84824121,3.15344733 2.62745729,5.3059617 C0.964944724,6.9186238 0,8.62798358 0,10.105855 C0,12.9324952 3.73748744,14.8235294 7.39429146,14.8235294 C12.1877186,14.8235294 15.3768844,11.9501778 15.3768844,9.80576471 C15.3768844,8.50974008 14.2514774,7.77442408 13.2402211,7.47054172 Z M7.40424121,13.5561176 C4.48625126,13.8315595 1.9678794,12.5686293 1.77811055,10.7327524 C1.58870352,8.89773735 3.80098492,7.18579207 6.71861307,6.90948837 C9.63678392,6.63266758 12.1556985,7.89663201 12.3447437,9.73164706 C12.533608,11.5675239 10.3227739,13.2796416 7.40424121,13.5561176 Z M18,5.16875787 C17.9985528,2.31402189 15.5695477,0 12.5728643,0 C12.222995,0 11.9396985,0.270098495 11.9396985,0.603283174 C11.9396985,0.936640219 12.222995,1.20656635 12.5728643,1.20656635 C14.8708945,1.20656635 16.7336683,2.98159781 16.7336683,5.17099863 C16.7336683,5.50435568 17.0173266,5.77428181 17.3668342,5.77428181 C17.7167035,5.77428181 18,5.50435568 18,5.17099863 C18,5.17099863 18,5.1696197 18,5.16875787 Z M15.4841608,5.08016142 C15.1948945,3.73415048 14.0812462,2.67323393 12.6683819,2.39744733 C12.3262915,2.33039672 11.9914372,2.54051163 11.9212462,2.86680164 C11.8506935,3.19309166 12.0712161,3.51179754 12.4133065,3.57919289 C13.3319397,3.75845417 14.0559196,4.44774829 14.2438794,5.32302599 C14.3146131,5.64931601 14.6491055,5.85925855 14.9915578,5.7923803 C15.3338291,5.72498495 15.5541709,5.40627907 15.4841608,5.08016142 Z M5.90761809,8.7069275 C4.7321005,8.9320383 3.93901508,9.87126402 4.1358392,10.8044569 C4.33248241,11.7378222 5.44504523,12.311803 6.62056281,12.0865198 C7.79571859,11.861409 8.58916583,10.922528 8.3921608,9.98899042 C8.19569849,9.0559699 7.08277387,8.48181669 5.90761809,8.7069275 Z"></path> </g> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.youtube.com/user/cellvideoabstracts" title="YouTube" target="_blank"><svg width="18px" height="13px" viewBox="0 0 18 13" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-76.000000, -19.000000)" fill-rule="nonzero" fill="#969696"> <g id="youtube" transform="translate(76.000000, 14.000000)"> <path d="M17.2984219,6.41974219 C16.6486641,5.64735937 15.4490625,5.33232422 13.1580703,5.33232422 L4.84175391,5.33232422 C2.49834375,5.33232422 1.27838672,5.66771484 0.631089844,6.49001953 C0,7.29172266 0,8.47304297 0,10.1080547 L0,13.2243047 C0,16.3917773 0.748792969,18 4.84175391,18 L13.1581055,18 C15.1448555,18 16.2457383,17.7219844 16.9579688,17.040375 C17.688375,16.3413984 18,15.2001211 18,13.2243047 L18,10.1080547 C18,8.38381641 17.951168,7.19553516 17.2984219,6.41974219 Z M11.5560703,12.0963867 L7.77965625,14.0700586 C7.69524609,14.1141797 7.60289062,14.136082 7.51071094,14.136082 C7.40629687,14.136082 7.30212891,14.1079922 7.20987891,14.0521289 C7.03613672,13.9468711 6.93007031,13.7585391 6.93007031,13.5554414 L6.93007031,9.62075391 C6.93007031,9.41800781 7.03585547,9.22985156 7.20924609,9.12452344 C7.38267187,9.01919531 7.59839062,9.01198828 7.77832031,9.10546875 L11.5547344,11.0664141 C11.7468633,11.1661523 11.8675195,11.3645039 11.8678008,11.5809258 C11.8680469,11.7975586 11.747918,11.9961914 11.5560703,12.0963867 Z"></path> </g> </g> </g></svg></a></li>
            
        </ul>
    </div>
</div>

<style>

.ux3 .footer__logo svg {
    max-width: 160px !important;
}

.ux3 .footer__social-links a svg {
    max-width: 26px;
    height: 1.15rem;
    width: auto;
}

.ux3 .footer__social-links a:hover svg path {
    fill: #353535;
}

</style></div>

            

        

    

        


    

            

            
                <div class="footer__bottom text-onDark">
            

            <div data-widget-id="06227714-c621-4651-9879-b0ce5176cccc" data-widget-name="ux3-layout-widget"><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="07e1d276-b4dd-4870-b858-ed74e70d64ef" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Life &amp; medical sciences journals</h2>
		<ul class="rlist clearfix sided">
		<li>
			<a alt="Cell" href="/cell/home">Cell</a>
		</li>
		<li>
			<a alt="Cancer Cell" href="/cancer-cell/home">Cancer Cell</a>
		</li>
		<li>
			<a alt="Cell Chemical Biology" href="/cell-chemical-biology">Cell Chemical Biology</a>
		</li>
		<li>
			<a alt="Cell Genomics" href="/cell-genomics/home">Cell Genomics</a>
		</li>
		<li>
			<a alt="Cell Host and Microbe" href="/cell-host-microbe/home">Cell Host &amp; Microbe</a>
		</li>
		<li>
			<a alt="Cell Metabolism" href="/cell-metabolism/home">Cell Metabolism</a>
		</li>
		<li>
			<a alt="Cell Reports" href="/cell-reports/home">Cell Reports</a>
		</li>
		<li>
			<a alt="Cell Reports Medicine" href="/cell-reports-medicine/home">Cell Reports Medicine</a>
		</li>
		<li>
			<a alt="Cell Stem Cell" href="/cell-stem-cell/home">Cell Stem Cell</a>
		</li>
		<li>
			<a alt="Cell Systems" href="/cell-systems/home">Cell Systems</a>
		</li>
		<li>
			<a alt="Current Biology" href="/current-biology/home">Current Biology</a>
		</li>
		<li>
			<a alt="Developmental Cell" href="/developmental-cell/home">Developmental Cell</a>
		</li>
		<li>
			<a alt="Immunity" href="/immunity/home">Immunity</a>
		</li>
		<li>
			<a alt="Med" href="/med/home">Med</a>
		</li>
		<li>
			<a alt="Molecular Cell" href="/molecular-cell/home">Molecular Cell</a>
		</li>
		<li>
			<a alt="Neuron" href="/neuron/home">Neuron</a>
		</li>
		<li>
			<a alt="Structure" href="/structure/home">Structure</a>
		</li>
		<li>
			<a alt="American Journal of Human Genetics" href="/ajhg/home">American Journal of Human Genetics (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Journal" href="/biophysj/home">Biophysical Journal (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Reports" href="/biophysreports/home">Biophysical Reports (<i>partner</i>)</a>
		</li>	
		<li>
			<a alt="HGG Advances" href="/hgg-advances/home">Human Genetics and Genomics Advances (<i>partner</i>)</a></li>
		<li>
			<a alt="Molecular Plant" href="/molecular-plant/home">Molecular Plant (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy" href="/molecular-therapy-family/molecular-therapy/home">Molecular Therapy (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Methods and Clinical Development" href="/molecular-therapy-family/methods/home">Molecular Therapy Methods &amp; Clinical Development (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Nucleic Acids" href="/molecular-therapy-family/nucleic-acids/home">Molecular Therapy Nucleic Acids (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Oncology" href="/molecular-therapy-family/oncology/home">Molecular Therapy Oncology (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Plant Communications" href="/plant-communications/home">Plant Communications (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Stem Cell Reports" href="/stem-cell-reports/home">Stem Cell Reports (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biochemical Sciences" href="/trends/biochemical-sciences/home">Trends in Biochemical Sciences</a>
		</li>
		<li>
		</li><li>
			<a alt="Trends in Cancer" href="/trends/cancer/home">Trends in Cancer</a>
		</li>
		<li>
			<a alt="Trends in Cell Biology" href="/trends/cell-biology/home">Trends in Cell Biology</a>
		</li>
		<li>
			<a alt="Trends in Ecology and Evolution" href="/trends/ecology-evolution/home">Trends in Ecology &amp; Evolution</a>
		</li>
		<li>
			<a alt="Trends in Endocrinology and Metabolism" href="/trends/endocrinology-metabolism/home">Trends in Endocrinology &amp; Metabolism</a>
		</li>
		<li>
			<a alt="Trends in Genetics" href="/trends/genetics/home">Trends in Genetics</a>
		</li>
		<li>
			<a alt="Trends in Immunology" href="/trends/immunology/home">Trends in Immunology</a>
		</li>
		<li>
			<a alt="Trends in Microbiology" href="/trends/microbiology/home">Trends in Microbiology</a>
		</li>
		<li>
			<a alt="Trends in Molecular Medicine" href="/trends/molecular-medicine/home">Trends in Molecular Medicine</a>
		</li>
		<li>
			<a alt="Trends in Neurosciences" href="/trends/neurosciences/home">Trends in Neurosciences</a>
		</li>
		<li>
			<a alt="Trends in Parasitology" href="/trends/parasitology/home">Trends in Parasitology</a>
		</li>
		<li>
			<a alt="Trends in Pharmacological Sciences" href="/trends/pharmacological-sciences/home">Trends in Pharmacological Sciences</a>
		</li>
		<li>
			<a alt="Trends in Plant Science" href="/trends/plant-science/home">Trends in Plant Science</a>
		</li>
		</ul>
	</div>

	<div class="group">
		<h2 class="group__title">Physical sciences &amp; engineering journals</h2>
		<ul class="rlist clearfix sided">
		  <li><a alt="Cell Biomaterials" href="/cell-biomaterials/home">Cell Biomaterials</a></li>
		  <li>
			<a alt="Cell Reports Physical Science" href="/cell-reports-physical-science/home">Cell Reports Physical Science</a>
		</li>
		<li>
			<a alt="Chem" href="/chem/home">Chem</a>
		</li>
		<li>
			<a alt="Chem Catalysis" href="/chem-catalysis/home">Chem Catalysis</a>
		</li>
		<li>
			<a alt="Device" href="/device/home">Device</a>
		</li>
		<li>
			<a alt="Joule" href="/joule/home">Joule</a>
		</li>
		<li>
			<a alt="Matter" href="/matter/home">Matter</a>
		</li>	
		<li><a alt="Matter" href="/newton/home">Newton</a></li>
		<li>
			<a alt="Trends in Chemistry" href="/trends/chemistry/home">Trends in Chemistry</a>
		</li>			
		</ul>
	</div>

<div class="group">
	<h2 class="group__title">Multidisciplinary journals</h2>
	<ul class="rlist clearfix sided">
	  		<li>
			<a alt="Cell Reports Methods" href="/cell-reports-methods/home">Cell Reports Methods</a>
		</li>
		<li>
			<a alt="Cell Reports Sustainability" href="/cell-reports-sustainability/home">Cell Reports Sustainability</a>
		</li>
		<li>
			<a alt="Heliyon" href="/heliyon/home">Heliyon</a>
		</li>	
		<li>
			<a alt="iScience" href="/iscience/home">iScience</a>
		</li>
		<li>
			<a alt="One Earth" href="/one-earth/home">One Earth</a>
		</li>
		<li>
			<a alt="Patterns" href="/patterns/home">Patterns</a>
		</li>
		<li>
			<a alt="STAR Protocols" href="/star-protocols/home">STAR Protocols</a>
		</li>
		<li>
			<a alt="Nexus" href="/nexus/home">Nexus (<i>partner</i>)</a>
		</li>			
        <li>
			<a alt="The Innovation" href="/the-innovation/home">The Innovation (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biotechnology" href="/trends/biotechnology/home">Trends in Biotechnology</a>
		</li>
		<li>
			<a alt="Trends in Cognitive Sciences" href="/trends/cognitive-sciences/home">Trends in Cognitive Sciences</a>
		</li>
	</ul>
</div>

</div>
</div>

            

        
</div><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="850476de-00cb-4c0d-943c-bf1881da24f9" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="clearfix">
		<div class="group sided">
			<h2 class="group__title">Authors</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Submit article" href="/submit-to-cell-press">Submit article</a>
				</li>
				<li>
					<a alt="Multi-Journal Submission" href="/multi-journal-submission">Multi-Journal Submission</a>
				</li>
				<li>
					<a alt="STAR Methods" href="/star-authors-guide">STAR Methods</a>
				</li>
				<li>
					<a alt="Sneak Peek – Preprints" href="/sneakpeek">Sneak Peek – Preprints</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Reviewers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Reviewers" href="/reviewers">Information for reviewers</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">News &amp; events</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Newsroom" href="/newsroom">Newsroom</a>
				</li>
				<li>
					<a alt="Events" href="/events">Events</a>
				</li>
				<li>
					<a alt="Cell Symposia" href="/symposia">Cell Symposia</a>
				</li>
				<li>
					<a alt="Consortia Hub" href="/consortia">Consortia Hub</a>
				</li>
				<li>
					<a alt="Webinars" href="/webinars">Webinars</a>
				</li>
								<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Multimedia</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Podcast" href="/podcast">Cell Press Podcast</a>
				</li>
				<li>
					<a alt="Cell Press Videos" href="/video">Cell Press Videos</a>
				</li>
				<li>
					<a alt="Color and Comics" href="/comics">Coloring and Comics</a>
				</li>
				<li>
					<a alt="Figure360" href="/video-guidelines">Figure360</a>
				</li>
				<li>
					<a alt="Cell Picture Show" href="/pictureshow">Cell Picture Show</a>
				</li>
				<li>
					<a alt="Research Arc" href="/research-arc">Research Arc</a>
				</li>
			</ul>
		</div>

		<div class="group sided">
			<h2 class="group__title">About</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="About Cell Press" href="/about">About Cell Press</a>
				</li>

				<li>
					<a alt="Open access" href="/open-access">Open access</a>
				</li>
				<li>
					<a alt="COVID Hub" href="/covid-19">COVID Hub</a>
				</li>
				<li>
					<a alt="Sustainability" href="/sustainability">Sustainability hub</a>
				</li>
				<li>
					<a alt="Inclusion and diversity" href="/diversity">Inclusion and diversity</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Contact</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Contact us" href="/contact">Contact us</a>
				</li>
				<li>
					<a alt="Help and Support" href="https://service.elsevier.com/app/overview/cell-press/" target="_blank">Help &amp; Support</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Careers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Careers" href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" target="_blank">Cell Press Careers</a>
				</li>
			</ul>
		</div>
	</div>
</div></div>

            

        
</div><div class="col-sm-4 col-md-2 clearfix">
    

        


    

            

            

            <div data-widget-id="beafac41-1cfc-440b-9b55-74aba4a5612c" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Access</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Subscribe" href="/subscribe">Subscribe</a>
			</li>
			<li>
				<a alt="Claim" href="/activate">Claim</a>
			</li>
			<li>
				<a alt="Read It Now" href="/read-it-now">Read-It-Now</a>
			</li>
			<li>
				<a alt="Recommend to Librarian" href="http://info.cell.com/request-access-to-cell-press-content" target="_blank">Recommend to Librarian</a>
			</li>
			<li>
				<a alt="Publication Alerts" href="/action/showPreferences?menuTab=Alerts">Publication Alerts</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Collections</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Best of Cell Press" href="/bestof">Best of Cell Press</a>
			</li>
			<li>
				<a alt="Cell Press Reviews" href="/reviews">Cell Press Reviews</a>
			</li>
			<li>
				<a alt="Cell Selections" href="/selections">Cell Press Selections</a>
			</li>
			<li>
				<a alt="Nucleus Collections" href="/nucleus">Nucleus Collections</a>
			</li>
			<li>
				<a alt="SnapShots" href="/snapshots">SnapShot Archive</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Information</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="For Advertisters" href="/media-kit">For Advertisers</a>
			</li>
			<li>
				<a alt="For Recruiters" target="_blank" href="/pb-assets/Cell/common/CP-RecruitmentKit-US-2018-LowRes-1712070648.pdf">For Recruiters</a>
			</li>
			<li>
				<a alt="For Librarians" target="_blank" href="https://www.elsevier.com/products/sciencedirect/journals/direct-subscription-journals">For Librarians</a>
			</li>
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms and Conditions</a>
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>
			</li>
		</ul>
	</div>
</div></div>

            

        
</div></div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="779ad11f-7bcd-4a2a-a2cd-8c67b649cbb2" data-widget-name="UX3HTMLWidget"><style>
 
button#cookieBtn {
   text-decoration: none;
   background-color: transparent;
   color: #005789;
   font-weight: bold;
   padding: 0;
   margin: 0;
   font-size: 14px;
}
 
button#cookieBtn:hover {
   text-decoration: underline;
}

</style>
<script>
// HIDE ONETRUST BACKGROUND AFTER USER PRESSES ESCAPE KEY
setTimeout(function(){ 
   $("#onetrust-pc-sdk").on("keydown", function(e) { 
      if (e.keyCode == 27) {  // ESC key
         setTimeout(function(){ 
            $(".onetrust-pc-dark-filter").css("display","none");
         }, 100); 
      }
   });
}, 5000);
</script>

<span class="align-center copy-right">
<hr>
<p align="center"><b>The content on this site is intended for healthcare professionals and researchers across all fields of science.</b></p>
<hr>
<div>
<p>We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the 
      <b><button id="cookieBtn" class="ot-sdk-show-settings" type="button" aria-label="Manage cookie consent preferences">Cookie Settings</button></b> for this site.<br>

All content on this site: Copyright © 2025 Elsevier Inc., its licensors, and contributors. <br>All rights are reserved, including those for text and data mining, AI training, and similar technologies. <br>For all open access content, the relevant licensing terms apply.
</p>
<ul class="rlist--inline">
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms &amp; Conditions</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Help and Support" target="_blank" href="https://service.elsevier.com/app/overview/cell-press/">Help &amp; Support</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Contact" href="/contact">Contact</a>
			</li>
			</ul>
<p>
<a href="https://www.relx.com"><img src="/pb/assets/raw/Health%20Advance/images/relx-1554393210983.png" alt="RELX" rel="nofollow" target="_new"></a></p>
</div>

</span></div>

            

        

    

        


    

            

            

            <div data-widget-id="c5e179c1-156e-41e3-af7f-5e307efa8acf" data-widget-name="UX3HTMLWidget"><style>#brandingRow{
    background-color:#fff;
    padding:7px 26px 7px 30px;
    color:#007DBC;
    font-size:14px;
    clear:both;
    width:100%
}
#brandingRow a{
    text-decoration:none;
    color:#007DBC
}
#brandingRow a:hover{
    text-decoration:underline
}
#brandingRowRight{
    display:inline;
    float:right;
    width:auto;
    padding:0;
    margin:0
}
svg#cp_logo {
  float: none;
  height: 36px;
  width: 36px;
  margin-left: 0px;
  margin-top: 0px;
}

footer hr {
  display: block;
}

@media screen and (max-width: 600px){
    #brandingRow{
        font-size:12px
    }
}
@media screen and (max-width: 750px){
    #brandingRow{
        padding:7px 18px 7px 16px
    }
    svg#cp_logo{
        margin-right:10px
    }
}
@media screen and (max-width: 800px) {
   a#cpIconLnk {
      display: none;
   }
}

.header__wrapper.clearfix .col-xs-6:first-of-type{
    width:55%
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2){
    width:45%
}
@media screen and (min-width: 800px) and (max-width: 1000px){
    .header__wrapper.clearfix .col-xs-6:first-of-type{
        width:75%
    }
    .header__wrapper.clearfix .col-xs-6:nth-of-type(2){
        width:25%
    }
}

</style>

<script>
var partnerx = false;
var overrideEndorsement = "";
var tmpj = $("input[name='journalCode']").attr("value");
	
if (window.location.pathname == "/molecular-therapy-family/home") {
	tmpj = "ymthe";
}
	
var ribbonx = "";
if (tmpj == "ajhg" || tmpj == "bpj" || tmpj == "molp" || tmpj == "xplc" || tmpj == "stemcr" || tmpj == "ymthe" || tmpj == "xhgg" || tmpj == "omtn" || tmpj == "omto" || tmpj == "omtm" || tmpj == "biophysreports" ||  tmpj == "bpr" || tmpj == "xinn" || tmpj == "omton") {
	partnerx = true;
	ribbonx = "<a href='https://www.cell.com' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press partner journal</a>";
} else if (tmpj != "" && tmpj != "undefined" && tmpj != undefined) {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press journal</a>";
} else {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press resource</a>";
}
	
if (window.location.pathname == "/") {
	ribbonx = "";
}
if (overrideEndorsement != "") {
	ribbonx = overrideEndorsement;
}

$(".header__wrapper.clearfix").prepend("<div id='brandingRow'><a href='/' data-aa-name='science that inspires' data-aa-region='cp global header' title='Visit Cell.com'>Science that inspires</a><p id='brandingRowRight'>" + ribbonx + "</p></div>");
	
// handle scrolling effect on article pages
if ($("article").length > 0) {
	var scrollx;
	$(window).scroll(function() {
		scrollx = $(window).scrollTop();
		if (scrollx > 0) { 
			$("#brandingRow").css("display","none"); 
		} else {
			$("#brandingRow").css("display","block");
		}
	});
}

if (window.location.pathname == "/" || partnerx == false) {
               $("<a href='/home' id='cpIconLnk' data-aa-name='cell press logo' data-aa-region='cp global header' title='Cell Press' target='_blank'><svg id='cp_logo' version='1.1' xmlns='http://www.w3.org/2000/svg' xmlns:xlink='http://www.w3.org/1999/xlink' x='0px' y='0px' viewBox='0 0 100 98.1' style='enable-background:new 0 0 100 98.1;' xml:space='preserve' height='100' width='98.1'><path style='fill:#FFFFFF;' d='M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z'/></svg></a>").insertBefore(".header__wrapper.clearfix .journal-logos:eq(0)");
}


</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="1af759b7-9bb6-4413-ada9-51a8333e8fb8" data-widget-name="UX3HTMLWidget"><style>
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-444969 - c#4]*/
    [data-tab-id="changelogTab"] {
        display: none !important;
    }
    
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-518839]*/
    @media (min-width: 769px) {
        .ux3 .quick-search .dropBlock [data-db-target-of],
        .quick-search .dropBlock [data-db-target-of] {
            width: 100vw !important;
        }
    }
</style></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="d7e0813b-a300-497a-ab37-9c3ddaf03e71" data-widget-name="UX3HTMLWidget"><!--
<div class="session-reminder hidden">
    <div class="session-reminder__overlay">
        <div class="session-reminder__dialog">
            <div class="session-reminder__dialog-inner">
                <div class="dialog-header" role="dialog" aria-labelledby="dialog-title" aria-describedby="dialog-desc">
                    <h2 class="dialog-header-title" id="dialog-title">
                        <span>Session Timeout</span>
                        <div class="dialog-timer">(2:00)</div>
                    </h2>
                    <button class="dialog-close" type="button" aria-label="close dialog">
                        <i class="icon-tools_close" aria-hidden="true"></i>
                    </button>
                </div>
                <div class="dialog-body">
                    <p class="dialog-desc" id="dialog-desc">Your session will expire shortly. If you are still working, click the ‘Keep Me Logged In’ button below. If you do not respond within the next minute, you will be automatically logged out.</p>
                    <p class="dialog-expired sr-only" aria-live="polite"></p>
                </div>
                <div class="dialog-footer">
                    <button class="session-reset" type="button">Keep Me Logged In</button>
                </div>
            </div>
        </div>
    </div>
</div>
<a class="sr-only" href="javascript:void(0)" aria-hidden="true"></a>
--></div>

            

        
        </div>
    </div>


































    



















        
        
            
                <script src="/products/marlin/cell/releasedAssets/js/main.bundle-90475670808d5d3eee41.js"></script>
            
        
        
        

    




<script type="text/javascript">
    var pageData =  {"journal":{"specialty":"Cell Press","issn":"0092-8674","name":"Cell"},"page":{"loadTimestamp":"1749591844906","server":"cell","environment":"prod","businessUnit":"ELS:RAP:JBS","noTracking":"","name":"fulltext:html","section":"Cell","language":"en","type":"CP-CA","productName":"JB"},"visitor":{"departmentName":"|ae:ScienceDirect Guests","accessType":"ae:ANON_GUEST|ae:ANON_GUEST","accountId":"ae:838949|ae:228598","accountName":"ae:Cell Guest Account|ae:ScienceDirect Guests","departmentId":"ae:977212|ae:291352","ipAddress":"189.120.74.179","loginStatus":"anonymous","userId":"ae:246228266|ae:12975512"},"content":[{"accessType":"article:free:openarchive","volumeNumber":"184","issueNumber":"22","viewState":"fulltext","format":"MIME-HTML","id":"pii:S009286742101165X","coverDate":"202110","type":"XOCS-JOURNAL:SCOPE-FULL","title":"Panebolavirus protective therapy by two multifunctional human antibodies","status":"S300"}]};
</script>

<script type="text/javascript">
    if(typeof pageDataTracker !== "undefined") {
        pageDataTracker.trackPageLoad();
    }
</script>
<script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'94dc0c3f9d3a4ecb',t:'MTc0OTU5MTg0NC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script><iframe height="1" width="1" style="position: absolute; top: 0px; left: 0px; border: none; visibility: hidden;"></iframe><script defer="" src="https://static.cloudflareinsights.com/beacon.min.js/vcd15cbe7772f49c399c6a5babf22c1241717689176015" integrity="sha512-ZpsOmlRQV6y907TI0dKBHq9Md29nnaEIPlkf84rnaERnq6zvWvPUqr2ft8M1aS28oN72PdrCzSjY4U6VaAw1EQ==" data-cf-beacon="{&quot;rayId&quot;:&quot;94dc0c3f9d3a4ecb&quot;,&quot;serverTiming&quot;:{&quot;name&quot;:{&quot;cfExtPri&quot;:true,&quot;cfEdge&quot;:true,&quot;cfOrigin&quot;:true,&quot;cfL4&quot;:true,&quot;cfSpeedBrain&quot;:true,&quot;cfCacheStatus&quot;:true}},&quot;version&quot;:&quot;2025.5.0&quot;,&quot;token&quot;:&quot;57a02315956f4b2e82817b3dfa99b1a2&quot;}" crossorigin="anonymous"></script>


<div id="addtoany" style="position: static;"><div class="a2a_overlay" id="a2a_overlay"></div><div id="a2a_modal" class="a2a_modal a2a_hide" role="dialog" tabindex="-1" aria-label=""><div class="a2a_modal_body a2a_menu a2a_hide" id="a2a_copy_link"><label for="a2a_copy_link_text" id="a2a_copy_link_icon" class="a2a_svg a2a_s_link a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><title>Copy link</title><path fill="#FFF" d="M7.591 21.177c0-.36.126-.665.377-.917l2.804-2.804a1.235 1.235 0 0 1 .913-.378c.377 0 .7.144.97.43-.026.028-.11.11-.255.25-.144.14-.24.236-.29.29a2.82 2.82 0 0 0-.2.256 1.056 1.056 0 0 0-.177.344 1.43 1.43 0 0 0-.046.37c0 .36.126.666.377.918a1.25 1.25 0 0 0 .918.377c.126.001.251-.015.373-.047.125-.037.242-.096.345-.175.09-.06.176-.127.256-.2.1-.094.196-.19.29-.29.14-.142.223-.23.25-.254.297.28.445.607.445.984 0 .36-.126.664-.377.916l-2.778 2.79a1.242 1.242 0 0 1-.917.364c-.36 0-.665-.118-.917-.35l-1.982-1.97a1.223 1.223 0 0 1-.378-.9l-.001-.004Zm9.477-9.504c0-.36.126-.665.377-.917l2.777-2.79a1.235 1.235 0 0 1 .913-.378c.35 0 .656.12.917.364l1.984 1.968c.254.252.38.553.38.903 0 .36-.126.665-.38.917l-2.802 2.804a1.238 1.238 0 0 1-.916.364c-.377 0-.7-.14-.97-.418.026-.027.11-.11.255-.25a7.5 7.5 0 0 0 .29-.29c.072-.08.139-.166.2-.255.08-.103.14-.22.176-.344.032-.12.048-.245.047-.37 0-.36-.126-.662-.377-.914a1.247 1.247 0 0 0-.917-.377c-.136 0-.26.015-.37.046-.114.03-.23.09-.346.175a3.868 3.868 0 0 0-.256.2c-.054.05-.15.148-.29.29-.14.146-.222.23-.25.258-.294-.278-.442-.606-.442-.983v-.003ZM5.003 21.177c0 1.078.382 1.99 1.146 2.736l1.982 1.968c.745.75 1.658 1.12 2.736 1.12 1.087 0 2.004-.38 2.75-1.143l2.777-2.79c.75-.747 1.12-1.66 1.12-2.737 0-1.106-.392-2.046-1.183-2.818l1.186-1.185c.774.79 1.708 1.186 2.805 1.186 1.078 0 1.995-.376 2.75-1.13l2.803-2.81c.751-.754 1.128-1.671 1.128-2.748 0-1.08-.382-1.993-1.146-2.738L23.875 6.12C23.13 5.372 22.218 5 21.139 5c-1.087 0-2.004.382-2.75 1.146l-2.777 2.79c-.75.747-1.12 1.66-1.12 2.737 0 1.105.392 2.045 1.183 2.817l-1.186 1.186c-.774-.79-1.708-1.186-2.805-1.186-1.078 0-1.995.377-2.75 1.132L6.13 18.426c-.754.755-1.13 1.672-1.13 2.75l.003.001Z"></path></svg></label><input id="a2a_copy_link_text" type="text" title="Copy link" readonly=""><div id="a2a_copy_link_copied">✓</div></div><div class="a2a_modal_body a2a_menu a2a_thanks a2a_hide" id="a2a_thanks"><div class="a2a_localize" data-a2a-localize="inner,ThanksForSharing">Thanks for sharing!</div></div></div><div class="a2a_menu a2a_full a2a_localize" id="a2apage_full" role="dialog" tabindex="-1" aria-label="Share" data-a2a-localize="title,Share"><div class="a2a_full_header"><div id="a2apage_find_container" class="a2a_menu_find_container"><label for="a2apage_find" id="a2apage_find_icon" class="a2a_svg a2a_s_find"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" aria-hidden="true"><title>Find any service</title><path fill="#CCC" d="M19.7 18.2l-4.5-4.5c.7-1.1 1.2-2.3 1.2-3.6 0-3.5-2.8-6.3-6.3-6.3s-6.3 2.8-6.3 6.3 2.8 6.3 6.3 6.3c1.4 0 2.6-.4 3.6-1.2l4.5 4.5c.6.6 1.3.7 1.7.2.5-.4.4-1.1-.2-1.7zm-9.6-3.6c-2.5 0-4.5-2.1-4.5-4.5 0-2.5 2.1-4.5 4.5-4.5 2.5 0 4.5 2.1 4.5 4.5s-2 4.5-4.5 4.5z"></path></svg></label><input id="a2apage_find" class="a2a_menu_find a2a_localize" type="text" autocomplete="off" title="Find any service" data-a2a-localize="title,FindAnyServiceToAddTo"></div></div><div class="a2a_full_services" id="a2apage_full_services" role="presentation"></div><div class="a2a_full_footer"><a href="https://www.addtoany.com" title="Share Buttons" rel="noopener" target="_blank"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span>AddToAny</a></div></div><div id="a2apage_dropdown" class="a2a_menu a2a_mini a2a_localize a2a_hide" tabindex="-1" aria-label="Share" data-a2a-localize="label,Share"><div class="a2a_mini_services" id="a2apage_mini_services"></div><div id="a2apage_cols_container" class="a2a_cols_container"><div class="a2a_col1" id="a2apage_col1"></div><div id="a2apage_2_col1" class="a2a_hide"></div><div class="a2a_clear"></div></div><div class="a2apage_wide a2a_wide"><a href="#addtoany" id="a2apage_show_more_less" class="a2a_more a2a_localize" title="Show all" data-a2a-localize="title,ShowAll"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span><span class="a2a_localize" data-a2a-localize="inner,More">More…</span></a></div></div><div style="height: 1px; width: 1px; position: absolute; z-index: 100000; top: 0px; visibility: hidden;"><iframe id="a2a_sm_ifr" title="AddToAny Utility Frame" aria-hidden="true" src="https://static.addtoany.com/menu/sm.25.html#type=core&amp;event=load" style="height: 1px; width: 1px; border: 0px; left: 0px; top: 0px; position: absolute; z-index: 100000; display: none;"></iframe></div></div><div role="status" aria-live="assertive" aria-relevant="additions" class="ui-helper-hidden-accessible"></div><div id="crossmark-widget" style="display: none;"><div class="crossmark-reset crossmark-overlay"></div><div class="crossmark-reset crossmark-popup"><div class="crossmark-reset crossmark-popup__offset"><div class="crossmark-reset crossmark-popup__inner"><div class="crossmark-reset crossmark-popup__header"><button class="crossmark-reset crossmark-popup__btn-close"><span class="sr-only">__("articleCrossmark.closePopup")</span></button></div><div class="crossmark-reset crossmark-popup__content-wrapper"><iframe class="crossmark-reset crossmark-popup__content" title="Crossmark service - Intentionally blank" aria-hidden="false" tabindex="0" src="https://crossmark.crossref.org/dialog?doi=10.1016%2Fj.cell.2021.09.035&amp;domain=www.cell.com&amp;uri_scheme=https%3A&amp;cm_version=v2.0"></iframe></div></div></div></div></div><div id="onetrust-consent-sdk" data-nosnippet="true"><div class="onetrust-pc-dark-filter ot-fade-in" style="z-index:2147483645;"></div><div id="onetrust-banner-sdk" class="otFlat bottom ot-wo-title ot-buttons-fw" tabindex="0" role="region" aria-label="Cookie banner"><div role="dialog" aria-modal="true" aria-label="Privacy"><div class="ot-sdk-container"><div class="ot-sdk-row"><div id="onetrust-group-container" class="ot-sdk-eight ot-sdk-columns"><div class="banner_logo"></div><div id="onetrust-policy"><div id="onetrust-policy-text">We use cookies that are necessary to make our site work. We may also use additional cookies to analyze, improve, and personalize our content and your digital experience. For more information, see our<a class="ot-cookie-policy-link" href="https://www.elsevier.com/legal/cookienotice" target="_blank" aria-label=", opens in a new tab" rel="noopener">Cookie Policy</a></div></div></div><div id="onetrust-button-group-parent" class="ot-sdk-three ot-sdk-columns"><div id="onetrust-button-group"><button id="onetrust-pc-btn-handler" class="cookie-setting-link">Cookie Settings</button>  <button id="onetrust-accept-btn-handler">Accept all cookies</button></div></div></div></div><!-- Close Button --><div id="onetrust-close-btn-container"></div><!-- Close Button END--></div></div><div id="onetrust-pc-sdk" class="otPcCenter ot-hide ot-fade-in" lang="en" aria-label="Preference center" role="region"><div role="dialog" aria-modal="true" style="height: 100%;" aria-label="Cookie Preference Center"><!-- Close Button --><div class="ot-pc-header"><!-- Logo Tag --><div class="ot-pc-logo" role="img" aria-label="Company Logo"><img alt="Company Logo" src="https://cdn.cookielaw.org/logos/static/ot_company_logo.png"></div></div><!-- Close Button --><div id="ot-pc-content" class="ot-pc-scrollbar"><div class="ot-optout-signal ot-hide"><div class="ot-optout-icon"><svg xmlns="http://www.w3.org/2000/svg"><path class="ot-floating-button__svg-fill" d="M14.588 0l.445.328c1.807 1.303 3.961 2.533 6.461 3.688 2.015.93 4.576 1.746 7.682 2.446 0 14.178-4.73 24.133-14.19 29.864l-.398.236C4.863 30.87 0 20.837 0 6.462c3.107-.7 5.668-1.516 7.682-2.446 2.709-1.251 5.01-2.59 6.906-4.016zm5.87 13.88a.75.75 0 00-.974.159l-5.475 6.625-3.005-2.997-.077-.067a.75.75 0 00-.983 1.13l4.172 4.16 6.525-7.895.06-.083a.75.75 0 00-.16-.973z" fill="#FFF" fill-rule="evenodd"></path></svg></div><span></span></div><h2 id="ot-pc-title">Cookie Preference Center</h2><div id="ot-pc-desc">We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our <a href="https://www.elsevier.com/legal/cookienotice/_nocache" target="_blank">Cookie Policy</a> and the list of <a href="https://support.google.com/admanager/answer/9012903" target="_blank">Google Ad-Tech Vendors</a>.
<br>
<br>
You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer. See the different category headings below to find out more or change your settings.
<br>
</div><button id="accept-recommended-btn-handler">Allow all</button><section class="ot-sdk-row ot-cat-grp"><h3 id="ot-category-title"> Manage Consent Preferences</h3><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="1"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-1" aria-labelledby="ot-header-id-1 ot-status-id-1"></button><!-- Accordion header --><div class="ot-acc-hdr ot-always-active-group"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-1">Strictly Necessary Cookies</h4><div id="ot-status-id-1" class="ot-always-active">Always active</div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-1">These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
<br><br></p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="1">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="3"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-3" aria-labelledby="ot-header-id-3"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-3">Functional Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-3" id="ot-group-id-3" role="switch" class="category-switch-handler" data-optanongroupid="3" aria-labelledby="ot-header-id-3"> <label class="ot-switch" for="ot-group-id-3"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Functional Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-3">These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="3">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="2"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-2" aria-labelledby="ot-header-id-2"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-2">Performance Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-2" id="ot-group-id-2" role="switch" class="category-switch-handler" data-optanongroupid="2" aria-labelledby="ot-header-id-2"> <label class="ot-switch" for="ot-group-id-2"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Performance Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-2">These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="2">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="4"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-4" aria-labelledby="ot-header-id-4"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-4">Targeting Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-4" id="ot-group-id-4" role="switch" class="category-switch-handler" data-optanongroupid="4" aria-labelledby="ot-header-id-4"> <label class="ot-switch" for="ot-group-id-4"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Targeting Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-4">These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. If you do not allow these cookies, you will experience less targeted advertising.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="4">Cookie Details List‎</button></div></div></div><!-- Groups sections starts --><!-- Group section ends --><!-- Accordion Group section starts --><!-- Accordion Group section ends --></section></div><section id="ot-pc-lst" class="ot-hide ot-hosts-ui ot-pc-scrollbar"><div id="ot-pc-hdr"><div id="ot-lst-title"><button class="ot-link-btn back-btn-handler" aria-label="Back"><svg id="ot-back-arw" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 444.531 444.531" xml:space="preserve"><title>Back Button</title><g><path fill="#656565" d="M213.13,222.409L351.88,83.653c7.05-7.043,10.567-15.657,10.567-25.841c0-10.183-3.518-18.793-10.567-25.835
                    l-21.409-21.416C323.432,3.521,314.817,0,304.637,0s-18.791,3.521-25.841,10.561L92.649,196.425
                    c-7.044,7.043-10.566,15.656-10.566,25.841s3.521,18.791,10.566,25.837l186.146,185.864c7.05,7.043,15.66,10.564,25.841,10.564
                    s18.795-3.521,25.834-10.564l21.409-21.412c7.05-7.039,10.567-15.604,10.567-25.697c0-10.085-3.518-18.746-10.567-25.978
                    L213.13,222.409z"></path></g></svg></button><h3>Cookie List</h3></div><div class="ot-lst-subhdr"><div class="ot-search-cntr"><p role="status" class="ot-scrn-rdr"></p><input id="vendor-search-handler" type="text" name="vendor-search-handler" placeholder="Search…" aria-label="Cookie list search"> <svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 -30 110 110" aria-hidden="true"><title>Search Icon</title><path fill="#2e3644" d="M55.146,51.887L41.588,37.786c3.486-4.144,5.396-9.358,5.396-14.786c0-12.682-10.318-23-23-23s-23,10.318-23,23
            s10.318,23,23,23c4.761,0,9.298-1.436,13.177-4.162l13.661,14.208c0.571,0.593,1.339,0.92,2.162,0.92
            c0.779,0,1.518-0.297,2.079-0.837C56.255,54.982,56.293,53.08,55.146,51.887z M23.984,6c9.374,0,17,7.626,17,17s-7.626,17-17,17
            s-17-7.626-17-17S14.61,6,23.984,6z"></path></svg></div><div class="ot-fltr-cntr"><button id="filter-btn-handler" aria-label="Filter" aria-haspopup="true"><svg role="presentation" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 402.577 402.577" xml:space="preserve"><title>Filter Icon</title><g><path fill="#fff" d="M400.858,11.427c-3.241-7.421-8.85-11.132-16.854-11.136H18.564c-7.993,0-13.61,3.715-16.846,11.136
      c-3.234,7.801-1.903,14.467,3.999,19.985l140.757,140.753v138.755c0,4.955,1.809,9.232,5.424,12.854l73.085,73.083
      c3.429,3.614,7.71,5.428,12.851,5.428c2.282,0,4.66-0.479,7.135-1.43c7.426-3.238,11.14-8.851,11.14-16.845V172.166L396.861,31.413
      C402.765,25.895,404.093,19.231,400.858,11.427z"></path></g></svg></button></div><div id="ot-anchor"></div><section id="ot-fltr-modal"><div id="ot-fltr-cnt"><button id="clear-filters-handler">Clear</button><div class="ot-fltr-scrlcnt ot-pc-scrollbar"><div class="ot-fltr-opts" role="list"><div class="ot-fltr-opt" role="listitem"><div class="ot-chkbox"><input id="chkbox-id" type="checkbox" class="category-filter-handler"> <label for="chkbox-id"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div><div class="ot-fltr-btns"><button id="filter-apply-handler">Apply</button> <button id="filter-cancel-handler">Cancel</button></div></div></div></section></div></div><section id="ot-lst-cnt" class="ot-host-cnt ot-pc-scrollbar"><div id="ot-sel-blk"><div class="ot-sel-all"><div class="ot-sel-all-hdr"><span class="ot-consent-hdr">Consent</span> <span class="ot-li-hdr">Leg.Interest</span></div><div class="ot-sel-all-chkbox"><div class="ot-chkbox" id="ot-selall-hostcntr"><input id="select-all-hosts-groups-handler" type="checkbox"> <label for="select-all-hosts-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-vencntr"><input id="select-all-vendor-groups-handler" type="checkbox"> <label for="select-all-vendor-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-licntr"><input id="select-all-vendor-leg-handler" type="checkbox"> <label for="select-all-vendor-leg-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div></div><div class="ot-sdk-row"><div class="ot-sdk-column"><ul id="ot-host-lst"></ul></div></div></section></section><div class="ot-pc-footer ot-pc-scrollbar"><div class="ot-btn-container"> <button class="save-preference-btn-handler onetrust-close-btn-handler">Confirm my choices</button></div><!-- Footer logo --><div class="ot-pc-footer-logo"><a href="https://www.onetrust.com/products/cookie-consent/" target="_blank" rel="noopener noreferrer" aria-label="Powered by OneTrust Opens in a new Tab"><img alt="Powered by Onetrust" src="https://cdn.cookielaw.org/logos/static/powered_by_logo.svg" title="Powered by OneTrust Opens in a new Tab"></a></div></div><!-- Cookie subgroup container --><!-- Vendor list link --><!-- Cookie lost link --><!-- Toggle HTML element --><!-- Checkbox HTML --><!-- plus minus--><!-- Arrow SVG element --><!-- Accordion basic element --><span class="ot-scrn-rdr" aria-atomic="true" aria-live="polite"></span><!-- Vendor Service container and item template --></div><iframe class="ot-text-resize" sandbox="allow-same-origin" title="onetrust-text-resize" style="position: absolute; top: -50000px; width: 100em;" aria-hidden="true"></iframe></div></div></body></html>